DK151338B - METHOD OF ANALOGUE FOR THE PREPARATION OF RACEMIC OR OPTICALLY ACTIVE PENICILLIN OR CEPHALOSPORINES - Google Patents

METHOD OF ANALOGUE FOR THE PREPARATION OF RACEMIC OR OPTICALLY ACTIVE PENICILLIN OR CEPHALOSPORINES Download PDF

Info

Publication number
DK151338B
DK151338B DK201975AA DK201975A DK151338B DK 151338 B DK151338 B DK 151338B DK 201975A A DK201975A A DK 201975AA DK 201975 A DK201975 A DK 201975A DK 151338 B DK151338 B DK 151338B
Authority
DK
Denmark
Prior art keywords
dioxo
acid
group
piperazinocarbonylamino
solution
Prior art date
Application number
DK201975AA
Other languages
Danish (da)
Other versions
DK201975A (en
DK151338C (en
Inventor
Isamu Saikawa
Shuntaro Takano
Chosaku Yoshida
Okuta Takashima
Kaishu Momonoi
Seietsu Kuroda
Miwako Komatsu
Takashi Yasuda
Yutaka Kodama
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5066374A external-priority patent/JPS539238B2/ja
Priority claimed from JP5225474A external-priority patent/JPS539239B2/ja
Priority claimed from JP6078774A external-priority patent/JPS539240B2/ja
Priority claimed from JP9199674A external-priority patent/JPS5123284A/en
Priority claimed from JP10995474A external-priority patent/JPS5139687A/en
Priority claimed from JP14249974A external-priority patent/JPS5170788A/en
Priority claimed from JP50037207A external-priority patent/JPS51113890A/en
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of DK201975A publication Critical patent/DK201975A/en
Priority to DK104979A priority Critical patent/DK149950C/en
Priority to DK95880A priority patent/DK151958C/en
Publication of DK151338B publication Critical patent/DK151338B/en
Publication of DK151338C publication Critical patent/DK151338C/en
Application granted granted Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Description

* * ·\ 151338* * · \ 151338

Opfindelsen angår en analogifremgangsmåde til fremstilling af hidtil ukendte penicilliner eller cephalosporiner med den i krav l's indledning angivne almene formel (I).The invention relates to an analogous process for the preparation of novel penicillins or cephalosporins of the general formula (I) as set forth in claim 1.

De ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser har et bredt antibakterielt spektrum overfor Gram-positive og Gram-negative bakterier, og de er især effektive overfor arterne Pseudomonas aeruginosa, Klebsiella pneumoniae og Proteus. Endvidere har de omhandlede forbindelser høj bestandighed overfor (3-lactamase, som produceres af bakterier, og de har en effektiv an-tibakteriel aktivitet selv overfor kliniske isolater af bakterier, 2 15133; som i klinisk henseende er signifikante. Som følge deraf er de omhandlede forbindelser ganske effektive som terapeutiske midler for mennesker og dyr, som har infektionssygdomme, der skyldes de ovennævnte pathogene mikroorganismer.The compounds of the present invention have a broad antibacterial spectrum against Gram-positive and Gram-negative bacteria, and are particularly effective against the species Pseudomonas aeruginosa, Klebsiella pneumoniae and Proteus. Furthermore, the compounds of the invention have a high resistance to (3-lactamase produced by bacteria) and they have an effective antibacterial activity even against clinical isolates of bacteria, which are clinically significant. compounds quite effective as therapeutic agents for humans and animals having infectious diseases caused by the aforementioned pathogenic microorganisms.

Det er allerede kendt, at 6-aeylaminopenicillansyre og 7-aeylamino cephalosporansyre med en aminogruppe ved α-positionen af acylgrup-pen udviser kraftig antibakteriel aktivitet ikke blot overfor gram-positive bakterier, men også overfor gram-negative bakterier. De beskrevne kendte forbindelser lider dog af den ulempe, at de ikke blot ikke har nogen effektiv antibakteriel aktivitet overfor Pseudomonas aeruginosa, Klebsiella pneumoniae og Proteus arter, son har forårsaget mange klinisk alvorlige infektionssygdomme, men også overfor resistente bakterier, der hyppigt isoleres på mange kliniske hospitaler. De har endvidere tilbøjelighed til at blive hydrolyseret af /3-lactamase, der produceres af mange lægemiddelresistente bakterier.It is already known that 6-aeylaminopenicillanic acid and 7-aeylamino cephalosporanoic acid with an amino group at the α-position of the acyl group exhibit potent antibacterial activity not only against gram-positive bacteria but also against gram-negative bacteria. However, the known compounds described suffer from the disadvantage that they not only have no effective antibacterial activity against Pseudomonas aeruginosa, Klebsiella pneumoniae and Proteus species, which have caused many clinically serious infectious diseases, but also against resistant bacteria that are frequently isolated in many clinical hospitals. Furthermore, they tend to be hydrolyzed by β-lactamase, which is produced by many drug-resistant bacteria.

De ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser udviser et bredt antibakterielt spektrum, de har høj resistens overfor £>-lactamase, der produceres af bakterier, og de er effektive over for kliniske isolater af bakterier.The compounds prepared by the process of the invention exhibit a broad antibacterial spectrum, have high resistance to β-lactamase produced by bacteria, and are effective against clinical isolates of bacteria.

De udmærkede egenskaber hos forbindelserne med den almene formel (I) og ikke-toxiske salte deraf er afledt af den følgende del i molekylet (0) /Ή A-N N — C-NH- 2^ 3 “The excellent properties of the compounds of general formula (I) and their non-toxic salts are derived from the following part of the molecule (0) / Ή A-N N - C-NH-2

RZ KRZ K

2 3 hvori A, R , R og n har den i krav 1 angivne betydning. Det ses klart, at disse forbindelser har en ureido-binding repræsenteret ved formlen ^ N-C-NH-2 wherein A, R, R and n are as defined in claim 1. It is clearly seen that these compounds have an ureido bond represented by the formula

/ «I/ «I

OISLAND

og er karakteriseret ved, at denne ureido-binding er dannet i forbindelse med oxo- eller dioxopiperazin-ringen ovenfor.and is characterized in that this ureido bond is formed in association with the oxo or dioxopiperazine ring above.

3 1513383 151338

Der kendes nogle penicillinforbindelser af ureido-typen, f.eks. Mezlocillin-natrium med formlen JK (01 -c. /00¾ CH,S0,lf N-CONHCHCONH—i- \ / A 1 I 3 V / [Q] cr COONaSome ureido-type penicillin compounds are known, e.g. Mezlocillin sodium of formula JK (01 -c. / 00¾ CH, SO, lf N-CONHCHCONH-i- \ / A 1 I 3 V / [Q] cr COONa

Denne forbindelse indeholder en ureido-binding og er den nærmest beslægtede i kemisk struktur med de ifølge opfindelsen fremstillede forbindelser, selv om der også er afgørende, forskelle som forklaret nedenfor. Forbindelserne af Mezlocillin-typen indeholder den følgende gruppe 0 0' -n-c-n-c-nh- I_l 0 «V " nemlig en ureido-binding repræsenteret ved formlen ->N-C-NH-og også en cyclisk ureido-binding i 2-oxoimidazolidin-ringen repræsenteret ved formlen -b-This compound contains an ureido bond and is the most closely related in chemical structure to the compounds of the invention, although there are also crucial differences as explained below. The Mezlocillin-type compounds contain the following group 0 0 '-ncnc-nh-I-10 0 V', namely an ureido bond represented by the formula -> NC-NH- and also a cyclic ureido bond represented in the 2-oxoimidazolidine ring by the formula -b-

Det vil sige, at der dannes en biureido-binding, og det karakteristiske træk ved denne type forbindelser ligger i denne kemiske struktur. Derfor er de ifølge opfindelsen fremstillede forbindelser og ureido-forbindelserne af Mezlocillin-typen afgjort forskellige.That is, a biureido bond is formed and the characteristic feature of this type of compound lies in this chemical structure. Therefore, the compounds of the invention and the Mezlocillin type ureido compounds are decidedly different.

Endvidere har det ved sammenligning af den nyttige virkning af de her omhandlede penicilliner med virkningen af Mezlocillin, som er en typisk repræsentant for forbindelserne af biureido-typen, vist sig, at de ifølge opfindelsen fremstillede forbindelser, f.eks. Piperacillin med formlen (I), hvori A er ethyl, 2 3 5 R og R er H, og R er phenyl, har et meget bredere anti-bakte-rielt spektrum end Mezlocillin, som det fremgår af referaterne fra 18th Interscience (1-4. oktober 1978), Session 6, No. 39 og Session 12, No. 116.Furthermore, by comparing the useful effect of the penicillins of this invention with the action of Mezlocillin, which is a typical representative of the biureido-type compounds, it has been found that the compounds of the invention, e.g. Piperacillin of formula (I) wherein A is ethyl, R 2 and R are H, and R is phenyl, have a much broader anti-bacterial spectrum than Mezlocillin, as shown in the 18th Interscience (1- October 4, 1978), Session 6, no. 39 and Session 12, no. 116th

Det er en selvfølge, at de her omhandlede cephalosporiner med formlen (i) er helt forskellige i kemisk henseende fra Mezlocil- 4 1513 3 ί lin. De Omhandlede cephalosporiner har udmærkede egenskaber, som aldrig er blevet opnået af konventionelle cephalosporiner.It goes without saying that the cephalosporins of formula (i) here are quite different in chemistry from Mezlocil. The present cephalosporins have excellent properties which have never been achieved by conventional cephalosporins.

De omhandlede forbindelser med formlen (I) har deres optiske isomere, og alle D-isomere, L-isomere og racemiske forbindelser deraf kan fremstilles ved fremgangsmåden ifølge opfindelsen.The present compounds of formula (I) have their optical isomers and all D-isomers, L-isomers and racemic compounds thereof can be prepared by the process of the invention.

Fremgangsmåden ifølge opfindelsen er ejendommelig ved det i krav 1's kendetegnende del anførte.The process according to the invention is characterized by the characterizing part of claim 1.

13 I formlerne (II),(IV) og (VI) betyder R et hydrogenatom, en saltdannende kation eller en beskyttende gruppe, som er kendt inden for penicillin- eller cephalosporin-området. De beskyttende grupper kan mere konkret være (1) esterdannende grupper, der kan fjernes ved katalytisk reduktion, kemisk reduktion eller hydrolyse under milde betingelser, f.eks. arylsulfonylalkylgrupper, såsom toluen-sulfonylethyl; substituetede eller usubstituerede aralkylgrupper, såsom benzyl, 4-nitrobenzyl, diphenylmethyl, trityl eller 3,5-di-(tert.-butyl)-4-hydroxybenzyl; substituerede eller usubstituerede alkylgrupper, såsom tert.-butyl eller trichlorethyl; phenacyl-grupper; alkoxyalkylgrupper, såsom methoxymethyl; eller usubstituerede eller alkyl-substituerede cycliske aminoalkylgrupper, såsom piperidinoethyl, 4-methylpyperidinoethy1, morpholinoethyl eller pyrrolidinoethyl; (2) esterdannende grupper, der let kan fjernes af enzymer i levende organismer, f.eks. acyloxyalkylgrupper, såsom pivaloyloxymethyl; phthalidyl eller indanyl; (3) sili-ciumholdige grupper, phosphorholdige grupper eller tinholdige grupper, som let fjernes ved behandling med i^O eller en alkohol, såsom (CH..) -jSi-, —CL Ο,,Η,-Ο.In formulas (II), (IV) and (VI), R is a hydrogen atom, a salt-forming cation, or a protecting group known in the art of penicillin or cephalosporin. More specifically, the protecting groups may be (1) ester-forming groups which can be removed by catalytic reduction, chemical reduction or hydrolysis under mild conditions, e.g. arylsulfonylalkyl groups such as toluene sulfonylethyl; substituted or unsubstituted aralkyl groups such as benzyl, 4-nitrobenzyl, diphenylmethyl, trityl or 3,5-di- (tert-butyl) -4-hydroxybenzyl; substituted or unsubstituted alkyl groups such as tert-butyl or trichloroethyl; phenacyl groups; alkoxyalkyl groups such as methoxymethyl; or unsubstituted or alkyl-substituted cyclic aminoalkyl groups such as piperidinoethyl, 4-methylpyperidinoethyl, morpholinoethyl or pyrrolidinoethyl; (2) ester forming groups which can be easily removed by enzymes in living organisms, e.g. acyloxyalkyl groups such as pivaloyloxymethyl; phthalidyl or indanyl; (3) silicon-containing groups, phosphorus-containing groups or tin-containing groups, which are readily removed by treatment with IO or an alcohol such as (CH CH) -₂Si, -CLCL, Η, -Ο.

P-, ^ P- eller (C.H0),Sn-.P-, ^ P- or (C.H0), Sn-.

/ / 4 y 3 0 C2H5°// 4 y 3 0 C2H5 °

De beskyttende grupper, der er nævnt ovenfor under (1), (2) og (3) er typiske, og andre eksempler fremgår af US patentskrifterne nr.The protecting groups mentioned above under (1), (2) and (3) are typical, and other examples are set forth in U.S. Pat.

3 499 909, 3 573 296 og 3 641 018 samt DE offentliggørelsesskrifterne nr. 2 301 014, 2 253 287 og 2 337 105. Den saltdannende kation kan være af samme art, som anvendes i penicillin- eller cephalosporin- forbindelser·,· fortrinsvis sådanne, som danner ikke-giftige salte. Saltene kan være alkalimetalsalte, såsom natriumsalte eller 5 151338 kaliumsalte, jordalkalimetalsalte, såsom calciumsalte og magnesium-salte, ammoniumsalte og sålte med nitrogenholdige organiske forbindelser, såsom procain, dibenzylamin, N-benzyl-$-phenethylamin, 1-ephenamin og .Ν,Ν-dibenzylethylendiamin. Udover de ovennævnte kationer kan der anvendes sådanne kationer, som er i stand til at danne salte med andre nitrogenholdige organiske baser, såsom tri-methylamin, triethylamin, tributylamin, pyridin, dimethylanilin, N-methylpiperidin, N-methylmorpholin, diethylamin og dicyclohexyl-amin. Kationen kan også være en kvaternær ammoniumgruppe dannet i 3-positionen af cephemringen, såsom pyridinium, quinolinium, isoquinolinium eller pyrimidinium. I dette tilfælde dannes en be-tain-struktur i molekylet.3 499 909, 3 573 296 and 3 641 018 and DE Publication Nos. 2 301 014, 2 253 287 and 2 337 105. The salt-forming cation can be of the same kind used in penicillin or cephalosporin compounds ·, preferably those which form non-toxic salts. The salts may be alkali metal salts such as sodium salts or potassium salts, alkaline earth metal salts such as calcium salts and magnesium salts, ammonium salts and salts with nitrogenous organic compounds such as procaine, dibenzylamine, N-benzyl - $ - phenethylamine, 1-ephenamine and. dibenzylethylenediamine. In addition to the above cations, such cations which are capable of forming salts with other nitrogenous organic bases such as trimethylamine, triethylamine, tributylamine, pyridine, dimethylaniline, N-methylpiperidine, N-methylmorpholine, diethylamine and dicyclohexylamine may be used. . The cation may also be a quaternary ammonium group formed at the 3-position of the cephalic ring, such as pyridinium, quinolinium, isoquinolinium or pyrimidinium. In this case, a betain structure is formed in the molecule.

7 I formlerne (II) og (IV) betyder R hydrogen eller en konventionel beskyttende siliciumholdig eller phosphorholdig gruppe, som let kan fjernes ved behandling med vand eller en alkohol. Disse grup-per kan f.eks. være de samme som nævnt for R ovenfor under (3).In formulas (II) and (IV), R means hydrogen or a conventional protecting silicon-containing or phosphorus-containing group which can be easily removed by treatment with water or an alcohol. These groups can e.g. be the same as mentioned for R above under (3).

I formlen (VI) under fremgangsmådens variant (c) repræsenterer B en substituent, der let erstattes af et nucleophilt reagens, og eksempler herpå er halogenatomer, såsom chlor og brom; lavere al-kanoyloxygrupper, såsom formyloxy, acetoxy, propionyloxy, buty-tyloxy og pivaloyloxy; arylcarbonyloxygrupper, såsom benzoyloxy eller naphthoyloxy; arylcarbonylthiogrupper, såsom benzoylthio eller naphthoylthio; carbamoyloxygrupper; heteroaromatiske amin-N-oxid-thiogrupper med en thiogruppe ved carbonatomet op til N-oxidgruppen i molekylet, såsom pyridin-l-oxid-2-ylthio eller py-ridazin-l-oxid-6-ylthio.In formula (VI) under variant (c) of the process, B represents a substituent readily replaced by a nucleophilic reagent and examples thereof are halogen atoms such as chlorine and bromine; lower alkanoyloxy groups such as formyloxy, acetoxy, propionyloxy, butyloxy and pivaloyloxy; arylcarbonyloxy groups such as benzoyloxy or naphthoyloxy; arylcarbonylthio groups such as benzoylthio or naphthoylthio; carbamoyloxy groups; heteroaromatic amine N-oxide thio groups having a thio group at the carbon atom up to the N-oxide group of the molecule, such as pyridin-1-oxide-2-ylthio or pyridazine-1-oxide-6-ylthio.

Hver af de ovennævnte grupper for B kan være substitueret med en vilkårlig af sådanne.substituenter som f. eks. halogenatomer, nitrogrupper, alkylgrupper, alkoxygrupper, alkylthiogrupper eller acylgrupper.Each of the above groups for B may be substituted by any of such substituents as, for example, halogen atoms, nitro groups, alkyl groups, alkoxy groups, alkylthio groups or acyl groups.

Som forbindelse (II) under fremgangsmådens variant (a) kan der anvendes enhver D-isomer, L-isomer eller racemisk forbindelse.As compound (II) under the variant (a) of the process, any D-isomer, L-isomer or racemic compound can be used.

6 1513386 151338

Som reaktivt derivat af carboxylgruppen af forbindelsen med formlen (III) kan der anvendes et reaktivt derivat af en carboxylsyre, som sædvanligvis anvendes til syntese af syreamidforbindel-ser. Eksempler på sådanne reaktive derivater er syrehalogenider, syreazid, syrecyanid, blandede syreanhydrider, aktive estere og aktive amider. Særligt foretrukne eksempler derpå er syrehalogenider, såsom syrechlorider og syrebromider, og aktive estere, såsom cyanmethylester eller trichlormethylester.As a reactive derivative of the carboxyl group of the compound of formula (III), a reactive derivative of a carboxylic acid which is usually used for the synthesis of acid amide compounds may be used. Examples of such reactive derivatives are acid halides, acid azide, acid cyanide, mixed acid anhydrides, active esters and active amides. Particularly preferred examples thereof are acid halides, such as acid chlorides and acid bromides, and active esters such as cyanomethyl ester or trichloromethyl ester.

Det reaktive derivat af carboxylgruppen i forbindelsen med formlen (III) kan let fås ved f.eks. at omsætte en oxopiperazin med formlen A-U ]JH (VIII) 2/3 3The reactive derivative of the carboxyl group of the compound of formula (III) can be readily obtained by e.g. reacting an oxopiperazine of formula A-U] JH (VIII) 2/3 3

RR

2 3 hvori A, R , R og n har den i krav 1 angivne betydning, syntetiseret på i og for sig kendt måde som angivet i de efterfølgende litteraturreferencer, med phosgen eller trichlormethylesteren af chlormyresyre.Wherein A, R, R and n are as defined in claim 1, synthesized in a manner known per se as set forth in the subsequent literature references, with the phosgene or trichloromethyl ester of chloroformic acid.

Litteraturreferencer: V.G. Granik, Khim-Farm. Zh., KV), 16-19 (1967) (Russ);Literature References: V.G. Granik, Khim-Farm. Zh., KV), 16-19 (1967) (Russ);

Samuel R. Aspinall, J. An. Chem. Soc., 62, 1202-V (19V0);Samuel R. Aspinall, J. An. Chem. Soc., 62, 1202-V (19V0);

Kuniyoshi MASUZAWA, Pharm. Bull. (Japan), 38 2078-2081 (1966);Kuniyoshi MASUZAWA, Pharm. Bull. (Japan), 38 2078-2081 (1966);

Arthur P. Phillips, Ger. 1135V72, Aug. 30 (1962); J. L. Riebsomer, J. Org. Chem., l£ 68-73 (1950); 151338 7Arthur P. Phillips, Ger. 1135V72, Aug. 30 (1962); J. L. Riebsomer, J. Org. Chem., £ 68-73 (1950); 151338 7

Litteraturreference: (fortsat)Literature Reference: (continued)

Jongkees, Rec. trav. Chim., 2£ 305;Boy, Rec. trot. Chim., £ 2 305;

Patric T. Izzo, J. Am. Chem. Soc., 8l k668-k670 (1959); og B. H. Chase & A. M. Downes, J. Chem. Soc., 387^-3877 (1953).Patric T. Izzo, J. Am. Chem. Soc., 8l k668-k670 (1959); and B. H. Chase & A. M. Downes, J. Chem. Soc., 387-3877 (1953).

Konkrete eksempler på forbindelser med formlen (VIII) og de reaktive derivater af carboxylgruppen af forbindelsen med formlen (III) er anført i henholdsvis tabel 1 og tabel 2.Specific examples of compounds of formula (VIII) and the reactive derivatives of the carboxyl group of the compound of formula (III) are given in Table 1 and Table 2, respectively.

8 1513388 151338

Tabel 1Table 1

Forbindelser med formlen (VIII) --- ,Compounds of formula (VIII) ---,

Smp. (omkrystal-Mp. (omkrystal-

Forbindelse lisationsmiddel) (cm-1) 1Connection agent) (cm-1) 1

0 o Jc=0 1640 I0 o Jc = 0 1640 I

rA 136°C (( )) , ΗΪΓ^ΝΗ . 0 Vhh ' 3450 - 3250 0 kp. 122 - , V-% 125°C/2 mmHg Yn=0 1650 - 1630 ! mm .rA 136 ° C (()), ΗΪΓ ^ ΝΗ. 0 Vhh '3450 - 3250 0 kp. 122 -, V-% 125 ° C / 2 mmHg In = 0 1650 - 1630! mm.

140 - 14-1°C (IPA) Vuh 3260, 3170 CH3 0 _ ^ ^G=Q 1645' 1625 A 112 - 113°C ((O) ) ) ° CH3C0F^JIH ^ YM 3380, 3220 o γ*π_η 1650, 1630 A 129 - 130°C (IPA) , cicHaCQE^jm vm 3270 0 ^0=0 1660-1630 r< 134 - 135°C (IPA) j C12CHC0N HH Vm 3280 0 Vc=0 1670, 1640 , λ A 96 - 97°C (CC1J j 0Η5(0Η2)ΐ30Η200Ι^Μ ^ YM 3200 0 \/n_n 1660, 1620 A 80 - 8l°C (IPE) , 0Η3(0Η2)50Η200ΪΓ^ΚΗ vm 3250 0 . Vp_ri 1660, 1620140 - 14-1 ° C (IPA) Vuh 3260, 3170 CH3 0 _ ^^ G = Q 1645 '1625 A 112 - 113 ° C ((O))) ° CH3COF ^ JIH ^ YM 3380, 3220 o γ * π_η 1650, 1630 A 129 - 130 ° C (IPA), cicHaCQE ^ m m vm 3270 0 ^ 0 = 0 1660-1630 r <134 - 135 ° C (IPA) j C12CHC0N HH Vm 3280 0 Vc = 0 1670, 1640, λ A 96 - 97 ° C (CC1J j 0Η5 (0Η2) ΐ30Η200Ι ^ Μ ^ YM 3200 0 / n_n 1660, 1620 A 80 - 8l ° C (IPE), 0Η3 (0Η2) 50Η200ΪΓ ^ ΚΗ vm 3250 0. Vp_ri 1660, 1620

, . A 83 - 84°c (IPE) J,. A 83 - 84 ° C (IPE) J

CH3(CH2)4CH2C01Sr HH )/m 3250 0 Vn=n 1660, 1620 . . A 99 - 100°C (CC14) , ch3(ch2)3ch2copv_jih 4 vM 3250 o ^0=0 χ680 A 167 - 168°C (EtOH) Vim 3200CH3 (CH2) 4CH2C01Sr HH) / m 3250 0 Vn = n 1660, 1620. . A 99 - 100 ° C (CC14), ch3 (ch2) 3ch2copv_jih 4 vM 3250 o = 0 0680 A 167 - 168 ° C (EtOH) Vim 3200

CH^SOpU HHCH ^ SOpU HH

2 2 w_ Vs02N< 1310, 1140 9 1513382 2 w_ Vs02N <1310, 1140 9 151338

Tabel 1 (fortsat) /? o Vn_o 1650, 1620 rA 189 - 190°c (IPA) , u (ΟΗ·^) 3 TCH2-, NH V jjj-g 525Ο 0 Vc=0 1650 - 1650 r4 olieagtigt materi- , CH3(CH2)4CH2-N NH ale ' ym 3270 P 3250 r-J( olieagtigt materi- .Table 1 (continued) /? o Vn_o 1650, 1620 rA 189 - 190 ° c (IPA), u (ΟΗ · ^) 3 TCH2-, NH V jjj-g 525Ο 0 Vc = 0 1650 - 1650 r4 oily material, CH3 (CH2) 4CH2-N NH ale 3270 P 3250 rJ (oily material.

CH3(CH2)2CH2-N_NH ale Yc=0 1650 - 1630 -- - ...... — A ' ^ ^ . 4=0 1650 - 1620 CH,(CHo)o0Ho-N NH olieagtigt maten- 5 2 2 2 ale _cb____ 0 fe, 1650 - 16J0 rA olieagtigt materi- Hydrochloride CH3(CH2)6CH2-N NH ale Vc=o 1680 ' ' Vjjjj 3200, 3080 ______ _______ — — — ----« — ......... M ----1 o ^c=o 1620 V\ kp · 104°C/4 mmHg , ch3nwnh vm 5275 0 Vq-o 1610 }~y olieagtigt materi- , CH3CH2-N NH ale VNH 3250 olieagtigt materi- ^0=0 ^10 ch3(ch2)2ch2-\_nh ale v’jju 3250 ..... .. .... . .. .... .... - 1 —ft — -.....—— - 0 olieagtigt materi- V^O 1610 V-\ ale . 1 (CH3)2CH-N_jm vm 3400 - 3200 0 , . 4..4. 4. . vL0 1620 ^ olieagtigt materi- w u CH3(CH2)3CH2-N__NH ale ' )lm 3270 0 ^ . ^0-0 1620 CH rA olieagtigt materi- ^CHCH2CH2-N NH ale Vjjh 3270 CH3 " j _:_____ _:_! 10 151338CH3 (CH2) 2CH2-N_NH all Yc = 0 1650 - 1630 - - ...... - A '^ ^. 4 = 0 1650 - 1620 CH, (CHo) 0Ho-N NH oily food 5 2 2 2 all _cb____ 0 fe, 1650 - 16J0 rA oily material- Hydrochloride CH3 (CH2) 6CH2-N NH all Vc = o 1680 '' Vjjjj 3200, 3080 ______ _______ - - - ---- «- ......... M ---- 1 o ^ c = o 1620 V \ kp · 104 ° C / 4 mmHg, ch3nwnh vm 5275 0 Vq-o 1610} ~ y oily matter, CH3CH2-N NH ale VNH 3250 oily matter- ^ 0 = 0 ^ 10 ch3 (ch2) 2ch2 - \ _ nh ale v'jju 3250 ..... .. .. ... .. .... .... - 1 —ft - -.....—— - 0 oily matter— V ^ O 1610 V- \ all. 1 (CH3) 2CH-N_jm vm 3400 - 3200 0 ,. 4..4. 4.. vL0 1620 ^ oily material- CH3 (CH2) 3CH2-N__NH ale ') lm 3270 0 ^. ^ 0-0 1620 CH rA oily material- ^ CHCH2CH2-N NH ale Vjjh 3270 CH3 "j _: _____ _: _! 10 151338

Tabel 1 (fortsat) 0 , Vc=0 1620 olieagtigt materi- , CH5(CH2)4CH2-N_JIH ale Vm 3270 ^ olieagtigt materi- ^0=0 1620 CH5(CH2)5CH2-N NH ale 3270 0 _. .. , . Vn—n 1620 olieagtigt materi- CH3(CH2)6CH2-FJJH al® ' \)m 3270 0 olieagtigt materi- Vø_o ^20 y—N. ale i CH3 (CH2) 10CH2-NJJH Vm 3270 0 Vn n 1620 V olieagtigt materi- b-u ale Vrø 5300 0 · i K V1630 CH-z (CHp) nCHp-U NH olieagtigt materi- ' 2 2 2 H ale J 3300 ch5 mTable 1 (continued) 0, Vc = 0 1620 oily material, CH5 (CH2) 4CH2-N_JIH all Vm 3270 ^ oily material- ^ 0 = 0 1620 CH5 (CH2) 5CH2-N NH all 3270 0 _. ..,. Vn-n 1620 oily material CH3 (CH2) 6CH2-FJJH al® '\) m 3270 0 oily material- V0_o ^ 20 y-N. all in CH3 (CH2) 10CH2-NJJH Vm 3270 0 Vn n 1620 V oily material Vrø 5300 0 · i K V1630 CH-z (CHp) nCHp-U NH oily material 2 2 2 H ale J 3300 ch5 m

0 I0 I

. . ^ olieagtigt materi- ^C=0 1630 CH3(CH2)2CH2-E ER ale - ) M Vra 3200 ch5 0 or'0', ^C=0 1650 /-\ K 157 - 158°C (Γ J ) j (O/-0H2-]i ffl Ό Vjih 3300 0 i ^ kp. 183- l85°C/2mmHg ^0=0 1620 HOCHgCHg-F BH * J J ' 6 °N olieagtigt materi- ^0=0 1650 y—s. ‘ pip - ) CH2=CHCH2-ir MH Vm 3300 n 151338. . ^ oily matter- ^ C = 0 1630 CH3 (CH2) 2CH2-E ER all -) M From 3200 ch5 0 or'0 ', ^ C = 0 1650 / - \ K 157 - 158 ° C (Γ J) j ( O / -0H2-] i ffl Ό Vjih 3300 0 i ^ pp. 183- l85 ° C / 2mmHg ^ 0 = 0 1620 HOCHgCHg-F BH * JJ '6 ° N oily matter- ^ 0 = 0 1650 y — s. 'pip -) CH2 = CHCH2-ir MH Vm 3300 n 151338

Tabel 1 (fortsat) °K ^0=0 1620 0Η?=0Η0Η-1ί EH olieagtigt materi- , I ^ ale Vm 3300 CH3 V-n ^0=0 1640 CHp=CCH2-E EH olieagtigt materi- , I ^ ale Vjjjj 3300 CH3 0 , 0H=0HCH2-H ra Olieagtigt materi- '0=° 1660 I w ale Vm 3350 CH5 0 0 ^0=0 1695, 1660 V-f . 158°C (IPA) » CH^-EMffl Vlffi 3220 ° ,° olieagtigt materi- ^C=0 I730 - 1650Table 1 (continued) ° K ^ 0 = 0 1620 0Η? = 0Η0Η-1ί EH oily matter, I ^ all Vm 3300 CH3 Vn ^ 0 = 0 1640 CHp = CCH2-E EH oily matter, I ^ all Vjjjj 3300 CH3 0, 0H = 0HCH2-H ra Oily material- 0 = ° 1660 I wm Vm 3350 CH5 0 0 ^ 0 = 0 1695, 1660 Vf. 158 ° C (IPA) CH CH ^ -EMffl Vlffi 3220 °, ° oily material = C = 0 I730 - 1650

alp Ialp I

CH5C00CH2CH2-H HH Υ^Η 3300 - 3200 00 n ,0s ^0=0 1680, 1650 W 124°C (( ]) , CH^CHp-E EH 0^ V^j 3250 00 Vp=o 1680, 1650 V/ 98 - 100°C {( j) , CH3CH2CH2-N HH 0 VNH 3200, 3100 00 n VC=o 1695, 1670 W7 Hl - 113 C (CClr) , CH5(CH2)2CH2-N HH ^ YNH 3240, 3150 0 0 ^C-0 1650 S-4 166 - 167°C (( ] ) , (CH5)2CH-H HH ^0^ Vm 3300 - 3200 0 0 VC=0 1700, 1660CH5C00CH2CH2-H HH Υ ^ Η 3300 - 3200 00 n, 0s ^ 0 = 0 1680, 1650 W 124 ° C ((]), CH ^ CHp-E EH 0 ^ V ^ j 3250 00 Vp = o 1680, 1650 V / 98 - 100 ° C {(j), CH3CH2CH2-N HH 0 VNH 3200, 3100 00 n VC = o 1695, 1670 W7 H1 - 113 C (CClr), CH5 (CH2) 2CH2-N HH ^ YNH 3240, 3150 0 0 C-0 1650 S-4 166 - 167 ° C ((]), (CH 5) 2CH-H HH ^ 0 ^ Vm 3300 - 3200 0 0 VC = 0 1700, 1660

Vf 104 - 106°C (IPE) , CH3(CH2)3CH2-N HH vm 3200, 3100 12 151338 _ _Tabel 1 (fortsat) 0 0 Vq_q 1700, 1660Vf 104 - 106 ° C (IPE), CH3 (CH2) 3CH2-N HH vm 3200, 3100 12 151338 _Table 1 (continued) 0 0 Vq_q 1700, 1660

'M' 111 - 115°G (ΙΡΞ) I'M' 111 - 115 ° G (ΙΡΞ) I

ΟΗ5(ΟΗ2)4ΟΗρ-Ν HH VM 3200, 3100 0 0 Vc=o 1700, 1660ΟΗ5 (ΟΗ2) 4ΟΗρ-Ν HH VM 3200, 3100 0 0 Vc = o 1700, 1660

YJf 112 - Π 5°Π (TPP) IYJf 112 - Π 5 ° Π (TPP) I

CH5(CH2)5CH2-N^NH Vhh 3200, 3100 00 n Vn=0 1700, 1660 \-4 116 - 120°C (IPE) \ CH5(CH2)6CH2-H HH Vm 3225, 3100 O O ^C=0 1680, 1655 V-T 136 - I37°c » CH2=CHCH2-NJM (Acetone) 3200, 3100 O O Vc=o 1690, 1645 ΓΛ ^ 202 - 20H-°C (IPA) .CH5 (CH2) 5CH2-N ^ NH Vhh 3200, 3100 00 n Vn = 0 1700, 1660 \ -4 116 - 120 ° C (IPE) \ CH5 (CH2) 6CH2-H H Vm 3225, 3100 OO ^ C = 0 1680, 1655 VT 136 - I37 ° C »CH2 = CHCH2-NJM (Acetone) 3200, 3100 ° C = o 1690, 1645 ° C 202 - 20H- ° C (IPA).

(0)-NJSIH VkH 3260 j O O ^0=0 !700 - I650 M 128 - 129°C (EtOH) , CICHgCHglSr HH Vjjfj 3200 - 3100 O O } 'M' 0 »0=0 1660 CH5CH2-N HH 127 - I280C (AcOEt) , M Vm 3200, 3080 CH3 O O ) M' n *0=0 1660 CH3-N NH 146 - 1^7 C (il) .(0) -NJSIH VkH 3260 j OO ^ 0 = 0! 700 - I650 M 128 - 129 ° C (EtOH), CICHgCHglSr HH Vjjfj 3200 - 3100 OO} 'M' 0 »0 = 0 1660 CH5CH2-N HH 127 - I280C (AcOEt), M Vm 3200, 3080 CH3 OO) M a * 0 = 0 1660 CH3-N NH 146 - 1 ^ 7 C (il).

M Oy Vra 3200, 3100 -ch5 ---j-J- " -------M Oy Ask 3200, 3100 -ch5 --- j-J- "-------

Note: IPA = (CH5)2CH0HNote: IPA = (CH5) 2CH0H

ipe = (ch3)2choch(ch3)2ipe = (ch3) 2choch (ch3) 2

AcOEt = CH3C00CH2CH3AcOEt = CH3C00CH2CH3

EtOH = CH3CH2OHEtOH = CH 3 CH 2 OH

13 15133813 151338

Tabel 2Table 2

Reaktive derivater af forbindelser med formlen (III)Reactive derivatives of compounds of formula (III)

Forbindelse. Fysiske egenskaber I*R· (cm-1) 0 · , rA ....... Vø_0 1790, 1710, CH^CO-N N-C0C1 .olieagtigt materi- ^ w · ale 1640 0 ' ^C=0 1790,Connection. Physical Properties I * R · (cm-1) 0 ·, rA ....... V0_0 1790, 1710, CH ^ CO-N N-COC1. Oily material- ^ w · all 1640 0 '^ C = 0 1790

rAraw

ciCH2oo-ir ir-coci 1730 - 1650 o 4=0 1790, Λ C12CHC0-N N-C0C1 1730 - 1650 0 Vc=0 1740, 1.660, CH3(CH2)13CH2CO-Nwli-COCl " 1640 0 Vc=0 1740, rA " ch5(ch2)5ch2co-it w-σοσι i680 - 1640 o 1=0 1740, i-H " CH5(CH2)4CH2C0-N_^N-C0C1 1680 - 1640 \ o Vc=o 1790, 1710,ciCH2oo-ir ir-coci 1730 - 1650 o 4 = 0 1790, Λ C12CHCO-N N-COC1 1730 - 1650 0 Vc = 0 1740, 1.660, CH3 (CH2) 13CH2CO-Nwli-COCl "1640 0 Vc = 0 1740, rA "ch5 (ch2) 5ch2co-it w-σοσι i680 - 1640 o 1 = 0 1740, iH" CH5 (CH2) 4CH2C0-N_ ^ N-C0C1 1680 - 1640 \ o Vc = o 1790, 1710,

rAraw

CH5(CH2)3CH2CO-li N-C0C1 1640 --, 0 Vc=o 1790, 1700 CE5S02-ir N-C0C1 f VSo2 2.320, 1140 14 151338CH5 (CH2) 3CH2CO-li N-COC1 1640 -, 0 Vc = o 1790, 1700 CE5S02-ir N-COC1 f VSo2 2.320, 1140 14 151338

Tabel 2 (fortsat) 0 VC=o 1740 - 1720, t^ olieagtigt (CH5)3CC00CH2-N N-C0C1 materiale 1670 „ ^0=0 1790, 1720 CH5 (CH2) 4CH2-I'Tjl-C0Cl 0 ) A " VC=0 1790, 1720 CHj (CH2) 2CH2~U^j:T-C0Cl oTable 2 (continued) 0 VC = 0 1740 - 1720, oily (CH5) 3CC00CH2-N N-COC1 material 1670 "^ 0 = 0 1790, 1720 CH5 (CH2) 4CH2-I'Tjl-COCl 0) A" VC = 0 1790, 1720 CH 2 (CH 2) 2 CH 2

AA

CH3(0H2)2CH2-K 1T-C0C1 " YCz=Q 1790, 1720CH3 (OH) 2CH2-K 1T-COC1 "YCz = Q 1790, 1720

MM

ch5 0 \ A " Vc=0 1790, 1720 CH5 (CH2) 6CH2-1'I_rl-COCl 0 smp.= 115 - 116°C j (dekomp.) M1=0 1720, 1660 “U'0001 (fra (6) ) 0 ^ ) HN N-C0C1 krystal Yc=;q 1720, 1660 ge3 K olieagtigt m0 16;0 CH^-F K-C0C1 materiale 0 u w 0 K " VG=0 1750, 1650 CH5(CH2)2CH2-N N-C0C1 -1—-1- 15ch5 0 \ A "Vc = 0 1790, 1720 CH5 (CH2) 6CH2-1'I_rl-COCl 0 m.p. = 115 - 116 ° C j (decomp.) M1 = 0 1720, 1660" U'0001 (from (6 )) 0 ^) HN N-COC1 crystal Yc =; q 1720, 1660 ge3 K oily m0 16; 0 CH ^ -F K-COC1 material 0 your 0 K "VG = 0 1750, 1650 CH5 (CH2) 2CH2-N N-COC1 -1-1-1 15

Tabel 2 (fortsat) K olieagtict ^C=0 ^30, 1650 ch3ch2-hwij-coci 0 ) K " vc=0 1720, 1640 (CH^CH-I^Ji-CGCl 0 ) K « vq_o 1730, 1640 ch3(0H2)5ch2-n N-C0C1 0 ) K " VC=0 1720, 1640 (ch3)2CHCH2CH2-N N-C0C] 0 ) K " vc=0 1730, 1640 ch3(CH2)4CH2-N N-C0C1 0 j \-y " Vc=0 1730, 1640 ch3 ( ch2 ) 5CH2-N N-C0C1 0 ) K " YC=0 1720, 1640 CH3 (CH2) gCH2-lT_N-C0C1 0 i K " V Q—π 1720, 1640 CH3(CH2)10CH2-N N-C0C1 —\ K ” Vc=o 1730, 1640 H>-1 1T-C0C1 —' \_f 16 151338Table 2 (continued) K oleactict ^ C = 0 ^ 30, 1650 ch3ch2-hwij-coci 0) K "vc = 0 1720, 1640 (CH ^ CH-I ^ Ji-CGCl 0) K« vq_o 1730, 1640 ch3 ( 0H2) 5ch2-n N-COC1 0) K "VC = 0 1720, 1640 (ch3) 2CHCH2CH2-N N-COC] 0) K" vc = 0 1730, 1640 ch3 (CH2) 4CH2-N N-COC1 0 j \ -y "Vc = 0 1730, 1640 ch3 (ch2) 5CH2-N N-COC1 0) K" YC = 0 1720, 1640 CH3 (CH2) gCH2-lT_N-COC1 0 in K "VQ-π 1720, 1640 CH3 (CH2) 10CH2-N N-COC1 - \ K ”Vc = o 1730, 1640 H> -1 1T-COC1 - '\ _f 16 151338

Tabel 2 (fortsat)Table 2 (continued)

0 r H0 r H

0¾ (CHo) oCHo-H N-C0C1 olieagtigt } 7 y-t materiale Yq=q 1720, 1540 CH^,0¾ (CHo) oCHo-H N-COCl oily} 7 y-t material Yq = q 1720, 1540 CH

SS

00

Υ“λ « IΥ “λ” I

CH5(CH2 )2CH2-W BT-COCl vc=o 1730, 1650 CH3 y-, · ’ " ^C=0 1720, 1645 (O/-CH2-N_N-C0Cl 0 Vc=0 1730, )-Λ " HOCH2CH2-IT Έ-C0C1 ' 1660 - 1630 0 ) K " Vq_o 1720, 1640 CH2=CHCH2-N N-C0C1 0 K · ) CH2=CHCM N-C0C1 " Vc=o 1730, 1650 I v—1 CH3 0 ^—v ) CH2=CCH2-ir IT-C0C1 " Vc=0 1730, 1650 CH3 CH-zCH 0 CHCH^N^JT-COCl ' Vc=0 173Ο, 1650 (trans-) 17 151338CH5 (CH2) 2CH2-W BT-COCl vc = o 1730, 1650 CH3 y-, · '"C = 0 1720, 1645 (O / -CH2-N_N-COCl 0 Vc = 0 1730,) -Λ" HOCH2CH2 -IT Έ-COC1 '1660 - 1630 0) K "Vq_o 1720, 1640 CH2 = CHCH2-N N-COC1 0 K ·) CH2 = CHCM N-COC1" Vc = o 1730, 1650 I v-1 CH3 0 ^ - v) CH2 = CCH2-ir IT-COC1 "Vc = 0 1730, 1650 CH3 CH-zCH 0 CHCH ^ N ^ JT-COCl 'Vc = 0 173Ο, 1650 (trans) 17 151338

Tabel 2 (fortsat) π η smp. 94 - 95°C , 0 (dekqmp.) ^0=0 1790, 1680 CH3-N_N-C0C1 (fra CH2Et|0) olieagtigt materi- ^C=0 Π90, 17^0, / \ o'] λ CH5C00CH2CH2-N N-C0C1 axe 1670 O π snip. 95 - 96°c u u (dekomp.) Vc=0 1780, 1660 ch3ch2-n^n-coci (fra Ac0Bu^ olieagtigt materi- ^C=0 4780 > CH3CH2 CH2-C0C1 ale 1710 - 1640 0 0 j " Vc_0 1780, 1660 CH3(CH2)2CH2-N N-G0C1 0 0 smp. 130 - 131°C \ M VC=0 1780, 1660 (CH3) 2CH-ir N-C0C1 (dekDmp.) olieagtigt materi- ^0=0 1790, CH3(CH2)3CH2-Njr-COCl ale 1720 _ 1665 0 0 Vr_n 1780,Table 2 (continued) π η m.p. 94 - 95 ° C, 0 (decqmp.) ^ 0 = 0 1790, 1680 CH3-N_N-COC1 (from CH2Et | 0) oily material- ^ C = 0 Π90, 17 ^ 0, / \ o '] λ CH5C00CH2CH2- N N-C0C1 ax 1670 O π snip. 95 - 96 ° cuu (decomp.) Vc = 0 1780, 1660 ch3ch2-n ^ n-coci (from Ac0Bu ^ oily material- ^ C = 0 4780> CH3CH2 CH2-C0C1 all 1710 - 1640 0 0 j "Vc_0 1780, 1660 CH3 (CH2) 2CH2-N N-G0C1 0 0 mp 130 - 131 ° C \ M VC = 0 1780, 1660 (CH3) 2CH-N N-COC1 (decDmp.) Oily material- 0 = 0 1790, CH3 (CH2) 3CH2-Njr-COCl all 1720 _ 1665 0 0 Fr_n 1780,

MM

CH3(CH2)4CH2-I^ir-C0Cl 1720 - 1640 0 0 Vq=0 1780, M' CH5(CH2)5CH2-N N-C0C1 1720 - 1640 i8 151338CH3 (CH2) 4CH2-I-ir-COCl 1720 - 1640 0 0 Vq = 0 1780, M 'CH5 (CH2) 5CH2-N N-COCl 1720 - 1640 i8 151338

Tabel 2 (fortsat) 0 0 Vc=0 1780, CH3(CH2)6CH2-hMt-C0C1 1720 - 1640 0 0 V^o 1775, i( krystal CH2=CHCH2-N^N-C0C1 1660 - 1620 i O O \ic=0 1785, /—\ krystal (OZ-N^JT-COCl 1720 - 1650 olieagtigt materi- ^c=0 1790 * 1720 ’ C1CH2CH2-N N-C0C1 a±e 1680 00 h-i smpl 65 - 70 C .Table 2 (continued) 0 0 Vc = 0 1780, CH3 (CH2) 6CH2-hMt-COC1 1720 - 1640 0 0 V ^ o 1775, i (crystal CH2 = CHCH2-N ^ N-COC1 1660 - 1620 in OO \ ic = 0 1785, / - \ crystal (OZ-N ^ JT-COCl 1720 - 1650 oily matter- ^ c = 0 1790 * 1720 'C1CH2CH2-N N-C0C1 a ± e 1680 00 hi mp 65 - 70 C.

CH3CH2-F N-C0C1 VC=Q 1785, 1680 ^-( . (dekomp.) ch5CH3CH2-F N-COC1 VC = Q 1785, 1680 ^ - (. (Decomp.) Ch5

Note: Et20 = CH3CH20CH2CH3Note: Et20 = CH3CH20CH2CH3

AcOBu = CH3C00(CH2)3CH3 19 151338AcOBu = CH3C00 (CH2) 3CH3 19 151338

Forbindelsen med den almene formel (V) under fremgangsmådens variant (b) kan let fås ved omsætning af f.eks. et alkalimetal- eller jordalkalimetalsalt eller salt med en nitrogenholdig organisk base af en aminosyre (enhver D-isomer, L-isomer eller racemisk forbindelse) med den almene formel (IX): H„N-CH-COOH (IX)The compound of the general formula (V) under the variant (b) of the process can easily be obtained by reacting e.g. an alkali metal or alkaline earth metal salt or salt having a nitrogenous organic base of an amino acid (any D-isomer, L-isomer or racemic compound) of the general formula (IX): H + N-CH-COOH (IX)

Δ 15 RΔ 15 R

5 hvor R har den i krav 1 angivne betydning, med et reaktivt derivat i henseende til carboxylgruppen af en forbindelse med den almene formel (III) i et opløsningsmiddel, som er inert overfor reaktionen, i nærvær af et syrebindende middel.5 wherein R is as defined in claim 1, with a reactive derivative with respect to the carboxyl group of a compound of general formula (III) in a solvent inert to the reaction, in the presence of an acid binding agent.

Som reaktivt derivat i henseende til carboxylgruppen af forbindelsen med dei almene formel (V) anvendes et reaktivt derivat af en carboxylsyre, som sædvanligvis anvendes til syntese af syreamider. Sådanne reaktive derivater omfatter f. eks. syrehalogenider, syre-anhydrider, blandede syreanhydrider med organiske eller uorganiske syrer, aktive syreamider, syrecyanider og aktive estere. Særligt foretrukne er syrechlorider, blandede syreanhydrider og aktive syreamider. Eksempler på blandede syreanhydrider er blandede syre- · anhydrider med substitueret eddikesyre, alkylcarbonsyre, arylcar-bonsyre og aralkylcarbonsyre; eksempler på de aktive estere er cyanomethylestere,' substituerede phenylestere, substituerede ben-zylestere, substituerede thienylestere; og eksempler på aktive syreamider er N-acyl-sacchariner, N-acylimidazoler, N-acyl-benzoyl-amider, N,N-dicyclohexyl-N-acylurinstoffer og N-acyl-sulfonamider.As a reactive derivative with respect to the carboxyl group of the compound of the general formula (V), a reactive derivative of a carboxylic acid is usually used for the synthesis of acid amides. Such reactive derivatives include, for example, acid halides, acid anhydrides, mixed acid anhydrides with organic or inorganic acids, active acid amides, acid cyanides and active esters. Particularly preferred are acid chlorides, mixed acid anhydrides and active acid amides. Examples of mixed acid anhydrides are mixed acid anhydrides with substituted acetic acid, alkyl carbonic acid, aryl carbonic acid and aralkyl carbonic acid; examples of the active esters are cyanomethyl esters, substituted phenyl esters, substituted benzyl esters, substituted thienyl esters; and examples of active acid amides are N-acyl saccharins, N-acylimidazoles, N-acyl benzoyl amides, N, N-dicyclohexyl-N-acylureas and N-acylsulfonamides.

Forbindelser med formlen (VI) under fremgangsmådens variant (c) kan fås f.eks. ifølge varianterne (a) eller (b). Nogle af forbindelserne dannet ved variant (c) kan yderligere anvendes som udgangsmateriale ved variant (c). Enhver D-, L- og racemisk forbindelse med formlen (VI) kan anvendes.Compounds of formula (VI) under the variant (c) of the process can be obtained e.g. according to variants (a) or (b). Some of the compounds formed by variant (c) can be further used as starting material by variant (c). Any D, L and racemic compound of formula (VI) may be used.

Den praktiske gennemførelse af fremgangsmådevarianterne (a), (b) og (c) er forklaret i det efterfølgende.The practical implementation of process variants (a), (b) and (c) is explained below.

Varianterne (a) og (b) kan udføres under i det væsentlige samme 20 1 5 1 3 3 8 ' betingelser. Således kan forbindelsen med formlen (II) eller (IV) opløses eller suspenderes i mindst et af opløsningsmidlerne: vand, acetone, tetrahydrofuran, dioxan, acetonitrile, dimethylformamid, methanol, ethanol, methoxyethanol, diethylether, isopropylether, benzen, toluen, methylenchlorid, chloroform, ethylacetat og methyl-isobutylketon. Den dannede opløsning eller suspension omsættes med et reaktivt derivat af forbindelsen med formlen (III) eller med forbindelsen med formlen (V) eller et reaktivt derivat i henseende til carboxylgruppen af forbindelsen med formlen (V) i nærværelse eller fraværelse af en base ved en temperatur mellem -r60° og 80°C, fortrinsvis mellem -t40° og 30°Cj reaktionstiden er sædvanligvis 5 minutter til 5 timer. Eksempler på baser, der anvendes ved ovennævnte reaktion, er uorganiske baser, såsom alkalihydroxider, alka-lihydrogencarbonater, alkalicarbonater og alkaliacetater; tertiære aminer, såsom trimethylamin, triethylamin, tributylamin, pyridin, N-methylpiperidin, N-methylmorpholin, lutidin eller collidin; og sekundære aminer, såsom dicyclohexylamin eller diethylamin. Når forbindelsen med formlen (V) anvendes i form af en fri syre eller et salt ved fremgangsmådevarianten (a), kan reaktionen ifølge variant (a) udføres i nærvær af et dehydratiserende kondensationsmiddel, såsom Ν,Ν-dicyclohexylcarbodiimid, N-cyclohexyl-N'-morpho-liniethylcarbodiimid, N,N1-diethylcarbodiimid, N,N1-carbonyl-(2-methylimidazol), en trialkylester af phosphorsyre, ethylester af polyphosphorsyre, phosphorixychlorid, phosphortrichlorid, 2-chlor- 1,3,2-dioxaphospholan eller oxazolylchlorid. Saltet af forbindelsen med formlen (V) omfatter alkalimetalsalte, jordalkalimetalsal-te, ammoniumsalte og salte med organiske baser, såsom trimethylamin eller dicyclohexylamin.The variants (a) and (b) can be performed under substantially the same conditions. Thus, the compound of formula (II) or (IV) can be dissolved or suspended in at least one of the solvents: water, acetone, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, methanol, ethanol, methoxyethanol, diethyl ether, isopropyl ether, benzene, toluene, methylene chloride, chloroform , ethyl acetate and methyl isobutyl ketone. The resulting solution or suspension is reacted with a reactive derivative of the compound of formula (III) or with the compound of formula (V) or a reactive derivative with respect to the carboxyl group of the compound of formula (V) in the presence or absence of a base at a temperature between -r60 ° and 80 ° C, preferably between -t40 ° and 30 ° C. The reaction time is usually 5 minutes to 5 hours. Examples of bases used in the above reaction are inorganic bases such as alkali hydroxides, alkali hydrogen carbonates, alkali carbonates and alkali acetates; tertiary amines such as trimethylamine, triethylamine, tributylamine, pyridine, N-methylpiperidine, N-methylmorpholine, lutidine or collidine; and secondary amines such as dicyclohexylamine or diethylamine. When the compound of formula (V) is used in the form of a free acid or salt in the process variant (a), the reaction of variant (a) can be carried out in the presence of a dehydrating condensing agent such as Ν, Ν-dicyclohexylcarbodiimide, N-cyclohexyl-N N-N1-diethylcarbodiimide, N, N1-carbonyl- (2-methylimidazole), a trialkyl ester of phosphoric acid, ethyl ester of polyphosphoric acid, phosphorus oxychloride, phosphorous trichloride, 2-chloro-1,3,2-dioxaphospholane . The salt of the compound of formula (V) comprises alkali metal salts, alkaline earth metal salts, ammonium salts and salts with organic bases such as trimethylamine or dicyclohexylamine.

Praktiske udførelsesformer for variant (c) er som følger: Når B i formel (VI) er forskellig fra en hetero-aromatisk N-oxid-thio-gruppe med en thiogruppe ved carbonatomet ved siden af N-oxid-gruppen i molekylet, omsættes forbindelsen med formlen (VI) med en forbindelse med formlen (VII) eller en tertiær amin i mindst et opløsningsmiddel, f.eks. vand, methanol, ethanol, propanol, isopropanol, butanol, acetone, methylethylketon, methylisobutylketon, tetrahydrofuran, dioxan, acetonitril, ethylacetat, methoxyethanol, dimethoxyethan, dimethylformamid, dimethyl- 21 151338 sulfoxid, dichlormethan, chloroform eller dichlorethan. Ovennævnte reaktion udføres fortrinsvis i et stærkt polært opløsningsmiddel, såsom vand. I dette tilfælde er det hensigtsmæssigt at indstille pH værdien af reaktionsblandingen til 2-10, fortrinsvis 4-8. Den ønskede pH værdi kan opnås ved tilsætning af en pufferopløsning, såsom natriumphosphat. Reaktionsbetingelserne er ikke særlig begrænsede, men reaktionen udføres sædvanligvis mellem 0°C og 100°C i løbet af flere timer indtil 10 timer. Når B i fprmlen (Vi) er en heteroaromatisk N-oxid-thio-gruppe med en thiogruppe ved car-bonatomet nær N-oxidgruppen i molekylet, omsættes forbindelsen med formlen (VI) med forbindelsen (VII) i ovennævnte opløsningsmiddel i nærvær af en cupriforbindelse. Denne reaktion er særlig velegnet, hvis en alkohol, såsom methylalkohol, ethylalkohol, propylalkohol, isopropylalkohol, n-butylalkohol, benzylalkohol eller ethylenglycol, anvendes som forbindelsen med formlen (VII).Practical embodiments of variant (c) are as follows: When B of formula (VI) is different from a hetero-aromatic N-oxide thio group with a thio group at the carbon atom next to the N-oxide group in the molecule, the compound is reacted of formula (VI) having a compound of formula (VII) or a tertiary amine in at least one solvent, e.g. water, methanol, ethanol, propanol, isopropanol, butanol, acetone, methyl ethyl ketone, methyl isobutyl ketone, tetrahydrofuran, dioxane, acetonitrile, ethyl acetate, methoxyethanol, dimethoxyethane, dimethylformamide, dimethylsulfoxide, dichloromethane, chloroform or dichloro. The above reaction is preferably carried out in a highly polar solvent such as water. In this case, it is convenient to adjust the pH of the reaction mixture to 2-10, preferably 4-8. The desired pH value can be obtained by adding a buffer solution such as sodium phosphate. The reaction conditions are not very limited, but the reaction is usually carried out between 0 ° C and 100 ° C over several hours up to 10 hours. When B in the formula (Vi) is a heteroaromatic N-oxide thio group with a thio group at the carbon atom near the N-oxide group of the molecule, the compound of formula (VI) is reacted with the compound (VII) in the above solvent in the presence of a cupriforbindelse. This reaction is particularly suitable if an alcohol such as methyl alcohol, ethyl alcohol, propyl alcohol, isopropyl alcohol, n-butyl alcohol, benzyl alcohol or ethylene glycol is used as the compound of formula (VII).

I dette tilfælde forløber reaktionen glat ved anvendelse af overskud af alkohol, idet denne også virker som reaktionsmedium. Den ved fremgangsmåden anvendte cupriforbindelse kan være organisk eller uorganisk, såsom cuprichlorid, -bromid, -fluorid, -nitrat, -sulfat, -borat, -phosphat, -cyanid, -formiat, -acetat, propio-nat, -citrat, -tartrat, -benzoat eller -salicylat. Mængden af anvendt cupriforbindelse er fortrinsvis et halvt mol pr. mol af forbindelsen med formlen (VI). Reaktionstemperaturen og reaktionstiden kan varieres i afhængighed af arten af forbindelsen med formlen (VI), cupriforbindelsen og forbindelsen med formlen (VII), men som regel foretrækkes temperaturer mellem 0 °C og 100 °C, og reaktionstiden kan hensigtsmæssigt ligge mellem flere minutter og flere dage.In this case, the reaction proceeds smoothly using excess alcohol as it also acts as a reaction medium. The cupric compound used in the process may be organic or inorganic, such as cuprichloride, bromide, fluoride, nitrate, sulfate, borate, phosphate, cyanide, formate, acetate, propionate, citrate, tartrate , benzoate or salicylate. Preferably, the amount of cupric compound used is half a mole per minute. moles of the compound of formula (VI). The reaction temperature and reaction time can be varied depending on the nature of the compound of formula (VI), the cupric compound and the compound of formula (VII), but temperatures are preferably between 0 ° C and 100 ° C, and the reaction time may conveniently be between several minutes and more. days.

Reaktionsbetingelserne ved fremgangsmådevarianterne (a), (b) og (c) er ikke begrænset til de ovennævnte, men kan varieres i afhængighed af arten af reagenser.The reaction conditions of process variants (a), (b) and (c) are not limited to the above, but can be varied depending on the nature of the reagents.

Endvidere kan man let fremstille ugiftige salte med den ovennævnte formel (I), hvori er e.n saltdannende kation, på i og for sig kendt måde ud fra forbindelser med formlen (I), hvori R1 er et hydrogenatom eller en blokerende gruppe.Furthermore, one can readily prepare non-toxic salts of the above formula (I), which is a salt-forming cation, known per se from compounds of formula (I) wherein R 1 is a hydrogen atom or a blocking group.

22 1 5 1 3 3 822 1 5 1 3 3 8

Blandt forbindelserne med formlen (I) kan penicillinerne let fås ved en af de ovennævnte fremgangsmådevarianter (a) og (b), medens cephalosporinerne let kan fås ved enhver af varianterne (a), (b) eller (c).Among the compounds of formula (I), the penicillins can be readily obtained by one of the aforementioned process variants (a) and (b), while the cephalosporins can be readily obtained by any of the variants (a), (b) or (c).

I det efterfølgende er beskrevet undersøgelsesmetoden for aktiviteten af de omhandlede forbindelser.In the following, the study method for the activity of the compounds of the invention is described.

(1) De minimale inhiberende koncentrationer (MIC) af forbindelserne over for forskellige standardstammer er vist i tabellerne 3 og 4.(1) The minimum inhibitory concentrations (MICs) of the compounds against different standard strains are shown in Tables 3 and 4.

Den minimale inhiberende koncentration (MIC) blev bestemt ved en plade-metode, som er offentliggjort i "Chemotherapy" (Japan),The minimum inhibitory concentration (MIC) was determined by a plate method published in "Chemotherapy" (Japan),

Vol. 16, (1968), sider 98-99. Dyrkningsmediet var hjerteinfusionsagar (pH = 7,4). Antal celler pr. plade i podematerialet var ΙΟ4 (106 celler/ml).Vol. 16, (1968), pages 98-99. The culture medium was cardiac infusion agar (pH = 7.4). Number of cells per cell plate in the seed material was ΙΟ4 (106 cells / ml).

23 15133823 151338

'"Π ” & I&Quot; "

ft ft ' θ' Ο m I- 1 Φ cd ηι ο +3 ί)( Ο ι\| ιΗ Ο OH, η ft 3 Λ \/ft ft 'θ' Ο m I- 1 Φ cd ηι ο +3 ί) (Ο ι \ | ιΗ Ο OH, η ft 3 Λ \ /

ft ί> S Vft ί> S V

_Ο_____ ft Φ γΗ Cd ι—I ·Η φ ft ο ο·ο •γ-Ι Ο ο in ο ο 03 Ω S ™ <Μ Φ φ κ, Λ Λ Η ft ^ Μ 2J___ ω cd cd f5 m ο ο „ „ a so ο ο ο ο ·Η · Ο ιη m_Ο _____ ft Φ γΗ Cd ι —I · Η φ ft ο ο · ο • γ-Ο Ο ο in ο ο 03 <S ™ <Μ Φ φ κ, Λ Λ ^ ft ^ Μ 2J___ ω cd cd f5 m ο ο " „A so ο ο ο · Η · Ο ιη m

ΤΒ tiflfe OJIf tiflfe OJ

3 3 · Φ ίπ Μ Λ CQ Φ Ρη cd cd •ri *“3 jft t ri OH C- C- t> ft a tn m m φ ·3 3 · Φ ίπ Μ Λ CQ Φ Ρη cd cd • ri * “3 jft t ri OH C- C- t> ft a tn m m φ ·

Λ ί-F Η Η HΛ ί-F Η Η H

03 G \/ V03 G \ / V

fed V V _ ft cn 1 o ^ O C\1 c- c-bold V V _ ft cn 1 o ^ O C \ 1 c- c-

H in tn HH in tn H

>5 03 0C3 · · . * Λ 3 3 Η H tn ft O Φ> 5 03 0C3 · ·. * Λ 3 3 Η H tn ft O Φ

Cd O ft w \/Cd O ft w \ /

43 O 3 V V43 O 3 V V

cn o cd tncn o cd tn

rHrh

03 . r—> - - ,Q ft ft03. r—> - -, Q ft ft

cd ·Η -Hcd · Η -H

£4 --'•HH£ 4 - '• HH

ft Η Hft Η H

«Η *H *H«Η * H * H

, Η I O I O, Η I O I O

åd g 3 |3 tj-h "£.2 "^5 fd ft 43 % id |4 IS gråbreath g 3 | 3 tj-h "£ .2" ^ 5 fd ft 43% id | 4 IS gray

HH

(1) e n O cd cd ft iw å !2i a ft tn tno tn tno tn tno(1) e n O cd cd ft iw! 2i a ft tn tno tn tno tn tno

ft a BO a BO a W Oft a BO a BO a W O

jj 000 000 000 3 V-f νγjj 000 000 000 3 V-f νγ

Jj CQ I CQ I CQ IJj CQ I CQ I CQ I

+J \-& N-fe pl\ “Λ· 1 o o 1 o o o a o a o od 00 o tn a a a o a o+ J \ - & N-fe pl · Λ · 1 o o 1 o o a o a o od 00 o tn a a a o a o

O—a 0 — 0 C3 — CQO - a 0 - 0 C3 - CQ

(O) Co) Cot -Γ-1--*--- 0) ' (xoaq-TOH) fea x> I-,-1-—;-—-1-1-.151338, = I · -tø o ff) !> .0). I g iflI CM . Ln - 5 ™ ft -ilt « ' - - "> - ti >0(O) Co) Cot -Γ-1 - * --- 0) '(xoaq-TOH) fea x> I -, - 1 -—; -—- 1-1-.151338, = I · -to o ff)!> .0). In g according to CM. Ln - 5 ™ ft -ilt «'- -"> - ti> 0

^ £. V^ £. V

ω co O . .ω co O. .

I S § 02 w u. + tf £ •l-fg « - - o . . d o “I S § 02 w u. + Tf £ • l-fg «- - o. . d o “

fl. > ^ V V Vfl. > ^ V V V

'3 d - .'3 d -.

§ o £ Lo Lq Jo Lo§ o £ Lo Lq Jo Lo

S.E O lo .- ^ N · CN (M (MS.E O. lo .- ^ N · CN (M (M

-^^’li. Csl "Ό ^ sO so sO J-0 ω αϊ ^ ^ Æ « ' ci-.- ^^ 'li. Csl "Ό ^ sO so sO J-0 ω αϊ ^ ^ Æ« 'ci-.

“S l_ t> t> _ _ F> '£ — l2 Lo lo Lo - . Lo O) ~Q X _1 _1 O o o Ίδζνν V V V V v“S l_ t> t> _ _ F> '£ - l2 Lo lo Lo -. Lo O) ~ Q X _1 _1 O o o Ίδζνν V V V V v

UJUJ

J11 £ .'£ & t - ^ * 'g §-« Έ V V V v ' ft *-__· X · Z 2 χ 2 z 2 xx° £ £· 2 xx9 ·£ -P o .p -P o -P-Po ">->'o* .5X8 ajs. . 5Sa sjs 5ja 5ja Xs - ti · ·? . T ' t_ X » ' · s —i lT li Ρΐ Vi Vi Vi ‘ Μ V. —<%. —k_ —Is —k —k~ —k_ 0 o nq o o o o oJ11 £. '£ & t - ^ *' g §- «Έ VVV v 'ft * -__ · X · Z 2 χ 2 z 2 xx ° £ £ · 2 xx9 · £ -P o .p -P o - P-Po "> -> 'o * .5X8 ajs. 5Sa sjs 5ja 5ja Xs - ti · ·?. T' t_ X» '· s —i lT li Ρΐ Vi Vi Vi' Μ V. - <%. —K_ —Is —k —k ~ —k_ 0 o nq ooooo

ή X X X X x x Xή X X X X x x X

li i i l I i s 1 a 3-© g §-© § 5-© S |-@ § §-© s 5-@ § 5-© 4JZ 2 Z Z 2 X 2 “ 8 S 8 8 8 8 I ' <) £ » X> » X) X .li iil I is 1 a 3- © g §- © § 5- © S | - @ § §- © s 5- @ § 5- © 4JZ 2 ZZ 2 X 2 “8 S 8 8 8 8 I '<) £ »X>» X) X.

o* & af . d d X § co 0 ϋ 5 5 o. x! 0 -5 3? x ί § u ϋ o S £ i c -η ω , .o * & af. d d X § co 0 ϋ 5 5 o. x! 0 -5 3? x ί § u ϋ o S £ i c -η ω ,.

-0. ™ CO — cl 0Q xf- Lo sD-0. ™ CO - cl 0Q xf- Lo sD

m i—t * n sj o cd m i 3 π fa Ti c I ______ _ 25 __ 151338 « s t> 5 Q in t> O _L In ^Olo^ k ' Lr> O N . Lom i — t * n sj o cd m i 3 π fa Ti c I ______ _ 25 __ 151338 «s t> 5 Q in t> O _L In ^ Olo ^ k 'Lr> O N. lo

0] = I . u\ - - — N0] = I. u \ - - - N

-ώ 3 V- so _ - o o W-ώ 3 V- so _ - o o W

i I r v v ~v~ a.i I r v v ~ v ~ a.

w u) O ^ ί« ° E & ^ ^ 5 y £ z — — — ό ο _ οw u) O ^ ί «° E & ^^ 5 y £ z - - - ό ο _ ο

oli^v V V V Voli ^ v V V V V

! t --------1- S !! t -------- 1- S!

How . s K; « a a a -| ^Ll N vo 'so <n vo so so 0 ¢) ~* Æ« __ |.. b 5 B ' 6 - - B t 0) I A - - °, ® - oHow. s K; «A a a - | ^ Ll N vo 'so <n vo so so 0 ¢) ~ * Æ «__ | .. b 5 B' 6 - - B t 0) I A - - °, ® - o

Ο δ 7 X/ V V V V V VΟ δ 7 X / V V V V V V

W Z V -W Z V -

LULU

1 0- J δ S £ £ ^ t> y - ^ * Ί- as v .y v v ω ^_________.1 0- J δ S £ £ ^ t> y - ^ * Ί- if v .y v v ω ^ _________.

i d 4 4* d d d cf z z „ z z z z z< ^ .5^ 5 58 ξ&3 Sig ψβ Sig ϊβ-Ρ Q)(/j w tø (/) (λ ω tø μ V-Z V-;: V:: V:- V-Z V":: V":: · tj Ko - Ko Ko Ko Ko K° Koid 4 4 * ddd cf zz „zzzzz <^ .5 ^ 5 58 ξ & 3 Sig ψβ Sig ϊβ-Ρ Q) (/ jw tø (/) (λ ω tø µ VZ V-;: V :: V: - VZ V ":: V" :: · tj Ko - Ko Ko Ko Ko K ° Ko

% X X x X 5 XX% X X x X 5 XX

.rS z . x x S S z z gS 'S 8 8 o 8 8 ΰ s S-@ § §-<3> § §-© § S-® S S-@ s g 5-@i “i z i 2 g z z 8 8 8-8 § § 8.rS z. xx SS zz gS 'S 8 8 o 8 8 ΰ s S- @ § §- <3> § §- © § S-® S S- @ sg 5- @ i “izi 2 gzz 8 8 8-8 § § 8

X X) X X x X XX X) X X x X X

5 X x" f f g·. f ! © Ϊ 5 5 § ° s § s s s 3 s -1---- _ rt · •Η Φ •S”-o 00 o- £ - £! !25 X x "f f g ·. F! © Ϊ 5 5 § ° s § s s s s 3 s -1 ---- _ rt · • Η Φ • S" -o 00 o- £ - £! 2

O (DUO (DU

foTj ΰ 26 15 1338 g "ο I δ ^ ' Ν . 'Φ . S'foTj ΰ 26 15 1338 g "ο I δ ^ 'Ν.' Φ. S '

Jl* ei " * ? . få S ° ft ^ S- W V) t>Jl * ei "*?. Get S ° ft ^ S- W V) t>

ir n fs 0s* . O O o CNir n fs 0s *. O O o CN

O n ' Lo O· O ISO n 'Lo O · O IS

K O o , d o 6K O o, d o 6

£L § & V V£ L § & V V

§ c? s: w i/) · Ln .§ c? s: w i /) · Ln.

I.? O li) · . . Μ i/) · £N Lo HIN.? O li) ·. . Μ i /) · £ N Lo H

“I t*H - " il fN ^ ^ si <U (U ; “ Æs Λ Ί-h ' g; .g: t > + 4 «- " •S 8 g ώ $ V “ 5 d 6"In t * H -" il fN ^^ si <U (U; "Æs Λ Ί-h 'g;. G: t> + 4« - "• S 8 g ώ $ V“ 5 d 6

LULU

O nO n

o y o* . Qx (S O CSo y o *. Qx (S O CS

t . ^ . [> ES £ κ ~X ir ^ ° ° o - o O ot. ^. [> ES £ κ ~ X ir ^ ° ° o - o O o

Ί- tf g V V _VΊ- tf g V V _V

^ = - .. ,.^ = - ..,.

' x- . I n Q · Q · (o) I δ 2 5 -f 3 M ° o g o o .-¾ - o<| x ^ Si -p P x o-| ° 5 5 o o · .¾'x-. I n Q · Q · (o) I δ 2 5 -f 3 M ° o g o o.-¾ - o <| x ^ Si -p P x o- | ° 5 5 o o · .¾

-g -P o P P O -g -P o m"0 ""O « « c *> ·? O-g -P o P P O -g -P o m "0" "O« «c *> ·? O

. “Χδ “Lp ^Xs “Ja 5Χδ 5|s 5j5S. “Χδ“ Lp ^ Xs “Yes 5Χδ 5 | s 5j5S

u \i il il Q u il.; 1 Ko .'i Ko Ko Ko Kq Ko Ko X- ' Χ X X -X X xu \ i il il Q u il .; 1 Ko .'i Ko Ko Ko Kq Ko Ko X- 'Χ X X -X X x

S 8 8 I 1.1 I SS 8 8 I 1.1 I S

I af© §§-© Sf® §f® §f® §f® §5-® 3 Z O 2 ° 8 O O · s K 50 50 50 S 50 Si x"> £ ^ f> £ 'Ί x1 o o o U O 5 o ro ' X 3? O 6 i ' “ " 1 :I of © §§- © Sf® §f® §f® §f® §5-® 3 ZO 2 ° 8 OO · s K 50 50 50 S 50 Si x "> £ ^ f> £ 'Ί x1 ooo UO 5 o ro 'X 3? O 6 i' “" 1:

CC

-HQ)·.-Hq) ·.

m“ . L {£) ^0 I> OO o- Om ". L {£) ^ 0 I> OO o- O

O 0) U ~ CNO 0) U ~ CN

C___ _!____27 —.__ 151338 —'2 o · i ^ ^C___ _! ____ 27 —.__ 151338 —'2 o · i ^^

<0 o S 1Λ , ~ LO . fNJ<0 o S 1Λ, ~ LO. FNJ

-If)1- d ^ w - ft-If) 1- d ^ w - ft

Si v t r—-^-- --1 1 i j ω co t> ['—. (v.Si v t r —- ^ - --1 1 i j ω co t> ['-. (V.

| X§ 2 £ 2 2 2 B £ 2 i O w v ° ^ I CL > ^ v i——- w a a o § o . . . ίο lo S.EOlr) io lo CM CM N io ~1 ϊΓ H °* ^ — νό I vO J \£) I £4 tl) QJ * & s % ._ b 3j- . C> L/> ^ ~ L)| X§ 2 £ 2 2 2 B £ 2 i O w v ° ^ I CL> ^ v i ——- w a a o § o. . . ίο lo S.EOlr) io lo CM CM N io ~ 1 ϊΓ H ° * ^ - νό I vO J \ £) I £ 4 tl) QJ * & s% ._ b 3j-. C> L /> ^ ~ L)

Qj-^Xo d — 0 — m —Qj- ^ Xo d - 0 - m -

-50.5 V V V V V V-50.5 V V V V V V

w <c v LU . · ^ t> ,4.-- c- _ 0 g 3 0 t> in x lo . ίο d 6 - 0 -_i 0 ^w <c v LU. · ^ T>, 4 .-- c- _ 0 g 3 0 t> in x lo. ίο d 6 - 0 -_i 0 ^

“a. g V V v ^ V V V"A. g V V v ^ V V V

£ Ll if)£ Ll if)

. φ ' I. φ 'I

NN

5 I 4 -Sf «i -5 ci ο X x z ^ x 25 I 4 -Sf «i -5 ci ο X x z ^ x 2

» JJ o J5 ί> O "><50 4? .2 Q ""O J2 J? o J?J? O»JJ o J5 ί> O"> <50 4? .2 Q "" O J2 J? O J? J? O

SXs 5J8 5AS ^ 5^8 Jig 5^8SXs 5J8 5AS ^ 5 ^ 8 Jig 5 ^ 8

Vj, *0 Q * O C-l WW:Vj, * 0 Q * O C-l WW:

H "ί-o H*o · Ko |“^o KH "ί-o H * o · Ko |" ^ o K

2 I I X 5 5 χχ· oR 8-8 S § 8 8 § 5-© § o-O a ο-ζΡ e o-<g) g |-<g> s 5-<§>-o § P Z Z .2 Z 2 2 z 0 8 8 8 8 ^ 8 8 02 IIX 5 5 χχ · oR 8-8 S § 8 8 § 5- © § oO a ο-ζΡ e o- <g) g | - <g> s 5- <§> -o § PZZ .2 Z 2 2 z 0 8 8 8 8 ^ 8 8 0

5 -JO X) X X>" X X X5 -JO X) X X> "X X X

Ί £ ί α Ϊ 5"· δ .¾ U χ* υ ϋ 5 ° j C! · !q w — cm 00 4- in . . v£> t>Ί £ ί α Ϊ 5 "· δ .¾ U χ * υ ϋ 5 ° j C! ·! Q w - cm 00 4- in. V £> t>

Mr-t.N <N CM 04 CN CM (MMr-t.N <N CM 04 CN CM (M

0 a; m fe xs c: _____ | ___ϋ__ 151338 c5 v —; '5 q m , . O" o- , i/i0 a; m fe xs c: _____ | ___ ϋ__ 151338 c5 v -; '5 q m ,. O „o-, i / i

i O Ifl ~ / Φ t> [> <Ni O Ifl ~ / Φ t> [> <N

-S 3 y- οο ό o o ^ c\| Μ a_ j----------:- I.-S 3 y- οο ό o o ^ c \ | Μ a_ j ----------: - I.

! ω <0 1> ! ‘ ffl k O bl Γ0 O" £* t> C" ?> il«, v d 6 ~ " v g d! ω <0 1>! 'Ffl k O bl Γ0 O "£ * t> C"?> Il «, v d 6 ~" v g d

. 11 o io 2 C2 52 lo S. 11 o io 2 C2 52 lo S

Ί 15¾ ^ "ϊ Λ3 Λ) N iQ >0 Φ at — 1-b 5 · s - 5 B B 5 g) ~q X _< O O O — __Ί 15¾ ^ "ϊ Λ3 Λ) N iQ> 0 Φ at - 1-b 5 · s - 5 B B 5 g) ~ q X _ <O O O - __

-f8zv V .V V V V V-f8zv V .V V V V V

lil .lil.

1 £L1 £ L

8 il I i t t " B . Ef B8 il I i t t "B. Eph. B

|S2 v d ° ° v v v &*-_____i_ p>| S2 v d ° ° v v v & * -_____ i_ p>

XX

SS

o (8> 8o (8> 8

4 ~r $ r? °<| 5 <S4 ~ r $ r? ° <| 5 <S.

Z z z Z o-| 5 z "? J? o -P-PS -P -r o ·? -? o 4? -5 o "«o *> " o 5Xa ^£s ψ& πβ& sfa sis W w i tø co c/ι cø w ^ w w ' y-f y? y? y? i Ko Ko Ko Ko Ko K° KoZ z z Z o- | 5 z "? J? O -P-PS -P -ro ·? -? O 4? -5 o" «o *>" o 5Xa ^ £ s ψ & πβ & sfa sis W wi tø co c / ι cø w ^ ww 'yf y? y? y? i Ko Ko Ko Ko Ko K ° Ko

nx X ' x x X 5 Xnx X 'x x X 5 X

°ZX ΖΓ Z Z Z ^ 8 o o o g g I s|J? § g-® s|® §f® §|® §"-© §1-® ” * d5 K K K :ΰ s 1 Λ ^ χ1 A χ O O fil u o o° ZX ΖΓ Z Z Z ^ 8 o o o g g I s | J? § g-® s | ® §f® § | ® § "- © §1-®" * d5 K K K: ΰ s 1 Λ ^ χ1 A χ O O fil u o o

Si, j ^ i <P ">Si, j ^ i <P ">

5 5 & 3 S5 5 & 3 S

___I______ i β Λ ra OO O o — ol Γ0 xf· nin · CM Csi ro ro ro to ro 0,(U S-t 1¾¾ s _ ___ 29 ,___^-!__,..taJ338 β g "a i 8 in ^ Μ m to t* vd * 8 5 J {5 N vO ' w> 10 ^ i i|r ; v ~ j ^ 3- j__~______ i 1 Γ~ j j w V) l> ! li% as s s. £..5 5 s I ? δ - - - ^ V V ° 8 d ' - sz o I·- O io 10 · ΙΌ . ,. ΙΛ "ijji cvi <N £4 (¾ N N ft___I______ i β Λ ra OO O o - ol Γ0 xf · nin · CM Csi ro ro ro to ro 0, (U St 1¾¾ s _ ___ 29, ___ ^ -! __, .. taJ338 β g "ai 8 in ^ Μ m to t * vd * 8 5 J {5 N vO 'w> 10 ^ ii | r; v ~ j ^ 3- j__ ~ ______ i 1 Γ ~ jjw V) l>! li% as s s. £ .. 5 5 s I? Δ - - - ^ VV ° 8 d '- sz o I · - O io 10 · ΙΌ.,. ΙΛ "ijji cvi <N £ 4 (¾ NN ft

Q) QJQ) QJ

(£ « d ~ h O' O' g P~ P* O'.(£ «d ~ h O 'O' g P ~ P * O '.

Z χ rø Λ7 W ^ ^ ^ °2Z χ rø Λ7 W ^ ^ ^ ° 2

Γ2 °.· ° V V VΓ2 °. · ° V V V

HIHI

i q.i q.

J lag £ s P'S 5 & 'J lag £ s P'S 5 & '

° ° V V V° ° V V V

<8 ^ · _____]___[___ z z: z 2 Z Z z<8 ^ · _____] ___ [___ z z: z 2 Z Z z

;; o irS ÆxS £χο xxS -r-Ps xxS;; o irS ÆxS £ χο xxS -r-Ps xxS

5Xs sia 5Sa s ja s Ss $IJ ^§a5Xs sia 5Sa s yes s Ss $ IJ ^ §a

(/) W W <0 CO I (0 CO I(/) W W <0 CO I (0 CO I

y-z w yi' yi y? yi μ : Ht rs= ns H»o H*o n° 1¾ g I I ' x x 5 .5 x 8 8 i I I I I 8 fj §y@ § s.® § |h@ ' §s-® § §-© §f® . §y-z w yi 'yi y? yi µ: Ht rs = ns H »o H * on ° 1¾ g II 'xx 5 .5 x 8 8 i IIII 8 fj §y @ § s.® § | h @' §s-® § §- © § f®. §

5 : Z Z 2 Z 2* Z Z5: Z Z 2 Z 2 * Z Z

t<50 o O Q o Ot <50 o O Q o O

gSoooOoo * X X) X X) X Ό Ό J3 x 5 3 ? Of. 0 o ^ s ^ S 5 A, 5 3" g 3’ S' <sl .gSoooOoo * X X) X X) X Ό Ό J3 x 5 3? Of. 0 o ^ s ^ S 5 A, 5 3 "g 3 'S' <sl.

__ - ; ~ 7 · •rl <U . ^ Λ in in vD £r- 00 o- 0 — M H · CO CO CO 10 ro ip xh 0 0) u ' 1¾¾ gj_______ ,___:_I_:_30_^__ 151338 ί is__ -; ~ 7 · • rl <U. ^ Λ in in vD £ r- 00 o- 0 - M H · CO CO CO 10 ro ip xh 0 0) u '1¾¾ gj_______, ___: _ I _: _ 30 _ ^ __ 151338 ί is

I O I g io 10 ^ rø lo lo HI O I g io 10 ^ rø lo lo H

! J|>- ^ N >0 ti d ^ ri m S- ί ;___________ ... — .... > .. -........—.— . - —Ϊ i . —.! J |> - ^ N> 0 ti d ^ ri m S- ί; ___________ ... - ....> .. -........ — .—. - —Ϊ i. -.

i ιο ϋ) t> S S S fi £ 2 j£|g« - --- - - 7 » i________ • If £ {Q " Ϊ} ’ oj. Ί S 5 QJ G) £s e “S h 00 00 o~- C- r> "£ IZ -2 ^ C> t> m CO lo Lr) 185v ° . o ° ° v f LLi i. 1 o.i ιο ϋ) t> SSS fi £ 2 j £ | g «- --- - - 7» i________ • If £ {Q "Ϊ} 'oj. Ί S 5 QJ G) £ see“ S h 00 00 o ~ - C- r> "£ IZ -2 ^ C> t> m CO lo Lr) 185v °. o ° ° v f LLi in. 1 o.

i i s I ε s g g g e «i i s i ε s g g g e «

Ils v ° d ·ό v å 1 , __ i i . i i i i iIls v ° d · ό v å 1, __ i i. i i i i i i

4? -P O T-rS ΓΤ O ·£> -? O -P -P O -P-Po ""O4? -P O T-rS ΓΤ O · £> -? O -P -P O -P-Po "" O

SXs Ά£β 5^8 δ S s sgg 5 g§ 5X8 tø w tø co μ ω w W V-;- V-;r * V-:: \_Z \—:i \—2 1 Ko Ko Ko Ko Ko K°- Ko ol 5 · . i έ Ι i i Ή 8 8 8 8 8 8 8 S s^g> §S^ gf-<g> § §5^5) §„-© §5-@SXs Ά £ β 5 ^ 8 δ S s sgg 5 g§ 5X8 tø w tø co µ ω w W V -; - V-; r * V- :: \ _Z \ -: i \ —2 1 Ko Ko Ko Ko Ko Ko K ° - Ko ol 5 ·. i έ Ι i i Ή 8 8 8 8 8 8 8 S S ^ g> §S ^ gf- <g> § §5 ^ 5) § „- © §5- @

z 2 Z 2 2 2 Zz 2 Z 2 2 2 Z

Γ.Ο o o O *7 O OΓ.Ο o o O * 7 O O

W O O O O o o o * *0 °0 Ό *0 \) “0 Q o o o o oN ^W O O O O o o * * 0 ° 0 Ό * 0 \) “0 Q o o o o oN ^

cl O o Cj W · Icl O o Cj W · I

5 g 3* $ xn i S5 g 3 * $ xn in S

o H 3 U· -O O £ ___o 1 g g ι a___° 15. i ? $ $ # $ $ O Cl) 5-1 (¾¾ c ·_______JL_:_L—___ _____,_-.31 _ 15133fto H 3 U · -O O £ ___o 1 g g ι a ___ ° 15. i? $ $ # $ $ O Cl) 5-1 (¾¾ c · _______ JL _: _ L —___ _____, _-. 31 _ 15133ft

' - I'- I

j | 6> f\ of L·) Lo Ln Ui ! J ! ^ * νό * ΰ - - d ; ^ S.j | 6> f \ of L ·) Lo Ln Ui! J! ^ * νό * ΰ - - d; ^ S.

I-------- ! Ill - B = S g 2 !Ifδ v - ° i ' i > ____________________________ .I --------! Ill - B = S g 2! Ifδ v - ° i 'i> ____________________________.

8 d 11 o *> u, JQ 2 -§'fX X 2- ft ΰ s6 j ft qj <u & a £ ~0 i_ O- t> Ο £- _rto r - 5 b) w Lo u) - , £ <d *n x _: -i __: _i ο o8 d 11 o *> u, JQ 2 -§'fX X 2- ft ΰ s6 j ft qj <u & a £ ~ 0 i_ O- t> Ο £ - _rto r - 5 b) w Lo u) -, £ <d * nx _: -i __: _i ο o

-§Ogv v v V V V Q-§Andv v v V V V Q

LULU

111¾ B § ' ' <? > g g |ls V V V v ·° ' ° ώ _l_^______ <d 4 _£ <i 4 d 4 z z z z 2 2; x111¾ B § '' <? > g g | ls V V V v · ° '° ώ _l _ ^ ______ <d 4 _ £ <i 4 d 4 z z z z 2 2; x

<P"?0 •r’-rS -P -r ° -£ -? Ο -P -P O -r-?0 -τ’-PS<P "? 0 • r'-rS -P -r ° - £ -? Ο -P -P O -r-? 0 -τ'-PS

i 5X8 sXa 5Χδ <Xs 5Xa sXa ^ls i vi · W v-l ·· V:: γΐ \-:ι V:: 6 ί Ro Ro Ko Ko" Ro Ro Roi 5X8 sXa 5Χδ <Xs 5Xa sXa ^ ls i vi · W v-l ·· V :: γΐ \ -: ι V :: 6 ί Ro Ro Ko Ko "Ro Ro Ro

£ j X X . X X x X X£ j X X. X X x X X

S ] I I I I I I IS] I I I I I I I I

I e 5h§) g §-@ § S-@ g §-® S 5-® g $-<5) § S-@>In e 5h§) g §- @ § S- @ g §-® S 5-® g $ - <5) § S - @>

ί 5 2 2 Z Z Z Zί 5 2 2 Z Z Z Z

]j o 8 8 8 § O o -£ jO «0 Æ 10 XiSi 3X 00 i 'S ϊ X g ~ g € s a A L-J j? 3? £ ¥ i @ ° u S 4 υ o υ i : p •H 0) -P“cr· P T- M <Y) d* lo ^ ^ Ψ ^ ^ lo JO ft ^] j o 8 8 8 § O o - £ jO «0 Æ 10 XiSi 3X 00 i 'S ϊ X g ~ g € s a A L-J j? 3? £ ¥ i @ ° u S 4 υ o υ i: p • H 0) -P “cr · P T- M <Y) d * lo ^ ^ Ψ ^^ lo JO ft ^

1¾¾ G1¾¾ G

__32 __151338 _ί S \ il 82 ™ ί2 ft ™ i. \ V) § I , — \ φ >* ^ ΓΟ 09 νθ (Υ) Η \ - \ !________\ | οι to ΐ> \ i lp iå 2 2. 2 ™ ft \ ί ε 3 Φ - ή 'ri ri ni S0 \ |11>υ '· \ | ------ ---“--:----—->------- S d \__32 __151338 _ί S \ il 82 ™ ί2 ft ™ i. \ V) § I, - \ φ> * ^ ΓΟ 09 νθ (Υ) Η \ - \! ________ \ | οι to ΐ> \ i lp iå 2 2. 2 ™ ft \ ί ε 3 Φ - ή 'ri ri ni S0 \ | 11> υ' · \ | ------ --- “-: ----—-> ------- S d \

Il O 52 ' 2 52 % L·) \ "§ ?h .-ri ri ri vi ^ ri \ Æs \ d \ 1=5 N. » « S' n E \ U z v \Il O 52 '2 52% L ·) \ "§? H.-Ri ri ri vi ^ ri \ Æs \ d \ 1 = 5 N.» «S a E \ U z v \

LU VLU V

____;______\ p fl_ r ·\____; ______ \ p fl_ r · \

Jfli £ S S. IS ' tg - E \ |asi 6 - - - - v \ å h . \ I -rm- i i \ i · \ ! d d 4 (S 4 . \ i Z z Z Z z 4 \ i <5^0 -P -? O -5-? O -p -2 o p p o P"0 \ | .^XS SXp 5Ss 5js 5*8 \ ( I vi Cl y ' v: . Cj Cl \ (D « o I 'o I so I o o \ six r X x ac x \ M ! z z z z z z \ 0 ; g Q O O 8 O \ 1 ; 8S-© §f-® S§-® S§® S|-<§> s|® \ i li g i it s € 1 g \ 8 i^Sr^Xr^Xi85 j:; jO \ r s" s1 i o § X \ ! ϊ ί δ 5* f ^ \ i_____|___,_}Jfli £ S S. IS 'tg - E \ | asi 6 - - - - v \ å h. \ I -rm- i i \ i · \! dd 4 (S 4. \ i Z z ZZ z 4 \ i <5 ^ 0 -P -? O -5-? O -p -2 oppo P "0 \ |. ^ XS SXp 5Ss 5js 5 * 8 \ ( I vi Cl y 'v:. Cj Cl \ (D «o I' o I so I oo \ six r X x ac x \ M! Zzzzzz \ 0; g QOO 8 O \ 1; 8S- © §f-® S§-® S§® S | - <§> s | ® \ i li gi it s € 1 g \ 8 i ^ Sr ^ Xr ^ Xi85 j:; jO \ rs "s1 io § X \! Ϊ ί δ 5 * f ^ \ i _____ | ___, _}

« X«X

•Η Φ _ \ Ætno r> Qa cn o — \ S-< I—1 · -Lo Dj X/J lo vO vO N.• Η Φ _ \ Ethno r> Qa cn o - \ S- <I — 1 · -Lo Dj X / J lo vO vO N.

O 0) H \ fa tj d ____[_[_____s^ "ΤΓΊ-^^-Π13.....I-. I 151336 !(? & & ' ε 2 2 2 κ ΙΐΛ · V ν - ^ m 3 g „22« & <d /το Ο O O > '· £-fz £ o O Ο Λ, W ΛίO 0) H \ fa tj d ____ [_ [_____ s ^ "ΤΓΊ - ^^ - Π13 ..... I-. I 151336! (? & & 'Ε 2 2 2 κ ΙΐΛ · V ν - ^ m 3 g „22« & <d / το Ο OO> '· £ -fz £ o O Ο Λ, W Λί

•£L > <& NN• £ L> <& NN

Se s: i .§ o g o § S *0 ’ 1Λ o §§·& S 8 N ^ w N · β 1¾ Λ Λ Α /«· “5 Hj [> £> fO . _ o- r - I uo 'Lo Lb ' ~". - . J> - o m _i _j. _i to c> . q ^ •5 ° z v V V λ V V V · • m -_·. . , .See s: i .§ o g o § S * 0 '1Λ o §§ · & S 8 N ^ w N · β 1¾ Λ Λ Α / «·“ 5 Hj [> £> fO. _ o- r - I uo 'Lo Lb' ~ ". -. J> - o m _i _j. _i to c>. q ^ • 5 ° z v V V λ V V V · • m -_ ·..,.

: r : - ..: r: - ..

£l.£ l.

8¾ O' £r t> D~ t> .O'' r^ O·.·8¾ O '£ r t> D ~ t> .O' 'r ^ O ·. ·

J g § ^ · *-0 ^ Lo I> - · R OJ g § ^ · * -0 ^ Lo I> - · R O

"ti å V -V v V ° ° +» LL 09 e1 X* "> o 5 § 5 S li, j^s g 5 -Ti, g . 8 8 H @ 8 8 H ."ti to V -V v V ° ° +» LL 09 e1 X * "> o 5 § 5 S li, j ^ s g 5 -Ti, g. 8 8 H @ 8 8 H.

o o (b © Z o o (/) -rt* _H _*« ri f« rt ? zz y ~£ P z® p© S zÉ .o 2 ^ (0 y-8 (oy-8 M 'y-S ifly-3 W y-υ w y- S U)y-δ 1 ft ' ft ft ft ft ft ft B x° x° x ° x° x° x° ±°oo (b © Z oo (/) -rt * _H _ * «ri f« rt? zz y ~ £ P z® p © S zÉ .o 2 ^ (0 y-8 (oy-8 M 'yS ifly- 3 W y-υ w y- SU) y-δ 1 ft 'ft ft ft ft ft ft B x ° x ° x ° x ° x ° x ° ± °

SgESSSSSSgESSSSS

H O · O O O O O OH O · O O O O O O

I §!-<§> έ i $“ &s-®. gs^ §!_© -s 3? μ i J g i ' i u Jj u JJ 55.I §! - <§> έ i $ “& s-®. gs ^ §! _ © -s 3? µ i J g i 'i u Jj u JJ 55.

f δ ί o g I = 4 cd cd t C O Z ““7 V" "7^ •H 0) _>N I Ίμ , O , ? 85 . J i J ' * j - . <N ro g-cfl 1 3 1 j 1 o 1^1___ ' _ 34 _ 151f δ ί o g I = 4 cd cd t C O Z ““ 7 V "" 7 ^ • H 0) _> N I Ίµ, O,? 85. J i J '* j -. <N ro g-cfl 1 3 1 j 1 o 1 ^ 1 ___ '_ 34 _ 151

_d S_d S

i» I e s: r w o- s: vo -g a > O .. -: Λ9 o 5 v — 55·· v v 3 ^ n t> _ l> ^ ov ^ | £ S ^ ^ 2 R & R t> p Ji° x — ' ή ' ~ — ° di »I e s: r w o- s: vo -g a> O .. -: Λ9 o 5 v - 55 ·· v v 3 ^ n t> _ l> ^ ov ^ | £ S ^ ^ 2 R & R t> p Ji ° x - 'ή' ~ - ° d

ί I * . Μ ^ V V Vί I *. Μ ^ V V V

1 g ^1 g ^

Jig s ft ft ft. d 5 1 if* __ ci h> -O'- _ o 0" Ov O'- f.Jig s ft ft ft. d 5 1 if * __ ci h> -O'- _ o 0 "Ov O'- f.

r ~ i t* ' S ' o t> Rr ~ i t * 'S' o t> R

ί (fi. H o ° - o 6 o ^ |°Z· V V ° v V v hi ' % 'ί (fi. H o ° - o 6 o ^ | ° Z · V V ° v V v hi '%'

§ CL§ CL

8^o ?: R μ ' t> s- £ 8 K r> — J> Lr>· t> c>8 ^ o ?: R µ 't> s- £ 8 K r> - J> Lr> · t> c>

>v_> C) ' ' rv ό O> v_> C) '' rv ό O

-fig v ° v v '~ v v $ ^_I_i__^_ ψ ζ· £H a u* 3 3 % a ©"2 3 g, _°ί yi ,® 4. 5 ί _J> ® /" z ,5 ^ co y-8 to y-8 w Ny-8 to ^-8 to y-8 w y-8 w y-8 1 ft ft R ft ft ft ft g X ° X ° x° x ° X ° X ° x ° *2 g § I g- I I § I g O-® e e 5~<o> § oRo) § 5Ro> § §-<o> § |-® szzzzzzz-fig v ° vv '~ vv $ ^ _I_i __ ^ _ ψ ζ · £ H au * 3 3% a © "2 3 g, _ ° ί yi, ® 4. 5 ί _J> ® /" z, 5 ^ co y-8 to y-8 w Ny-8 to ^ -8 to y-8 w y-8 w y-8 1 ft ft R ft ft ft ft g x ° X ° x ° x ° X ° X ° x ° * 2 g § I g- II § I g O-® ee 5 ~ <o> § oRo) § 5Ro> § §- <o> § | -® szzzzzzz

MO Q Ο Ο „ Ο Ο OMO Q Ο Ο Ο Ο O

+jo S> 2 Οχ1 ο ο o β JO X» Tf X> X 5? „ . g □? £> x* nf+ jo S> 2 Οχ1 ο ο o β JO X »Tf X> X 5? ". g □? £> x * nf

So O o O « 5 5 5 . 1 1 ‘ c -H (!) fj“ . ψ L0 vD [> CO 2.So O o O «5 5 5. 1 1 'c -H (!) Fj'. ψ L0 vD [> CO 2.

0 CD M 1¾¾ fi __ 35' _ 151338 j <ϋ _β _α ϋ § S sO . Ρ~ £> , ηΟ '^§|L0 Lo Ln to sf- " ~ -g S > -: - - o <=> trj it V V Ό ”? 2 J i> o t> c> ^ o ·£ SL 07 · *·° Lo Lo !> ^ Li) £ ~ ^ .°. - - —1 d O -0 CD M 1¾¾ fi __ 35 '_ 151338 j <ϋ _β _α ϋ § S sO. Ρ ~ £>, ηΟ '^ § | L0 Lo Ln to sf- "~ -g S> -: - - o <=> trj it VV Ό"? 2 J i> ot> c> ^ o · £ SL 07 · * · ° Lo Lo!> ^ Li) £ ~ ^. °. - - —1 d O -

£L > * V V£ L> * V V

3 * I O lo s c o . , , N lo •fffc β 5¾ M. ^ CL ft i§ [ _ "5 Η cn _ i> · t· · , <>. o 'C — Z t> / Lo lo ^ Jj, x fi H ό -.°. — — d Q — *5°zv v v v v v 111 > ___ -o H.3 * I O lo s c o. ,, N lo • fffc β 5¾ M. ^ CL ft i§ [_ "5 Η cn _ i> · t · ·, <>. O 'C - Z t> / Lo lo ^ Jj, x fi H ό - . °. - - d Q - * 5 ° zv vvvvv 111> ___ -o H.

Q V cs I** CN D*Q V cs I ** CN D *

Lo B) Z ^ w ^§^° d - - .° ' ° -Lo B) Z ^ w ^ § ^ ° d - -. ° '° -

t-<S ^ V V v v Vt- <S ^ V V v v V

+> LL+> LL

ω -τ’ m η Η_ 5 5 |=^ Ζ=( Ζ=< ζ=^ ί Ζ=\ ?=\ £ ?=\ X1 W |Λ ] « I ζ-ο Ο I ζ-δ Ι_?"υ ζΐ η η η *1 η Λ jfi Ji Jé Ji J4 Ji Jt, co y-δ iTiu w γ-8 w y-o w V-δ ω y-δ tø \"δ v-2 y·/ Vf γ-f Y~f Yf Vf S x ° x ° x° x° i ° i ° x ° .ω -τ 'm η Η_ 5 5 | = ^ Ζ = (Ζ = <ζ = ^ ί Ζ = \? = \ £? = \ X1 W | Λ] «I ζ-ο Ο I ζ-δ Ι_?" υ ζΐ η η η * 1 η Λ jfi Ji Jé Ji J4 Ji Jt, co y-δ iTiu w γ-8 w yo w V-δ ω y-δ t0 \ δ v-2 y · / Vf γ-f Y ~ f Yf Vf S x ° x ° x ° x ° i ° i ° x °.

o| 11 § I 1 Io | 11 § I 1 I

H § §-© § §-© s g-® § §-® § §-© S 5-© s Λ1 z z z z z z z ίο O O O o o oH § §- © § §- © s g-® § §-® § §- © S 5- © s Λ1 z z z z z z z ίο O O O o o o o

MOOOOOCJOMOOOOOCJO

s Λ 55 35 55 30 55 55 * ! i> é ! I é -1--- ri ' H d) -g ® _ — cm oo ·φ in · l>s Λ 55 35 55 30 55 55 *! i> é! I é -1 --- ri 'H d) -g ® _ - cm oo · φ in · l>

OtUri __ ~ .OtUri __ ~.

1¾¾ ri _· _ 36 _ 151538 d ϋ <u § ίο — ^ ™ IT' ηα ii ξι .· ' , Lo — ^ Ν i|v ™ 00 V ° d 'Γ S _L m m F' rr> i> r> # ± m T - - In - lo f>1¾¾ ri _ · _ 36 _ 151538 d ϋ <u § ίο - ^ ™ IT 'ηα ii ξι. ·', Lo - ^ Ν i | v ™ 00 V ° d 'Γ S _L mm F' rr> i> r > # ± m T - - In - lo f>

£-5^0 ^ no - r> - Z£ -5 ^ 0 ^ no - r> - Z

fl_ I * 3 « 1 s: <o o o Lo , _ S £ p Λ , ^ i/7 iiwvi ^ (M - S N ^ 1 s d “5 H O r> [> t> r ~ I ~ ^ Lo b? ^ Lo — «Jomo — z __: — ofl_ I * 3 «1 s: <ooo Lo, _ S £ p Λ, ^ i / 7 iiwvi ^ (M - SN ^ 1 sd“ 5 HO r> [> t> r ~ I ~ ^ Lo b? ^ Lo - «Jomo - z __: - o

ϋ ° z v v v v v v Vϋ ° z v v v v v v V V

ill t __ ; 8 a_ i o 2 E> £> [Τ' t~ C~ O t-'.ill t __; 8 a_ i o 2 E> £> [Τ 't ~ C ~ O t-'.

_2 £> § Lo b) Lo Lo Lo Lo LO£ 2> § Lo b) Lo Lo Lo Lo LO

~§-0 V 'V V V ' V V~ §-0 V 'V V V' V V

P LL LOP LL LO

JJ

fU f>x fix Π= fi r-, ll-l ±=( i=( M i=< L=K to) ±=Ρ 3 j. S 3. 3 ®? 3 _? 2 _y Ί _i z p z _S g /S © ,δ ^ «ΓΪ8 <Ty§ «'"i-s tTVl '«TVS cTt§ cTi§ V-z Vz V? V-z V-z \~i Vz i λ 4 -I 4 4 R 4 5 g S i |· i i ifU f> x fix Π = fi r-, ll-l ± = (i = (M i = <L = K to) ± = Ρ 3 j. S 3. 3 ®? 3 _? 2 _y Ί _i zpz _S g / S ©, δ ^ «ΓΪ8 <Ty§« '"is tTVl'« TVS cTt§ cTi§ Vz Vz V? Vz Vz \ ~ i Vz i λ 4 -I 4 4 R 4 5 g S i | · iii

I § §Ko>-£ s |^o> e o-{o> § 5-<o> s 5h@> § |-<g> SIn § §Ko> - £ s | ^ o> e o- {o> § 5- <o> s 5h @> § | - <g> S

pzxxxzzz lhq o o o q o o -u o o o o8 o o " » » » » S » » X · n? x" g" af0 3? 5"pzxxxzzz lhq o o o q o o -u o o o o8 o o "» »» »S» »X · n? x" g "af0 3? 5"

$ ° ° x"3 ° £ S$ ° ° x „3 ° £ S

δ ° δ a? o ! : s' -H 0 X^OQ (Y- O — CM Γ0 <4- g^ - - S N CN CM ^δ ° δ a? o! : s' -H 0 X ^ OQ (Y- O - CM Γ0 <4- g ^ - - S N CN CM ^

føT3 Sfet3 S

___ 37 · _ 151338___ 37 · _ 151338

J <u ¢5 OJ <u ¢ 5 O

"i o fi ί- 0“~ . , Λ. ro -¾ 5 » O c- ^ ^ l> - -g « > o O 6 o o 6 Λ) 5 §- w « gr ."i o fi ί- 0“ ~., Λ. ro -¾ 5 »O c- ^^ l> - -g«> o O 6 o o 6 Λ) 5 §- w «gr.

lis fe 2 fe fe £ = Slis fe 2 fe fe £ = S

di 3 ·' «' " S « i § Lo ro E * o lo , ^ - if-fc d g ^ n i! 8di 3 · '«'" S «i § Lo ro E * o lo, ^ - if-fc d g ^ n i! 8

r£§ Ir £ § I

i ^ , jj £ 2 o o 6 O 6 6i ^, jj £ 2 o o 6 O 6 6

•5°z° V V V V V• 5 ° z ° V V V V V

to lii , __ .to lii, __.

C3 ti.C3 ti.

8 ^ o n> t> £> ro t> £* _Ξ p § lo LO in iO — ^ t> - — — - . «) — ° 11·« £ 1¾ _____ 5~ i ί i 2=Z -p Z=K Z=? S Z=? 9 Z=?· 5 2=\ T ?-5 I y> I z-5 I 2-o I z-o m m 2=( i={ ±=< - H z=< 5 a % s a. a a s8 ^ o n> t> £> ro t> £ * _Ξ p § lo LO in iO - ^ t> - - - -. «) - ° 11 ·« £ 1¾ _____ 5 ~ i ί i 2 = Z -p Z = K Z =? S Z =? 9 Z =? · 5 2 = \ T? -5 I y> I z-5 I 2-o I z-o m m 2 = (i = {± = <- H z = <5 a% s a. A a s

δ J p-£ 1 fl δ ^ 5 2* £ Iδ J p- £ 1 fl δ ^ 5 2 * £ I

«ΓΥ8 «fyS «ys <TU «ΓΥ§ «Tys cTyå .«ΓΥ8« fyS «ys <TU« ΓΥ§ «Tys cTyå.

: - tf p μ ft ft ft · ft 1 § I I I 1 Γ r B § |-@ § e § |~® § 5-®-δ e |-®~£ § 5-©: - tf p µ ft ft ft · ft 1 § I I I 1 Γ r B § | - @ § e § | ~ ® § 5-®-δ e | -® ~ £ § 5- ©

I ~ Z 2 z É z Z ZI ~ Z 2 z É z Z Z

Po 0 Ci O o o o • M d o o α α o oPo 0 Ci O o o o • M d o o α α o o

s & X X Yj X X Xs & X X Yj X X X

0 3· . 3? x* < £ 2* 2 3, o o o o '-i. o S 2 1? X* x> 3? 3? af q 000 O o 1 -I______ β p $ lo >o C- 00 0.0 — CN (N fM fM N ro ro o α) μ0 3 ·. 3? x * <£ 2 * 2 3, o o o o '-i. o S 2 1? X * x> 3? 3? of q 000 O o 1 -I ______ β p $ lo> o C- 00 0.0 - CN (N fM fM N ro ro o α) μ

β _L______... -------Jβ _L ______... ------- J

38 _ 151338 ^ Μ 15 ! β Ο- J> C~ er- V I I L" t> lo iq in Lo iq38 _ 151338 ^ Μ 15! β Ο- J> C ~ er- V I I L „t> lo iq in Lo iq

So)· o " d — ~ ~ — ~So) · o "d - ~ ~ - ~

5&. V V V V5 &. V V V V

o ^ <3- £: t> r> j>o ^ <3- £: t> r> j>

N « > E> ^ &> 10 [λ LPN «> E> ^ &> 10 [λ LP

£-^2 ¢5 6 -' - - ' - β_ | & v V[V ~ v c w i C o , In · in f I w . (s ^ <>i - (N <n ci £ “£ - ^ 2 ¢ 5 6 - '- -' - β_ | & v V [V ~ v c w i C o, In · in f I w. (s ^ <> i - (N <n ci £

1-5 - - B 5 & B B1-5 - - B 5 & B B

<u a n o ° — _l _L — —<u a n o ° - _l _L - -

I ϋ2 v V V v V VI ϋ2 v V V v V V

inin

111 & & 5 ζ ζ·. B E111 & & 5 ζ ζ ·. B E

~ - - V 'V v v * ____ £ f=l £ 2=1 ^ ^ X 2=1 x Ο I 2-0 ° 2 2Γ z-o 8 ^ 8 8 8 =(~ - - V 'V v v * ____ £ f = l £ 2 = 1 ^^ X 2 = 1 x Ο I 2-0 ° 2 2Γ z-o 8 ^ 8 8 8 = (

O CO (rt O O O COO CO (rt O O O CO

-J* _£* _Jt N ft M-J * _ £ * _Jt N ft M

δ 4 y-i f z ,5 2rf 5 ^ ,s ^ P Zδ 4 y-i f z, 5 2rf 5 ^, s ^ P Z

. .ryg· «ryS ai <riB ciys <ry§ cTyg 1 W w W V-z V-z V-z Vz 14 4 4 4 4 4 4 Ϊ i ° i i ° i ° i ° 5 ° i ° 2 g . δ ο ο ο o. .gry · «ryS ai <riB ciys <ry§ cTyg 1 W w W V-z V-z V-z Vz 14 4 4 4 4 4 4 4 Ϊ i ° i i ° i ° i ° 5 ° i ° 2 g. δ ο ο ο o

I S3-® 8½ eo-§-5 s 54o>S §5-@> §5-^5 § 5-®-SI S3-® 8½ eo-§-5 s 54o> S §5 - @> §5- ^ 5 § 5-®-S

-^QOOOoOO- ^ QOOOoOO

ωοοοοδοο » J? » ^ » 3Q X> a? · i X of1 a? a? a? S o U « ϋ ο a ΐ p δ K 5· f ί g S S ° o u g i X ϋ ° cωοοοοδοο »J? »^» 3Q X> a? · I X or1 a? a? a? S o U «ϋ ο a ΐ p δ K 5 · f ί g S S ° o u g i X ϋ ° c

nm 01 00 Th in Ή £~ 0Onm 01 00 Th in Ή £ ~ 0O

^ of) · no no no no no no o a) m _1¾¾ a _______J_ i_1_1_f_ 39 · 151338 - -- \ \ \ \ i £ S F" £ \ \ \ \ v - ° \ \ \ \ 5"·_,____\_\1 \1 \ aS & r> O' \ \ \ \ I å g & > m \ \ \ \ £^"2 — o d \ \ . \ \ η. I * v \ \. \ \ 3* \ \ \ \ ‘ o| io . \ \ \ \ N 'd ^ \ \ \ <U m N.^ of) · no no no no no no oa) m _1¾¾ a _______J_ i_1_1_f_ 39 · 151338 - - \ \ \ \ i £ SF "£ \ \ \ \ v - ° \ \ \ \ 5" · _, ____ \ _ \ 1 \ 1 \ aS & r> O '\ \ \ \ I å g &> m \ \ \ \ £ ^ "2 - od \ \. \ \ Η. I * v \ \. \ \ 3 * \ \ \ \ 'o | io. \ \ \ \ N' d ^ \ \ \ <U m N.

æ* \| \ \| \ "5 >-> r> 'N. NS'S\ VS^\ l ~ I k> ” ~ \ \ \ \ ~S°Z v v V \ \ \ \ ω \ . \ · \] \ 0 CL \ \ \ \ δΗ & £ t> \ \ \ ‘ \ -2 £ cs P ·> . k> \ · \ \ \ i'i 0 — \ \ \ \ t-«*S V . \ \ \ \ W \ · \ \ \ 2.-==2. n 2—2 "> Z—Z * \ \ \ \ I 1-5 T >-5 I z-5 \ . \ \ \ z=( z=( \ \ \ \ 'J* Ji . Ji \ \ \ \ « K R R \ \ \ \ sil l \ \\ \ S g S-@-5 g |-@ § 5-<5> \ \ \ \ 44 Z Z· I \ \ \ \ μυ^υ \ \\ \ •d z. «V2^, °·^· X. \ \ \ \ • β ΰ \ \ \ \ 0 ‘ X Ϊ \ \ \ \ 5 0 \ \ \ \ , . g1 \ 1 \ -p ® Cr~ o “X ^X.æ * \ | \ \ | \ "5> -> r> 'N. NS'S \ VS ^ \ l ~ I k>” ~ \ \ \ \ ~ S ° Z vv V \ \ \ \ ω \. \ · \] \ 0 CL \ \ \ \ δΗ & £ t> \ \ \ '\ -2 £ cs P ·>. k> \ · \ \ \ i'i 0 - \ \ \ \ t - «* SV. \ \ \ \ W \ · \ \ \ 2 .- == 2. n 2—2 "> Z — Z * \ \ \ \ I 1-5 T> -5 I z-5 \. \ \ \ z = (z = (\ \ \ \ 'J * Ji. Ji \ \ \ \ «KRR \ \ \ \ will l \ \\ \ S g S - @ - 5 g | - @ § 5- < 5> \ \ \ \ 44 ZZ · I \ \ \ \ μυ ^ υ \ \\ \ • d z. «V2 ^, ° · ^ · X. \ \ \ \ • β ΰ \ \ \ \ 0 'X Ϊ \ \ \ \ 5 0 \ \ \ \,. G1 \ 1 \ -p ® Cr ~ o “X ^ X.

Odih ^ ^ \ X \ XOdih ^^ \ X \ X

feu c \ \ \_Xfeu c \ \ \ _X

40 151338 (2) De minimale inhiberende koncentrationer (MIC) af forbindelserne over for kliniske isolater af bakterier er vist i tabellerne 5 og 6, hvor numrene i tabel 5 henviser til forbindelserne i tabel 3, og numrene i tabel 6 henviser til forbindelserne i tabel.(2) The minimum inhibitory concentrations (MICs) of the compounds against clinical isolates of bacteria are shown in Tables 5 and 6, where the numbers in Table 5 refer to the compounds in Table 3 and the numbers in Table 6 refer to the compounds in Table .

4.4th

MIC blev bestemt på samme måde som beskrevet i ovennævnte afsnit (1).The MIC was determined in the same way as described in the above paragraph (1).

41 ___ 151338 tn O O O O O o o o41 ___ 151338 tn O O O O O o o o

ItnOOOOOOOItnOOOOOOO

Pm cm - nj cm ni cm Η HPm cm - nj cm ni cm Η H

Λ Λ Λ____ m in m in in m -^-ιηιηοιηιηιηιηιΗ . pt, CM CM CO CD CD CD CD K\Λ Λ Λ ____ m in m in in m - ^ - ιηιηοιηιηιηιηιΗ. pt, CM CM CO CD CD CD CD K \

Η HΗ H

m in ^ tn H cm C- | pL| m CD o m m tn m c— c— crv m cm C" Η H iH in in m· c~~ I ······· * pq o m m m Η Η o o in in m mm in ^ tn H cm C- | pL | m CD o m m tn m c— c— crv m cm C "Η H iH in m · c ~~ I ······ * pq o m m m Η Η o o in m m

H in cm cm inininni HH in cm cm inside H

I..... ...I ..... ...

(icMCOCOCMCMniCDfn(icMCOCOCMCMniCDfn

Η Η Η HΗ Η Η H

oo cd in m- m m m m c— 03 cd in CM H H H i—I H in ^oo ·'······oo cd in m- m m m m c— 03 cd in CM H H H i — I H in ^ oo · '·····

φ H cd m m m m m Hφ H cd m m m m m H

m to * s CC_______;__ 02m to * s CC _______; __ 02

d CDd CD

Η o m co m m m m m m ο ι o in in CM Η Η Η Η H m in o co · · · * · ’ * *Η o m co m m m m m m ο ι o in CM Η Η Η Η H m in o co · · · * · '* *

o HcDmmmmmHo HcDmmmmmH

how Φ H S .how Φ H S.

_0 >: _______- H------ +3 H m m m m m m m c— C72 C— H CM Η H H H H in 00 ....··· ·_0>: _______- H ------ +3 H m m m m m m m c— C72 C— H CM Η H H H H in 00 .... ··· ·

m cd m m m m m Hm cd m m m m m H

m g 00 coininmtnmm mom g 00 coininmtnmm mo

Li^CMCMHCMHHH in oo ······ ·Li ^ CMCMHCMHHH in oo ····· ·

cd cd m cd m .m m Hcd cd m cd m .m m H

m g H m m c- cr\ cn ‘ co ^ ι> H in c~- ^ ^ 00 o o m h" o o o om g H m m c- cr \ cn 'co ^ ι> H in c ~ - ^ ^ 00 o o m h "o o o o

g V V Vg V V V

/ , m σ\ oo o esc / in S CO Γ0 ’S'/, m σ \ oo o esc / in S CO Γ0 'S'

/ -Η *H/ -Η * H

/ HH* / ΰ Η H Sh / Η Ή ·Η β· / Η ο ϋ / CD I Η I -Η I ·Η 03/ HH * / ΰ Η H Sh / Η Ή · Η β · / Η ο ϋ / CD I Η I -Η I · Η 03

/ Kl S ·Η S ί3 g f! W/ Kl S · Η S ί3 g f! W

/ Ή 3 ° 3' 2 “ 2 Η / CD Ή Η ·γΊ η Ή Π CD _ _ / 'ΰ = - - / γ| +3 b 4° 10 -Ρ ^ d / η cd ^ cd ° cd ra ·Η1 / -° S |S jg £ j o. iojq.uo % o 151338 ----·. 42--[--- oo oooooo o o o o o o o o/ Ή 3 ° 3 '2 “2 Η / CD Ή Η · γΊ η Ή Π CD _ _ /' ΰ = - - / γ | +3 b 4 ° 10 -Ρ ^ d / η cd ^ cd ° cd ra · Η1 / - ° S | S jg £ j o. Iojq.uo% o 151338 ---- ·. 42 - [--- oo oooooo o o o o o o o o

CM CM CM CM CM CM CM CMCM CM CM CM CM CM CM CM CM

ΛΑΛΑ Λ Λ Λ ΛΛΑΛΑ Λ Λ Λ Λ

LO LO LO LO LO LO . LOLO LO LO LO LO LO LO. LO

CM CM CM CM CM * CM CM lOCM CM CM CM CM * CM CM lO

CO ' CO MD CO CO CD CO CMCO 'CO MD CO CO CD CO CM

HH

O CO CJV '' CTC C"- cre C— lo i—I c-Lo^-Lotr-in h’coohohoh to o 0 to c- tr- c—O CO CJV "" CTC C "- cre C— lo i — I c-Lo ^ -Lotr-in h'coohohoh to o 0 to c- tr- c—

rH LO LO LO rH LO LO LOrH LO LO LO rH LO LO LO

• · · ·. · · · ·• · · ·. · · · ·

CO Η Η H CO'H Η HCO Η Η H CO'H Η H

LO LO lo LO LO LOLO LO lo LO LO LO LO

LO LO CM CM CM CM CM CMLO LO CM CM CM CM CM CM CM

• · · · · · * ·• · · · · · ·

CM CM CO CO CD - CO CO COCM CM CO CO CD - CO CO CO

Η HΗ H

COCOCOCOCOCOt'-CO —I i—I i—I i—I i—ί i—I LO t—ICOCOCOCOCOCOCOt'-CO — I in — I in — I in — I in — in I — I LO t — I

CO CO CO CO CO CO H COCO CO CO CO CO CO H CO

PP

cdCD

CQCQ

-p --------- β 0-p --------- β 0

&JIOCOCOO-COCOCOCO& JIOCOCOO-COCOCOCO

' HHHloHHHiH'HHHloHHHiH

CO CO CO H COCOCOCOCO CO CO H COCOCOCO

i-1 LO________i-1 LO________

HH

® LO LO CO LO CO CO® LO LO CO LO CO CO

røCMLOCMHlOCMCMCM Cu········ROCMLOCMHlOCMCMCM Cu ········

E-Ico CM CO CO CM CO co COE-Ico CM CO CO CM CO co CO

r—I Hr — I H

CO CO . CO C— CO CO C"- COCO CO. CO C— CO CO C „- CO

i—| rH rH LO iH tH LO rHi- | rH rH LO iH tH LO rH

CO CO CO H KM CO H COCO CO CO H KM CO H CO

0Ί CT\ CO CO CO CO0Ί CT \ CO CO CO CO CO

C— to- c~- c:— c— c— ooooooooC— to— c ~ - c: - c— c— oooooooo

V VV V

CM r-l M •M4 LO O rH CMCM r-l M • M4 LO O rH CM

# 1—4 rM rH# 1-4 rM rH

u βu β

<D<D

ΜΜ

HH

CDCD

ββ

•H• H

SS

o I _____ 43 1 5 1 3 3 8 *-·- ----o I _____ 43 1 5 1 3 3 8 * - · - ----

LO LO LO tOLO LO LO tO

LO LO OI LO CM OJ H LOLO LO OI LO CM OJ H LO

i ....··· ·i .... ··· ·

• M CM OJ LO OJ LO LO tO CM• M CM OJ LO OJ LO LO tO CM

HH H HHH H H

fO O O O o o O o OfO O O O o o O o O

lOOOOOOtoO }*j CM CM OI OJ H OI OJlOOOOOOtoO} * j CM CM OI OJ H OI OJ

A Λ Λ Λ_____A_ ΙΟ LO ΙΟ roA Λ Λ Λ _____ A_ ΙΟ LO ΙΟ ro

OJ ΟΙ OJ LO CM LO HOJ ΟΙ OJ LO CM LO H

I · · · · · *I · · · · · ·

O LO LO CM LOLO CM tOLOO LO LO CM LOLO CM tOLO

^ H CM H__oi lo lo lo lo ro ro C"^ H CM H__oi lo lo lo lo ro ro C "

HCMOJOIOJHH LOLOHCMOJOIOJHH LOLO

I · · · · · · · ·I · · · · · · · ·

LO LO LO LO tO tO i I CMLO LO LO LO LO tO tO i I CM

rHrh

HH

LO O O O oLO O O O o

ro O O O Oro O O O O

•H oi OI CM CM• H oi OI CM CM

o § Λ ΛΑ a o--------- cdo § Λ ΛΑ a o --------- CD

•H LO• H LO

Λ LO ^Λ LO ^

•H o o O LO O OJ O• H o o O LO O OJ O

L. O O O OJ LO H LOL. O O O OJ LO H LO

φ Js; CM CM CMφ Js; CM CM CM

1 7 3 & A Λ LO CQ-------- pq φ LO LO . to LO O-1 7 3 & A Λ LO CQ -------- pq φ LO LO. to LO O-

H" OJ LO LO LO i I CM LOH „OJ LO LO LO i I CM LO

cri to* · · · * · *cri to * · · ·

(S LOOlOJ OjrOLQHLO(S LOOlOJ OjrOLQHLO

H S Η Η H OJH S Η Η H OJ

CDCD

tOrOLOLOLOtOLOlO-tOrOLOLOLOtOLOlO-

W h cm OJ OJ H Ol lO LOW h cm OJ OJ H Ol lO LO

to* · · · · ' * * tOLOLOLOtOLOHOlto * · · · · '* * tOLOLOLOtOLOHOl

fe Hfe H

ci3 CO LO LO LO LO toci3 CO LO LO LO LO LO to

H-OJ CM LO LO CM CM HH-OJ CM LO LO CM CM H

tO ...··* ·thaw ...··* ·

LO LO CM CM LO LO tO LOLO LO CM CM LO LO tO LO

iz; HH ^iz; HH ^

Ci3Ci3

j CM OL 00 O OLj CM OL 00 O OL

/ *3« CO CO "Φ *-Γ / ΰ d / *H ·Η · / Sh h h / HH H S5 / ri Ή ·Η / Irl ΙΟ ΙΟ Φ / Φ å-rl 0·Η S ·Η Μ /cQ3ci)3dPfiH / Η Η Η ·Η Φ Η Φ Φ / (D ,ίπ ft ί-η,Ω PrQ Ό = : = -/ * 3 «CO CO" Φ * -Γ / ΰ d / * H · Η · / Sh hh / HH H S5 / ri Ή · Η / Irl ΙΟ ΙΟ Φ / Φ å-rl 0 · Η S · Η Μ / cQ3ci) 3dPfiH / Η Η Η · Η Φ Η Φ Φ / (D, ππ ft ί-η, Ω PrQ Ό =: = -

/ Ό -Ρ Si -Ρ -PH S/ Ό -Ρ Si -Ρ -PH S

/ s cti-¾ cd cd tdp ·η/ s cti-¾ cd cd tdp · η

J «Η S fe O feco ,QJ «Η S fe O feco, Q

%, 10 JQ.U03 O%, 10 JQ.U03 O

' fa I ' ιιιι—J----- 151338 44 f- to cr> cn en cn m 'mHi>-iHC-i>-H-[>-H · m o o o o o o ._______V__ oooooooo O O O O O O m o'fa I' ιιιι — J ----- 151338 44 f- to cr> cn and cn m 'mHi> -iHC-i> -H - [> - H · m o o o o o ._______ V__ oooooooo O O O O O O m o

CM CM <M CM CM CM HCM CM <M CM CM CM H

Λ Λ Λ A A_____ tommC'-cnc--Cj'>r~- HCMHinHmc-m ········A Λ Λ A A_____ tommC'-cnc - Cj '> r ~ - HCMHinHmc-m ········

to vd m h m Η ο Htwo vd m h m Η ο H

to to c- c— cn σι Γ Η - in H m m C- C-’ m « ·· · · · · ·to to c- c— cn σι Γ Η - in H m m C- C- 'm «·· · · · · ·

to cm to Η H O O Htwo cm to Η H O O H

r—1l oooooooo o o o o o o o or — 1l oooooooo o o o o o o o o

CMCMCMCMCMCMCMCMCMCMCMCMCMCMCMCM

^λ αααλλαλ -p _____ cd--- J2 mm t w. w.^ λ αααλλαλ -p _____ cd --- J2 mm t w. w.

c2o O O m O m M3 md Ο o m cm m cm H cmc2o O O m O m M3 md Ο o m cm m cm H cm

CMCM

1--:------- in H to tocnc-t^cnc— ®H m H c— m m t- m1 -: ------- in H to tocnc-t ^ cnc— ®H m H c— m m t- m

QQ

CdtOCMCOOHHOHCdtOCMCOOHHOH

^ H^ H

c— m cn cn cti cn enc— m cn cn cti cn and

m H tH C— . C— C— H- IHm H tH C—. C— C— H— IH

H CO Ο Ο o' O O OH CO Ο Ο o 'O O O

VV

to m m r— ir- D- m c— H cm H m m m H m • · · · ·*· · ·to m m r— ir- D- m c— H cm H m m m H m • · · · · * · · ·

toMjmHHHmHtoMjmHHHmH

(Mi—i n << in o i—i cm r—( r—l i—t Λ(Mi — i n << in o i — i cm r— (r — l i — t Λ

(D(D

0101

HH

5 « o fa ______!__ 45 1 5 1 3 3 85 «o fa ______! __ 45 1 5 1 3 3 8

I~F1—^^— "V —I— II ~ F1 - ^^ - "V —I— I

0000

rn O O o o (._> o u4 Orn O O o o (._> o u4 O

O m IC\ in U\ 1(4 IM in fe cm ώ Λ ·O m IC \ in U \ 1 (4 IM in fe cm ώ Λ ·

CMOOOinOOCMO OininCMininHin 1¾ CMCMOOOinOOCMO OininCMininHin 1¾ CM

J^_A_____-_____ co in \o _ HOOOLna^LPvfMin Otninc\jc\ic\iHoj {25 c\j _^__A________ O tn 00 in in H in CT4 „ ....J ^ _A _____-_____ co in \ o _ HOOOLna ^ LPvfMin Otninc \ jc \ ic \ iHoj {25 c \ j _ ^ __ A________ O tn 00 in in H in CT4 „....

cm O O in m cm c\i cn cmcm O O in m cm c \ i cn cm

O LT> CM CM Η Η HO LT> CM CM Η Η H

fe cm _f__A_____l___ cfl m CQ io in o m ·fe cm _f__A_____l___ cfl m CQ io in o m ·

CjCMOOOOO OCMOCjCMOOOOO OCMO

•H ΟΟΟιηιηιη Ηιη• H ΟΟΟιηιηιη Ηιη

M fe <M OJ HM fe <M OJ H

d ώ * P< Λ φ td----------“ Η ram in css O · s3 h o O o in in in cm m 0 o O. in cm cm cm H cmd ώ * P <Λ φ td ---------- “Η ram in css O · s3 h o O o in in cm m 0 o O. in cm cm cm H cm

a fe cm Hand fe cm H

-.§ ^ Λ 3_____:------- ω-.§ ^ Λ 3 _____: ------- ω

ra Hra H

PM CMPM CM

cm O inintnO in in o K\ OCMCMCMinCMCVlincm O inintnO in a o K \ OCMCMCMinCMCVlin

I fe PMI fe PM

^ __Λ____._____r φ ’ £ j .»Q ^ iS ooo O O in O tnio in ^ OOinnjincM cm fe CM H .^ __Λ ____._____ r φ '£ j. »Q ^ iS ooo O O in O tnio in ^ OOinnjincM cm fe CM H.

__Λ__________ vo C— tn O o o m o O in o O m in oil tn in cm in fe cm _f__A__-___;_____ . in tn o__Λ __________ vo C— tn O o o m o O in o O m in oil tn in cm in fe cm _f__A __-___; _____. in tn o

H . O O O o O O in OH. O O O o O O in O

O O O o tn in cm m fe cm cm H h ° Λ Λ j cm σ\ oo o σι / p; L η n m·O O O o tn in cm m fe cm cm H h ° Λ Λ j cm σ \ oo o σι / p; L η n m ·

/ i ri '3 S/ i ri '3 S

/ *frl Ή vi ·/ / Φ I irl . I O - ί ’ O Φ /.« id li' 1¾ a: / ΦΗΟ Ή Φ . ·Η Φ Φ / « SM*H U& U& ’ϋ. - - - -/ * frl Ή vi · / / Φ I irl. I O - ί 'O Φ /. «Id li' 1¾ a: / ΦΗΟ Ή Φ. · Η Φ Φ / «SM * H U & U & 'ϋ. - - - -

/ W fij G/ W fij G

/ fi 0(8 ίΗ5 Λ3 »I/ fi 0 (8 ίΗ5 Λ3 »I

/ Λ fe·*? fe.a fe tQ 43 1 ____ / £. loj^trøa £ 46 151338 1(Λ Ιί*\ ΙΟ ‘ ΙΟ (\J t\l CM ΟΙ • * · · KO Ιΐλ V.O νο νϋ LO ΙΟ Ο CM <Μ (Μ ΙΟ/ Λ fe · *? fe.a fe tQ 43 1 ____ / £. loj ^ trøa £ 46 151338 1 (Λ Ιί * \ ΙΟ 'ΙΟ (\ J t \ l CM ΟΙ • * · · KO Ιΐλ V.O νο νϋ LO ΙΟ Ο CM <Μ (Μ ΙΟ

Lf\ LO LOLf \ LO LO

LO CM CM CM '-Ο • · · * ·LO CM CM CM '-Ο • · · * ·

CMOVOVOVOIOCMLOCMOVOVOVOIOCMLO

Η in CM Η OJΗ in CM Η OJ

ir\ to to in in cm in i—I rH cm in cm inir \ to in in cm in i — I rH cm in cm

VOCMtOtOVOCMVOCMVOCMtOtOVOCMVOCM

Η Η HΗ Η H

in to to lo in cm H i—l in cm inin to to lo in cm H i-l in cm in

cm in co to to CM vo CMcm in co to CM vo CM

H CM Η HH CM Η H

in in in ' inin in in in

inmCMCMCMlOCMlO CM CM rH r-I r-I CM rH CMinmCMCMCMlOCMlO CM CM rH r-I r-I CM rH CM

in to to m CM LO H H CM LO in to /—«·······in to m CM LO H H CM LO in to / - «·······

-P VO CM to tO VO CM CM CM-P VO CM to tO VO CM CM CM

cO Η Η Η HcO Η Η Η H

MM

•P• P

--------- 0 cu to lo in to in to--------- 0 cu to lo in to in to

wHCMCMHCMHLOwHCMCMHCMHLO

(Otovo vo tovo to CM io(Otovo vo tovo to CM io

1 H CM1 H CM

ΙΛ J_1 --- — — S in to to to in loΙΛ J_1 --- - - S in to to to in lo

. jjjCMCM.HHCMlOCMLO. jjjCMCM.HHCMlOCMLO

E-*VO VO totovo CM VO CME- * VO VO totovo CM VO CM

Η HΗ H

io to io toio to io to

CM ΙΟ H CM HCM ΙΟ H CM H

VO CM tO VO CO LO ΙΟ OVO CM tO VO CO LO ΙΟ O

H CM CM inH CM CM in

LO IOLO IO

LO O CM CM LO Ο O LOLO O CM CM LO Ο O LO

CM ΙΟ Η H CM ' IO IO CMCM ΙΟ Η H CM 'IO IO CM

OI rH n in O i—I CM |OI rH n in O i — I CM |

'< I—I rH rH'<I — I rH rH

• - .- s 0)• - .- s 0)

COCO

HH

<1> _ .<1> _.

X) - -- -- - « o fa _I_1_I_I_1_1_ I ’ "· -* · "* sX) - - - - «o fa _I_1_I_I_1_1_ I '" · - * · "* s

47 I47 I

., __,_,_--_,--i- 151338., __, _, _ - _, - i- 151338

‘ LP LP"LP LP

c— · ·c— · ·

HlPOOlPCMLPCMLP CPCMOOPJH CMHPJHlPOOlPCMLPCMLP CPCMOOPJH CMHPJ

CM CMCM CM

§ Λ Λ§ Λ Λ

- CD LP tP- CD LP tP

Cd O CM LP HCd O CM LP H

•H IP ...• H IP ...

£ CO O O LP MD CM LP IP£ CO O O LP MD CM LP IP

O tP LP O CM H PIO tP LP O CM H PI

g CMg CM

ω § Aω § A

si a______.____ cdshe and ______.____ cd

Η H rH COΗ H rH CO

(DO O O O O LP · O IP O(DO O O O O LP · O IP O

•Η -Μ- O O O O CM IP CM O• Η -Μ- O O O O CM IP CM O

CQ CM CM CM CM HCQ CM CM CM CM H

ω § A A A A .ω § A A A A.

rHrh

m____;___;___ t-m ____; ___; ___ t-

HH

HOOoOlpOlpO •^f-O Ο Ο O CM LP CM OHOOoOlpOlpO • ^ f-O Ο Ο O CM LP CM O

CM CM CM CM HCM CM CM CM H

g A A Ag A A A

^OOOOOOLPO^ OOOOOOLPO

lOOOlPLPLPCMLPlOOOlPLPLPCMLP

CQ CM CM HCQ CM CM H

C- rt AC- rt A

I to IP 0--------- £ H ·* <j)I to IP 0 --------- £ H · * <j)

.Ω p tP Ο Ο Ο Ο Ο Ο Ο O.Ω p tP Ο Ο Ο Ο Ο Ο Ο O

cd ft ι o o o ip ο o ip ocd ft ι o o o ip ο o ip o

EH^mcMCMH HH I HEH ^ mcMCMH HH I H

" Λ to <d-----1----- £ ! ο s Λ 0 CM O O O O O O lp o"Λ to <d ----- 1 ----- £! O s Λ 0 CM O O O O O O lp o

Ό ' I O O o O LP LP CM ; LPΌ 'I O O o O LP LP CM; LP

£ ra CM PI H H£ ra CM PI H H

Φ ΛΦ Λ

to Ato A

PL|______;____PL | ______; ____

LPLP

HO o o o O O PI OHO o o o O O PI O

I o o O LP ' . LP LP H LPI o o O LP '. LP LP H LP

m CM . CM Hm CM. CM H

AA

j cm cp oo o cn / =, .«rnroM*!^ /HH i / ·Η Ή · / £ Η Η ζί / ·Η ·Η ·Η ! I Η ίο ΙΟ Φ / ® SH S-H S-H to / ® 3 -Η 3« Η Η Η / Η ·Η Ο ·Η Φ ·Η Φ Φ /φη·η η ,ω U & ·ϋ / ^ -PH -Pin -PH Η γ = r = / η cd S 'cd cd cd 3 ·η / £ SC SO SW Æ / O I0JQ.U03 |gj cm cp oo o cn / =,. «rnroM *! ^ / HH i / · Η Ή · / £ Η Η ζί / · Η · Η · Η! I Η ίο ΙΟ Φ / ® SH SH SH to / ® 3 -Η 3 «Η Η Η / Η · Η Ο · Η Φ · Η Φ / φη · η η, ω U & · ϋ / ^ -PH-Pin -PH Η γ = r = / η cd S 'cd cd cd 3 · η / £ SC SO SW Æ / O I0JQ.U03 | g

/_SJ____]____ I/ _SJ ____] ____ I

.48 1 5 1 3 3 8 lp, ίο, ip- lp, ir- cn t- . cm in H m nj in r- in • •III···.48 1 5 1 3 3 8 lp, ίο, ip- lp, ir- cn t-. cm in H m nj in r- in • • III ···

VO'lMiPlr-lLPr-HOHVO'lMiPlr-LLPR HOH

I—II-I

lp, tn tn c— tnlp, tn tn c— tn

lp, c\i H m H in Hlp, c \ i H m H in H

. ······ pjinvotnmtnHtn. ······ pjinvotnmtnHtn

H ni HH never H

in in • ·in in • ·

O O O in o m-m ni OOinmoniHH H ni HO O O in o m-m ni OOinmoniHH H ni H

in in ΟΟΟίηοιηηιηιin a ΟΟΟίηοιηηιηι

ooinnimniHHooinnimniHH

HHHH

-P-P

d________d________

COCO

-P-P

L.L.

0 in in in0 in in

O o ni ni ni in o OO o never never in o o

ιηΟΗΗΗηιιηιη <t HιηΟΗΗΗηιιηιη <t H

in--------in --------

HH

Φ m «2 *Φ m «2 *

cdLnO ni in in O O OcdLnO ni in a O O O

E-ini inH ni ni in in in in in in • · · · CMinmmininooE-ini inH ni ni in in in in in in in • • · · CMinmmininoo

HniHHmniinin in m n • · · O-Omniniinoo ιηΟΗΗΗηιιηιη ni cd r-1 η ^ m o r-ι mHniHHmniinin in m n • · · O-Omniniinoo ιηΟΗΗΗηιιηιη ni cd r-1 η ^ m o r-ι m

. r-J i—l (H. r-J i-l (H

UU

SS

<D<D

COCO

HH

(!)(!)

Ti _ _ _ _ _ - - a " \ ~ " ' fiTi _ _ _ _ _ - - a "\ ~" 'fi

OISLAND

'_______ 49 ___ 151338 co n σο c- t-'_______ 49 ___ 151338 co n σο c- t-

LT\ H LA LA r- LA LALT \ H LA LA r- LA LA

d ω · · · *d ω · · · *

oj3 la cm la cm Ο Η Hoj3 la cm la cm Ο Η H

H τ-L H H CM HH τ-L H H CM H

H ft) CQ CD BH ft) CQ CD B

rf d_______ 0 i------rf d_______ 0 i ------

,B VO, B VO

01 ft CO „ _ ra>>HO ο ο ο ο ο o -pcmo o o o o.o o01 ft CO „_ ra >> HO ο ο ο ο o -pcmo o o o o.o o

CM CM CM CM CM CM HCM CM CM CM CM CM H

m Λ Λ Λ· Λm Λ Λ Λ · Λ

•H CFO• H CFO

d H VO LA LA LA LA LA LAd H VO LA LA LA LA LA LA

P CO LA CM CM CM CM CM HP CO LA CM CM CM CM CM H

J> .*·····J>. * ·····

-μ Η H CO VO VO VO VO LA-μ Η H CO VO VO VO VO LA

CQ cd H _ _______CQ cd H _ _______

1—I CD1 — In CD

d C50d C50

OVOC0 CA A- LA tA tA ΑΡΗ t> H in CM H H LAOVOC0 CA A- LA tA tA ΑΡΗ t> H in CM H H LA

H CM ...... *H CM ...... *

<jj O tA· H VO tA tA H<jj O tA · H VO tA tA H

tol Htol H

coco

H OO A- tA A- tA COH OO A- tA A- tA CO

ft) [A LA LA ΙΑ H LAH A~ <D 00 ...... ·ft) [A LA LA ΙΑ H LAH A ~ <D 00 ...... ·

Sj i—I i—I CM CM tA H tA OSj i — I i — I CM CM tA H tA O

Μ Η Η HΗ Η Η H

CDCD

H CQH CQ

l·) Hl ·) H

LA cd —-----:---- I H i-LA CD —-----: ---- I H i-

ΙΑ rl LA LAL rl LA LA

φ H LA CMφ H LA CM

rH ia£ CM ·rH ia £ CM ·

φ Η H O O O CM LA VOφ Η H O O O CM LA VO

s £ Hs £ H

EH “ A AEH “A A

Φ CM laΦ CM la

B tA LA CMB to LA CM

d CM · ·d CM · ·

OHO O O O CM LA LOOHO O O O CM LA LO

CQ Η Ο Ο Ο Ο H CMCQ Η Ο Ο Ο Ο H CM

CM CM CM CMCM CM CM CM

$ £ A A A A$ £ A A A A

rHrh

CD-------- •H LA LA CA LA A~CD -------- • H LA LA CA LA A ~

,dj LA CM LA LA H CM LA, dj LA CM LA LA H CM LA

cq a- · · „ · * · ?cq a- · · „· * ·?

Hvo CM O CM LA VO HHvo CM O CM LA VO H

Η Η Ο HΟ Η Ο H

CMCM

ξ Aξ A

/ r* rj CN GO 00 O/ r * rj CN GO 00 O

/ .Η -H η O -a* / Η H , / a Η H k / -Η ·Η -H 2/ .Η -H η O -a * / Η H, / a Η H k / -Η · Η -H 2

/ CD I 3 « £ « H/ CD I 3 «£« H

/“i-H jaa § si $/ “I-H jaa § si $

/ Ή ? o p CD p CD “J/ Ή? o p CD p CD “J

/ CD ·Η -Η Ή ,Ω Ή ,Ω Η / ij fti a f) ft ft) H ® / β -Pa ·μ«ι ·Ρί ·ΰ = = = / ·η cd -¾ cti ο cd ο ΰ/ CD · Η -Η Ή, Ω Ή, Ω Η / ij fti a f) ft ft) H ® / β -Pa · µ «ι · Ρί · ΰ = = = / · η cd -¾ cti ο cd ο ΰ

/ ,D S S5 £ *H/, D S S5 £ * H

/. & Ioaq.uo3 £ i___E ti . .1___ 50 151338 in tn crv in cr> cMinHC-cMir-H-^- , · · · · f « ·/. & Ioaq.uo3 £ i___E ti. .1 ___ 50 151338 in tn crv in cr> cMinHC-cMir-H - ^ -, · · · · f «·

" vo cm in O vo Ο Ο O"vo cm in O vo Ο Ο O

H -V VH -V V

0 o o o o o o o0 o o o o o o o

OOOOOO.inin C\J CM CM H CM' CMOOOOOO.inin C \ J CM CM H CM 'CM

Λ A Λ t— m c— σ^ι .r~- cnΛ A Λ t— m c— σ ^ ι .r ~ - cn

mcM in c— in in in HmcM in c— in in H

·.····*·· H vo H O Η Η H tn C'-tno'iOvD-cyva'iC- inHC-c-tnc-n-in • · · · · · ··. ···· * ·· H vo H O Η Η H tn C'-tno'iOvD-cyva'iC- inHC-c-tnc-n-in • · · · · · ·

rH tn ΟΌ H O Ο HrH tn ΟΌ H O Ο H

*!p tn m c— cn tn £— cn c— Φ H cm in ' c- H m IH m*! p tn m c— cn tn £ - cn c— Φ H cm in 'c- H m IH m

P tn vo Η O tn Η Ο HP tn vo Η O tn Η Ο H

β 0 m 1 in inβ 0 m 1 in

tn CM CMtn CM CM

Ho O in η o mvovoHo O in η o mvovo

0) o O CM CM in CM0) o O CM CM in CM

& H CM& H CM

CD .CD.

EH Λ in in cm O O O m o m cm voEH Λ in in cm O O O m o m cm vo

in O in cm in cm Hin O in cm in cm H

HH

tnintni>tn[r— cncn H cm H in H in c- c- · · · * * * · ·tnintni> tn [r— cncn H cm H in H in c- c- · · · * * * · ·

mvocnHtnHOOmvocnHtnHOO

CM i—I ΓΟ ·Μ* m O i—l mCM i — I ΓΟ · Μ * m O i — 1 m

t—! r-i rHt! r-i rH

» s Φ»S Φ

01 H CD01 H CD

β............ β

•Η fi Ο fa _L__J___1___ 51 151338 Η• Η fi Ο fa _L__J___1___ 51 151338 Η

• <L) LO• <L) LO

φ CM LfC LPi W) ...φ CM LfC LPi W) ...

-pOOO cOCMCMLf\-pOOO cOCMCMLf \

-P O O O rH r-l CM-P O O O rH r-l CM

φ CM CM CMφ CM CM CM

* Λ Λ 3 SHircOOH-GOr-ΐΗ-Η- ca ......* Λ Λ 3 SHircOOH-GOr-ΐΗ-Η- ca ......

MHOOOC^OOMHOOOC ^ OO

fl V V V Vfl V V V V

xa ri CD -H ^xa ri CD -H ^

P -H [> CO t<~\ CJIP -H [> CO t <~ \ CJI

o ri m H- h· ir\ · H 'S· oo ri m H- h · ir \ · H 'S · o

Cj cd · · · · * · ·Cj cd · · · · · · ·

P4WH O O H t^O OP4WH O O H t ^ O O

I V V v a --:------- i LT\ H 2 ϊ H c- cn co σ> ·ι-ΙΙθΟΟ(Γ-ΙθΗΗ-[Η TO JO· · · * · · · E-* φΗΟΟΗΚΛΟΟI V V v a -: ------- i LT \ H 2 ϊ H c- cn co σ> · ι-ΙΙθΟΟ (Γ-ΙθΗΗ- [Η TO JO · · · * · · · E- * φΗΟΟΗΚΛΟΟ

•g V V• g V V

/ ,Η O OC CM p-l / H § «φ rp / rH rH '· / ri Η H ri / -Η -Η ·Η rt / φ i H i O i O ^ / to a h g-Η å -d φ /'ri §·η g ri g. £ cq/, Η O OC CM pl / H § «φ rp / rH rH '· / ri Η H ri / -Η -Η · Η rt / φ i H i O i O ^ / to ah g-Η å -d φ / 'ri § · η g ri g. £ cq

/ 5 2 -H g 4 ® H/ 5 2 -H g 4 ® H

/ tti2 Sj ri Φ / ti - - r/ tti2 Sj ri Φ / ti - - r

/ -HdJca^cdcQ S/ -HdJca ^ cdcQ S

/ a s ^ s ° a “ -η / (S TO.1q.119a o i__:_ i fa i i i_i 52 151338 LTv LPi Lf\ t<~\ CTi LTV CM CM CM Η C~- ····«·/ a s ^ s ° a “-η / (S TO.1q.119a o i __: _ i fa i i i_i 52 151338 LTv LPi Lf \ t <~ \ CTi LTV CM CM CM Η C ~ - ····« ·

CM VO V£> MD ΚΛ OCM VO V £> MD ΚΛ O

r~\ ^ ^ ^ *···«· o o o o o or ~ \ ^ ^ ^ * ··· «· o o o o o o o

V V V V V VV V V V V V

-p d cq m jj cr> cn £j o o o o o o-p d cq m jj cr> cn £ j o o o o o o

w V V V Vw V V V V

VOVO

m______m______

HH

Φ ,Ο dΦ, Ο d

EHEH

*vh ^ -vt- ^ 'Φ ^ ·····* 0 o 0 0 0 0* vh ^ -vt- ^ 'Φ ^ ····· * 0 o 0 0 0 0

V V V V V VV V V V V V

co in 0 ι-i cm r—l I—1 i—l .§co in 0 ι-i cm r-l I-1 i-l .§

(D(D

raraw

HH

0)0)

Ti = r = = = sTi = r = = = s

•H• H

««

OISLAND

_Efa______ 151338 - -.- . * ·' i _____ii-------Γ" — -κ*—1-¾ . .1 ud on οο ω oo_Efa______ 151338 - -.-. * · 'I _____ ii ------- Γ "- -κ * —1-¾ .1 ud on οο ω oo

LH t— C~- m in C— Εν in H OOOOiMOJOOLH t— C ~ - m in C— Εν in H OOOOiMOJOO

pt) C\J LT\ LT\ Η Hpt) C \ J LT \ LT \ Η H

N> VD Cn VQ Ή3 in tnN> VD Cn VQ Ή3 in tn

,φρ-) -^f ^ Tf in rH Ln in CM pH, φρ-) - ^ f ^ Tf in rH Ln in CM pH

pi, tn O O O rH KN Η H MD tn ___V V V_________ V,o vjo VO VO VO €0 00 fOiLH Tf Tf Tf in in in in t- l>pi, tn O O O rH KN Η H MD tn ___V V V_________ V, o vjo VO VO VO € 0 00 fOiLH Tf Tf Tf in in in in t- l>

pt) f—i O O O Η H rH H O Opt) f — i O O O Η H rH H O O

___V V V__________V V V_______

UD oo VO 00 00 vo VOUD oo VO 00 00 vo VO

C\] m Tf "Tf C— LT\ C C— in inC \] m Tf "Tf C— LT \ C C— in in

p, h O OOOrHOOrHHp, h O OOOrHOOrHH

____V V V_______ N-N O0 tn K"\ tn tn M3 tn____V V V_______ N-N O0 tn K "\ tn tn M3 tn

, I , ( Tf C— ^ . i—I Η Η H . m rH, I, (Tf C— ^. I — I Η Η H. M rH

*j I · -· · · · · · * * P4 to, O O O tn tn cn cn H tn ___V___v_.______ S CO u3 ' IQ M0 MD M3 M3 M3 Φ MD in Tf Tf Tf LTD LT\ in LTD LTD LT\* j I · - · · · · · · * P4 to, O O O tn tn cn cn H tn ___ V ___ v _.______ S CO u3 'IQ M0 MD M3 M3 M3 Φ MD in Tf Tf Tf LTD LT \ in LTD LTD LT \

SjOO · · · .·. · · · · · 3 .,—1 O O ΟΗΗγΗΗΗγΗSjOO · · ·. · · · · · 3., - 1 O O ΟΗΗγΗΗΗγΗ

03 s V V V03 s V V V

CQCQ

-------- o-------- o

‘"i* O OY MD CO M> 00 M3 MD MD'"I * O OY MD CO M> 00 M3 MD MD

O LTD LTD Tf Tf Tf C— in C— in LO inO LTD LTD Tf Tf Tf C— in C— in LO in

H h °° H O O O O pH Ο Η Η HH h °° H O O O O pH Ο Η Η H

jS å I v v v g S'----------- in .p w tn c0 md md m> cn mdjS å I v v v g S '----------- in .p w tn c0 md md m> cn md

Tf 'if Tf C— in LTi in pH in 00· · · ·······Tf 'if Tf C— in LTi in pH in 00 · · · ·······

tn O OOOHrHHf^Htn O OOOHrHHf ^ H

S v v v '_____S v v v '_____

00 (θ\ VD V£) VO vD VD VD00 (θ \ VD V £) VO vD VD VD

Lp^ ,_| -Sj" ΙΓ\ ΙΓ\ lT\ LO Lf\ ΓΠ · · · ·······Lp ^, _ | -Sj "ΙΓ \ ΙΓ \ lT \ LO Lf \ ΓΠ · · · ······

O O OHHH HHHO O OHHH HHH

s V V Vs V V V

H- UD 00 MD 00 00 00 00 ud in Tf Tf Tf c- in c~- c~- O'- c- cn · · · ··#····H- OUT 00 MD 00 00 00 00 ud in Tf Tf Tf c- in c ~ - c ~ - O'- c- cn · · · ·· # ····

H o O O O pH O O O OH o O O O pH O O O O

S V V VS V V V

/ *r-f oj η "ϋ* oo od / JO Si rH S ^ / >5 ·Ή Si ·Η r-j / pH X! -ri N ^ / Φ S O go go Sh $ /μ3η3ηρνο^ / pH os ·Η c« ·Η cd H Cj / Φ U St U A UA g $ / S A f ft f ft Λ ό / cj (ή φ cd c) cd o i—1 □ — — ”~ ~/ * rf oj η "ϋ * oo od / JO Si rH S ^ /> 5 · Ή Si · Η rj / pH X! -ri N ^ / Φ SO go go Sh $ / µ3η3ηρνο ^ / pH os · Η c« · Η cd H Cj / Φ U St UA UA g $ / SA f ft f ft Λ ό / cj (ή φ cd c) cd oi — 1 □ - - ”~ ~

/.Hsoao ao®-H/.Hsoao ao®-H

/ g ° _ t /_o ' loag-noH_ tS__J_l__ 54 151338 to tn in in tn H cm c\i Ln cm V · · .../ g ° _ t / _o 'loag-noH_ tS__J_l__ 54 151338 to tn in in tn H cm c \ i Ln cm V · · ...

1 CM Ln tn CO LO CO LM CO1 CM Ln tn CO LO CO LM CO

|—I CM CM H| —I CM CM H

tn in O OOOOOOtn in O OOOOOO

I CM O O O 0.0 O mI CM O O O 0.0 O m

H CM CM CM H CMH CM CM CM H CM

Λ co in co m m in cMtn cm in H in cm in cm y H co (H tn cm co cm cdΛ co in co m m in cMtn cm in H in cm in cm y H co (H tn cm co cm cd

Η HΗ H

co m co tn in tn in tnco m co tn in tn in tn

H m cm in H cm h cm HH m cm in H cm h cm H

I. . . . · « · · · · y H co h tn- co tn co tn r—1 co m O icc Ο Ο O 0.0I.. . . · «· · · Y H co h tn- co tn co tn r — 1 co m O icc Ο Ο O 0.0

tn cm in cm OOOOOtn cm in cm OOOOO

,H H CM CM CM r-i H 1¾ λ, H H CM CM CM r-i H 1¾ λ

Ο O /NΟ O / N

OISLAND

cd •H in jo co in o 'si- in cm •H tn · ο cm LncoOOOLnin aj 5¾ H cm m O in cm cmcd • H in your co in o 'si- in cm • H tn · ο cm LncoOOOLnin aj 5¾ H cm m O in cm cm

cb Hcb H

CM o I m--------- co feCM o I m --------- co fe

CMCM

, t Lf\ DO 'sD tO LT\ LPi H LO LO H LO c\j t\J Lf\ o DO · · ······ ti DO C\J Η ίΟ C\J VO C\i, t Lf \ DO 'sD tO LT \ LPi H LO LO H LO c \ j t \ J Lf \ o DO · · ····· ti DO C \ J Η ίΟ C \ J VO C \ i

« g Π Η H«G Η Η H

in tn co in co . tn in tn in tnin tn co in co. tn in tn in tn

<3- in CM m H CM H cm H<3- in CM m H CM H cm H

tn · · · * * · * H co H tn co tn co cn g 00 tn co tn in tn in tntn · · · * H co H tn co tn co cn g 00 tn co tn in tn in tn

h ' m in i—I cm H cm Hh in m — I cm H cm H

tn · ·'· · ·· tn cm H tn co tn co tntn · · '· · ·· tn cm H tn co tn co tn

a Hand H

ci? / r-l CM 00ci? / r-l CM 00

/ S/ S

/ Ή 9 / ° 3 . g u / ΰ Λ -Η N fl / s I S’ I? 1¾ t « / -W in ΪΗ §N O “/ Ή 9 / ° 3. g u / ΰ Λ -Η N fl / s I S 'I? 1¾ t «/ -W in ΪΗ §N O“

/ Η P ω P cd P cd H i-J/ Η P ω P cd P cd H i-J

/ <D ·Η ·Η ,ij ·Η jil l\) Φ / £] -P φ -P Φ -Ρ φ Ρι S3 - - = / ·η cd ο cd ο cd ο φ ·η / & a a a ο λ / Ο ο / fe χΌΛΟ-ΐΙΟχ fe 55 151338 æ ^ 11' "g 8 8 8 S S § K a ;i;/ <D · Η · Η, ij · Η jil l \) Φ / £] -P φ -P Φ -Ρ φ Ρι S3 - - = / · η cd ο cd ο cd ο φ · η / & aaa ο λ / Ο ο / fe χΌΛΟ-ΐΙΟχ fe 55 151338 æ ^ 11 '"g 8 8 8 SS § K a; i;

te CM CM CM CM H cxl Mte CM CM CM CM H cxl M

ϋ Λ Λ Λ Λ________ 5ο ο Ο ο ο ιη Ο ,γν ιτ\ -8 S 8 8^^88^- § Λ A A Λ VD Ιβ in HO Ο Ο Ο Ο ΙΓ\ Ο ’ Ο ο Ο Ο ir\ cm ιια . £> ™ ^ C\| CM CVJ CM ι CM ιΗ r-l ώ Λ A A A ___ ω ιη in σ> ο ο ο ο ο lt\ ο " ^ CM Ο Ο Ο Ο LTv CM Lf\ I_j 1-1 CM C\J OJ OJ CM H r-1Λ Λ Λ Λ ________ 5ο ο Ο ο ιη Ο, γν ιτ \ -8 S 8 8 ^^ 88 ^ - § Λ AA Λ VD Ιβ in HO Ο Ο Ο Ο ΙΓ \ Ο 'Ο ο Ο Ο ir \ cm ιια . £> ™ ^ C \ | CM CVJ CM CM CM ιΗ r-l ώ Λ A A A ___ ω ιη in σ> ο ο ο οlt \ ο "^ CM Ο Ο Ο LTv CM Lf \ I_j 1-1 CM C \ J OJ OJ CM H r-1

§ A A A A§ A A A A

cfl m 0 i?i · Ο ο ο ο ο o So ο o 5 ™ S 8 8 8 8^3°°° g g Λ Λ Λ Λ U --- dj--—--;----: Cå ^ 1 S g Ο O 8 . & CM g © CM Ojcfl m 0 i? i · Ο ο ο ο o o So ο o 5 ™ S 8 8 8 8 ^ 3 °°° gg Λ Λ Λ Λ U --- dj --—--; ----: Cå ^ 1 S g Ο O 8. & CM g © CM Oj

o CM CM CM CM HinHHo CM CM CM CM HinHH

o § A A ΛΑ χί___- -. - -_____I___ 3--—— —— Φ }£> to ino § A A ΛΑ χί ___- -. - -_____ I___ 3 --—— —— Φ} £> to in

CQ H LTV CVJ ,-J CVJCQ H LTV CVJ, -J CVJ

Qj OJ · * . .Qj OJ · *. .

7 N 8 8 δδΒ^δ,κϊ^«·7 N 8 8 δδΒ ^ δ, κϊ ^ «·

Jj a . CM CM CM CM , 1X1 ^ * A A A Λ i ω---------;Jj a. CM CM CM CM, 1X1 ^ * A A A Λ i ω ---------;

,Ο I CCA, Ο In CCA

φ CM . ΙΓι ε·* ωο ο ο ο ο ιπ· ο 0 * ^· Ο Ο Ο OinCMO°vox3 a CM CM CM CM H ^ ® A A A A ___ Ό ^ . in in CCA Ο Ο Ο Ο O CM O ,—i λ . λι Ο O OOtnHOO^^φ CM. ΙΓι ε · * ωο ο ο ο ιπ · ο 0 * ^ · Ο Ο OinCMO ° vox3 a CM CM CM CM H ^ ® A A A A ___ Ό ^. into a CCA Ο Ο Ο Ο O CM O, —i λ. λι Ο O OOtnHOO ^^

a CM CM CM CM HlTArHMand CM CM CM CM HlTArHM

ώ A A A Aώ A A A A

in , o o o S o o o 0 0 o H 8 ° S SSSSs'"1'' g Λ Λ Λ Λ j r-c cm ο ^ οο σ> .in, o o o S o o o 0 0 o H 8 ° S SSSSs '"1"' g Λ Λ Λ Λ j r-c cm ο ^ οο σ>.

/ ri / O s) ri c!/ ri / O s) ri c!

/ >S H S3 ·Η g I/> S H S3 · Η g I

/ Η Λ -ri N » / I W) , -P I Η H g ./ Η Λ -ri N »/ I W), -P I Η H g.

/ <d Ej o Ιο i o u ®: / .ta 3 h In o / φ Τί'Λ ·Η'λ3 ·ηλ λ .,¾1. ' / ϊ s-s· *« £«' 3 3 8 8 * , ' / 5 a· ο «3 ο do φ η s, / £ S £ S ο,ω / ^ ---- £/ <d Not o Ιο i o u ®: / .ta 3 h In o / φ Τί'Λ · Η'λ3 · ηλ λ., ¾1. '/ ϊ s-s · * «£«' 3 3 8 8 *, '/ 5 a · ο «3 ο do φ η s, / £ S £ S ο, ω / ^ ---- £

j ο_, Toj^uoa_I g Ij ο_, Toj ^ uoa_I g I

56 1 5 1 3 3 8 p— vo to vo to LO ΙΟ LO CO vø 00 φ · H to H LTV H CM CM CVJ H in o- m · · · .......56 1 5 1 3 3 8 p— vo to vo to LO ΙΟ LO CO v0 00 φ · H to H LTV H CM CM CVJ H in o- m · · · …….

“ Η to H - to to vo vo to Η o S S3 o cb ω---- £ , Q (—1 3 tO to IT)“Η to H - to vo vo to Η o S S3 o cb ω ---- £, Q (—1 3 tO to IT)

CSOH LO H LO tO LO CMCSOH LO H LO tO LO CM

»—I · · · · * · · I I»—I · · · · * · · I I

□ to CM tO CM LO CM CM VO□ to CM to CM LO CM CM VO

φ ^ Η H CM Η Hφ ^ Η H CM Η H

•H Cb m ___ ,Ω <D--------- d t-• H Cb m ___, Ω <D --------- d t-

rH tO tO tOrH tO tO tO

Η H CM H LO LO CMΗ H CM H LO LO CM

«e- · · * · · ·ιι«E- · · * · · · ιι

to* VO to CM LO CM LO VOto * VO to CM LO CM LO VO

Jg rH CM rH CVJJg rH CM rH CVJ

cbcb

-si-O o O O O O 0-0 to O-si-O o O O O O 0-0 to O

ί ο o o o o to o ; o cm toί ο o o o o to o; o cm two

m CM CM . CM CM H CNJ Hm CM CM. CM CM H CNJ H

: Λ A A Λ πΓ .: Λ A A Λ πΓ.

tQ;___:__:----------- 0 .JL&to o o o o o ο ο o to otQ; ___: __: ----------- 0 .JL & to o o o o o ο ο o to o

H | o O O o O to O O CM LOH | o O O o O to O O CM LO

. S-iGQ CM CM CM . CM H CMH. S-iGQ CM CM CM. CM H CMH

® S Λ Λ Λ A® S Λ Λ Λ A

rP ----------♦--- ** tirP ---------- ♦ --- ** ti

SiSi

§i CM o o O O Ο O 0 .0 to LO§I CM o o O O Ο O 0 .0 to LO

5: ι Ο Ο Ο Ο O to Ο O CM CM5: ι Ο Ο Ο Ο O to Ο O CM CM

,01 02 CM CM CM CM H CM .H, 01 02 CM CM CM CM H CM .H

gf A A A Agf A A A A

tnj---:--;--------- fvtnj ---: -; --------- fv

HO ο O 0 0-0 0 0 to LOHO ο O 0 0-0 0 0 to LO

i o O O O O LO Ο O CM CMi o O O O O LO Ο O CM CM

£/2 CM CM CM CM . CM CM H£ / 2 CM CM CM CM. CM CM H

A A A AA A A A

/ rH CM O. CO 02 / s / ·Η / O S _ S . · - ·/ rH CM O. CO 02 / s / · Η / O S _ S. · - ·

/ >s -H S ·Η H/> s -H S · Η H

/ rH *S -H C3 W/ rH * S -H C3 W

/ ElO += Η -H/ ElO + = Η -H

/ Φ I Ο I Ο I Ο ΪΗ Φ / 03 §|H S'-1 S. μ ο ω/ Φ I Ο I Ο I Ο ΪΗ Φ / 03 § | H S'-1 S. μ ο ω

/ H PcC p®. ραί Η H/ H PcC p®. ραί Η H

/ φ Hil ή ,s φ ω 7 -d kft ίιΆ U Ά Λ 'd . _ , _ / d -Ρ ω -Ρ ® -ρω ft d - “ - - * / ·Η cdo ctfO £ΰ·ο ω ·Η / Ρ S S ί3- °' <? / £ . I0Jq.U02 £ ,/ φ Hil ή, s φ ω 7 -d kft ίιΆ U Ά Λ 'd. _, _ / d -Ρ ω -Ρ ® -ρω ft d - “- - * / · Η cdo ctfO £ ΰ · ο ω · Η / Ρ S S ί3- ° '<? / £. I0Jq.U02 £,

- ' ‘ ........” I- '' ........ '' I

57 151338 _Tabel 6-5_57 151338 _Table 6-5_

ProteusProteus

Forbindelse mirabilis morganii vulgaris rettgeriCompound mirabilis morganii vulgaris trial

Nairiv™r , 3.13 1.56 50 50Nairiv ™ r, 3.13 1.56 50 50

Cephaloglycm JCephaloglycm J

Forbindelse nr,· 1 3-13 3.13 1.56 6.25 " . 2 1.56 1.56 0.8 3.13 ' " 3 6.25 3.13 3.13 6.25 " 4 3.13 3.13 1.56 3.13 (3) Resistent aktivitet overfor β-lactamase, Pseudomonas aeruginosa GN 238:Compound No. · 1 3-13 3.13 1.56 6.25 ". 2 1.56 1.56 0.8 3.13" "3 6.25 3.13 3.13 6.25" 4 3.13 3.13 1.56 3.13 (3) Resistant activity against β-lactamase, Pseudomonas aeruginosa GN 238:

Den resistente aktivitet for hver forbindelse overfor β-lactamase blev målt som beskrevet i det efterfølgende, β-lactamase fremstilledes ud fra Pseudomonas aeruginosa CEN 238,The resistant activity of each compound to β-lactamase was measured as described below, β-lactamase was prepared from Pseudomonas aeruginosa CEN 238,

Denne mikroorganisme blev dyrket i 100 ml af et dyrkningsmedium indeholdende 2 g gærekstrakt, 10 g polypepton, 2 g glucose, 7 g dinatriumhydrogenphosphat, 2 g kaliumdihydrogenphosphat, 1,2 g ammoniumsulfat og 0,4 g magnesiumsulfat pr. liter i en 500 ml konisk kolbe i 6 timer ved rystning ved 37°C. De dannede celler blev opsamlet ved centrifugering (5.000 omdr./min. i 10 minutter), vaskedes 3 gange med 0,1 M phosphatpuffer (pH = 7,0). Derefter blev cellerne underkastet lydbehandling (20 KHz, 20 minutter) og derefter centrifugeret ved 15.000 omdr./min. i 60 minutter. Ved anvendelse af den ovenstående enzymvæske blev resistensen af hver forbindelse overfor β-lactamase bestemt ved iodometrisk prøve. De opnåede resultater er angivet i tabel 7, hvor numrene henviser til forbindelserne i tabel 3. Hvert tal i tabel 7 angiver en ‘relativ aktivitetsverdi, beregnet ved at antage en aktivitet på 100 for kalium penicillin G, der blev benyttet som kontrol.This microorganism was grown in 100 ml of a culture medium containing 2 g yeast extract, 10 g polypeptone, 2 g glucose, 7 g disodium hydrogen phosphate, 2 g potassium dihydrogen phosphate, 1.2 g ammonium sulphate and 0.4 g magnesium sulphate. liter in a 500 ml conical flask for 6 hours by shaking at 37 ° C. The cells formed were collected by centrifugation (5,000 rpm for 10 minutes), washed 3 times with 0.1 M phosphate buffer (pH = 7.0). Then, the cells were subjected to sound processing (20 KHz, 20 minutes) and then centrifuged at 15,000 rpm. for 60 minutes. Using the above enzyme fluid, the resistance of each compound to β-lactamase was determined by iodometric sample. The results obtained are given in Table 7, where the numbers refer to the compounds in Table 3. Each number in Table 7 indicates a relative activity value calculated by assuming an activity of 100 for potassium penicillin G used as a control.

' " * ·**—-' -,r 58 1 5 1 3 3 8'"* · ** —-' -, r 58 1 5 1 3 3 8

Tabel 7Table 7

Sammenligning af resistent aktivitet overfor β-lactamaseComparison of resistant activity to β-lactamase

Forbindelse Relativ aktivitet (%)Compound Relative Activity (%)

Kalium Penicillin G 100Potassium Penicillin G 100

Natrium-Amp i c illin 115Sodium Amp in c illin 115

Natrium-Carbenicillin 116Sodium Carbenicillin 116

Natrium-Sulbenicillin 50Sodium Sulbenicillin 50

Forbindelse nr. 49 3 » » 2 14 » » 1 15 » » 3 15 n η 4 15 Η tf . 5 15 » " 10 16 i » .· »11 1 12 » «12 ,1Compound No. 49 3 »» 2 14 »» 1 15 »» 3 15 n η 4 15 Η tf. 5 15 »» 10 16 i ». ·» 11 1 12 »« 12, 1

Af tabellerne 3-6 forstås, at de omhandlede forbindelser har et bredere antibakterielt spektrum og en højere antibakteriel aktivitet overfor ikke blot Pseudomonas aeruginosa, Klebsiella pneumoniae og Proteus-arter, men også mange lægemiddelresistente bakterier, end tilfældet er med ampicillin og cephaloglycin, der anvendes til kontrol, d.v.s. i forbindelse med en aminogruppe i a-stilling til acylgruppen. Det fremgår også af tabel 7, at forbindelsen ifølge opfindelsen har en langt højere resistens overfor β-lactamase end sammenligningsforbindelserne.From Tables 3-6, it is understood that the compounds of this invention have a broader antibacterial spectrum and a higher antibacterial activity against not only Pseudomonas aeruginosa, Klebsiella pneumoniae and Proteus species, but also many drug resistant bacteria than is the case with ampicillin and cephaloglycine used. for control, ie in conjunction with an amino group at the α-position of the acyl group. It is also apparent from Table 7 that the compound of the invention has a much higher resistance to β-lactamase than the comparison compounds.

Det fremgår af de ovennævnte resultater, at forbindelserne med formlen (I)» som indeholder to oxygenatomer knyttet til henholdsvis 2- og 3-positionen i piperazinringen, udviser særlige fremragende egenskaber, og særlig foretrukne forbindelser er sådanne, hvori A betyder et hydrogenatom, en (C2_4)alkenylgruppe, en phenylgruppe, en benzylgruppe eller en )alkylgruppe, som kan være substitueret med chlor, hydroxy eller carboxyl; og 3 og R hver for sig betyder et hydrogenatom eller en (C^_g)alkyl-gruppe. De mest foretrukne forbindelser er 6-Q)(-)-o&-(4-ethyl- 59 1 5 1 3 3 8 2,3-dioxo-l-piperazinocarbonylamino)-phenylacetamidq] penicillan-syre og 7-£p(-)-dr(4-ethyl~2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxyphenylacetamidoj —3—^*5— (1-methyl-1 ,2,3,4-tetrazolyl)thio-methylJ-^-cephem-4-carboxylsyre og farmaceutisk acceptable syre-additionssalte deraf.It is evident from the above results that the compounds of formula (I) containing two oxygen atoms attached to the 2 and 3 positions of the piperazine ring, respectively, exhibit particularly excellent properties, and particularly preferred compounds are those wherein A represents a hydrogen atom, a (C2-4) alkenyl group, a phenyl group, a benzyl group or an) alkyl group which may be substituted by chloro, hydroxy or carboxyl; and 3 and R each independently represent a hydrogen atom or a (C 1-6) alkyl group. The most preferred compounds are 6-Q) (-) - O & - (4-ethyl-59 1 5 1 3 3 8 2,3-dioxo-1-piperazinocarbonylamino) -phenylacetamide] penicillanic acid and 7- £ p (- ) -dr (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamidoj-3- [5- (1-methyl-1,2,3,4-tetrazolyl) thio-methyl] - cephem-4-carboxylic acid and pharmaceutically acceptable acid addition salts thereof.

De omhandlede penicilliner og cephalosporiner har sædvanligvis lav toxicitet. F.eks. har 6-[D(-)-a-(4-methyl-2,3-dioxo-l-piper-azinocarbonylamino)-phenylacetamido]penicillansyre og 6-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-penicillansyre en LD^0 (i.v. på mus af en vægt på 19 - 1 g) større end 5 g/kg.The present penicillins and cephalosporins usually have low toxicity. Eg. have 6- [D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid and 6- [D (-) - α- (4-ethyl-2, 3-Dioxo-1-piperazinocarbonylamino) phenylacetamido] -penicillanic acid an LD 50 (iv in mice weighing 19-1 g) greater than 5 g / kg

Forbindelserne med formel (i) kan indgives enten i form af de frie syrer eller i form af ikke-giftige salte eller fysiologisk acceptable estere. Endvidere kan de forbindelser, som har form af fysiologisk uacceptable estere, sædvanligvis bringes i anvendelse ved omdannelse til de frie syrer eller ikke-giftige salte ved fjernelse af den esterdannende gruppe på i og for sig kendt måde.The compounds of formula (i) can be administered either in the form of the free acids or in the form of non-toxic salts or physiologically acceptable esters. Furthermore, those compounds which are in the form of physiologically unacceptable esters can usually be used by conversion to the free acids or non-toxic salts by removal of the ester-forming group in a manner known per se.

De ifølge opfindelsen fremstillede forbindelser kan indgives mennesker og dyr i form af tabletter, kapsler, sirupper eller injektioner, på samme måde som de kendte penicilliner og cephalosporiner.The compounds of the invention can be administered to humans and animals in the form of tablets, capsules, syrups or injections, in the same manner as the known penicillins and cephalosporins.

Fremgangsmåden ifølge opfindelsen belyses nærmere ved de efterfølgende eksempler.The process according to the invention is further illustrated by the following examples.

EKSEMPEL 1 (l) Til en blanding af 2,5 g l-acetyl-3-oxo-piperazin, 3,45 g triethylamin og 20 ml vandfrit dioxan blev sat en opløsning af 3,71 g trimethylchlorsilan i 10 ml vandfri dioxan. Den dannede blanding blev kogt under tilbagesvaling i 17 timer og afkølet til udfældning af triethylamin-hydrochlorid, som derefter blev frafiltreret. Filtratet blev ved T40°C til -30°C dryppet til en opløsning af 1,8 g phosgen i 30 ml vandfrit methylenchlorid. Efter tildryp-ningen hævedes temperaturen af den dannede blanding til stuetemperatur, som opretholdtes i 30 minutter. Derefter blev overskud af 60 151338 phosgen og opløsningsmiddel fjernet ved.destillation under reduceret tryk til dannelse af 3,5 g lysebrunt olieagtigt 4-acetyl-2-oxo- 1- piperazinocarbonylchlorid.EXAMPLE 1 (1) To a mixture of 2.5 g of 1-acetyl-3-oxo-piperazine, 3.45 g of triethylamine and 20 ml of anhydrous dioxane was added a solution of 3.71 g of trimethylchlorosilane in 10 ml of anhydrous dioxane. The resulting mixture was refluxed for 17 hours and cooled to precipitate triethylamine hydrochloride, which was then filtered off. The filtrate was dripped at T40 ° C to -30 ° C to a solution of 1.8 g of phosgene in 30 ml of anhydrous methylene chloride. After the dripping, the temperature of the resulting mixture was raised to room temperature, which was maintained for 30 minutes. Then, excess of phosgene and solvent were removed by distillation under reduced pressure to give 3.5 g of light brown oily 4-acetyl-2-oxo-1-piperazinocarbonyl chloride.

IR (film) cm-1: ^C=o 1790» 1710» 1640 · (2) En suspension af 1,0 g 6-[D(-)-a-aminophenylacetamido]-penicillansyre i 20 ml tetrahydrofuran indeholdende 20 rumfangsprocent vand, indstilledes til pH =8,0 til 8,5 ved gradvis tilsætning af triethylamin under omrøring, og derpå afkøledes til 0°C. Til den således behandlede suspension dryppedes en opløsning af 900 mg af ovennævnte 4-acetyl-2-oxo-l-piperazinocarbonylchl0rid i 5 ml tetrahydrofuran ved den nævnte temperatur i løbet af 30 minutter. I dette tidsrum blev pH-værdien af suspensionen opretholdt på 7,5 til 8,0 ved gradvis tilsætning af triethylamin. Derefter blev temperaturen af den dannede blanding hævet til 5°C til 10°C, og blandingen blev omsat ved den nævnte temperatur i 1 time, medens pH-værdien opretholdtes på 7,5 til 8,0 ved tilsætning af triethylamin. Efter koncentrationen blev tetrahydrofuranen af-destilleret ved reduceret tryk, og remanensen blev opløst i et blandet opløsningsmiddel bestående af 30 ml ethylacetat og 10 ml vand. Den dannede opløsning blev indstillet på en pH-værdi på 1,5 til 2 ved tilsætning af fortyndet saltsyre under isafkøling, og derefter blev det organiske lag fraskilt. Det vandige lag blev genekstraheret med 20 ml ethylacetat, og det dannede organiske lag blev forenet med ovennævnte organiske lag. De forenede organiske lag blev vasket med vand, tørret over vandfrit magnesiumsulfat og derefter isafkølet. I dette organiske lag blev dryppet en opløsning af 470 mg af et natriumsalt af 2-ethylhexansyre i 20 ml ethylacetat til udfældning af hvide krystaller. De udfældede krystaller blev opsamlet ved filtrering, vasket med ethylacetat og derefter tørret til dannelse af 1,4 g natriumsalt af 6 - [D (-) - a- (4-acetyl- 2- oxo-l-piperazinocarbonylamino)phenylacetamido]penicillansyre, smp.: 2050 C (dekomp.), udbytte: 94%.IR (film) cm -1: C = o 1790 »1710» 1640 · (2) A suspension of 1.0 g of 6- [D (-) - α-aminophenylacetamido] penicillanic acid in 20 ml of tetrahydrofuran containing 20% by volume of water , was adjusted to pH = 8.0 to 8.5 by the gradual addition of triethylamine with stirring and then cooled to 0 ° C. To the suspension thus treated, a solution of 900 mg of the above-mentioned 4-acetyl-2-oxo-1-piperazinocarbonyl chloride was dropped into 5 ml of tetrahydrofuran at said temperature over 30 minutes. During this time, the pH of the suspension was maintained at 7.5 to 8.0 by the gradual addition of triethylamine. Then, the temperature of the resulting mixture was raised to 5 ° C to 10 ° C and the mixture was reacted at said temperature for 1 hour while maintaining the pH of 7.5 to 8.0 by the addition of triethylamine. After concentration, the tetrahydrofuran was distilled off at reduced pressure and the residue was dissolved in a mixed solvent consisting of 30 ml of ethyl acetate and 10 ml of water. The resulting solution was adjusted to a pH of 1.5 to 2 by the addition of dilute hydrochloric acid under ice-cooling, and then the organic layer was separated. The aqueous layer was re-extracted with 20 ml of ethyl acetate and the resulting organic layer was combined with the above organic layer. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate and then ice-cooled. In this organic layer was added a solution of 470 mg of a sodium salt of 2-ethylhexanoic acid in 20 ml of ethyl acetate to precipitate white crystals. The precipitated crystals were collected by filtration, washed with ethyl acetate and then dried to give 1.4 g of sodium salt of 6 - [D (-) - α- (4-acetyl-2-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, mp: 2050 ° C (decomp.), yield: 94%.

151338 IR (KBr) cm”1; yc=Q 1760 (lactam), 1600 - 1700 (-C00®, -CON<0 NMR: [(CD^)2S0 + D20] ^ værdier: 2,73 (5H), 4,35 (IH), 4,75 (2H), 5,75 (IH), 5,84 (2H), 6,42 (4H), 8,03 (3H), 8,52 (3H), 8,64 (3H).IR (KBr) cm ”1; γc = Q 1760 (lactam), 1600 - 1700 (-C00®, -CON <0 NMR: [(CD2) 2SO + D20] + values: 2.73 (5H), 4.35 (1H), 4, 75 (2H), 5.75 (1H), 5.84 (2H), 6.42 (4H), 8.03 (3H), 8.52 (3H), 8.64 (3H).

Ovennævnte operation blev gentaget med den ændring, at 4-acetyl-2-oxo-l-piperazinocarbonylchlorid blev erstattet med de i efterfølgende tabel 8 nævnte reaktive derivater af forbindelser med formlen (III), til dannelse af de i tabel 8 nævnte forbindelser. Strukturen af hvert af de dannede slutprodukter blev bekræftet ved IR og NMR.The above operation was repeated with the change that 4-acetyl-2-oxo-1-piperazinocarbonyl chloride was replaced with the reactive derivatives of compounds of formula (III) listed below to give the compounds listed in Table 8. The structure of each of the final products formed was confirmed by IR and NMR.

62 15133862 151338

Γ S SΓ S S

S. O (CS. O (C

o o o so 00 c- y_y ^o o o so 00 c- y_y ^

cS ^ ra L in ^ -PcS ^ ra L in ^ -P

a t* '-fe £ * Eand t * '-fe £ * E

fCN fOiO 4? I oo a TfCN fOiO 4? I oo and T

M K O !>i —1 KN KNO £?> o o o ,α > ω awo.· fl v_y o +1 000¾.M K O!> I —1 KN KNO £?> O o o, α> ω awo. · Fl v_y o +1 000¾.

r-[ 3 W -p y_/ 3 eq I * a >> Jn • Y? §> O _ g \a o° "i o S-(o) * _1 o <D O CM BO/ cm κι m a ,.-°.r- [3 W -p y_ / 3 eq I * a >> Jn • Y? §> O _ g \ a o ° "i o S- (o) * _1 o <D O CM BO / cm κι m a, .- °.

_i a i op g I_i a i on g I

tu o o o a i« O ,_„ KN I CM O K' I f® ~ °φ ! |^> ! n O · I · a £ o a o ft o ft ^ i a o a o · atu o o o a i «O, _„ KN I CM O K 'I f® ~ ° φ! | ^>! n O · I · a £ o a o ft o ft ^ i a o a o · a

-Jj Ov a O CM Q I O-Jj Ov and O CM Q I O

-¾ T Ί X Η X o^a λ ^ l J ω o ω T 1 5 ^ ^a a ft l J ft j i —' '—' —' !si '— co .TJ ° cm i h g · § p. < S ft Λ ° έ O 2 I ra I jg' m i /JjS to i ft-¾ T Ί X Η X o ^ a λ ^ l J ω o ω T 1 5 ^^ aa ft l J ft ji - '' - '-'! Si '- co .TJ ° cm ihg · § p. < S ft Λ ° έ O 2 I ra I jg 'mi / JjS to i ft

•H• H

?hH _i OH o ' WH § "S Vi? hH _i OH o 'WH § "S Vi

G! VG! V

> ?h O I co>? h O I co

•H O o O O• H O o O O

Ih CH [ O OIh CH [O O

® - Ov a 'CM I® - Ov a 'CM I

10 s T ) . s Vi ta *? ^ laj •H S O cm. 110 s T). s We take *? ^ laj • H S O cm. 1

4J φ O K O4J φ O K O

5 co a o o 3.3 I I é 63 1513385 co a o o 3.3 I I é 63 151338

κί ώ Sκί ώ S

S25 S - ίΛ ΚΛΟ > ΚΛtfvO m Μ tu Ο ., WMO S' ο ο ο © ο ο ο £ cd * y~f £ VV b ja O ral ·!>» ra I 5 CT\ cc\o CO \jg jb \_j2j ^ tt w o 1 13 I p 0 o o © —k S —k.S25 S - ίΛ ΚΛ> ftfvO m Ο tu Ο., WMO S 'ο ο ο © ο ο ο £ cd * y ~ f £ VV b ja O ral ·!> »Ra I 5 CT \ cc \ o CO \ jg jb \ _j2j ^ tt wo 1 13 I p 0 oo © —k S —k.

V/ 40 ^ / 1 -p o o ra I >, M o W o tf I 8 I- 8 £ J |-<°K g-®"V / 40 ^ / 1 -p o o ra I>, M o W o tf I 8 I- 8 £ J | - <° K g-® "

O '"CTi OH O CDO "" CTi OH O CD

o CF* O C~- O ir\o CF * O C ~ - O ir \

ffi /7Λ H IH I Hffi / 7Λ H IH I H

SA°) ~ V3-, ~ °ΤΒ] - g ά W g. y & o a i a iiSA °) ~ V3-, ~ ° ΤΒ] - g ά W g. Y & o a i a ii

10 CV1 O CM Q10 CV1 O CM Q

O^B 1¾ M tM W % V ί ω o © o © 1 J ^ H" ^ CM Tj 5 > * 3 g cm » tU » M · “ I o ft I O ft I O g, -P^ra g ^ gO ^ B 1¾ M tM W% V ί ω o © o © 1 J ^ H "^ CM Tj 5> * 3 g cm» tU »M ·" I o ft I O ft I O g, -P ^ ra g ^ g

P I jo, ·$ I ff\ tø 1 MP I jo, · $ I ff \ tø 1 M

u — j£ — m — pr;u - j £ - m - pr;

JH P O P U P OJH P O P U P O

0000

rHrh

© ©© ©

Eh iEh i

Η HΗ H

O OISLAND ISLAND

O OISLAND ISLAND

8 2 h °r^ °r } 8 y y o I 18 2 h ° r ^ ° r} 8 y y o I 1

I CM CMIn CM CM

γΊ 8 8 w ^ ^γΊ 8 8 w ^^

I CM CMIn CM CM

cm tu ffi ° O o .cm tu fi ° ° o.

tc\ tf*tc \ tf *

ftj· W Wftj · W W

O O OO O O

64 1 5 1 3 3 8 ώ Η $ ^ [§ am am to too64 1 5 1 3 3 8 ώ Η $ ^ [§ am to too

to too ra totoo ^ a a Oto too ra totoo ^ a a O

ggg · gg§ $ °v2,° y-f I y-r I iri * “J, I1 mJ= i Tf § 4, 3 -i 3 -A s x> v q 43 O O a 4s a o a o a · >> a c> a o o ft o o oh- o 'd o __ crv o __„ to a f7\ d %<§> 1 i·® , o a a o o o oo o cvj o ooggg · gg§ $ ° v2, ° yf I yr I iri * “J, I1 mJ = i Tf § 4, 3 -i 3 -A sx> vq 43 OO a 4s aoaoa · >> ac> aoo ft oo oh- o 'do __ crv o __ „to a f7 \ d% <§> 1 i · ®, oaaooo oo o cvj o oo

O to 00 o to I HO to 00 o to I H

i a h i h o. ,a^ cm rr ΐ o 2 v - a ft a s* i ft i a i a oj a CVJ · Q cvi o M o a « a o O ω O Φ O <1>i a h i h o., a ^ cm rr ΐ o 2 v - a ft a s * i ft i a i a oj a CVJ · Q cvi o M o a «a o O ω O Φ O <1>

-P cvj a vo ri o H-P cvj a vo ri o H

ra cvi cvi o +5 a · a * to · T. i ο ft i o ft i — ft q ^ a — to a er! i to ω i to ra i a ra w ^ w tt a ^ o ο o a o « ^ 00ra cvi cvi o +5 a · a * to · T. i ο ft i o ft i - ft q ^ a - to a is! i to ω i to ra i a ra w ^ w tt a ^ o ο o a o «^ 00

HH

0) ft «0) ft «

EHEH

H H oH H o

O O OO O O

o O oo O o

O to O IO to O I

r a i o> ar a i o> a

°tT Ύ) V° tT Ύ) V

^a & i I I cvj OJ CM a a a o 0.0 o CM VO o ,-v o CM CM o a a to o o ^.^ a & i I I cvj OJ CM a a a o o 0.0 o CM VO o, -v o CM CM o a a to o o ^.

^ w to to to a a a o o o ^ J--- 65 1 5 1 3 3 8 EKSEMPEL 2 (1) I en opløsning af 1,74 g natriumsalt af D(-)-a-aminophenyl-eddikesyre i 30 ml tetrahydrofuran indeholdende 20 rumfangsprocent vand, som er afkølet til 0°C, dryppedes en opløsning af 2,5 g 4-acetyl-2~oxo-l-piperazinocarbonyl i 5 ml tetrahydrofuran ved den nævnte temperatur i løbet af 30 minutter. I dette tidsrum blev pH-værdi en af reaktionsopløsningen holdt mellem 11,0 og 12.0 ved gradvis tilsætning af en 10% vandig natriumhydroxidopløsning. Derefter blev temperaturen af den dannede blandede opløsning hævet til 5 - 10°C, og opløsningen blev omsat ved stuetemperatur i 2 timer, medens pH-værdi en blev holdt mellem 10,0 og 11.0 ved tilsætning af 10% vandig natriumhydroxidopløsning. Efter reaktionen blev tetrahydrofuranet afdestilleret ved reduceret tryk. Remanensen blev opløst i et blandet opløsningsmiddel indeholdende 20 ml vand og 50 ml ethylacetat, og den dannede opløsning blev ind·?· stillet på en pH-værdi af 1,0 til 1,5 ved tilsætning af fortyndet saltsyre under isafkøling. Derefter blev det organiske lag fraskilt, vasket med vand og derefter tørret over vandfrit magnesiumsulfat. Til dette organiske lag sattes en opløsning af 1,66 g natriumsalt af 2-ethyl-hexansyre i 20 ml ethylacetat til udfældning af hvide krystaller. De udfældede krystaller blev opsamlet ved filtrering, vasket grundigt med ethylacetat og derefter tørret til dannelse af 1,89 g af et natriumsalt af D(-)-a-(4-acetyl-2-oxo-l-piperazinocarbonylamino)phenyleddikesyre, smp.: 115°C (dekomp.), udbytte 52%.EXAMPLE 2 (1) In a solution of 1.74 g of sodium salt of D (-) - α-aminophenyl acetic acid in 30 ml of tetrahydrofuran containing 20% by volume water, cooled to 0 ° C, a solution of 2.5 g of 4-acetyl-2-oxo-1-piperazinocarbonyl in 5 ml of tetrahydrofuran was dropped at said temperature over 30 minutes. During this time, the pH of one of the reaction solution was kept between 11.0 and 12.0 by gradually adding a 10% aqueous sodium hydroxide solution. Then the temperature of the resulting mixed solution was raised to 5 - 10 ° C and the solution was reacted at room temperature for 2 hours while maintaining a pH between 10.0 and 11.0 by adding 10% aqueous sodium hydroxide solution. After the reaction, the tetrahydrofuran was distilled off at reduced pressure. The residue was dissolved in a mixed solvent containing 20 ml of water and 50 ml of ethyl acetate and the resulting solution was adjusted to a pH of 1.0 to 1.5 by adding dilute hydrochloric acid under ice-cooling. Then, the organic layer was separated, washed with water and then dried over anhydrous magnesium sulfate. To this organic layer was added a solution of 1.66 g of sodium salt of 2-ethylhexanoic acid in 20 ml of ethyl acetate to precipitate white crystals. The precipitated crystals were collected by filtration, washed thoroughly with ethyl acetate and then dried to give 1.89 g of a sodium salt of D (-) - α- (4-acetyl-2-oxo-1-piperazinocarbonylamino) phenylacetic acid, m.p. : 115 ° C (decomp.), Yield 52%.

IR (KBr) cm”1: 1690, 1650 - 1600 (2) Til en suspension i 15 ml vandfri acetone af 833 mg af ovennævnte natrimsalt af D(-)-a-(4-acetyl-2-oxo-l-piperazinocarbonyl-amino) phenyl-eddike syre sattes 10 mg N-methylmorpholin. Den dannede blanding opsamledes ved -20°C til -15°C, og en opløsning af 286 mg ethylchlorcarbonat i 5 ml vandfri acetone tildryppedes blandingen i løbet af 5 minutter. Derefter omrørtes blandingen ved den nævnte temperatur i 60 minutter. I den således behandlede blanding dryppedes en opløsning af 646 mg triethylaminsalt af 6-aminopeni-cillansyre i 30 ml vandfrit methylenchlorid ved -40°C til -30°C i løbet af 10 minutter. Derefter omsattes blandingen under omrøring ved -30° C til -20° C i 60 minutter og ved -20° C til -1.0° C i 30 minutter og ved -10°C til 0°C i 30 minutter. Efter reaktionen blev det ,ί 66 1513.38 organiske opløsningsmiddel afdestilleret under reduceret tryk. Remanensen blev opløst i et blandet opløsningsmiddel bestående af 50 ml ethylacetat og 20 ml vand, og den dannede opløsning indstilledes på en pH-værdi på 1,5 til 2,0 ved tilsætning af fortyndet saltsyre under isafkøling. Derefter fraskiltes det organiske lag, der vaskedes grundigt med vand og tørredes derefter over vandfrit magnesiumsulfat, og ethylacetatet afdestilieredes ved reduceret tryk. Remanensen blev opløst i 50 ml acetone, og den dannede opløsning blev blandet med en opløsning af 340 mg natriumsalt af 2-ethylhexansyre i 20 ml acetone under isafkøling til udfældning af hvide krystaller. De udfældede krystaller opsamlede.· ved filtrering, vaskedes grundigt med acetone og tørredes derefter til dannelse af 1,16 g natriumsalt af 6-[D(-)-a-(4-acetyl-2-oxo-1-piperazinocarbonylamino)phenylacetamido]penicillansyre, smp.: 205°C (dekomp.), udbytte 94%.IR (KBr) cm -1: 1690, 1650 - 1600 (2) For a suspension in 15 ml of anhydrous acetone of 833 mg of the above sodium salt of D (-) - α- (4-acetyl-2-oxo-1-piperazinocarbonyl -amino) phenyl-acetic acid was added 10 mg of N-methylmorpholine. The resulting mixture was collected at -20 ° C to -15 ° C and a solution of 286 mg of ethyl chlorocarbonate in 5 ml of anhydrous acetone was added dropwise over 5 minutes. Then the mixture was stirred at said temperature for 60 minutes. In the thus treated mixture, a solution of 646 mg of triethylamine salt of 6-aminopeniacillanic acid in 30 ml of anhydrous methylene chloride was dropped at -40 ° C to -30 ° C over 10 minutes. Then the mixture was reacted with stirring at -30 ° C to -20 ° C for 60 minutes and at -20 ° C to -1.0 ° C for 30 minutes and at -10 ° C to 0 ° C for 30 minutes. After the reaction, the organic solvent was distilled off under reduced pressure. The residue was dissolved in a mixed solvent consisting of 50 ml of ethyl acetate and 20 ml of water and the resulting solution was adjusted to a pH of 1.5 to 2.0 by the addition of dilute hydrochloric acid under ice-cooling. Then, the organic layer was washed thoroughly with water and then dried over anhydrous magnesium sulfate and the ethyl acetate was distilled off at reduced pressure. The residue was dissolved in 50 ml of acetone and the resulting solution was mixed with a solution of 340 mg of sodium salt of 2-ethylhexanoic acid in 20 ml of acetone under ice-cooling to precipitate white crystals. The precipitated crystals were collected by filtration, washed thoroughly with acetone and then dried to give 1.16 g of sodium salt of 6- [D (-) - α- (4-acetyl-2-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, mp: 205 ° C (decomp.), yield 94%.

i EKSEMPEL 5in Example 5

Cl) Til en blanding af 1,0 g l-palmitoyl-3-oxo-piperazin, 0,6 g triethylamin og 20 ml vandfrit dioxan sattes en opløsning af 0,65 g trimethylchlorsilan i 10 ml vandfrit dioxan. Den dannede blanding kogtes under tilbagesvaling i 16 timer og afkøledes til udfældning af triethylaminhydrochlorid, som derefter frafiltreredes. Filtratet dryppedes ved -40°C til -30°C i en opløsning af 0,6 g phosgen i 30 ml vandfrit methylenchlorid. Efter tildrypningen blev temperaturen af den dannede blanding hævet, og blandingen omsattes til stuetemperatur i 30 minutter. Derefter blev overskud af phosgen og opløsningsmiddel afdestilleret ved reduceret tryk til dannelse af 1,1 g lysegul olieagtig 4-palmitoyl-2-ox0-l-piperazinocarbonyl-chlorid.Cl) To a mixture of 1.0 g of 1-palmitoyl-3-oxo-piperazine, 0.6 g of triethylamine and 20 ml of anhydrous dioxane was added a solution of 0.65 g of trimethylchlorosilane in 10 ml of anhydrous dioxane. The resulting mixture was refluxed for 16 hours and cooled to precipitate triethylamine hydrochloride which was then filtered off. The filtrate was dripped at -40 ° C to -30 ° C in a solution of 0.6 g of phosgene in 30 ml of anhydrous methylene chloride. After the drip, the temperature of the resulting mixture was raised and the mixture was reacted to room temperature for 30 minutes. Then, excess phosgene and solvent were distilled off at reduced pressure to give 1.1 g of pale yellow oily 4-palmitoyl-2-oxo-1-piperazinocarbonyl chloride.

IR (film) cm“^: Y^c=0 -*-740, 1660, 1640 (2) En suspension af 1,0 g 6-[D(-)-a-aminophenylacetamido]peni-cillansyre i 20 ml tetrahydrofuran indeholdende 20 rumfangsprocent vand indstilledes på en pH-værdi af 8,0 til 8,5 ved gradvis tilsætning af triethylamin under omrøring og afkøledes derefter til 0°C.IR (film) cm “:: Y ^ c = 0 - * - 740, 1660, 1640 (2) A suspension of 1.0 g of 6- [D (-) - α-aminophenylacetamido] penicillanic acid in 20 ml of tetrahydrofuran containing 20% by volume of water was adjusted to a pH of 8.0 to 8.5 by the gradual addition of triethylamine with stirring and then cooled to 0 ° C.

I den således behandlede suspension dryppedes en opløsning af 1,27 g af det ovennævnte palmitoyl-2-oxo-l-piperazinocarbonylchlorid i 5 ml tetrahydrofuran ved den nævnte temperatur i løbet af 30 minut- 67 1 5 1 3 3 8 ter. I dette tidsrum opretholdtes pH-værdien af suspensionen på 7,5 til 8,0 ved gradvis tilsætning af triethylamin. Derefter hævedes temperaturen af den dannede blanding til 5°C til 10°C, og blandingen omsattes ved den nævnte temperatur i 1 time, medens pH-værdien opretholdtes på 7,5 til 8,0 ved tilsætning af triethylamin. Efter reaktionen afdestilleredes tetrahydrofuranen ved reduceret tryk, og remanensen opløstes i et blandet opløsningsmiddel indeholdende 30 ml ethylacetat og 10 ml vand. Den dannede opløsning indstilledes til en pH-værdi på 1,0 til 2,0 ved tilsætning af fortyndet saltsyre under isafkøling, og derefter fraskiltes det organiske lag. Det vandige lag blev genekstraheret med 20 ml ethy-acetat, og det dannede organiske lag forenedes med det ovennævnte organiske lag. Det forenede organiske lag blev vasket med vand og tørret over vandfrit magnesiumsulfat. Dette organiske lag koncentreredes under reduceret tryk til fjernelse af opløsningsmidlet, og koncentratet blev indført i 10 ml diisopropylether til udfældning af krystaller. Derefter opsamledes krystallerne ved filtrering til dannelse af 1,65 g hvide krystaller af 6-[D(-)-a-(4-palmitoyl-2-oxo-l-piperazinocarbonylamino)phenylacetamido]penicillansyre, smp.: 121 - 123°C (dekomp.), udbytte 80%.In the suspension thus treated, a solution of 1.27 g of the above-mentioned palmitoyl-2-oxo-1-piperazinocarbonyl chloride was dripped into 5 ml of tetrahydrofuran at the said temperature over 30 minutes. During this time, the pH of the suspension of 7.5 to 8.0 was maintained by the gradual addition of triethylamine. Then the temperature of the resulting mixture was raised to 5 ° C to 10 ° C and the mixture was reacted at said temperature for 1 hour while maintaining the pH of 7.5 to 8.0 by the addition of triethylamine. After the reaction, the tetrahydrofuran was distilled off at reduced pressure and the residue was dissolved in a mixed solvent containing 30 ml of ethyl acetate and 10 ml of water. The resulting solution was adjusted to a pH of 1.0 to 2.0 by adding dilute hydrochloric acid under ice-cooling, and then the organic layer was separated. The aqueous layer was re-extracted with 20 ml of ethyl acetate and the resulting organic layer was combined with the above organic layer. The combined organic layer was washed with water and dried over anhydrous magnesium sulfate. This organic layer was concentrated under reduced pressure to remove the solvent and the concentrate was introduced into 10 ml of diisopropyl ether to precipitate crystals. The crystals were then collected by filtration to give 1.65 g of white crystals of 6- [D (-) - α- (4-palmitoyl-2-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, mp: 121 - 123 ° C (decomp.), yield 80%.

IR (KBr) cm"1: ^ C=Q 1770 (lactam), 1730 (-C00H), 1660 - 1630 (-CON O-IR (KBr) cm -1: C = Q 1770 (lactam), 1730 (-C00H), 1660 - 1630 (-CON O-

Ovennævnte operation gentoges med den ændring at 4-palmitoyl-2-oxo-l-piperazinocarbonylchloridet erstattedes med de reaktive derivater af forbindelser med formlen (III), som er vist i tabel 9, til dannelse af de ligeledes i tabel 9 viste slutprodukter. Strukturen af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that the 4-palmitoyl-2-oxo-1-piperazinocarbonyl chloride was replaced with the reactive derivatives of compounds of formula (III) shown in Table 9 to form the end products also shown in Table 9. The structure of the compounds formed was confirmed by IR and NMR.

ee 151358ee 151358

M M KSM M KS

(TV DAO o| to too · * O(TV DAO o | to too · * O

g g 8 « goo - g ®g g 8 «goo - g ®

π 5 y-[ i s Iπ 5 y- [i s I

CQ I ι_> GQ 1 .p ηηλ i3 I ' Vf · £ $ js I s 1 KMO «) 1¾¾CQ I ι_> GQ 1 .p ηηλ i3 I 'Vf · £ $ js I s 1 SME «) 1¾¾

N^. Ώ M fi Ο Ο O tft ΚΛΟ HN ^. Ώ M fi Ο Ο O tft ΚΛΟ H

m o 3 O ^ V/ ω mmo p ® td M 3 rn +- ο ο o “ B - b - - ra I if γ- 3 ' § o° 8 o° Ml’ «Π' o° 1 gÆ> K gÆ> £ -A 3 ti « 3 g^ H g^7 -1 B ° - K, -1 8 I ' 8 ' § g »H I h i . C- O If} 0.0mo 3 O ^ V / ω mmo p ® td M 3 rn + - ο ο o “B - b - - ra I if γ- 3 '§ o ° 8 o ° Ml'« Π 'o ° 1 gÆ> K gÆ > £ -A 3 ti «3 g ^ H g ^ 7 -1 B ° - K, -1 8 I '8' § g» HI hi. C- O If} 0.0

Ο Ϊ3 LTv O S LTv ffi /7\ Η O OJΟ Ϊ3 LTv O S LTv fi / 7 \ Η O OJ

i t ] H X) H §λ°>w g-/o> Hin t] H X) H §λ °> w g- / o> H

a V -.. V ~ § " g ^ ~ W O ft O ft O ft O ft +j o a o a ia o a ca (Μ o CM o o. a, S i-o ε m m .* ο^ΐ5κ # 0) ο ω ο ω I__J ® Y l ω M in m Ό ^sr Ό . L J Ό --- — --- I ^ B —a V - .. V ~ § "g ^ ~ WO ft O ft O ft O ft + joaoa ia oa ca (Μ o CM o o a, S io ε mm. * ο ^ ΐ5κ # 0) ο ω ο ω I__J ® Y l ω M in m Ό ^ sr Ό. LJ Ό --- - --- I ^ B -

<M CM ο I<M CM ο I

Μ Μ * ο · o I O * 'O .gc lft & o en ft 9---Μ S i g1 i m S I ra i ο ra MYi § H '— M cq — {xj χ- H LO J 1 ω ο o ft P ft o 33 & ca eh_;__.___Μ Μ * ο · o IO * 'O .gc lft & o and ft 9 --- Μ S i g1 im SI ra i ο ra MYi § H' - M cq - {xj χ- H LO J 1 ω ο o ft P ft o 33 & ca eh _; __.___

r"Nr "N

I HI H

g a h 8 8 <s o ^ o 2 H <Yj °f )g a h 8 8 <s o ^ o 2 H <Yj ° f)

Φ’Η ^B7 B^ Ο HB'Η ^ B7 B ^ Ο H

• -p Ο T i Ο o 1 ecu o o-Ο o > . o o _ i o• -p Ο T i Ο o 1 ecu o o-Ο o>. o o _ i o

H-ti CM CM o B^ IH-ti CM CM o B ^ I

j·« ® w Ή Y Ί o.b.j · «® w Ή Y Ί o.b.

:s a ο o LJ Ύ Ί: s a ο o LJ Ύ Ί

φ in tn B I Jφ in tn B I J

--- --- I B--- --- I B

Φ φ CM CM Ο IΦ φ CM CM Ο I

i> to · B M O, Oi> to · B M O, O

•hh 3 3 B ?• hh 3 3 B?

P φ KP φ K

vj >τ) en m o f/nlvj> τ) and m o f / nl

cad M M H OJcad M M H OJ

φ Η ο Ο o Μ,Ω 69 15133a ----Η-—--φ Η ο Ο o Μ, Ω 69 15133a ---- Η -—--

JRJR

VOVO

3 ® « σ\ co . σ\3 ® «σ \ co. σ \

HjHHJH

ffi (D too (¾ ixj Φ tOitOO -P WWO -P ; tfVtfO +? ωωο -p ooo -P' WKo -p OOO >> \V_/ κ*ν OOO >5 γ-γ g m\ s v-f <§ “U = y*i 3 °\i 3 _J o —^ o -1 o ο ο ο o Ο W 00 _ O tOv goj SO Μ ΚΛffi (D too (¾ ixj Φ tOitOO -P WWO -P; tfVtfO +? ωωο -p ooo -P 'WKo -p OOO >> \ V_ / κ * ν OOO> 5 γ-γ gm \ s vf <§ “ U = y * i 3 ° \ i 3 _J o - ^ o -1 o ο ο o o W 00 _ O to goj SO Μ ΚΛ

Η Ο H 13 H13 Ο H 13 H

O O __ OO O __ O

O I &} I O _ IO I &} I O _ I

|-<2>8 S 1^2) R-| - <2> 8 S 1 ^ 2) R-

g i—i O H g Hg i — i O H g H

ΐ ΐ °ΰ 1 °Å f « . 3 t λ Sr 44 p I Φ O <D I d) k Ο O τί Ο 5 λΦ i λΦ 1 /φ ί σ> i y 1 1 μ ‘ L aΐ ΐ ° ΰ 1 ° Å f «. 3 t λ Sr 44 p I Φ O <D I d) k Ο O τί Ο 5 λΦ i λΦ 1 / φ ί σ> i y 1 1 μ 'L a

w H ' Μ φΗ Hw H ′ Μ φΗ H

H f=) O O O Q OH f =) O O O Q O

<D rQ<D rQ

(ΰ EH---"--(ΰ EH --- "-

rHrh

Η Ο Η Ο Ο Ο Ο Ο Ο ο I οI Ο Η Ο Ο Ο Ο I I ο

I Ο ν g II Ο ν g I

Τ) υ °Φ 1 ° Λ ο ο οΤ) υ ° Φ 1 ° Λ ο ο ο

ο A HOο A HO

φ φ > Η ώ ρτ* Ο Ο Ο 70 151338 EKSEMPEL 4 .φ φ> Η ώ ρτ * Ο Ο Ο 70 EXAMPLE 4.

(1) Til en opløsning af 6,4 g l-formyl-3-oxo-piperazin i 10 ml vandfrit dimethylformamid sattes 2,7 g natriumhydrid (renhed 53%) under isafkøling, og den dannede blanding omsattes ved stuetemperatur i 1 time. Derefter indførtes blandingen i 7,1 g methyl-iodid, og der omsattes i 10 timer. Efter reaktionen afdestilleredes dimethylformamidet under reduceret tryk til dannelse af l-formyl-4-methyl-3-oxo-piperazin. Denne piperazin-forbindelse opløses i 70 ml af en 50% vandig acetoneopløsning indeholdende 2,2 g natriumhydroxid, og den dannede opløsning omsattes ved stuetemperatur i 3 timer. Derefter afdestilleredes opløsningsmidlet under reduceret tryk, og remanensen blev indført i acetone til udfældning af uopløselige stoffer. De uopløselige stoffer frafil-treredes, og acetonen afdestilleredes fra filtratet under reduceret tryk. Derefter underkastedes remanensen en destillation ved reduceret tryk til dannelse af 5,2 g l-methyl-2-oxo-piperazin, kp. 104°C/4 mmHg, udbytte 91%.(1) To a solution of 6.4 g of 1-formyl-3-oxo-piperazine in 10 ml of anhydrous dimethylformamide was added 2.7 g of sodium hydride (purity 53%) under ice-cooling and the resulting mixture was reacted at room temperature for 1 hour. Then the mixture was introduced into 7.1 g of methyl iodide and reacted for 10 hours. After the reaction, the dimethylformamide was distilled off under reduced pressure to give 1-formyl-4-methyl-3-oxo-piperazine. This piperazine compound is dissolved in 70 ml of a 50% aqueous acetone solution containing 2.2 g of sodium hydroxide and the resulting solution is reacted at room temperature for 3 hours. Then, the solvent was distilled off under reduced pressure and the residue was introduced into acetone to precipitate insoluble matter. The insolubles were filtered off and the acetone was distilled off from the filtrate under reduced pressure. Then the residue was subjected to distillation at reduced pressure to give 5.2 g of 1-methyl-2-oxo-piperazine, b.p. 104 ° C / 4 mmHg, yield 91%.

(2) I en opløsning af 1,9 g phosgen i 20 ml vandfrit dioxan dryp-· pedes ved 10°C 20 ml af en vandfri dioxanopløsning indeholdende 2,0 g l-methyl-2-oxo-piperazin og 1,95 g triethylamin, hvorefter reaktionen forløb til udfældning af hvide krystaller af triethyl-amin-hydrochlorid. De udfældede krystaller frafiltreredes, og filtratet inddampedes til tørhed til dannelse af 3,0 g lysegult olie-agtigt 4-methyl-3-oxo-l-piperazinocarbonylchlorid.(2) In a solution of 1.9 g of phosgene in 20 ml of anhydrous dioxane, drop at 10 ° C 20 ml of anhydrous dioxane solution containing 2.0 g of 1-methyl-2-oxo-piperazine and 1.95 g triethylamine, after which the reaction proceeded to precipitate white crystals of triethylamine hydrochloride. The precipitated crystals were filtered off and the filtrate was evaporated to dryness to give 3.0 g of pale yellow oily 4-methyl-3-oxo-1-piperazinocarbonyl chloride.

IR (film) cm”^: 1710, 1630 (3) En suspension af 4,0 g 6-[D(-)-a-aminophenylacetamido]peni-cillansyre i 40 ml tetrahydrofuran, indeholdende 20 rumfangsprocent vand, indstilledes på en pH-værdi på 8,0 til 8,5 ved gradvis tilsætning af triethylamin under omrøring, og derefter afkøledes til 0°C. Til den således behandlede suspension dryppedes 10 ml af en tetrahydrofuranopløsning indeholdende 2,2 g af ovennævnte 4-methyl- 3-oxo-l-piperazinocarbonylchlorid. I dette tidsrum opretholdtes pH-værdien af suspensionen på 7,5 til 8,5 ved gradvis tilsætning af triethylamin. Derefter omsattes den dannede blanding ved den nævnte temperatur i 30 minutter, og temperaturen hævedes til 10°C til 15°C, hvorefter blandingen yderligere omsattes ved den nævnte temperatur i 90 minutter, medens pH værdien holdtes på 7,5 til 8,0 7i 151338 ved tilsætning af triethylamin. Efter reaktionen afdestilleredes tetrahydrof uranet under reduceret tryk, og remanensen opløstes i 30 ml vand. Den dannede opløsning vaskedes med ethylacetat, hvorefter det vandige lag fraskiltes. Dette vandige lag isafkøledes og indstilledes derefter til en pH værdi på 1,5 ved tilsætning af fortyndet saltsyre til udfældning af hvide krystaller. De udfældede krystaller opsamledes ved filtrering, vaskedes flere gange med små mængder vand, tørredes og opløstes derefter i 100 ml acetone. Til den dannede opløsning sattes 1,9 g af et natriumsalt af 2- ethylhexansyre under isafkøling til udfældning af krystaller, som derefter opsamles ved filtrering til opnåelse af 5,4 g af et natriumsalt af 6-[D(-)-a-(4-methyl-3-oxo-l-piperazinocarbonylamino)-phenylacetamido]penicillansyre, smp.: 195°C (dekomp.), udbytte 92%.IR (film) cm ”:: 1710, 1630 (3) A suspension of 4.0 g of 6- [D (-) - α-aminophenylacetamido] penicillanic acid in 40 ml of tetrahydrofuran containing 20% by volume of water was adjusted to a pH value of 8.0 to 8.5 by gradual addition of triethylamine with stirring, and then cooled to 0 ° C. To the suspension thus treated was added 10 ml of a tetrahydrofuran solution containing 2.2 g of the above 4-methyl-3-oxo-1-piperazinocarbonyl chloride. During this time, the pH of the suspension was maintained at 7.5 to 8.5 by the gradual addition of triethylamine. Then, the resulting mixture was reacted at said temperature for 30 minutes, and the temperature was raised to 10 ° C to 15 ° C, then the mixture was further reacted at said temperature for 90 minutes while maintaining the pH of 7.5 to 8.0 µl. 151338 by the addition of triethylamine. After the reaction, the tetrahydro uranium was distilled off under reduced pressure and the residue was dissolved in 30 ml of water. The resulting solution was washed with ethyl acetate and the aqueous layer was separated. This aqueous layer was ice-cooled and then adjusted to a pH of 1.5 by the addition of dilute hydrochloric acid to precipitate white crystals. The precipitated crystals were collected by filtration, washed several times with small amounts of water, dried and then dissolved in 100 ml of acetone. To the resulting solution was added 1.9 g of a sodium salt of 2-ethylhexanoic acid under ice-cooling to precipitate crystals, which were then collected by filtration to give 5.4 g of a sodium salt of 6- [D (-) - α- ( 4-methyl-3-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, mp: 195 ° C (decomp.), Yield 92%.

IR (KBr) cm"1: C=Q 1760 (lactam), 1600 - 1660 (-CON , -C00 " ), NMR [(CD^^SO + D2O] værdier: 2.62 (5H), 4,48 (IH), 4,56 (2H), 5,97 (3H), 6.63 - 6,39 (4H), 7,13 (3H), 8,46 (3H), 8,55 (3H).IR (KBr) cm "1: C = Q 1760 (lactam), 1600-1660 (-CON, -C0000), NMR [(CD CD ^^ SO + D₂O] values: 2.62 (5H), 4.48 (1H) ), 4.56 (2H), 5.97 (3H), 6.63 - 6.39 (4H), 7.13 (3H), 8.46 (3H), 8.55 (3H).

Ovennævnte operation blev gentaget med den ændring, at 4-methyl- 3- oxo-l-piperazinocarbonylchlorid blev erstattet med hver af de i efterfølgende tabel 10 nævnte reaktive derivater af forbindelser med formlen (III) til dannelse af de ligeledes i tabel 10 nævnte respektive slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that 4-methyl-3-oxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of formula (III) listed in subsequent Table 10 to give the end products. The structure of each of the compounds formed was confirmed by IR and NMR.

72 151338 i S å72 151338 in S å

tA tAO m hiT'iT'StA tAO m hiT'iT'S

ooofi vs 0v„ OOOooofi vs 0v „OOO

>f g a S KV^S I n 1 ral a ^ a a o 00 colg^> f g a S KV ^ S I n 1 ral a ^ a a o 00 colg ^

Ro tA tAO ., o o o ., ya ! m I >r I. -λ gRo tA tAO., O o o., Ya! m I> r I. -λ g

. : a o 02 I £ i £ S'^D. : a o 02 I £ i £ S '^ D

a tr— V-a _L 'd S - £j $ g „ 8. -i 3 Ho =: 8 _ 1 a) ο-/<5\ 1 ο a § o §”^P) " Ό ϊΰ\—/ Mo o o W '—< o G a co a o- o ,_.oo Mo rl O O O O B /7\ o o o -g 8 S/ΤΛ ~ 8Λ°> ™ 2 8 fi ΓΒΊ ~ IA°> 7 8 2 : r*Ί ~ 4J o^&r a* o a 7 . a o^a ft m i ο o o .a^ q i a rt w js i ™ °a tr— Va _L 'd S - £ j $ g "8. -i 3 Ho =: 8 _ 1 a) ο - / <5 \ 1 ο a § o §" ^ P) "Ό ϊΰ \ - / Mo oo W '- <o G a co a o- o, _. oo Mo rl OOOOB / 7 \ ooo -g 8 S / ΤΛ ~ 8Λ °> ™ 2 8 fi ΓΒΊ ~ IA °> 7 8 2: r * Ί ~ 4J o ^ & r a * oa 7. ao ^ a ft mi ο oo .a ^ qia rt w js i ™ °

γη K a) .a^ ω 1 J ω Bγη K a) .a ^ ω 1 J ω B

-h o -o’ f a o^a -d Ο Φ 0 +> cm ^ 1. J ^ I ^ J? 3 o (q '—^ o a a -o, h g <m · i · ο · i cm § a ft cm a cm ft ; , a .-h o -o 'f a o ^ a -d Ο Φ 0 +> cm ^ 1. J ^ I ^ J? 3 o {q '- ^ o a a -o, h g <m · i · ο · i cm § a ft cm a cm ft ;, a.

ngio s i a si— s io © £ ^ w to ^~v o to ^ iA co ·· - 5* ,Q I tA I tA I a I a § co ^ a . —a —o χ angio s i a si— s io © £ ^ w to ^ ~ v o to ^ iA co ·· - 5 *, Q I tA I tA I a I a § co ^ a. —A —o χ a

EH ftO P ϋ P — POEH ftO P ϋ P - PO

/—s/ -s

H H I HH H I H

in'-' ,-1 'η a § d «5 ? 8in'- ', -1' η a § d «5? 8

ώ S £ Η Iώ S £ Η I

/,¾ f ] η o .a./, ¾ f] η o .a.

Po 1 J ο o f ΊPo 1 J ο o f Ί

cdSH o^a o . O _JLJcdSH o ^ a o. O _JLJ

!> _ i o . I ° a •h a cm i .a. i u ω a a. f Ί «μ <us o r 1 i, J a 3 cm J J o^a' o a — o^a i a +5 Φ CM I a i> w a cm o ^!> _ i o. I ° a • h a cm i .a. i u ω a a. f Ί «μ <us o r 1 i, J a 3 cm J J o ^ a 'o a - o ^ a i a +5 Φ CM I a i> w a cm o ^

•hh o a ™ H• hh o a ™ H

4j Φ v-- O -~1 O4j Φ v-- O - ~ 1 O

id a ia a ja w a a a a a a S a ο ο o a bp ° 73 151338 cdid a ia a yes w a a a a a a S a ο ο o a bp ° 73 151338 cd

KN KNO cd ^ ’ Cd cRKN KNO cd ^ 'Cd cR

K K O >25 ro s ffl o O O KN KNO ON KN KNO 00 V7 B B O B B O 'K K O> 25 ro s ffl o O O KN KNO ON KN KNO 00 V7 B B O B B O '

ΓΊ O O O ©' O O O CDΓΊ O O O © 'O O O CD

CQ I v_y -P V-/ -PCQ I v_y -P V- / -P

y? i <1 & «Π fe -4 ,σι Y-S £ Y-B £ κ ° ®’ p4 0 —k 3 S ij 1 o o S t? B O B oy? i <1 & «Π fe -4, σι Y-S £ Y-B £ κ ° ® 'p4 0 —k 3 S ij 1 o o S t? B O B o

o K5 B O S Oo K5 B O S O

Κ /ΖΛ jS o cnj o 'd-Κ / ΖΛ jS o cnj o 'd-

ο-(Ω> ^ o _ o O ___ ONο- (Ω> ^ o _ o O ___ ON

s i^°>7 mi _ o o 3 3s i ^ °> 7 mi _ o o 3 3

O I LfN O ON OHO I LfN O ON OH

-p [sl 00 O ΟΝ O KN ON-p [sl 00 O ΟΝ O KN ON

cd ^ .—1 I H I B' Hcd ^. — 1 I H I B 'H

t °Ύ x XV χ X 7° χ O Cd ft oXsXo ft 0*^3^ ft «Η - ixj a · S I at ° Ύ x XV χ X 7 ° χ O Cd ft oXsXo ft 0 * ^ 3 ^ ft «Η - ixj a · S I a

- o o (M O CM O- o o (M O CM O

c\i Μ B Λ KMc \ i Μ B Λ KM

O K o O CD O CDO K o O CD O CD

H OH cnj H CNJ HH OH cnj H CNJ H

H O CNJ · ,_£^ · CD OJ . K ø| . . hh 0, p 1 "" ft'3 & JL S sr PH T k" É I KN ^ .IKN ®H O CNJ ·, _ £ ^ · CD OJ. K ø | . . hh 0, p 1 "" ft'3 & JL S sr PH T k "É I KN ^ .IKN ®

H X δ ra — B ^ KH X δ ra - B ^ K

p W P O P op W P O P o

rHrh

O H HO H H

7 8 8 Λ ,2, Xe7 8 8 Λ, 2, Xe

°t 0yf oJX° t 0yf oJX

K I 1K I 1

o CNJ CNJo CNJ CNJ

cnj K Scnj K S

K o o o CNJ CdK o o o CNJ Cd

o Xl Xo Xl X

CNJ K BCNJ K B

^ o o KN ^ 'ti^ o o KN ^ 'ti

K KN KNK KN KN

o B Bo B B

o o 151338 74 || Il I ...... ...... *T I ............ ' ------- O !> t"- <3\ VO 00 <D cd Q> ω oi -P έι +3 +3o o 151338 74 || Il I ...... ...... * TI ............ '------- O!> T "- <3 \ VO 00 <D cd Q> ω oi -P έι +3 +3

. K p to ro +3 ^ P. K p to ro +3 ^ P

kokoo h KWO j>, O is KW op o o o p is- pkokoo h KWO j>, O is KW on o o o p is- p

o o o p y / p Po o o p y / p P

y-f 3 ran s 5 3 . cq I - ·" cd P cdy-f 3 ran s 5 3. cq I - · “cd P cd

y-K o i O K >, KOy-K o i O K>, KO

i O 1 O ΝΛ p ko koo o _i uo ^ uo WMO 5 WKooqi O 1 O ΝΛ p ko koo o _i uo ^ uo WMO 5 WKooq

V- O O O OOO p O O O HV- O O O OOO p O O O H

O H g H y_y ^ γ_/ CMO H g H y_y ^ γ_ / CM

§ I O I CQ 1 O CQ I I§ I O I CQ 1 O CQ I I

O _ O W _n\ O - V? °K0 Y^ ναO _ O W _n \ O - V? ° K0 Y ^ να

§-^θ) h g v?) η "i w |4o W§- ^ θ) h g v?) Η „i w | 4o W

Hj ' ^ O ^ K ° K ^Hj '^ O ^ K ° K ^

O O · K · KO O · K · K

0 o ft i 91 o ft o Pi +3 i a κ. a o a og 1 Xs) i «λ? i mi ih®«0 o ft i 91 o ft o Pi +3 i a κ. a o a and 1 Xs) i «λ? i mi ih® «

P O^K P I P K P KPP O ^ K P I P K P KP

O I w C\1 ^ o '—* O'—O I w C \ 1 ^ o '- * O'—

«Η coj . K O O«Η coj. K O O

^ K ’ q, , O · I · I · I O g* I ™ ft .K. Pi i /K. Pi ° id) ra2is oU g §^ K 'q,, O · I · I · I O g * I ™ ft .K. Pi i / K. Pi ° id) ra2is oU g §

Η P V P K W P KΗ P V P K W P K

Φ 3 EH--Φ 3 EH--

HH

h Sh S

o oIsland Island

o OIsland Island

X ) °Η HX) ° Η H

° »? kl - 8 8 ki W o o° »? at - 8 8 ki W o o

K O.I IK O.I I

O OO KO OO K

d i °v 75 151338 EKSEMPEL 5 (1) I en opløsning af 0,5 g phosgen i 10 ml vandfrit dioxan dryppedes ved 10°C 10 ml vandfrit dioxan indeholdende 0,56 g 1-allyl- 2-oxo-piperazin og 0,5 g triethylamin, hvorved der indledtes en reaktion til udfældning af hvide krystaller af triethylamin-hydro-chlorid. Derefter opsamledes de hvide krystaller ved filtrering, og filtratet inddampedes til tørhed til dannelse af 800 mg lysegult olieagtigt 4-allyl-3-oxo-l-piperazino-carbonylchlorid.Example 5 (1) In a solution of 0.5 g of phosgene in 10 ml of anhydrous dioxane, at 10 ° C 10 ml of anhydrous dioxane containing 0.56 g of 1-allyl-2-oxo-piperazine and 0 5 g of triethylamine, thereby initiating a reaction to precipitate white crystals of triethylamine hydrochloride. The white crystals were then collected by filtration and the filtrate was evaporated to dryness to give 800 mg of pale yellow oily 4-allyl-3-oxo-1-piperazino carbonyl chloride.

IR (film) cm"1: VC=Q 1720,.1640 (2) En suspension af 1,4 g 6-[D(-)-a-amino-phenylacetamido]penicil-lansyre i tetrahydrofuran indeholdende 20 rumfangsprocent vand, indstilledes til en pH-værdi af. 8,0 til 8,5 ved gradvis tilsætning af triethylamin under omrøring, og derefter afkøledes til 0°C. I den således behandlede dryppedes 10 ml tetrahydrofuranopløsning indeholdende 800 mg af ovennævnte 4-allyl-3-oxo-l-piperazinocarbonyl-chlorid. I dette tidsrum opretholdtes pH-værdien af suspensionen ved 7,5 til 8,5 ved gradvis tilsætning af triethylamin. Derefter omsattes den dannede blanding ved den nævnte temperatur i 30 minutter, og temperaturen hævedes til 10° til 15°C, hvorefter blandingen yderligere omsattes ved den nævnte temperatur i 90 minutter, medens pH-værdien indstilledes på 7,5 til 8,0 ved tilsætning af triethylamin. Efter reaktionen afdestilieredes tetrahydrofuranet under reduceret tryk, og remanensen opsamledes i 20 ml vand. Den dannede opløsning vaskedes med ethylacetat, og det vandige lag fraskiltes. Dette vandige lag isafkøledes og indstilledes på en pH-værdi på 1,5 ved tilsætning af fortyndet saltsyre til udfældning af hvide krystaller. De udfældede krystaller opsamledes ved filtrering, vaskedes grundigt med vand og tørredes derefter til opnåelse af 1,8 g 6-[p(-)-(K-(4-allyl-3-oxo-l-piperazinocarbonylamino) phenylac etami do] penicillansyre, smp. 92°C (dekomp.), udbytte 90%.IR (film) cm to a pH of 8.0 to 8.5 by gradual addition of triethylamine with stirring and then cooled to 0 ° C. In the thus treated 10 ml of tetrahydrofuran solution containing 800 mg of the above 4-allyl-3-oxo was added dropwise. During this time, the pH of the suspension was maintained at 7.5 to 8.5 by the gradual addition of triethylamine, then the resulting mixture was reacted at said temperature for 30 minutes and the temperature was raised to 10 ° C. The mixture was further reacted at said temperature for 90 minutes while the pH was adjusted to 7.5 to 8.0 by the addition of triethylamine. After the reaction, the tetrahydrofuran was distilled off under reduced pressure and the residue was collected in 20 ml of water. The resulting solution was washed with ethyl acetate, and other layers were separated. This aqueous layer was ice-cooled and adjusted to a pH of 1.5 by the addition of dilute hydrochloric acid to precipitate white crystals. The precipitated crystals were collected by filtration, washed thoroughly with water and then dried to give 1.8 g of 6- [p (-) - (K- (4-allyl-3-oxo-1-piperazinocarbonylamino) phenylac etamido] penicillanic acid , mp 92 ° C (decomp.), yield 90%.

IR (KBr) cm-1; V^c=0 1760 (lactam), 1720- 1620 (-C00H, -CONC )IR (KBr) cm -1; V c = 0 1760 (lactam), 1720-1620 (-C00H, -CONC)

- ------J- ------ J

76 15133876 151338

Ovennævnte operation blev gentaget med den ændring, at 4-allyl-3-oxo-l-piperazinocarbonylchloridet blev erstattet af hver af de i tabel 11 angivne reaktive derivater af forbindelserne med formlen (III) til dannelse af de respektive slutprodukter, der ligeledes er vist i tabel 11 <> Strukturen af hver forbindelse blev bekræftet . ved IR og NMR.The above operation was repeated with the change that the 4-allyl-3-oxo-1-piperazinocarbonyl chloride was replaced by each of the reactive derivatives of formula (III) listed in Table 11 to form the respective end products also shown. in Table 11 <> The structure of each compound was confirmed. by IR and NMR.

77 15133877 151338

Κ'ΚΛ Ο k\co§ 'SR WΚ'ΚΛ Ο k \ co§ 'SR W

66 8 § S68 S i«g 3 „ Y-f φ Yi o φ “ rav^i i ravs £ <1 £ 3 Hg Hg _i g S og.· o g 3 !q M p kp ,-,°66 8 § S68 S i «g 3" Y-f φ Yi o φ "amber ^ i i amber £ <1 £ 3 Hg Hg _i g S and. · O g 3! Q M p kp, -, °

-p fe ·. fe W-p fe ·. fe W

P O O O g ~P O O O g ~

O O O O O O OO O O O O O O

m ω /T\ cm ffi /~\ o o om ω / T \ cm ffi / ~ \ o o o

Ϊ i^>3 |^>S g-© SΪ i ^> 3 | ^> S g- © S

rH O O }Si '—'rH O O} Si '-'

rH O · O OrH O · O O

p fe i* s a J ap fe i * s a J a

§ X) s x) 5 AS§ X) s x) 5 AS

S °isf K. 5 ° T 5 cAe1 5S ° isf K. 5 ° T 5 cAe1 5

Eli hri tti — C\1 — I ' ' 'Eli hri tti - C \ 1 - I '' '

0—0 Μ (Λ CM I0—0 Μ (Λ CM I

W . O fe . , _ W 2 · X “ & X “-° & A g=o § § η j, ^ S i »" § λ “ £ ® H po O O O O'—' H /~vW. O fe. , _ W 2 · X “& X“ - ° & A g = o § § η j, ^ S i »" § λ “£ ® H po O O O O'— 'H / ~ v

Φ HΦ H

O H-----O H -----

03 H03 H

Eh βEh β

<D<D

HH

a &a &

Ή OΉ Oh

Η HΗ H

p-ri o op-ri o o

+1^0 O H+ 1 ^ 0 O H

ξ 2 o o oξ 2 o o o

> S I I O> S I I O

Ή . så fe OΉ. then fairy O

fe § i) i) afe § i) i) a

*3 ° 7 1Λ °Ύ JJ* 3 ° 7 1Λ ° Ύ JJ

-P Φ W W cm o fe >·ϋ o — o jxj to i ^-P Φ W W cm o fe> · ϋ o - o jxj to i ^

H S3 W O M CM IH S3 W O M CM I

+5 ·η o O — o wra+5 · η o O - o wra

,y O il il W_ o S, y O il il W_ o S

riSU CM CM 0 = 0 03riSU CM CM 0 = 0 03

So W W ^ w £So W W ^ w £

EEJCH o o g -PECHY o o g -P

78 1 5 1 3 3 8 w £:. w w78 1 5 1 3 3 8 w £:. w w

ΚΛ fT\Q (Τ' [Ov fOO tf> tfOΚΛ fT \ Q {Τ '[Ov fOO tf> tfO

W W O _ W W O M WOW W O _ W W O M WO

ooo $ ooo oooooo $ ooo ooo

Yi S y-f I yy fe 02 I ,>> cq I cr\ ca I (TiYi S y-f I yy fe 02 I, >> cq I cr \ ca I {Ti

VS 4 VS VSUS 4 US VS

4. ? 4 ! 4 ! O ** O !>> i_rW ^ w o S θ S £ a o S t) S ti Ο Ο O p o p o o __O _ ^ . mi i-©» i-®» g g o S o o 00 o o o o4.? 4! 4! O ** O! >> i_rW ^ w o S θ S £ a o S t) S ti Ο Ο O p o p o o __O _ ^. mi i- © »i-®» g g o S o o 00 o o o o

U CM O c\j Ο HU CM O c \ j Ο H

I Η I Η I HI Η I Η I H

-P „S. 4¾. ^ “ O^V ft o^ ft o^w ft-P „S. 4¾. ^ “O ^ V ft o ^ ft o ^ w ft

Li i a i a i s 0 CM O CM O CM o £ W Λ W -¾ Μ ΛLi i a i i a i s 0 CM O CM O CM o £ W Λ W -¾ Μ Λ

JT ο ω ο a) o <DJT ο ω ο a) o <D

<3- -ri m 'ti co 'ϋ<3- -ri m 'ti co' ϋ

V cm CM CMV cm CM CM

H W · W « W * h i o ; 1 o ft o p, 1 2 I ϊί §5« § cd no no noH W · W «W * h i o; 1 o ft o p, 1 2 I ϊί §5 «§ cd no no no

i—I rH rHi — I rH rH

OOO OOO OOOOOO OOO OOO

Λ ή Λ 0*Sr O^ÉT o*Ss i i iΛ ή Λ 0 * Sr O ^ ÉT o * Ss i i i

CM CM CMCM CM CM

W W WW W W

OOO ^ LTV COOOO ^ LTV CO

CM CM CMCM CM CM

WWWWWW

OOO tA to ΚΛOOO tA to ΚΛ

WWWWWW

ooo 79 1 5 1 3 3 8 Μ ΚΛ ΚΛΟ ΜΚο ο ο ο Y-f ^ £ CQ I '«Ο £~ y Μ 00 Κω μ ω +5 to too -ρ ο -μ Μ Μ ο -Ρ Μ >, ο ο ο >> og γγ g ο g ο I ο μ /7λ Vs |Λ2) - Λ - g ο " ο ο ο _ ο ο Ο Ό Μ ^ i ο a toooo 79 1 5 1 3 3 8 Μ ΚΛ ΚΛΟ ΜΚ Y f f Yf ^ £ CQ I '«Ο £ ~ y Μ 00 Κω μ ω +5 to too -ρ ο -μ Μ ο -Ρ Μ>, ο ο ο >> and γγ g ο g ο I ο μ / 7λ Vs | Λ2) - Λ - g ο "ο ο ο _ ο Ο Μ Μ ^ ο in two

/-s s H OH/ -s s H OH

Ϊ XJ ~ ~ 5 ° T i S<2/ iΪ XJ ~ ~ 5 ° T i S <2 / i

U O) S S SU O) S S S

O tti · O O QO tti · O O Q

cS o ,y o ο O ω i ωcS o, y o ο O ω i ω

Η H HΗ H H

d w X J ~ H Mi cy'tt ft , i o o i . a i 2 # § 2 ώ ra ® P O P '-d w X J ~ H Mi cy'tt ft, i o o i. a i 2 # § 2 ώ ra ® P O P '-

H ' OH 'O

o o ό cT-tso o ό cT-ts

C\J HC \ J H

M O.M O.

O OISLAND ISLAND

O OISLAND ISLAND

Η IΗ I

g oVg oV

i ώ O - 80 151338 EKSEMPEL· 6 (1) Til en blanding af 8 g diethylester af oxalsyre og 8 ml ethanol dryppedes ved stuetemperatur 4,4 g N-ethyl-ethylendiamin. Den dannede blanding henstilledes til reaktion i 3 timer, og derefter opvarmedes til fjernelse af ethanolet. Derpå omkrystalliseredes remanensen af 10 ml dioxan til dannelse af 5,4 g l-ethyl-2,3-dioxo-piperazin, smp. 124°C, udbytte 76,0%.EXAMPLE 6 (1) To a mixture of 8 g of diethyl ester of oxalic acid and 8 ml of ethanol, 4.4 g of N-ethyl-ethylenediamine was dropped at room temperature. The resulting mixture was allowed to react for 3 hours and then heated to remove the ethanol. Then, the residue of 10 ml of dioxane was recrystallized to give 5.4 g of 1-ethyl-2,3-dioxopiperazine, m.p. 124 ° C, yield 76.0%.

(2) Til en suspension af 0,71 g af ovennævnte l-ethyl-2,3-dioxo-piperazin i 15 ml vandfrit dioxan sattes under omrøring 0,70 g trimethylsilylchlorid og 0,83 ml triethylamin. Den dannede blanding omrørtes ved stuetemperatur i 20 timer til udfældning af tri-ethylamin-hydrochlorid. Dette hydrochlorid blev frafiltreret, og filtratet dryppedes.ved 5° til 10°C i en opløsning af 0,70 g phosgen i 10 ml vandfrit tetrahydrofuran. Derpå omsattes den dannede blanding ved 5° til 10°C i 30 minutter og ved stuetemperatur i 2 timer, hvorefter opløsningsmidlet afdestilléredes under reduceret tryk til dannelse af 1,0 g lysegule krystaller af 4-ethyl-2,3-dioxo-l-piperazinocarbonylchlorid.(2) To a suspension of 0.71 g of the above-mentioned 1-ethyl-2,3-dioxo-piperazine in 15 ml of anhydrous dioxane was added with stirring 0.70 g of trimethylsilyl chloride and 0.83 ml of triethylamine. The resulting mixture was stirred at room temperature for 20 hours to precipitate triethylamine hydrochloride. This hydrochloride was filtered off and the filtrate was dripped at 5 ° to 10 ° C in a solution of 0.70 g of phosgene in 10 ml of anhydrous tetrahydrofuran. Then, the resulting mixture was reacted at 5 ° to 10 ° C for 30 minutes and at room temperature for 2 hours, after which the solvent was distilled off under reduced pressure to give 1.0 g of light yellow crystals of 4-ethyl-2,3-dioxo-1 piperazinocarbonylchlorid.

(3) En suspension af 1,75 g 6-[d(-)-a-aminophenylacetamidcTjpeni-cillansyre i 50 ml tetrahydrofuran indeholdende 20% efter volumen vand indstilledes på pH 8,0 til 8,5 ved tilsætning af triethylamin under omrøring til dannelse af en opløsning. Denne opløsning afkøledes til 0° til 5°C, hvorefter 7 ml vandfrit tetrahydrofuranopløsning indeholdende 1,0 g af ovennævnte 4-ethyl-2,3-dioxo-l-piper-azinocarbonylchlorid dryppedes i opløsningen. I denne periode opretholdtes pH-værdien af reaktionsopløsningen ved 7,5 til 8,0 ved gradvis tilsætning af'triethylamin. Den dannede blandede opløsning omsattes ved den nævnte temperatur i 30 minutter og derefter ved 5° til 10°C i en time, medens pH-værdien holdtes ved 7,5 til 8,0. Efter reaktionen fjernedes tetrahydrofuranen ved destillation under reduceret tryk, og remanensen opløstes i 20 ml vand og vaskedes derefter to gange med 20 ml ethylacetat. Til det vandige 81 151358 lag sattes igen 50 ml ethylacetat, og den dannede blanding indstilledes på en pH-værdi på 1,5 ved gradvis tilsætning af fortyndet saltsyre under isafkøling. Derefter fraskiltes ethylacetatlaget, som Vaskedes grundigt med vand og derpå tørredes over vandfrit magnesiumsulfat. Til det således behandlede lag dryppedes 10 ml af en ethylacetatopløsning indeholdende 0,85 g natrium-2-ethyl-hexanoat til udfældning af hvide krystaller. De udfældede krystaller opsamledes ved filtrering, vaskedes grundigt med ethylacetat, vaskedes derefter med diethylether og tørredes til dannelse af 2,4 g natriumsalt af 6-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocar-bonylamino)phenylacetamido]penicillansyre, smp. 183-185°C (dekomp.), udbytte 89%.(3) A suspension of 1.75 g of 6- [d (-) - α-aminophenylacetamide-Chippenicillanic acid in 50 ml of tetrahydrofuran containing 20% by volume of water was adjusted to pH 8.0 to 8.5 by addition of triethylamine with stirring. forming a solution. This solution was cooled to 0 ° to 5 ° C and then 7 ml of anhydrous tetrahydrofuran solution containing 1.0 g of the above 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride was dripped into the solution. During this period, the pH of the reaction solution was maintained at 7.5 to 8.0 by the gradual addition of triethylamine. The resulting mixed solution was reacted at said temperature for 30 minutes and then at 5 ° to 10 ° C for one hour while maintaining the pH at 7.5 to 8.0. After the reaction, the tetrahydrofuran was removed by distillation under reduced pressure and the residue was dissolved in 20 ml of water and then washed twice with 20 ml of ethyl acetate. 50 ml of ethyl acetate was again added to the aqueous layer and the resulting mixture was adjusted to a pH of 1.5 by gradually adding dilute hydrochloric acid under ice-cooling. Then, the ethyl acetate layer was separated, which was washed thoroughly with water and then dried over anhydrous magnesium sulfate. To the thus treated layer was added 10 ml of an ethyl acetate solution containing 0.85 g of sodium 2-ethyl hexanoate to precipitate white crystals. The precipitated crystals were collected by filtration, washed thoroughly with ethyl acetate, then washed with diethyl ether and dried to give 2.4 g of sodium salt of 6- [D (-) - α- (4-ethyl-2,3-dioxo-1 piperazinocarbonylamino) phenylacetamido] penicillanic acid, m.p. 183-185 ° C (decomp.), Yield 89%.

IR (KBr) cm”1: V^c=0 (lactam), 1720 - 1670 (-C0N<), 1600 (-C00®) NMR ((01)3)280 + D20) Έ værdier: 2.62 (5H), 4.31 (IH), 4.50 (IH), 4.70 (1E), ' 6.05 (IH), 6.35 - 6.65 (6H), 8.49 (3H), 8.60 (3H), 8.91 (3H)IR (KBr) cm ”1: V ^ c = O (lactam), 1720 - 1670 (-CON <), 1600 (-C00®) NMR ((01) 3) 280 + D20) Έ values: 2.62 (5H) , 4.31 (1H), 4.50 (1H), 4.70 (1E), 6.05 (1H), 6.35 - 6.65 (6H), 8.49 (3H), 8.60 (3H), 8.91 (3H)

Ovennævnte operation gentoges med den ændring, at 4-ethyl-2,3-dioxo-1-piperazinocarbonylchlorid erstattedes med hvert af de i tabel 12 angivne reaktive derivater af forbindelser med formlen (III) til dannelse af de ligeledes i tabel 12 nævnte slutprodukter. Strukturen af hver fremstillet forbinuelse blev bekræftet ved IR og NMR.The above operation was repeated with the change that 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of formula (III) listed in Table 12 to give the end products also listed in Table 12. The structure of each compound produced was confirmed by IR and NMR.

82 1 5713 33 d Μ pa pao82 1 5713 33 d Μ pa pao

d M M Od M M O

g O o o § pa tao cS. y_/ oo oo o oo ra I co d © Y~f © ω © S P ca I p · _l +3 to ta tao -p VS ‘ P> +3 J ggg έ -J £ 8 5 c 4 3 r° 1 I 3 s = s o g© o 'S E 5 g^-7 H 2 s ® O o °y!2L ^ 3 I-©1 § Vs § °S i m g — o ] J o cm og O o o § pa tao cS. y_ / oo oo o oo ra I co d © Y ~ f © ω © SP ca I p · _l +3 to ta tao -p VS 'P> +3 J ggg έ -J £ 8 5 c 4 3 r ° 1 I 3 s = sug © o 'SE 5 g ^ -7 H 2 s ® O o ° y! 2L ^ 3 I- © 1 § Vs § ° S img - o] J o cm o

g OX o^isT X MXg OX o ^ isT X MX

© o © T © o © M I rtf CM Tj cm -¾ h o. S. ^ M 4, ^ T ) 4 ai . M i .© o © T © o © M I rtf CM Tj cm -¾ h o. S. ^ M 4, ^ T) 4 ai. M i.

Λ°Τ θ Λ B & Λ E §· ^ ”Em^ w MO MO MO·Λ ° Τ θ Λ B & Λ E § · ^ ”Em ^ w MO MO MO ·

rHrh

CD ______CD ______

E-* PE- * P

PP

? H? H

i- HI h

wo , SWed, S

• erf c Η O• erf c Η O

ro. £ O Oro. £ O O

; ©.·£ S °*A; ©. · £ S ° * A

:jhj Η °γ^Ί •5.1 g oV k ® φ 8 k g: jhj Η ° γ ^ Ί • 5.1 g oV k ® φ 8 k g

ό tt Ον Μ M CMCM tt Ον Μ M CM

r- V Ί O —r- V Ί O -

© © J J CM CM© © J J CM CM

>rti O^B Μ M> rti O ^ B Μ M

•Η 'β I Ο O• Η 'β I Ο O

P ή ta ta XM Μ M taTake XM Μ M

d ο ο Md ο ο M

© o o© o o

M *HM * H

83 1 5 1 3 38 SR.83 1 5 1 3 38 SR.

m a ^ d ® <s3 Ο Ο O . „ a +?m a ^ d ® <s3 Ο Ο O. "A +?

Jzj \/ j to tOO -PJzj \ / j to tOO -P

to too m 7~i cn a a o >>to too m 7 ~ i cn a a o >>

Kao co ral t>- uooig ο ο o v-^ „ V-/ 's y-f i _i ί ®i 3 W I +3 V -P y-a Λ f I ! K0 <g o 3 o p a o Θ - 8-(3) - .8 -7 ο o a V—/ o q i ο o a o a at\ _ a AT\ Ο LO o-(0) 00 g<°> a s i^-7 s § „ γΊ .-. 8 ~ +3 ^ a o^a a g< d o^.aN a i a T Ί aKao co ral t> - uooig ο ο o v- ^ „V- / 's y-f i _i ί ®i 3 W I +3 V -P y-a Λ f I! K0 <go 3 opao Θ - 8- (3) - .8 -7 ο oa V— / oqi ο oaoa at \ _ a AT \ Ο LO o- (0) 00 g <°> asi ^ -7 s § „ γΊ .-. 8 ~ +3 ^ a o ^ a a g <d o ^ .aN a i a T Ί a

to Y 1 O CM o J J Qto Y 1 O CM o J J Q

-P 1 J ^ a At o^ar λ T on? CD ο ω I ω o . I ^ cvi - * ™ ch a — a ^ a — w o o u CM é O · hh ,· ., 1--- ft I o ft I o ft ™ -—to g — u 3-7-11 a ^ 1 a m 1 jn ra · ™ ra w· 0 a 'r' a ^ O v_- fl 0 00 £> cd-P 1 J ^ a At o ^ ar λ T on? CD ο ω I ω o. I ^ cvi - * ™ ch a - a ^ a - wo CM é O · hh, ·., 1 --- ft I o ft I o ft ™ -—to g - u 3-7-11 a ^ 1 am 1 jn ra · ™ ra w · 0 a 'r' a ^ O v_- fl 0 00 £> cd

Eh---Eh ---

HH

OISLAND

OISLAND

O HO H

Η I OΗ I O

8 °γΒΊ 8 ° o<Sc °^b-,8 ° γΒΊ 8 ° o <Sc ° ^ b-,

°Λ A·· oV° Λ A ·· oV

°v % k, 8 8 8 cm o a — 0 0° v% k, 8 8 8 cm o a - 0 0

to Ο IIto Ο II

K to CMK to CM

0 a a w 0 0 ..0 a a w 0 0..

i! 84 15133¾in! 84 15133¾

ω $ )Rω $) R

oo c- σ\ ω φ +3 μ -Ρ φ t å ^ t £ ►?> ο £) · cd !>> Υ β ΜΜ ο 00 Ε3 Ρ Κ* ^ ο ο ο κν tno tJ . ·9 cd 3 V / ω W Κ ο ø °3 ^ 1¾ /—ί -Ρ ο ο ο § ρ ΚΛ ΚΛΟ CQ I -μ V/ ggg ο V? £ «Π ο @68 ο y-f <*. A y* °*- v-f % cq 1 ω o 3 _i^7 o? I c- l i ο ο W I _J ·oo c- σ \ ω φ +3 μ -Ρ φ t å ^ t £ ►?> ο £) · cd! >> Υ β ΜΜ ο Ε 00 Ε3 Ρ Κ * ^ ο ο κν tno tJ. · 9 cd 3 V / ω W Κ ο ø ° 3 ^ 1¾ / —ί -Ρ ο ο ο § ρ ΚΛ ΚΛΟ CQ I -μ V / ggg ο V? £ «Π ο @ 68 ο y-f <*. A y * ° * - v-f% cq 1 ω o 3 _i ^ 7 o? I c- l i ο ο W I _J ·

n o lt\ W /ΤΛ Ο O ir\ ° [Tn o lt \ W / ΤΛ Ο O ir \ ° [T

8 * l^71 |Ao) A g A8 * l ^ 71 | Ao) A g A

ξ 6-(o) έ 2 & I & |Ao) έξ 6- (o) έ 2 & I & | Ao) έ

s g^71 vs § “ « I I Is g ^ 71 vs § “« I I I

-Ρ o -¾ 11,¾ 0,¾ ,o /2} 0/¾-Ρ o -¾ 11, ¾ 0, ¾, o / 2} 0 / ¾

Ih ο ω oA^Y ω YT ® O φ O I ·ϋ I "d 1 -d ^ T 1¾ -S- ΰ, °r^ w m ^ °^? a °γ^γ° ~ Λ°^τ ft Λ ^ ft' Ag a A °*V éIh ο ω oA ^ Y ω YT ® O φ OI · ϋ I "d 1 -d ^ T 1¾ -S- ΰ, ° r ^ wm ^ ° ^? A ° γ ^ γ ° ~ Λ ° ^ τ ft Λ ^ ft 'Ag a A ° * V é

A @ A o AS ASA @ A o AS AS

SS

EH__.______EH __.______

HH

OISLAND

Ο HΟ H

O OISLAND ISLAND

e3 °yS Ί $ g 8 °V °γγϋ o $ o i y °V ο B oe3 ° yS Ί $ g 8 ° V ° γγϋ o $ o i y ° V ο B o

°iBJ 8o g °V° iBJ 8o g ° V

fAil o r, £*fAil o r, £ *

@ o 6 S@ o 6 S

I ..... I — — I b ----- ------I ..... I - - I b ----- ------

Eksempel 7 85 151338Example 7 85 151338

En suspension af 1,4 g 6-jp(-)-oc-aminophenylacetamidoj[penicillansyre i 30 ml tetrahydrofuran indeholdende 20% efter volumen vand indstilledes til pH = 8,0 til 8,5 ved tilsætning af triethylamin under omrøring til dannelse af en opløsning. Denne opløsning afkøledes til 0° til 5°C, og 10 ml af en tetrahydrofuranopløsning indeholdende 1,2 g af 4-n-pentyl-2,3-d.ioxo-l-piperazinocarbonylchlorid til-dryppedes til opløsningen. I denne periode opretholdtes pH-værdien af reaktionsblandingen på 7,5 til 8,5 ved gradvis tilsætning af triethylamin. Derefter omsattes den dannede blanding ved den nævnte temperatur i 30 minutter og derpå ved 10° til 15°C i 90 minutter, medens pH-værdien holdtes på 7,5 til 8,5» Efter reaktionen afdestilléredes tetrahydrofuranet under reduceret tryk, og remanensen opløstes i 20 ml vand og vaskedes derefter to gange med 20 ml ethylacetat. Til det vandige lag sattes yderligere 30 ml ethylacetat, og den dannede blanding indstilledes på en pH-vær-•di på 1,5 ved tilsætning af fortyndet saltsyre under isafkøling. Derefter fraskiltes ethylacetatlaget, som vaskedes grundigt med vand, tørredes over magnesiumsulfat og derefter befriedes for opløsningsmidlet ved destillation under reduceret tryk. Remanensen omkrystalliseredes ved tilsætning af diisopropylether til opnåelse af 1,8 g krystaller af 6- 0>( -)-a-(4-pentyl-2,3-dioxo-l-piper-azinocarbonylamino)phenylacetamidoJ penicillansyre, smp. 96°C (dekomp.), udbytte 80,5%.A suspension of 1.4 g of 6-jp (-) - oc-aminophenylacetamidoj [penicillanic acid in 30 ml of tetrahydrofuran containing 20% by volume of water was adjusted to pH = 8.0 to 8.5 by addition of triethylamine with stirring to give a resolution. This solution was cooled to 0 ° to 5 ° C and 10 ml of a tetrahydrofuran solution containing 1.2 g of 4-n-pentyl-2,3-dioxo-1-piperazinocarbonyl chloride was added to the solution. During this period, the pH of the reaction mixture was maintained at 7.5 to 8.5 by the gradual addition of triethylamine. Then, the resulting mixture was reacted at said temperature for 30 minutes and then at 10 ° to 15 ° C for 90 minutes while maintaining the pH of 7.5 to 8.5. After the reaction, the tetrahydrofuran was distilled off under reduced pressure and the residue dissolved. in 20 ml of water and then washed twice with 20 ml of ethyl acetate. To the aqueous layer was added an additional 30 ml of ethyl acetate and the resulting mixture was adjusted to a pH of 1.5 by adding dilute hydrochloric acid under ice-cooling. Then, the ethyl acetate layer, which was thoroughly washed with water, was separated, dried over magnesium sulfate and then freed of the solvent by distillation under reduced pressure. The residue was recrystallized by the addition of diisopropyl ether to give 1.8 g of crystals of 6- O (-) - α- (4-pentyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, m.p. 96 ° C (decomp.), Yield 80.5%.

IR (KBr) cm-1; ^C=Q i770 (lactam), 1720 - 1660 (-CrøC, -C00H) MR ((CD^SO + D20) T værdier: 2.62 (5H), 4.31 (IH), 4.51 - 4.69 (2H), 6.04 (IH), 6.20 - 6.90 (6H), 8.50 (3H), 8.60 (3H), 8.75 (6H), 8.90 (3H) 86 151338IR (KBr) cm -1; C = Q i770 (lactam), 1720 - 1660 (-CroC, -C00H) MR ((CD2 SO + D20) T values: 2.62 (5H), 4.31 (1H), 4.51 - 4.69 (2H), 6.04) IH), 6.20 - 6.90 (6H), 8.50 (3H), 8.60 (3H), 8.75 (6H), 8.90 (3H) 86 151338

Ovennævnte operation gentoges med den ændring, at 4-n-pentyl- 2,3-dioxo-l- piperazinocarbonylchlorid erstattedes med enhver af de i efterfølgende tabel 13 nævnte reaktive derivater af forbindelser med formlen (III) til dannelse af de ligeledes i tabel 13 nævnte slutprodukter. Strukturen af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that 4-n-pentyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with any of the reactive derivatives mentioned in Table 13 below to form compounds of formula (III) said end products. The structure of the compounds formed was confirmed by IR and NMR.

c 87 15133¾ I j-j HjH jrj kn JT^JTS Voc 87 15133¾ I j-j HjH jrj kn JT ^ JTS Vo

Sgg ggg * ggg fc w * xV “i h ;Sgg ggg * ggg fc w * xV “i h;

02 I CO 03 I 00 03 i IN02 I CO 03 I 00 03 i IN

\_!s; V-fc 00 V-S\ _! S; V-fc 00 V-S

A I -Λ ® £ 3 § 3 1^1 I ^ 5 •I !-®o S-© - ·|·©ο jh !zi o SO So O Sc- O o O LT; IW ο Ο O c\l O CTi i Η i σ> . i S °fl - °r*) ~ YS - 3 °V & oiS & ° t tA I -Λ ® £ 3 § 3 1 ^ 1 I ^ 5 • I! -®o S- © - · | · © ο jh! Zi o SO So O Sc- O o O LT; IW ο Ο O c \ l O CTi i Η i σ>. in S ° fl - ° r *) ~ YS - 3 ° V & oiS & ° t t

+) C\J O CM O CM O+) C \ J O CM O CM O

7n ffi id WX a ,¾ g Ο ^ ο Ώ ο ω7n fi id WX a, ¾ g Ο ^ ο Ώ ο ω

Φ ^ a LT\ 70 COA ^ a LT \ 70 CO

£ ST'S1"" S ^ 10 p, 1 0 ft Λ 3 a 2 s §15" ® ~ n a o O 0 p 0£ ST'S1 "" S ^ 10 p, 1 0 ft Λ 3 a 2 s §15 "® ~ n a o O 0 p 0

pHpH

H ^__________H ^ __________

2 H2 H

3 tj H 33 tj H 3

. H. H

«Η <0 . H«Η <0. H

¢0 S Ο Η Ή¢ 0 S Ο Η Ή

"go O O"go O O

p Ο Ο Ο Op Ο Ο Ο O

Φ<Η Ω fe 7 7 1¾ X) °f) Y) •H S 7 O^S^ O^S^Φ <Η Ω fe 7 7 1¾ X) ° f) Y) • H S 7 O ^ S ^ O ^ S ^

M CM I IM CM I I

© © a CM CM© © and CM CM

d« 0 a wd «0 a w

Η τ^· O OΗ τ ^ · O O

ω ω ^ lo. co > >d cm ^ ^ω ω ^ lo. co>> d cm ^^

H <3 a CM CMH <3 and CM CM

-P -H 0 a w-P -H 0 and w

w O Ow O O

cd P to ^ -< φ ° a r\ JT1 a'H 0 0 0 « 151338’cd P to ^ - <φ ° a r \ JT1 a'H 0 0 0 «151338 '

Eksempel $Example $

Med 1,7 g triethylaminsalt af 6-[p(-)-a-amino-p-hydroxyphenyl-acetamidojpenicillansyre og 0,7 g 4-methyl-2,3--dioxo-l-piperazino-carbonylchlorid gentoges fremgangsmåden ifølge eksempel 7 til” dannelse af 1,2 g natriumsalt af 6-jD(-)-a-(4-methyl-2,3-dioxo-1-piperazinocarbonylamino)-p-hydroxyphenylacetamido] penicillansyre, smp. 170-172°C (dekomp.), udbytte 75%.With 1.7 g of triethylamine salt of 6- [p (-) - α-amino-p-hydroxyphenyl-acetamidojpenicillanic acid and 0.7 g of 4-methyl-2,3-dioxo-1-piperazino carbonyl chloride were repeated in the procedure of Example 7 to give 1.2 g of sodium salt of 6-jD (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] penicillanic acid, m.p. 170-172 ° C (decomp.), Yield 75%.

IR (KBr) cm-1: vfø.Q 1760 (lactam), 1710 - 1660 (-COirO, 1600 (-000Θ) fflR ((CD^)2SO) 'X værdier: 2*8 - 3.3 (4H), 4.45 (IH), 4.65 (2H), 6.05 (IH), 6.2 (4H), 6.97 (3H), 8.48 (3H), 8.60 (3Ξ) På samme måde som angivet ovenfor dannedes natriumsaltet af 6-[d(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxy-phenylacetamidojpenicillansyre, smp0 175°C (dekomp.), udbytte 72%, ud fra 4-ethyl-2,3-'dioxo-l-piperazinocarbonylchlorid og et triethylaminsalt af 6-[p(-)-α-amino-p-hydroxyphenylacetamidoj penicillansyre.IR (KBr) cm -1: vF 1760 (lactam), 1710 - 1660 (-COIRO, 1600 (-000 °) fflR ((CD4) 2 SO) x values: 2 * 8 - 3.3 (4H), 4.45 (1H), 4.65 (2H), 6.05 (1H), 6.2 (4H), 6.97 (3H), 8.48 (3H), 8.60 (3Ξ) In the same manner as indicated above, the sodium salt of 6- [d (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -β-hydroxy-phenylacetamidojpenicillanic acid, mp 175 ° C (decomp.), yield 72%, from 4-ethyl-2,3-dioxo 1-piperazinocarbonyl chloride and a triethylamine salt of 6- [p (-) - α-amino-p-hydroxyphenylacetamidoj penicillanic acid.

Eksempel 9Example 9

Til en opløsning af 0,8 g phthalidester af 6-[p(-)-a-aminophenyl-acetamidoj penicillansyre i 10 ml tetrahydrofuran sattes 0,25 ml triethylamin. I den dannede blanding dryppedes 0,32 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid med isafkøling, og blandingen omsattes ved stuetemperatur i 2 timer. Efter reaktionen afdestilleredes opløsningsmidlet under reduceret tryk. Remanensen blev opløst i et blandet opløsningsmiddel bestående af 20 ml ethylace-tat og 20 ml vand, og den dannede opløsning indstilledes på pH-værdi af 2 ved tilsætning af fortyndet saltsyre. Derefter fra- 89 151338 skiltes det organiske lag, som vaskedes med vand, vaskedes med en 2% vandig natriumhydrogencarbonatopløsning, vaskedes med vand, tørredes over magnesiumsulfat og derefter inddampedes til en væske på 2 ml. Til koncentratet sattes 20 ml diisopropylether til udfældning af krystaller, som derefter opsamledes til dannelse af 0,95 g krystaller af phthalidester af 6-[jD (-) -oc- (4-methy 1-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido] penicillansyre, smp. 157-l60°C (dekomp.), udbytte 90,0^.To a solution of 0.8 g of phthalide ester of 6- [p (-) - α-aminophenyl-acetamidoj penicillanic acid in 10 ml of tetrahydrofuran was added 0.25 ml of triethylamine. In the resulting mixture, 0.32 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was dripped with ice cooling and the mixture was reacted at room temperature for 2 hours. After the reaction, the solvent was distilled off under reduced pressure. The residue was dissolved in a mixed solvent consisting of 20 ml of ethyl acetate and 20 ml of water and the resulting solution was adjusted to pH 2 by the addition of dilute hydrochloric acid. Then, the organic layer which was washed with water was separated, washed with a 2% aqueous sodium bicarbonate solution, washed with water, dried over magnesium sulfate and then evaporated to a 2 ml liquid. To the concentrate was added 20 ml of diisopropyl ether to precipitate crystals, which were then collected to give 0.95 g of phthalide ester crystals of 6- [ioD (-) -oc- (4-methyl 1-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, m.p. 157-160 ° C (decomp.), Yield 90.0

IR (KBr) cm -'-i V^,_q 1780 (lactam), 1715 (ester), 1680 (-COnC) MR ((01)3)200 + D2O) 71 værdier: 2.12 (4H), 2.40 (IH), 2.58 (5H), 4.25 - 4.60 (3H), 5.45 (IH), 5.85 - 6.42 (4H), 6.90 (3H), 8.50 (6H)IR (KBr) cm - in V₂, q 1780 (lactam), 1715 (ester), 1680 (-COnC) MR ((01) 3) 200 + D₂O) 71 values: 2.12 (4H), 2.40 (1H) ), 2.58 (5H), 4.25 - 4.60 (3H), 5.45 (1H), 5.85 - 6.42 (4H), 6.90 (3H), 8.50 (6H)

Ovennævnte operation gentoges med den ændring, at :4-methy 1-2,3-dioxo-1-piperazinocarbonylchlorid erstattedes med hver af de reaktive derivater af forbindelser med formlen (III), som er angivet i tabel 14, til dannelse af de ligeledes i tabel 14 nævnte slutprodukter. Strukturen af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that: 4-methyl 1-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of compounds of formula (III) listed in Table 14 to give the Table 14 end products mentioned. The structure of the compounds formed was confirmed by IR and NMR.

90 151338 @> ·>§. r-\ Ο νο 6 (Ο) w ο4 /—\ σ> yd/ ω νγ ω 0=\ $ η no α, °< S °- I Η°° £ \ β WWO fi docoo ’d o o o 'o \Jsi fi go 8 3 Yi 3 -13 v / 02 I ^ /I ~ vs - o O) 02 I O I O W o tn VS o —λ o S o90 151338 @> ·> §. r- \ Ο νο 6 (Ο) w ο4 / - \ σ> yd / ω νγ ω 0 = \ $ η no α, ° <S ° - I Η °° £ \ β WWO fi docoo 'dooo' o \ Jsi fi go 8 3 Yi 3 -13 v / 02 I ^ / I ~ vs - o O) 02 IOIOW o tn VS o —λ o S o

rH I O \ O OrH I O \ O O

0) -4 H O DO o h0) -4 H O DO o h

>d \ί Η S H W _/r\ H> d \ ί Η S H W _ / r \ H

a . o s , 2λΟ> .a. o s, 2λΟ>.

Ml o I W \—( IMl o I W \ - {I

jQ S O SjQ S O S

g g S SÆ) S 8 Sg g S SÆ) S 8 S

" SÆ) H S^-7 H °,A H"SÆ) H S ^ -7 H °, A H

V M \_/ O ^ Τ Ί “ & å “g. oV ftV M \ _ / O ^ Τ Ί “& å” g. oV ft

s ?ι vs I ™ Is? ι vs I ™ I

3 °γ·ΒΊ % oU I s I3 ° γ · ΒΊ% oU I s I

I <A4 S si S ™ 3I <A4 S are S ™ 3

u I o CMu I o CM

£ CM · CM · . ffi · 1 W P. 1 ^ ft I O ft£ CM · CM ·. ffi · 1 W P. 1 ^ ft I O ft

_ I DO g I M CO I DO CQ_ I DO g I M CO I DO CQ

^ ν_^ωυ··ν_^ο wM^ ν_ ^ ωυ ·· ν_ ^ ο wM

1-1 SO ft w P O1-1 SO ft w P O

Γ—1Γ-1

<D<D

5 —-----5 —-----

® H® H

Η HΗ H

H ·

HH

<Η Φ , ag s P o g<Η Φ, ag s P o g

©«M J I© «M J I

i« H § °Y^i «H § ° Y ^

,J d O O X J, J d O O X J

f1 W O I O^Sf1 W O I O ^ S

g« 'f vs i,g «'f vs i,

'ft tQ o. M J I M'ft tQ o. M J I M

• <U CD J J I CM• <U CD J J I CM

>ft O^S M —> ft O ^ S M -

•H fl I O CM• H fl I O CM

-P ·Η CM CM M-P · Η CM CM M

a p m . — o cå P o do χ-ia p m. - o På do χ-i

φ o CO M DOφ o CO M DO

«Ή g 3 g I_l_l_i 91 151338. !«Ή g 3 g I_l_l_i 91 151338.!

Eksempel 10Example 10

En opløsning af 0,86 g hydrochloric! af methoxymethylester af 6-[d (-)-a-aminophenylac etamido] -penicillansyre i 15 ml tetrahydro-furan indeholdende 20 rumfangsprocent vand, indstilledes på en pH-værdi på 8,0 til 8,5 ved tilsætning af triethylamin ved 0° til 5°C. Til denne opløsning dryppedes en opløsning af 0,38 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid i 10 ml tetrahydro-furan i løbet af 10 minutter. I denne periode opretholdtes reaktionsblandingens pH-værdi på 7,5 til 8,0 ved gradvis tilsætning af triethylamin. Den dannede blandede opløsning omsattes i 30 minutter, medens pH-værdien opretholdtes til 7,5 til 8,0. Efter reaktionens afslutning fjernedes tétrahydrofuranet ved destillation under reduceret tryk. Remanensen opløstes i et blandet opløsningsmiddel indeholdende 50 ml vand og 50 ml ethylacetat, og den dannede opløsning indstilledes på en pH-værdi på 1,5 ved tilsætning af fortyndet saltsyre under isafkøling. Derefter fraskiltes det organiske lag, som vaskedes med vand, tørredes over vandfrit magnesiumsulfat og derefter befriedes for opløsningsmidlet ved destillation under reduceret tryk til dannelse af krystaller.A solution of 0.86 g of hydrochloric acid! of methoxymethyl ester of 6- [d (-) - α-aminophenylac etamido] penicillanic acid in 15 ml of tetrahydrofuran containing 20% by volume of water was adjusted to a pH of 8.0 to 8.5 by addition of triethylamine at 0 ° to 5 ° C. To this solution was added a solution of 0.38 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride in 10 ml of tetrahydrofuran over 10 minutes. During this period, the pH of the reaction mixture was maintained at 7.5 to 8.0 by the gradual addition of triethylamine. The resulting mixed solution was reacted for 30 minutes while maintaining the pH to 7.5 to 8.0. After completion of the reaction, the tetrahydrofuran was removed by distillation under reduced pressure. The residue was dissolved in a mixed solvent containing 50 ml of water and 50 ml of ethyl acetate and the resulting solution was adjusted to a pH of 1.5 by adding dilute hydrochloric acid under ice-cooling. Then, the organic layer which was washed with water was separated, dried over anhydrous magnesium sulfate and then freed of the solvent by distillation under reduced pressure to form crystals.

De således dannede krystaller vaskedes med diethylether til dannelse af 0,9 g methoxymethylester af 6-{p(-)-a-(4-methyl-2,3-dioxo-1-piperazinocarbonylamino)-phenylacetamido]penicillansyre, smp.The crystals thus formed were washed with diethyl ether to give 0.9 g of methoxymethyl ester of 6- {p (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, m.p.

111-115°C (dekomp.), udbytte 82,5%.111-115 ° C (decomp.), Yield 82.5%.

IR (KBr) cm-1; vfø_Q 1780 (lactam), 1740 (ester), 1700 - 1660 ’(-CONCC) NMR ((CDj )200) 'Z værdi: 0.15 (IH), 2.0 (IH), 2.67 (5H), 4.3 - 4.5 (3H), 4.75 (2H), 5.7 (IH), 6.55 (4H), 6.97 (3H), 7.25 (3H), 8.84 (3H), 8.60 (3H) 92 1 5 1 3 3 8IR (KBr) cm -1; 1780 (lactam), 1740 (ester), 1700 - 1660 '(-CONCC) NMR ((CD₂) 200)' Z value: 0.15 (1H), 2.0 (1H), 2.67 (5H), 4.3 - 4.5 (3H) ), 4.75 (2H), 5.7 (1H), 6.55 (4H), 6.97 (3H), 7.25 (3H), 8.84 (3H), 8.60 (3H) 92 1 5 1 3 3 8

Ovennævnte operation gentoges med den ændring, at 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid erstattedes med hver af de i tabel 15 viste reaktive derivater af forbindelserne med formlen (III) til dannelse af de ligeledes.i tabel 15 viste slutproduk ter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of formula (III) shown in Table 15 to give the final product also shown in Table 15. ter. The structure of each of the compounds formed was confirmed by IR and NMR.

93 1 5 1 3 3 8 to93 1 5 1 3 3 8 to

tUtU

ο Ο νρ VP CNJ CO, ^ trj ώ ^ ΚΛ Ο νρ Ο * W rT to, too Ο ° γλ og W Ko g ™ ω o ω o o o w Μ t^1 © y~( s to, tooο Ο νρ VP CNJ CO, ^ trj ώ ^ ΚΛ Ο νρ Ο * W rT two, too Ο ° γλ and W Ko g ™ ω o ω o o o w Μ t ^ 1 © y ~ (s two, too

o -jf ra I if tU tU o -Po -jf ra I if tU tU o -P

to\ too f \_a if o o o >, tu iu o i o1 y-{ s m o o o β —k B ,/ ¾ S; v / <& \> 'd co i 3 5 ^ 3 g ° s ri S H O So [Λ o 5 _I O o O I ° ° •H -^ lp, M /—\ O tU LO, •8 a ° ω |λ2) 00 I m S g g 1 S λ=ν 1 , O _ to, O 00 0-(0) to P tU /TTv oo i o tu \—/ cnto \ too f \ _a if o o o>, tu iu o i o1 y- {s m o o o β —k B, / ¾ S; v / <& \> 'd co i 3 5 ^ 3 g ° s ri SHO So [Λ o 5 _I O o OI ° ° • H - ^ lp, M / - \ O tU LO, • 8 a ° ω | λ2) 00 I m S gg 1 S λ = ν 1, O _ to, O 00 0- (0) to P tU / TTv oo io tu \ - / cn

5 |Λ2> ~ °ν^ - I5 | Λ2> ~ ° ν ^ - I

.—i g · J I o H O PM O^SsT ft I g< +> od i a ovs a 1 °ν^ι I øl oXzP # H 1 J -d <aj -d l d · fe ^ ^ -w tu ^. — I g · J I o H O PM O ^ SsT ft I g <+> od i a ovs a 1 ° ν ^ ι I beer oXzP # H 1 J -d <aj -d l d · fe ^^ -w tu ^

I CM OIn CM O

CM tu · CMCM tu · CM

i tu ØH i o Øi i ft . ^ o a ^ ^ S'-'to g i to, . μ i- to, cq i tu tai tu ØH i o Øi i ft. ^ o a ^^ S '-' to g i to ,. µ i- to, or i tu ta

—- i±J —- jxj -— O—— i ± J —— jxj —— O.

in p o p o P ^a p o p o P ^

HH

φ----φ ----

S HS H

S HS H

H HH H

ll

Η HΗ H

H CD OH CD O

cd a o u . ocd a o u. island

U O _ IU O _ I

H °tB1 OH ° tB1 O

gi 8 oKs gare given 8 oKs g

.Jj ej O I I.Jj not O I I

u - 0 > £ °V^u - 0> £ ° V ^

® ® °vsi g I J® ® ° vsi g I J

p* i ^ i 5¾ CM tu o S3 g s ™ tc\ tov CO, • S te tu tu tu © o o o o (U 'H — 0, 151338 94 ΚΛ Μ Ο O vp CM ^ w 7 ο * ία WKO »- ο ο ο Υ-Υ · s ca I -Ρ V125 s° ί ο ο ο ο |-{θ) ? ο ο ο I C- Τ> ~ cYlzT ft * ι ύ Ο* cm ο ώ ο <øp * i ^ i 5¾ CM tu o S3 gs ™ tc \ tov CO, • S te tu tu tu © oooo (U 'H - 0, 151338 94 ΚΛ Μ Ο O vp CM ^ w 7 ο * ία WKO »- ο ο ο Υ-Υs ca I -Ρ V125 s ° ί ο ο ο ο | - {θ)? ο ο ο I C- Τ> ~ cYlzT ft * ι ύ Ο * cm ο ώ ο <ø

νχ \0 tJνχ \ 0 tJ

£η CM ο Ο Η ft 3 '3 s 7 Υι Μ£ η CM ο Ο Η ft 3 '3 s 7 Υι Μ

in — Win - W

r-) p o i-l ω ,ω -- a)r-) p o i-l ω, ω - a)

Bi ΗBi Η

OISLAND

OISLAND

C\1 w o in c\iC \ 1 w o in c \ i

WW

o K\OK\

WW

OISLAND

Eksempel li « 151338Example 151538

Med 1,5 g hydrochlorid af pivaloyloxymetiiylester af 6-[l)(-)-a-aminophenylacetamido] -penicillansyre og 0,6 g 4-methyl-2,3-dioxo-1-piperazinocarbonylchlorid gentoges fremgangsmåden ifølge eksempel 10 til dannelse af en pivaloyloxymetiiylester af 6-[d(-)-oc-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidoJ penicillansyre, smp. 108-111°C (dekomp.), udbytte 75%.With 1.5 g of hydrochloride of pivaloyloxymethyl ester of 6- [l) (-) - α-aminophenylacetamido] -penicillanic acid and 0.6 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride, the procedure of Example 10 was repeated. a pivaloyloxymethyl ester of 6- [d (-) - oc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, m.p. 108-111 ° C (decomp.), Yield 75%.

t IR (KBr) cm"!-: Vc-0 ^780 (lactam), 1750 (ester),t IR (KBr) cm -1: Vc-O 780 (lactam), 1750 (ester),

1710 - 1660 (-CORO1710 - 1660 (-CORO

Ovennævnte fremgangsmåde gentoges med den ændring, at 4-methyl- 2,3-dioxo-l-piperazinocarbonylchloridet erstattedes med hver af de reaktive derivater af forbindelser med formlen (III) vist i tabel 16, til dannelse af de respektive forbindelser, som er vist i tabel 16. Strukturen af hver forbindelse blev bekræftet ved IR og NMR.The above procedure was repeated with the change that the 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of compounds of formula (III) shown in Table 16 to give the respective compounds shown in Table 16. The structure of each compound was confirmed by IR and NMR.

96 151338 to to96 151338 to two

WW

o to o o to o w oo to o o to o w o

o CMo CM

o N· to too cmo N · to too cm

o IN · W W O INo IN · W W O IN

O o o o cm © \/ / ώ +1 /1 ' +3 o -P ml fO o o o cm © \ / / ώ +1 / 1 '+3 o -P ml f

to too N, V-SZ5 Nto too N, V-SZ5 N

S 888 € J É Ϊ Nf 3 Γ\> 3 1 °vi - 8 -S 888 € J É Ϊ Nf 3 Γ \> 3 1 ° vi - 8 -

•S I O O O• S I O O O

2 __i o o o £ —\ 00 W /4Λ j£> O o O-(0) ^2 __i o o o £ - \ 00 W / 4Λ j £> O o O- (0) ^

*» g I i I* »G I i I

Jj O o ® ®_/nS ^ o i ™ 3 |^>~ °fi - +? Oft ft “ o a i a s I o cm o © Ov g Js! ixj ^ U T Ί © o © 1¾ J J MD >d o^fer — — — 1 ^ ΙΛ C\J O W · 2 IK ft I O ft ^ ^ o g1 ^ ^ g Η Λ ^ B S & © no n o cdJj O o ® ®_ / nS ^ o i ™ 3 | ^> ~ ° fi - +? Often ft «o a i a s I o cm o © Ov g Js! ixj ^ U T Ί © o © 1¾ J J MD> d o ^ fer - - - 1 ^ ΙΛ C \ J O W · 2 IK ft I O ft ^ ^ o g1 ^ ^ g Η Λ ^ B S & © no n o cd

EHEH

-7—Τ'------ ----------7 — Τ '------ ---------

HH

HH

HH

's-τ' • H ^ 'H © 3 os S o's-τ' • H ^ 'H © 3 os S o

Μ OΜ Oh

Ο IΟ I

©<Η Ον ia lefl g T )© <Η Ον ia lefl g T)

•31 8 ° V31 ° C

k 1 CMk 1 CM

© CD ο ν S W© CD ο ν S W

% ) %%)%

gS °T SgS ° T S

S3 å1 8 as # © o w w ffj <H ° ° __J_I-S3 å1 8 as # © o w w ffj <H ° ° __J_I-

Eksempel 12 97 15.1338Example 12 97 15.1338

Med 0,81 g hydrochlorid af β-piperidinoethylester af 6-[ρ(-)-α-aminophenylacetamidojpenicillansyre og 0,3 g 4-methyl-2,3-dioxo-1-piperazinocarbonylchlorid, gentoges fremgangsmåden ifølge eksempel 10 til dannelse af 0,75 g β-piperidinoethylester af 6-[p(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidojpeni-cillansyre, smp. l66-l69°C (dekomp.), udbytte 78%.With 0.81 g of hydrochloride of β-piperidinoethyl ester of 6- [ρ (-) - α-aminophenylacetamidojpenicillanic acid and 0.3 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride, the procedure of Example 10 was repeated. 75 g of β-piperidinoethyl ester of 6- [p (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidojpenicillanic acid, m.p. 1666-169 ° C (decomp.), yield 78%.

IR (KBr) cm"l; Vq_q· 1780 (lactam), 1740 (ester),IR (KBr) cm "l; qq · q · 1780 (lactam), 1740 (ester),

1710 - 1670 (-C0nO1710 - 1670 (-C0nO

HMR (CDCl·^) X værdier: 2.7 (5H), 4.5 - 4.6 (3H), 5-7 (IH), 5.75 (2H), 6.0 (2H), 6.4 (2H), 6.9 (3H), 7.45 (2H), 7.6 (4H), 8.5 (12H)HMR (CDCl3) λ values: 2.7 (5H), 4.5 - 4.6 (3H), 5-7 (1H), 5.75 (2H), 6.0 (2H), 6.4 (2H), 6.9 (3H), 7.45 ( 2H), 7.6 (4H), 8.5 (12H)

Ovennævnte fremgangsmåde gentoges med den ændring, at 4-methyl- 2.3- dioxo-l-piperazinocarbonylchloridet erstattedes med 4-n-octyl- 2.3- dioxo-l-piperazinocarbonylchlorid til dannelse af β-piperidino-ethylester af 6-[b(-)-a-(4-n-octyl-2,3-dioxo-l-piperazinocarbonyl-amino)phenylacetamido]penicillansyre, smp. 110-115°C (dekomp.), udbytte 73,58%.The above procedure was repeated with the change that the 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with 4-n-octyl-2,3-dioxo-1-piperazinocarbonyl chloride to give β-piperidino-ethyl ester of 6- [b (-) -α- (4-n-octyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, m.p. 110-115 ° C (decomp.), Yield 73.58%.

Eksempel 13Example 13

Med 0,93 g hydrochlorid af β-morpholinoethylester af 6-[p(-)~a-amino-phenylacetamido]-penicillansyre og 0,39 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid gentoges samme fremgangsmåde som i eksempel 10 til dannelse af 0,8 g β-morpholinoethylester af 6-{p(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidoJ-penicillansyre, smp. 150-153°C (dekomp.), udbytte 73%.With 0.93 g of hydrochloride of β-morpholinoethyl ester of 6- [p (-) ~ α-amino-phenylacetamido] -penicillanic acid and 0.39 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride, the same procedure was repeated. Example 10 to give 0.8 g of β-morpholinoethyl ester of 6- {p (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidoJ-penicillanic acid, m.p. 150-153 ° C (decomp.), Yield 73%.

98 151338“- IR (KBr) cm-1: ^q~q 1780 (lactam), 1740 (ester),98 (IR) (KBr) cm -1: δ q ~ q 1780 (lactam), 1740 (ester),

1710 - 1680 (-COtfO1710 - 1680 (-COtfO

MMR (CDCI3) X værdier; 2.55 (5H), 4.5 - 4.55 (3H), 5.6 (IH), 5.7 (3H), 6.0 (2H), 6.3 (2H), 7.4 (2H), 7.5 (4Ξ), 8.5 (6H)MMR (CDCl3) X values; 2.55 (5H), 4.5 - 4.55 (3H), 5.6 (1H), 5.7 (3H), 6.0 (2H), 6.3 (2H), 7.4 (2H), 7.5 (4Ξ), 8.5 (6H)

Ovennævnte fremgangsmåde gentoges med den ændring, at 4-methyl-2,3-dioxo-l-piperazinocarbonylchloridet erstattedes med 4-n-octyl- 2,3-dioxo-l-piperazinocarbonylchlorid til dannelse af β-morpholino-ethylester af 6- [D(-)-a -(4-n-octyl-2,3-dioxo-l-piperazinocarbonyl-amino)phenylacetamidojpenicillansyre, smp. 103-105°C (dekomp.), udbytte 70%.The above procedure was repeated with the change that the 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with 4-n-octyl-2,3-dioxo-1-piperazinocarbonyl chloride to give β-morpholino ethyl ester of 6- [ D (-) - α - (4-n-octyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidojpenicillanic acid, m.p. 103-105 ° C (decomp.), Yield 70%.

Eksempel 14 <D - - # λExample 14 <D - - # λ

Til en opløsning af 8,7 g natriumsalt af D(-)-a-phenylglycin i 50 ml vand sattes 50 ml ethylacetat og 5,05 g triethylamin. Til den dannede blanding sattes gradvis 9,5 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid ved 0° til 5°C i løbet af 15 minutter, hvorefter blandingen omsattes ved 5° til 15°C i 30 minutter. Efter reaktionen fraskiltes det vandige lag, som vaskedes med diethylether, og derefter indstilledes pH-værdien på 1,5 ved tilsætning af fortyndet saltsyre til udfældning af krystaller. De udfældede kry-- staller opsamledes ved filtrering,', vaskedes med vand og tørredes til dannelse af 14,1 g D(-)-oc-(4-methyl-2,3-dioxo-l-piperazino-carbonylamino)phenyleddikesyre, smp. 138-14l°C (dekomp.), udbytte 87%. Omkrystallisationen af vandigt butanol gav hvide krystaller, smp. 14o-142°C (dekomp.).To a solution of 8.7 g of sodium salt of D (-) - α-phenylglycine in 50 ml of water was added 50 ml of ethyl acetate and 5.05 g of triethylamine. To the resulting mixture was gradually added 9.5 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride at 0 ° to 5 ° C over 15 minutes, after which the mixture was reacted at 5 ° to 15 ° C for 30 minutes. After the reaction, the aqueous layer washed with diethyl ether was separated and then the pH was adjusted to 1.5 by adding dilute hydrochloric acid to precipitate crystals. The precipitated crystals were collected by filtration, washed with water and dried to give 14.1 g of D (-) - oc- (4-methyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetic acid, mp. 138-14 ° C (decomp.), Yield 87%. The recrystallization of aqueous butanol gave white crystals, m.p. 14 DEG-142 DEG C. (decomp.).

99' 15133899 '151338

Elementær analyse - (for :Elemental Analysis - (for:

Beregnet - : {<?») C: 52.01 H: 5.30 Ή: 13.00 Fundet- (<fo) C: 52.24 H: 5-32 N: 12.87 IR (KBr) cm-1: Vq=q 1710, 1700, 1660 .Calculated -: {<? ») C: 52.01 H: 5.30 Ή: 13.00 Found- (<fo) C: 52.24 H: 5-32 N: 12.87 IR (KBr) cm -1: Vq = q 1710, 1700, 1660 .

(2) I en opløsning af 10 g af ovennævnte D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre i 200 ml acetone dryppedes en opløsning af 5,2 g natriumsalt af 2-ethylhexansyre i 50 ml acetone med omrøring til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering og vaskedes derefter med acetone til dannelse af 9,6 g natriumsalt af D(-)-a-(4-methyl- 2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre, smp. 165°C (dekomp.), udbytte 95%· (3) Til en suspension af 8,8 g af ovennævnte natriumsalt af D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre i 80 ml methylenchlorid sattes 20 mg N-methylmorpholin. Til den dannede blanding dryppedes en opløsning af 3,1 g ethylchlorcarbo-nat i 20 ml methylenchlorid ved -r20° til -HL5°C i løbet af 5 minutter, og blandingen omsattes ved den nævnte temperatur i en time.(2) In a solution of 10 g of the above D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid in 200 ml of acetone, a solution of 5.2 g of sodium salt of 2- ethyl hexanoic acid in 50 ml of acetone with stirring to precipitate crystals. The precipitated crystals were collected by filtration and then washed with acetone to give 9.6 g of sodium salt of D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid, m.p. 165 ° C (decomp.), Yield 95% · (3) To a suspension of 8.8 g of the above sodium salt of D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid In 80 ml of methylene chloride 20 mg of N-methylmorpholine was added. To the resulting mixture, a solution of 3.1 g of ethyl chloro carbonate in 20 ml of methylene chloride was dropped at -r20 ° to -HL5 ° C over 5 minutes and the mixture was reacted at said temperature for one hour.

Til denne reaktionsvæske dryppedes en opløsning af 9,4 g af et triethylaminsalt af 6-aminopenicillansyre i 40 ml methylenchlorid ved -r40° til -i-30oC i løbet af 10 minutter, og den dannede blanding omsattes ved -f40° til -r20°C i løbet af en time. Efter reaktionen blev temperaturen af reaktionsvæsken gradvis hævet til 0°C i løbet af en time, og blandingen underkastedes ekstraktion med 100 ml vand. Derefter fraskiltes det vandige lag, og methylen-chloridlaget underkastedes yderligere ekstraktion med 50 ml vand, og det dannede vandige lag forenedes med det ovennævnte vandige lag. De forenede vandige lag indstilledes på en pH-værdi på 2 ved tilsætning af fortyndet saltsyre under isafkøling til udfældning af krystaller. De udfældede krystaller opsameldes ved filtrering, vaskedes grundigt med vand, tørredes og opløstes derefter i 200 ml acetone. Til den dannede opløsning dryppedes en opløsning af 4 g natriumsalt af 2-ethylhexansyre i 40 ml acetone i løbet af 10 minutter til udfældning af krystaller. De udfældede loo 151338 krystaller opsamledes ved filtrering, vaskedes med acetone og tørredes derefter til dannelse af 11,4 g natriumsalt af 6—Qd(—)— (4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidoj peni-cillansyre, smp. 170°C (dekomp.), udbytte 80,8%.To this reaction liquid was added a solution of 9.4 g of a triethylamine salt of 6-aminopenicillanic acid in 40 ml of methylene chloride at -r40 ° to -i-30 ° C over 10 minutes, and the resulting mixture was reacted at -f40 ° to -r20 ° C within an hour. After the reaction, the temperature of the reaction liquid was gradually raised to 0 ° C over one hour and the mixture was extracted with 100 ml of water. The aqueous layer was then separated and the methylene chloride layer was subjected to further extraction with 50 ml of water and the resulting aqueous layer was combined with the above aqueous layer. The combined aqueous layers were adjusted to a pH of 2 by the addition of dilute hydrochloric acid under ice-cooling to precipitate crystals. The precipitated crystals were collected by filtration, washed thoroughly with water, dried and then dissolved in 200 ml of acetone. To the resulting solution, a solution of 4 g of sodium salt of 2-ethylhexanoic acid in 40 ml of acetone was added dropwise over 10 minutes to precipitate crystals. The precipitated loo 151338 crystals were collected by filtration, washed with acetone and then dried to give 11.4 g of sodium salt of 6-Qd (-) - (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidoj penicillanic acid , m.p. 170 ° C (decomp.), Yield 80.8%.

Ovennævnte operation blev gentaget med den ændring, at (4-methy1-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyren erstattedes med de i tabel 17 angivne forbindelser med formlen (V) til dannelse af de ligeledes i tabel 17 viste slutprodukter. Strukturen af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that the (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid was replaced with the compounds of formula (V) listed in Table 17 to give the final products also shown in Table 17. The structure of the compounds formed was confirmed by IR and NMR.

ιοί 151338 cdιοί 151338 cd

SS

ΝΛ ΙΛΟ cd W W o 1¾ o o o t<-\ t<AO V-/ cd K W o is? o o o cq ! ΚΛ KXD V / VsΝΛ ΙΛΟ cd W W o 1¾ o o o t <- \ t <AO V- / cd K W o is? o o o cq! ΚΛ KXD V / Vs

Μ Μ O Π IΜ Μ O Π I

o o o m i —Ao o o m i —A

g 21 R |T0 I ti i ° § i r° s„ m g 1 §l2> 8g 21 R | T0 I ti i ° § i r ° s „m g 1 §l2> 8

Ή K /“λ g IΉ K / “λ g I

« r® ? T) 3 § °ϊβ3 ° t ϊ γΊ °V g S 1 ) c\i c\l 0) onaf W ~«R®? T) 3 § ° ϊβ3 ° t ϊ γΊ ° V g S 1) c \ i c \ l 0) on W ~

Ml O CMMl O CM

fe CM CM Mfe CM CM M

i ill I td i o ^ O '-"O v_^ I JO I tfv i — p —-- W ·χ· w £ O O o O fi oi ill I td i o ^ O '- "O v_ ^ I JO I tfv i - p —-- W · χ · w £ O O o O fi o

HH

Q) -----Q) -----

PP

cdCD

EHEH

[> W[> W

oisland

OISLAND

_I hrt O_I hear O

1 „ § m s i -mi 1 , t® s °v^1 „§ m s i -mi 1, t® s ° v ^

Ξ I °YS °VΞ I ° YS ° V

ra i 11 cm H O- !3 O^tsr w φ V ^ r ora i 11 cm H O-! 3 O ^ tsr w φ V ^ r o

d 1 J cm CMd 1 J cm CM

Hl O CMHl O CM

XI CM CM wXI CM CM w

fe Λ g Ag ASfe Ag g Ag AS

* A ff A tT A ff ' p o p o p o* A ff A tT A ff 'p o p o p o

Eksempel 15 102 151338 (1) Til en opløsning af 2,28 g D(-)-a-amino-l,4-cyclohexadienyl-eddikesyre i 15 ml N NaOH sattes 20 ml ethylacetat og 2,1 ml tri-ethylamin, og den dannede blanding afkøledes til 0°C. Til denne blanding sattes gradvis 1,69 g 4-methyl-2,3-dioxo-l-piperazino~ carbonylchlorid i løbet af 10 minutter. Derefter omsattes blandingen i 30 minutter under isafkøling, og det vandige lag fraskiltes. Til det vandige lag sattes yderligere 20 ml ethylacetat. Den dannede blanding indstilledes på en pH-værdi på 2 ved tilsætning af 2N saltsyre under isafkøling, og ethylacetatlaget fraskiltes. Det organiske lag vaskedes grundigt med vand, tørredes over vandfrit magnesiumsulfat, befriedes for opløsningsmiddel ved destillation under reduceret tryk og indførtes derefter i isopropanol til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering til dannelse af 2,5 g hvide krystaller af D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)-l,4-cyclohexadienyl-eddikesyre, smp. 140-145°C (dekomp.), udbytte lk%.Example 15 102 151338 (1) To a solution of 2.28 g of D (-) - α-amino-1,4-cyclohexadienyl acetic acid in 15 ml of N NaOH was added 20 ml of ethyl acetate and 2.1 ml of triethylamine, and the resulting mixture was cooled to 0 ° C. To this mixture was gradually added 1.69 g of 4-methyl-2,3-dioxo-1-piperazino-carbonyl chloride over 10 minutes. Then, the mixture was reacted for 30 minutes under ice-cooling and the aqueous layer separated. An additional 20 ml of ethyl acetate was added to the aqueous layer. The resulting mixture was adjusted to a pH of 2 by the addition of 2N hydrochloric acid under ice-cooling and the ethyl acetate layer was separated. The organic layer was thoroughly washed with water, dried over anhydrous magnesium sulfate, freed of solvent by distillation under reduced pressure and then introduced into isopropanol to precipitate crystals. The precipitated crystals were collected by filtration to give 2.5 g of white crystals of D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -1,4-cyclohexadienyl acetic acid, m.p. 140-145 ° C (decomp.), Yield lk%.

IR (KBr) cm”1: 3300, ^Q=0 1715, 1660 MR (dg-DMSO) Z værdiers 0.57 (IH, d), 4.26 (IH, s), 4.36 (2H, s), 5.29 (IH, d), 6.07 - 6.18 (2H, m), 6.38 - 6.49 (2H, m), 7.05 (3H, s), 7.35 (4H, s) (2) Til en suspension af 0,45 g af ovennævnte D(-)-cc-(4-methyl- 2,3-dioxo-l-piperazinocarbonylamino) -1,4-cyclohexadienyleddikesyre i 15 ml vandfrit methylenchlorid sattes 0,24 ml N-methyl-morpho-lin under omrøring til dannelse af en opløsning. Efter afkøling af opløsningen til -HL0°C tildryppedes 3 ml af en vandfri methylen-chloridopløsning indeholdende 0,4 g ethylchlorcarbonat, og den dannede blanding omsattes ved den nævnte temperatur i 90 minutter. Derefter afkøledes reaktionsvæsken til t20°C, og 5 ml af en methy- 103 1 5 1 3 38 lenchloridopløsning indeholdende 0,70 g triethylaminsalt af 6-aminopenicillansyre og 0,31 ml triethylamin dryppedes gradvis i reaktionsvæsken. Den dannede blanding omsattes ved +20°C i en time, ved -^20° til 0°C i en time og ved 0° til 5°C i en time. Derefter befriedes reaktionsvæsken for opløsningsmidlet ved destillation under reduceret tryk. Remanensen opløstes i 10 ml vand og vaskedes derefter med 10 ml ethylacetat. Det vandige lag indførtes atter i 15 ml ethylacetat, og blandingen indstilledes på en pH-værdi på 2,0 ved tilsætning af 2N HC1 under isafkøling. Derefter fraskiltes ethylacetatlaget, som vaskedes med vand, tørredes over vandfrit magnesiumsulfat og befriedes for opløsningsmidlet ved destillation under reduceret tryk til dannelse af 0,74 g hvide krystaller af 6- [d (-) -oc- (4-methyl-2,3-dioxo-l-piperazinocarbonyl-amino)-1,4-cyclohexadienylacetamidcTjpenicillansyre, smp. 84-87°C (dekomp.), udbytte 87%.IR (KBr) cm ”1: 3300, Q Q = 0 1715, 1660 MR (dg-DMSO) Z values 0.57 (1H, d), 4.26 (1H, s), 4.36 (2H, s), 5.29 (1H, d), 6.07 - 6.18 (2H, m), 6.38 - 6.49 (2H, m), 7.05 (3H, s), 7.35 (4H, s) (2) For a suspension of 0.45 g of the above D (- ) -cc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -1,4-cyclohexadienylacetic acid in 15 ml of anhydrous methylene chloride was added 0.24 ml of N-methyl morpholine with stirring to form a solution. After cooling the solution to -HLO ° C, 3 ml of anhydrous methylene chloride solution containing 0.4 g of ethyl chlorocarbonate was added dropwise and the resulting mixture was reacted at said temperature for 90 minutes. Then, the reaction liquid was cooled to t20 ° C and 5 ml of a methylene chloride solution containing 0.70 g of triethylamine salt of 6-aminopenicillanic acid and 0.31 ml of triethylamine was gradually dropped into the reaction liquid. The resulting mixture was reacted at + 20 ° C for one hour, at - ^ 20 ° to 0 ° C for one hour, and at 0 ° to 5 ° C for one hour. Then, the reaction liquid of the solvent is distilled off under reduced pressure. The residue was dissolved in 10 ml of water and then washed with 10 ml of ethyl acetate. The aqueous layer was again introduced into 15 ml of ethyl acetate and the mixture was adjusted to a pH of 2.0 by the addition of 2N HCl under ice-cooling. Then the ethyl acetate layer which was washed with water was separated, dried over anhydrous magnesium sulfate and freed from the solvent by distillation under reduced pressure to give 0.74 g of white crystals of 6- [d (-) -oc- (4-methyl-2.3). -dioxo-1-piperazinocarbonylamino) -1,4-cyclohexadienylacetamide-Cyptenicillanic acid, 84-87 ° C (decomp.), Yield 87%.

UMR (dg-DMSO) X værdier: 0.55 (IH, d), 0.95 (IH, d), 4.22 (IH, s), 4.35 (2H, s), 4.'41 - 4.61 (2H, s), 4.92 (IH, d), 5.75 (IH, s), 6.05 (2H, bs), 6.40 (2H, bs), 7.03 (3H, s), 7.35 (4H, s), 8.40 (3H, s), 8.52 (3H, s)UMR (dg-DMSO) X values: 0.55 (1H, d), 0.95 (1H, d), 4.22 (1H, s), 4.35 (2H, s), 4.41 - 4.61 (2H, s), 4.92 (1H, d), 5.75 (1H, s), 6.05 (2H, bs), 6.40 (2H, bs), 7.03 (3H, s), 7.35 (4H, s), 8.40 (3H, s), 8.52 ( 3H, s)

Det således dannede produkt indstilledes på en pH-værdi på 7,0 ved neutralisation med vandig natriumhydrogencarbonatopløsning og underkastedes derefter en filtrering og frysetørring til dannelse af natriumsaltet deraf.The product thus formed was adjusted to a pH of 7.0 by neutralization with aqueous sodium hydrogen carbonate solution and then subjected to filtration and freeze-drying to form the sodium salt thereof.

Den ovennævnte operation blev gentaget med den ændring, at D(-)-oc- (4-me thyl-2,3-dioxo-l-piperazinocarbonylamino) -1,4-cyclohexa-dienyleddikesyre blev erstattet med hver af de i tabel 18 viste forbindelser med formlen (V) til dannelse af de ligeledes i tabel 18 viste slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that D (-) - oc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -1,4-cyclohexa-dienylacetic acid was replaced with each of the ones in Table 18 compounds of formula (V) to form the end products also shown in Table 18. The structure of each of the compounds formed was confirmed by IR and NMR.

104 151338·104 151338 ·

o3 Ko3 K

to cooto coo

cd K K Ocd K K O

S o o o CO ΚΌ V_/ cd K K o 1¾ o O O CQ 1 CO [ΛΟ V / Y-E3 S S S il -4, H t5 r°S o o o CO ΚΌ V_ / cd K K o 1¾ o O O CQ 1 CO [ΛΟ V / Y-E3 S S S il -4, H t5 r °

i G Γ" Sin G Γ "S

1 o 1 so dg κ /ΓΛ g ^ o κ \_y 91 o 1 so dg κ / ΓΛ g ^ o κ \ _y 9

0 jxj λ—v g I0 jxj λ — v g I

: rO e γγ 2 g 0ΥΒ-, ° ΐ: rO e γγ 2 g 0ΥΒ-, ° ΐ

r-l I i J CMr-l I i J CM

•H O K 0^*f g m J 1 cm cm § ° *? @ 3 ® ϋ , i« . § >-< - o ^ o ^ ' i to i co 1 co• H O K 0 ^ * f g m J 1 cm cm § ° *? @ 3 ® ϋ, i «. §> - <- o ^ o ^ 'i two i co 1 co

H ^ M — {Xi KH ^ M - {Xi K

CD fi U fi O o OCD fi U fi O o O

s EH____ >s EH____>

W MW M

si o ω k o H oK /T\ S o o-(/ /) k K o _ K \_jy 5 § IO g 1 1^0 1 °r^ Φ o ossi o ω k o H oK / T \ S o o - (/ /) k K o _ K \ _jy 5 § IO g 1 1 ^ 0 1 ° r ^ Φ o os

Η ^ Y ) CMY ^ Y) CM

•S Ϊ 3 CM ° •3 oiV § 'S.• S Ϊ 3 CM ° • 3 oiV § 'S.

P CM CM KP CM CM K

fe I K I K l o 0^0 ^ o "" ^fe I K I K l o 0 ^ 0 ^ o "" ^

&4 | CO I CO I CO& 4 | CO I CO I CO

^ K — K K^ K - K K

fi o O O P Ofi o O O P O

Eksempel 16 105 151338 (1) Til en opløsning af 2,2 g DL-oc-amino-2-thieny 1 eddikesyre i 14 ml N natriumhydroxidopløsning sattes ved 0°C 2,2 g triethylamin.Example 16 105 151338 (1) To a solution of 2.2 g of DL-oc-amino-2-thienyl acetic acid in 14 ml of N sodium hydroxide solution was added 2.2 g of triethylamine at 0 ° C.

Til den dannede blanding sattes yderligere 3,6 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid lidt efter lidt ved nævnte temperatur. Derefter omsattes blandingen ved 0°C i 30 minutter og derpå ved stuetemperatur i 30 minutter. Efter reaktionen indstilledes reaktionsvæsken på en pH-værdi på 1,0 ved tilsætning af fortyndet saltsyre til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering, vaskedes med vand og tørredes derefter til dannelse af 3,5 g DL-a-(4-methyl-2,3-dioxo-l~piperazino-carbonylamino)-2-thienyleddikesyre, smp. 2l4-215°C (dekomp.), udbytte 80,5#!· IR (KBr) cm"1: \^c=0 ^10^ ^80 " (2) I en opløsning af 3,5 g af ovennævnte DL-oc-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)-2-thienyleddikesyre i 100 ml acetone dryppedes en opløsning af 1,86 g natriumsalt af 2-ethylhexansyre i 50 ml acetone, hvorefter krystallerne udfældedes. De udfældede krystaller opsamledes ved filtrering og vaskedes derefter med a-cetone til dannelse af 3,5 g natriumsalt af DL-oc-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)-2-thienyleddikesyre, smp. 175-176°C (dekomp.) (3) Til en suspension af 3,3 g af. ovennævnte natriumsalt af DL-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)-2-thienyleddike-syre i 50 ml methylenchlorid sattes 30 mg N-methylmorpholin, og den dannede blanding afkøledes til -ί-20ο til -HL5°C. Til den dannede blanding dryppedes en opløsning af 1,3 g ethylchlorcarbonat i 20 ml methylenchlorid i løbet af 5 minutter, og blandingen om-rørtes ved den nævnte temperatur i 90 minutter. Derefter dryppedes en opløsning af 3,3 g triethylaminsalt af 6-aminopenicillansyre i 50 ml methylenchlorid i blandingen ved -r50° til -r40°C i løbet af 20 minutter, og den dannede blanding omsattes under omrøring ved -f40° til -r30°C i 30 minutter, ved -^30° til -r-20°C i 30 minutter 106 1 5 1 3 3 8 og derefter ved τ·20° til 0°C i 30 minutter. Efter reaktionen af-destilleredes opløsningsmidlet under reduceret tryk, og remanensen opløstes i vand. Den dannede vandige opløsning indstilledes på en pH-værdi på 2,0 ved tilsætning af fortyndet saltsyre under isafkøling til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering, vaskedes grundigt med vand og tørredes derefter til opnåelse af 4,1 g 6-jj)L-a-(4-methyl-2,3-dioxo-l-pi-perazinocarbonylamino)-2-thienylacetamidoj penicillansyre, smp.To the resulting mixture was added an additional 3.6 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride little by little at said temperature. Then the mixture was reacted at 0 ° C for 30 minutes and then at room temperature for 30 minutes. After the reaction, the reaction liquid was adjusted to a pH of 1.0 by the addition of dilute hydrochloric acid to precipitate crystals. The precipitated crystals were collected by filtration, washed with water and then dried to give 3.5 g of DL-α- (4-methyl-2,3-dioxo-1-piperazino-carbonylamino) -2-thienylacetic acid, m.p. 2.14-215 ° C (decomp.), Yield 80.5 # IR · KBr) cm "1: \ c = 0 ^ 10 ^ 80" (2) In a solution of 3.5 g of the above DL -oc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -2-thienylacetic acid in 100 ml of acetone was added a solution of 1.86 g of sodium salt of 2-ethylhexanoic acid in 50 ml of acetone and the crystals precipitated. The precipitated crystals were collected by filtration and then washed with α-cetone to give 3.5 g of sodium salt of DL-oc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -2-thienylacetic acid, m.p. 175-176 ° C (decomp.) (3) To a suspension of 3.3 g of. the above sodium salt of DL-α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -2-thienylacetic acid in 50 ml of methylene chloride was added 30 mg of N-methylmorpholine and the resulting mixture was cooled to -ί-20ο to -HL5 ° C. To the resulting mixture was added a solution of 1.3 g of ethyl chlorocarbonate in 20 ml of methylene chloride over 5 minutes and the mixture was stirred at said temperature for 90 minutes. Then, a solution of 3.3 g of triethylamine salt of 6-aminopenicillanic acid in 50 ml of methylene chloride in the mixture was dropped at -r50 ° to -r40 ° C over 20 minutes and the resulting mixture was reacted with stirring at -f40 ° to -r30 ° C for 30 minutes, at - ^ 30 ° to -r-20 ° C for 30 minutes 106 1 5 1 3 3 8 and then at τ · 20 ° to 0 ° C for 30 minutes. After the reaction, the solvent was distilled off under reduced pressure and the residue dissolved in water. The aqueous solution formed was adjusted to a pH of 2.0 by the addition of dilute hydrochloric acid under ice-cooling to precipitate crystals. The precipitated crystals were collected by filtration, washed thoroughly with water and then dried to give 4.1 g of 6-jl of (1- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -2-thienylacetamidoj penicillanic acid, mp.

185°C (dekomp.), udbytte 80,5%.185 ° C (decomp.), Yield 80.5%.

IR (nujol) cm-1: Vc=0 1780 (lactam), 1715 (-C00H), 1685 - 1675 (-C0NO MR ((CD3) 2CO) T værdier: 0.5 (IH), 1.8 (IH), 2.6 (IH), 2.85 - 3.05 (2H), 4.0 (IH), 4.2 - 4.5 (2H), 5.7 (IH), 5.8 - 6.0 (2H), 6.2 - 6.4 (2H), 6.95 (3H), 8.4 (3H), 8.45 (3H)IR (nujol) cm -1: Vc = 0 1780 (lactam), 1715 (-C00H), 1685 - 1675 (-CONO MR ((CD3) 2CO) T values: 0.5 (1H), 1.8 (1H), 2.6 ( IH), 2.85 - 3.05 (2H), 4.0 (IH), 4.2 - 4.5 (2H), 5.7 (IH), 5.8 - 6.0 (2H), 6.2 - 6.4 (2H), 6.95 (3H), 8.4 (3H) , 8.45 (3H)

Det således dannede produkt indstilledes på en pH-værdi på 7,0 ved neutralisation med en vandig natriumhydrogencarbonatopløs-ning og filtreredes derefter og frysetørredes til opnåelse af natriumsaltet deraf.The product thus formed was adjusted to a pH of 7.0 by neutralization with an aqueous sodium hydrogen carbonate solution and then filtered and lyophilized to give the sodium salt thereof.

Ovennævnte operation gentoges med den ændring, at natriumsaltet af DL-oc- (4-methyl-2,3-dioxo-l-piperazinocarbonylamino) -2-thienyleddi-kesyre erstattedes med hver af de i tabel 19 nævnte forbindelser med formlen (V) til dannelse af de ligeledes i tabel 19 viste slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that the sodium salt of DL-oc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -2-thienylacetic acid was replaced with each of the compounds of formula (V) to form the end products also shown in Table 19. The structure of each of the compounds formed was confirmed by IR and NMR.

iG7 151338 cd a [Λ too ffi W o cd o o o S3 \ / j cd to too /f a a a o ra l fo, too o o o yaiG7 151338 cd a [Λ too ffi W o cd o o o S3 \ / j cd to too / f a a o ra l fo, too o o o ya

W«o V-/ IW «o V- / I

(ϋ RP® oH H(ϋ RP® oH H

Ϊ ^ ti ' s ° h y~^ f\v °Ϊ ^ ti 's ° h y ~ ^ f \ v °

λ I ° §JOλ I ° §JO

-p o o o ra s g sjrn g *n o p-Njt o 41 g n b 2-p o o o ra s g sjrn g * n o p-Njt o 41 g n b 2

^ gV 8 °fS^ gV 8 ° fS

•ri O• ri O

£ 8 I J k i °yS g£ 8 I J k i ° yS g

}_, JL J cm CM} _, JL J cm CM

* °V § w* ° V § w

CM CM WCM CM W

W W o ev o o — S L to I to I toW W o ev o o - S L to I to I to

^ P M P a ^ M^ P M P a ^ M

Η P O P O P OΗ P O P O P O

CDCD

3 ________ ÉH-- - ·ο> cd3 ________ EH-- - · ο> CD

> S> S

v_^ Ov_ ^ O

cd o S § sxi H & 9 8 ra ® o aj Π a £ S i—n a =° o «ri § i 1:. I ^ § °Y*) s o o.a_ ® 8 ϊ 1 Jm H °V^ °"Y g -d o^a' a —cd o S § sxi H & 9 8 ra ® o aj Π a £ S i — n a = ° o «ri § i 1:. I ^ § ° Y *) s o o.a_ ® 8 ϊ 1 Jm H ° V ^ ° "Y g -d o ^ a 'a -

fl i o CMfl i o CM

•ri CM CM a p a a o u o o — O I to I to I to a p a p a p a p o · p o p o• ri CM CM a p a a o u o o - O I to I to I to a p a p a p a p o · p o p o

Eksempel 17 108 151338Example 17 108 151338

Til en suspension af 0,9 g 6- [d(-)-ct-aminophenylacetamidoj peni-cillansyre i 30 ml vandfrit ethylacetat sattes ved 5° til 10°C 0,55 g triethylamin og 0,6 g trimethylsilylchlorid. Den dannede blanding omsattes ved 15° til 20°C i 3 timer til dannelse af tri-methylsilyleret 6-|jD( - )-a-aminophenylacet amidojpenicillansyre.To a suspension of 0.9 g of 6- [d (-) - ct-aminophenylacetamidoj penicillanic acid in 30 ml of anhydrous ethyl acetate was added at 5 ° to 10 ° C 0.55 g of triethylamine and 0.6 g of trimethylsilyl chloride. The resulting mixture was reacted at 15 ° to 20 ° C for 3 hours to form trimethylsilylated 6- µD (-) -α-aminophenylacetamidojpenicillanic acid.

Til denne syre sattes derpå 1 g 4-ethyl-2,3-dioxo-l-piperazino-carbonylchlorid, og den dannede blanding omsattes ved 15° til 20°C i 2 timer. Efter reaktionen udskiltes et bundfald af triethyl-amin-hydrochlorid ved filtrering, og filtratet indførtes i 0,4 g n-butanol til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering til dannelse af 1,25 g hvide krystaller r* af 6-|D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenyl-acetamidojpenicillansyre. I en opløsning af de nævnte krystaller i 30 ml tetrahydrofuran dryppedes en opløsning af 0,38 g af natriumsaltet af 2-ethylhexansyre i 10 ml tetrahydrofuran, hvorefter hvide krystaller blev udfældet. De udfældede krystaller opsamledes ved filtrering, vaskedes grundigt med tetrahydrofuran og tørredes derefter til opnåelse af 1,25 g natriumsalt af 6-[p(-)-oc- (4-ethyl-2,3-dioxo-l-piperazinocarbonylamino )phenylacetamidoJ penicillansyre, smp. 183-185°C (dekomp·), udbytte 90%.To this acid was then added 1 g of 4-ethyl-2,3-dioxo-1-piperazino carbonyl chloride and the resulting mixture was reacted at 15 ° to 20 ° C for 2 hours. After the reaction, a precipitate of triethylamine hydrochloride was separated by filtration and the filtrate was introduced into 0.4 g of n-butanol to precipitate crystals. The precipitated crystals were collected by filtration to give 1.25 g of white crystals r * of 6- [D (-) - o- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidojpenicillanic acid. In a solution of the said crystals in 30 ml of tetrahydrofuran, a solution of 0.38 g of the sodium salt of 2-ethylhexanoic acid in 10 ml of tetrahydrofuran was dropped and white crystals precipitated. The precipitated crystals were collected by filtration, washed thoroughly with tetrahydrofuran and then dried to give 1.25 g of sodium salt of 6- [p (-) - oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid , m.p. 183-185 ° C (decomp.), Yield 90%.

Eksempel 18Example 18

Til en suspension af 4 g trihydrat af 6-[i)(-)-a-aminophenylaceta-midoj penicillansyre i 40 ml vand sattes 20 ml ethylacetat, og den dannede blanding afkøles til 2°C. Derefter forenedes blandingen ned 1,37 g kaliumcarbonat, og der omrørtes ved 2° til 3°C i 2 minutter. Derefter sattes 1,89 g 4-methyl-2,3-dioxo-l-piperazinocar-bonylchlorid til blandingen ved den nævnte temperatur i løbet af 10 minutter, og den dannede blanding omsattes ved den nævnte temperatur i 15 minutter. Efter reaktionen udskiltet små mængder uopløseligt stof ved filtrering, og filtratet indførtes i 80 ml ethylacetat. I den dannede blanding dryppedes 5 ml 2N saltsyre ved 20° til 22°C i løbet af 5 minutter, og blandingen omrørtes ved den nævnte temperatur i 5 timer til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering, vaskedes to gange 109 151338 med 4 ml vand, vaskedes yderligere to gange med 4 ml isopropanol og tørredes derefter til opnåelse af 4,0 g dihydrat af 6-{jD(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidoj penicillansyre, smp. 156-157°C (dekomp.), udbytte 75,4%· IR (KBr) cm-lj JQ=Q 1775, 1740, 1695, 1670 MR (ds-DMSO) T værdier: 0.18 (IH, d), 0.77 (IH, d), 2.66 (5H, s), 4.30 (IH, d), 4.40 (3H, br), 4-48 (IH, g), 4.65 (IH, d), 5.80 (IH, s), 6.12 (2H, bs), 6.45 (2H, bs), 7.06 (3H, s), 8.48 (3H, s), 8.60 (3H, s)To a suspension of 4 g of trihydrate of 6- [i) (-) - α-aminophenylacetamido penicillanic acid in 40 ml of water was added 20 ml of ethyl acetate and the resulting mixture was cooled to 2 ° C. Then, the mixture was combined with 1.37 g of potassium carbonate and stirred at 2 ° to 3 ° C for 2 minutes. Then 1.89 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was added to the mixture at said temperature over 10 minutes and the resulting mixture was reacted at said temperature for 15 minutes. After the reaction, small amounts of insoluble matter were separated by filtration and the filtrate was introduced into 80 ml of ethyl acetate. In the resulting mixture, 5 ml of 2N hydrochloric acid was dripped at 20 ° to 22 ° C over 5 minutes and the mixture was stirred at said temperature for 5 hours to precipitate crystals. The precipitated crystals were collected by filtration, washed twice with 4 ml of water, washed twice more with 4 ml of isopropanol and then dried to give 4.0 g of dihydrate of 6- {jD (-) - α- (4- methyl 2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidoj penicillanic acid, m.p. 156-157 ° C (decomp.), Yield 75.4% · IR (KBr) cm-1j JQ = Q 1775, 1740, 1695, 1670 MR (ds-DMSO) T values: 0.18 (1H, d), 0.77 (1H, d), 2.66 (5H, s), 4.30 (1H, d), 4.40 (3H, br), 4-48 (1H, g), 4.65 (1H, d), 5.80 (1H, s), 6.12 (2H, bs), 6.45 (2H, bs), 7.06 (3H, s), 8.48 (3H, s), 8.60 (3H, s)

Ovennævnte fremgamgsmåde gentoges idet 4-methyl-2,3-dioxo-l-pi-perazinocarbonylchloridet erstattedes med 4-ethyl-2,3-dioxo-l-piperazinocarbonylchlorid til dannelse af et monohydrat af 6-{d(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenylacetamidoj penicillansyre, smp· 154-156°C (dekomp.), udbytte 84,8%· IR (KBr) cm-1: JQ=Q 1775, 1735, 1705, 1680, 1665 NMR (dg-DMSO) Z værdier: 0.20 (IH, d), *0.76 (IH, d), 2.69 (5H, s), 4.32 (IH, d), 4.53 (IH, q), 4.64 (IH, d), 5.00 (3H, br), 5.83 (IH, s), 6.13 (2H, bs), 6.49 (2H, bs), 6.62 (2H, q), 8.44 (3H, s), 8.58 (3H, s), 8.91 (3H, t)The above procedure was repeated as the 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride to form a monohydrate of 6- {d (-) - (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -phenylacetamidoj penicillanic acid, mp · 154-156 ° C (decomp.), Yield 84.8% IR (KBr) cm -1: J = Q 1775, 1735, 1705, 1680, 1665 NMR (dg-DMSO) Z values: 0.20 (1H, d), * 0.76 (1H, d), 2.69 (5H, s), 4.32 (1H, d), 4.53 (1H, q) ), 4.64 (1H, d), 5.00 (3H, br), 5.83 (1H, s), 6.13 (2H, bs), 6.49 (2H, bs), 6.62 (2H, q), 8.44 (3H, s) , 8.58 (3H, s), 8.91 (3H, t)

Det således dannede monohydrat neutraliseredes med en vandig natriumhydrogencarbonatopløsning, og derefter filtreredes blandingen, og filtratet frysetørredes til dannelse af natriumsaltet af 6-[p(-)-<x-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidoj -penicillansyre· 110 151338The monohydrate thus formed was neutralized with an aqueous sodium bicarbonate solution and then the mixture was filtered and the filtrate was freeze-dried to give the sodium salt of 6- [p (-) - <x- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidoj -penicillanoic acid · 110 151338

Yderligere henstilledes en opløsning af 2 g af det ovennævnte dihydrat af 6-[p(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenylacetamidojpenicillansyre i 18 timer til udfældning af krystaller, som frafiltreredes til dannelse af 2 g monohydrat af et nitromethan-additionsprodukt af 6-[p (-) -a- (4-methyl-2,3-dioxo-l-piperazinocarbonylamino )phenylacetamidoj| penicillansyre, smp. 128-130°C (dekomp.), udbytte 92,2%.Further, a solution of 2 g of the above dihydrate of 6- [p (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidojpenicillanic acid for 18 hours was precipitated to precipitate crystals which were filtered off to form of 2 g of monohydrate of a nitromethane addition product of 6- [p (-) -a- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidoj | penicillanic acid, m.p. 128-130 ° C (decomp.), Yield 92.2%.

Elementær analyse (for 022^25^5^7^0^1^02 ‘^O):Elemental Analysis (for 022 ^ 25 ^ 5 ^ 7 ^ 0 ^ 1 ^ 02 '^ O):

Beregnet^ (%) C: 47.42 Η: 5·19 H: 14.43 Fundet - (%) C: 47-94 H: 5.13 N: 14.53 IR (KBr) cm"1: ^0=0 1770 ’ 1755’ 1700 ’ 1680 NMR (d6-DMS0) X værdier: 0.22 (IH, d), 0.80 (IH, d), 2.69 (5H, s), 3.3Ο (3H, hr), 4.30 {IH, d), 4.46 - 4.70 (2H), 5.67 (3H, s), 5.81 (IH, s), 6.13 (2H, bs), 6.46 (2H, bs), 7.07 (3H, s), 8.45 (3H, s), 8.58 (3H, s)Calcd. (%) C: 47.42 Η: 5 · 19 H: 14.43 Found - (%) C: 47-94 H: 5.13 N: 14.53 IR (KBr) cm -1: 0 = 0 1770 '1755' 1700 ' 1680 NMR (d6-DMSO) λ values: 0.22 (1H, d), 0.80 (1H, d), 2.69 (5H, s), 3.3Ο (3H, hr), 4.30 (1H, d), 4.46 - 4.70 ( 2H), 5.67 (3H, s), 5.81 (1H, s), 6.13 (2H, bs), 6.46 (2H, bs), 7.07 (3H, s), 8.45 (3H, s), 8.58 (3H, s) )

Eksempel 19Example 19

Til en suspension af 1,6 g trihydrat af D(-)-a-aminobenzyl-peni-cillin i 20 ml vand sattes ved 2° til 3°C 0,54 g kaliumcarbonat, og den dannede blanding omrørtes i 3 minutter. Til blandingen sattes gradvis 0,81 g 4-ethyl-2,3-dioxo-l-piperazinocarbonylchlorid ved den nævnte temperatur i løbet af 10 minutter, og blandingen omsattes i 15 minutter. Efter reaktionen blev små mængder uopløselige stoffer frafiltreret, og filtratet indførtes i 10 ml methyl-n-propyl-keton. Til den dannede blanding dryppedes 1,98 ml 2N saltsyre ved 15° til 20°C i løbet af 2 minutter, og blandin- 111 151338 gen omrørtes ved den nævnte temperatur i to timer til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering, vaskedes to gange med 2 ml vand, vaskedes yderligere to gange med 2 ml methyl-n-propyl-keton, og tørredes derefter til dannelse af 1,7 g monohydrat af D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocar-bonylamino)benzylpenicillin, smp. 152-154°C (dekomp.), udbytte 80,2%.To a suspension of 1.6 g trihydrate of D (-) - α-aminobenzyl-penicillin in 20 ml of water was added 0.52 g of potassium carbonate at 2 ° to 3 ° C and the resulting mixture was stirred for 3 minutes. To the mixture was gradually added 0.81 g of 4-ethyl-2,3-dioxo-1-piperazinocarbonyl chloride at said temperature over 10 minutes and the mixture was reacted for 15 minutes. After the reaction, small amounts of insoluble matter were filtered off and the filtrate was introduced into 10 ml of methyl n-propyl ketone. To the resulting mixture, 1.98 ml of 2N hydrochloric acid was added dropwise at 15 ° to 20 ° C over 2 minutes, and the mixture was stirred at said temperature for two hours to precipitate crystals. The precipitated crystals were collected by filtration, washed twice with 2 ml of water, washed twice more with 2 ml of methyl-n-propyl ketone, and then dried to give 1.7 g of monohydrate of D (-) - a- ( 4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) benzylpenicillin, m.p. 152-154 ° C (decomp.), Yield 80.2%.

Det således dannede produkt neutraliseredes med en vandig natrium-hydrogencarbonatopløsning og underkastedes derefter en filtrering og frysetørredes til dannelse af et natriumsalt af det nævnte produkt.The product thus formed was neutralized with an aqueous sodium hydrogen carbonate solution and then subjected to filtration and freeze-dried to give a sodium salt of said product.

Eksempel 20Example 20

En suspension af 4,0 g monohydrat af 7-(D(-)-a-aminophenylaceta-midoj-3-methyl- A^-cephem-4-carboxylsyre i 60 ml tetrahydrofuran indeholdende 20 rumfangsprocent vand, indstilledes på en pH-vær-di på 8,0 til 8,5 ved gradvis tilsætning af triethylamin under omrøring til dannelse af en opløsning, som derefter afkøledes til 0°C. Til denne opløsning sattes gradvis 2,5 g krystaller af 4-methyl-2,3-dioxo-l-p.iperazLino-cår.bOnylchlorid i løbet af 10 minut ter. Under denne periode opretholdtes reaktionsblandingens pH-værdi på 7,5 til 8,0 ved gradvis tilsætning af triethylamin. Derefter omsattes den dannede blanding ved 0° til 5°C i 15 minutter, medens pH-værdien opretholdtes ved 7,5 til 8,0. Efter reaktionen omrørtes reaktionsblandingen sammen med 60 ml diethylether og 70 ml vand, og derefter fraskiltes det vandige lag. Det således dannede vandige lag vaskedes med 30 ml ethylacetat, afkøledes til 0° til 5°C og indstilledes derefter på en pH-værdi på 1,5 ved tilsætning af fortyndet saltsyre til udfældning af hvide krystaller.A suspension of 4.0 g of monohydrate of 7- (D (-) - α-aminophenylacetamido-3-methyl-Δ-cephem-4-carboxylic acid in 60 ml of tetrahydrofuran containing 20% by volume of water was adjusted to a pH value. -di of 8.0 to 8.5 by gradually adding triethylamine with stirring to form a solution which was then cooled to 0 ° C. To this solution was gradually added 2.5 g of crystals of 4-methyl-2,3- dioxo-l.piperazlino-carbonyl chloride over 10 minutes ter During this period the pH of the reaction mixture was maintained at 7.5 to 8.0 by the gradual addition of triethylamine and then the resulting mixture was reacted at 0 ° to 5 ° C. for 15 minutes while maintaining the pH at 7.5 to 8.0 After the reaction, the reaction mixture was stirred with 60 ml of diethyl ether and 70 ml of water and then the aqueous layer was separated. The aqueous layer thus formed was washed with 30 ml of ethyl acetate. cooled to 0 ° to 5 ° C and then adjusted to a pH of 1.5 by adding dilute hydrochloric acid to precipitation of white crystals.

De udfældede krystaller opsamledes ved filtrering, vaskedes grundigt med vand og tørredes derefter til dannelse af 4,7 g hvide krystaller af 7- (p(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)-phenylacet amido] -3-methyl- A^-cephem-4-carboxylsyre, smp. 185-186°C (dekomp.), udbytte 86%.The precipitated crystals were collected by filtration, washed thoroughly with water and then dried to give 4.7 g of white crystals of 7- (p (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) - phenylacetamido] -3-methyl-Δ-cephem-4-carboxylic acid, mp 185-186 ° C (decomp), yield 86%

r 112 151338 IR (KBr) cm-1: v\j=0 1770 - 1760 (lactam), 1720 - 1660 (-COUCT» -C00H) MR (dg-DMSO) T værdier: 0.1 (IH, d), 0.56 (1H, d), 2.62 (5H, s), 4.26 - 4.37 (2H, dd.), 5.05 (1H, d), 6.1 (2H, bs), 6.47 (2H, bs), 6.63 (2H, s), 7.05 (3H, s), 8.02 (3H, s)r 112 151338 IR (KBr) cm -1: v = j = 0 1770 - 1760 (lactam), 1720 - 1660 (-COUCT-C00H) MR (dg-DMSO) T values: 0.1 (1H, d), 0.56 (1H, d), 2.62 (5H, s), 4.26 - 4.37 (2H, dd), 5.05 (1H, d), 6.1 (2H, bs), 6.47 (2H, bs), 6.63 (2H, s) , 7.05 (3H, s), 8.02 (3H, s)

Ovennævnte operation blev gentaget med den ændring, at 4-methyl- 2,3-dioxo-l-piperazinocarbonylchloridet erstattedes med hver af de i tabel .20 viste reaktive derivater af forbindelser med formlen (III) til dannelse af de ligeledes i tabel 20 viste slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that the 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of compounds of formula (III) shown in Table 20 to form the ones also shown in Table 20. end products. The structure of each of the compounds formed was confirmed by IR and NMR.

113 151338 tOl « m ^ in ο M vo S' MO ΓΛ o V£> CO O M CO CQ Vo D- k\ __i o y-iz; Μ Φ ® I ®113 151338 tOl «m ^ in ο M vo S 'MO ΓΛ o V £> CO O M CO CQ Vo D- k \ __i o y-iz; Μ Φ ® I ®

ο K -p co Vo -p _i -Pο K -p co Vo -p _i -P

i ° V> V-izi -P -Pi ° V> V-izi -P -P

ri ° >> i >» ^ ° bri °>> i> »^ ° b

co Vo h4 _i p g Pco Vo h4 _i p g P

ω 13 μ ° 3 g 3 " . § gYo> - ω ω ο ο ο ω \y/ ο Ό g ο fcri Γ~\ ο § ο β g οο ο-(0) ° ° ο ρ ο ό frj \_/ νο ο m 2 gVo) Η § Η oJ, ο g'η-/ ~ ο 'Τ X ) " , ο ft ft ft +· ο a τ i a i s <u i o 1 J o cm oω 13 µ ° 3 g 3 ". § gYo> - ω ω ο ο ω \ y / ο Ό g ο fcri Γ ~ \ ο § ο β g οο ο - (0) ° ° ο ρ ό ο frj \ _ / νο ο m 2 gVo) Η § Η oJ, ο g'η- / ~ ο 'Τ X) ", ο ft ft ft + · ο a τ iais <uio 1 J o cm o

rH o ώ M CVS ,¾ K .MrH o ώ M CVS, ¾ K .M

,h t i 'S I ω o ω, h t i 'S I ω o ω

•H I I T3 CM 'Ti CM P• H I I T3 CM 'Ti CM P

+1 crSg — K " -+1 crSg - K "-

IQ 7 O . CMIQ 7 O. CM

S CM . CM 0. W i φ i g ρ^,Λο s 3 &S CM. CM 0. W i φ i g ρ ^, Λο s 3 &

° έ! 7 § i ^ ra m I° έ! 7 § i ^ ra m I

M vSk ω — K WM vSk ω - K W

p o p o op o p o o

rH <DrH <D

PP

ø---- EH ^ø ---- EH ^

HH

HH

HH

s__' £ ωs__ '£ ω

CH P PCH P P

Cd a oCd a o

fH OfH O

ίπ O H oίπ O H o

®<H O I® <H O I

tP OtP O

ctCd p o T ΊctCd p o T Ί

S s g oVS s g oV

s« g l) ™ «5 o a ° >f g ω $ „XJ & y £*g ° ^ S cms «g l) ™« 5 o a °> f g ω $ „XJ & y £ * g ° ^ S cm

Sp i i § lå if i i __I-- • 114 151338Sp i i § lay if i i __I-- • 114 151338

Eksempel 21 (1) Til en opløsning af 0,92 g l-n-pentyl-2,3-dioxo-piperazin i 15 ml vandfrit dioxan sattes 1,1 ml triethylamin og 1,08 g trimethyl-silylchlorid. Den dannede blanding omrørtes ved stuetemperatur i 20 timer til dannelse af triethylamin-hydrochlorid. Dette hydro-chlorid frafiltreredes, og filtratet dryppedes ved 0° til 5°C i en opløsning af 0,6 g phosgen i 10 ml vandfrit tetrahydrofuran. Derefter omsattes den dannede blanding ved 5° til 10°C i 30 minutter og derpå ved stuetemperatur i 2 timer. Derefter afdestille-redes opløsningsmidlet under reduceret tryk til dannelse af 1,21 g lysegult olieagtigt 4-n-pentyl-2,3-dioxo-l-piperazinocarbonylchlo-rid.Example 21 (1) To a solution of 0.92 g of 1-n-pentyl-2,3-dioxo-piperazine in 15 ml of anhydrous dioxane was added 1.1 ml of triethylamine and 1.08 g of trimethylsilyl chloride. The resulting mixture was stirred at room temperature for 20 hours to give triethylamine hydrochloride. This hydrochloride was filtered off and the filtrate was dripped at 0 ° to 5 ° C in a solution of 0.6 g of phosgene in 10 ml of anhydrous tetrahydrofuran. Then, the resulting mixture was reacted at 5 ° to 10 ° C for 30 minutes and then at room temperature for 2 hours. The solvent was then distilled off under reduced pressure to give 1.21 g of pale yellow oily 4-n-pentyl-2,3-dioxo-1-piperazinocarbonyl chloride.

IR (film) cm-1: Vc=o 1790’ 1720 ~ 1665 (2) En suspension af 1,70 g monohydrat af 7-{p(-)-a-aminophenyl-acetamido] -3-methyl-A?-cephem-4-carboxylsyre i 50 ml tetrahydro-furan indeholdende 20 rumfangsprocent vand, indstilledes til en pH-vær di på 8,0 til 8,5 ved tilsætning af triethylamin vinder omrøring til dannelse af en opløsning. Denne opløsning afkøledes til 0° til 5°C, og 7 ml af en vandfri tetradydrofuranopløsning indeholdende 1,21 g 4-n-pentyl-2,3-dioxo-piperazinocarbonylchlorid fra trin (l) dryppedes i opløsningen. Under denne periode indstilledes pH-værdien af opløsningen på 7,5 til 8,0 ved tilsætning af triethylamin.Derefter omsattes den dannede blanding ved 0° til 5°C i 1 time og derefter ved 5° til 10°C i 2 timer, medens pH-værdien holdtes på 7,5 til 8,0. Efter reaktionen afdestilleredes tetrahydro-furanet under reduceret tryk, og remanensen opløstes i 20 ml vand og vaskedes derpå to gange med 20 ml ethylacetat. Det vandige lag blandedes derpå igen med 40 ml ethylacetat og indstilledes på en pH-værdi på 1,5 ved gradvis tilsætning af fortyndet saltsyre vinder isafkøling. Derefter fraskiltes ethylacetatlaget, som vaskedes med vand og derpå tørredes over vandfrit magnesiumsvuLfat. Derefter dryppedes 10 ml af en ethylacetatopløsning indeholdende 0,75 g 115 151338 natrium-2-ethylhexanoat i laget ved 0° til 5°C til udfældning af hvide krystaller. De udfældede krystaller opsamledes ved filtrering og vaskedes med ethylacetat og derpå med diethylether til dannelse af 1,95 g natriumsalt af 7- [p (-)-a-(4-n-pentyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-methyl- Λ^-cephem-4-carboxylsyre, smp. 164-166°C (dekomp.), udbytte 75%.IR (film) cm -1: Vc = 0 1790 1720 ~ 1665 (2) A suspension of 1.70 g monohydrate of 7- {p (-) -? -Aminophenyl-acetamido] -3-methyl-A? - cephem-4-carboxylic acid in 50 ml of tetrahydrofuran containing 20% by volume of water was adjusted to a pH value of 8.0 to 8.5 by the addition of triethylamine, stirring to form a solution. This solution was cooled to 0 ° to 5 ° C and 7 ml of anhydrous tetradydrofuran solution containing 1.21 g of 4-n-pentyl-2,3-dioxo-piperazinocarbonyl chloride from step (1) was dripped into the solution. During this period, the pH of the solution was adjusted to 7.5 to 8.0 by the addition of triethylamine. Then the resulting mixture was reacted at 0 ° to 5 ° C for 1 hour and then at 5 ° to 10 ° C for 2 hours. while maintaining the pH of 7.5 to 8.0. After the reaction, the tetrahydrofuran was distilled off under reduced pressure and the residue was dissolved in 20 ml of water and then washed twice with 20 ml of ethyl acetate. The aqueous layer was then mixed again with 40 ml of ethyl acetate and adjusted to a pH of 1.5 by gradually adding dilute hydrochloric acid to ice-cooling. Then, the ethyl acetate layer was separated, which was washed with water and then dried over anhydrous magnesium sulfate. Then, 10 ml of an ethyl acetate solution containing 0.75 g of sodium 2-ethyl hexanoate was dropped into the layer at 0 ° to 5 ° C to precipitate white crystals. The precipitated crystals were collected by filtration and washed with ethyl acetate and then with diethyl ether to give 1.95 g of sodium salt of 7- [p (-) - α- (4-n-pentyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-methyl-β-cephem-4-carboxylic acid, m.p. 164-166 ° C (decomp.), Yield 75%.

IR (KBr) cm-1: VC=Q 1750 (lactam), 1720 - • 1660 (-C0RO, 1-590 (-C009) NMR (dg-DMSO + D20) T værdier: 2.58 (5H,· s), 4.33 (IH, s), 4.49 (IH, d), 5.17 (IH, d), 6.10 (2H, bs), 6.42 - 6.87 (6H, m), 8.09 (3H, s), 8.60 - 8.90 (6H, bs), 9.12 (3H, t) 1IR (KBr) cm -1: VC = Q 1750 (lactam), 1720 - 1660 (-COO, 1-590 (-C009)) NMR (dg-DMSO + D20) T values: 2.58 (5H, · s), 4.33 (1H, s), 4.49 (1H, d), 5.17 (1H, d), 6.10 (2H, bs), 6.42 - 6.87 (6H, m), 8.09 (3H, s), 8.60 - 8.90 (6H, bs), 9.12 (3H, t) 1

Ovennævnte operation blev gentaget med den ændring, at 4-n-pen-tyl-2,3”dioxo-l-piperazinocarbonylchloridet blev erstattet med hver af de i tabel 21 viste reaktive derivater af forbindelser med formlen (III) til dannelse af de ligeledes i tabel 21 angivne slutprodukter. Strukturen af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that the 4-n-pentyl-2,3 ”dioxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of compounds of formula (III) shown in Table 21 to give the end products listed in Table 21. The structure of the compounds formed was confirmed by IR and NMR.

n« 151338 ΚΛ . ΚΝ ΚΝ ώ CO Μ ^ ώ C0n «151338 ΚΛ. ΚΝ ΚΝ ώ CO Μ ^ ώ C0

ο S Ν 0¾ ο Sο S Ν 0¾ ο S

,_ι Ο ’ « __I Ο cS i Ο cR, _ι Ο '«__I Ο cS i Ο cR

/\ ο is- 1 \\ ο ω /—i. ο 00 CQ 7-0 ι>- m VO 1ST CQ'VolS- •VB y-3 V® i CD I 0) I ω ® Ά £ ^ £ -Λ. £ m W $ ω ,Ω M £> « 1¾ id g -d g S3 'o o w o 3 ο η 3 l<2> |Xo> 0- |xo) p o o o oo o -tr o vo o m o lo/ \ ο is- 1 \\ ο ω / —i. ο 00 CQ 7-0 ι> - m VO 1ST CQ'VolS- • VB y-3 V® i CD I 0) I ω ® Ά £ ^ £ -Λ. £ m W $ ω, Ω M £> «1¾ id g -d g S3 'o o w o 3 o η 3 l <2> | Xo> 0- | xo) p o o o oo o -tr o vo o m o lo

4-> I Η I Η I H4-> I Η I Η I H

^ °f) ~ TD ~ °I) O^ ° f) ~ TD ~ ° I) O

•rt o‘ST a Ciw a o^s ft 4J ι a ι a ι a• rt o'ST a Ciw a o ^ s ft 4J ι a ι a ι a

ra CM o CM O CM Ora CM o CM O CM O

S W Λ Μ A! w Λ ο ϋ ο ο ω ο ο >4- r^j m <d co ΌS W Λ Μ A! w Λ ο ϋ ο ω ο ο> 4- r ^ j m <d co Ό

^ ^"c\J CM CM^^ "c \ J CM CM

K · W * frj · I o p, I o ft Λ S ft 3 § Λ §K · W * frj · I o p, I o ft Λ S ft 3 § Λ §

Η P Ο P Ο P OΗ P Ο P Ο P O

Φ & 05____Φ & 05____

EHEH

V—>L->

HH

HH

HH

V>V>

SS

<D<D

*H Η Η Η H* H Η Η Η H

CO S ο ο o p o o oCO S ο ο o p o o o

POO o OPOO o O

(Dpi I I(Dpi I I

P O OvBP O OvB

il 0y oV oUil 0y oV oU

'58 g S $ <d$ * j? ^'58 g S $ <d $ * j? ^

!>'d CM CM CM!> 'd CM CM CM

3 w w w -P -H o o o (0 p fPv fcs na3 w w w -P -H o o o (0 p fPv fcs na

(DO B M W(DO B M W

Dip ο ο o __I--!- 117 151338 __Dip ο ο o __I -! - 117 151338 __

CVJCVJ

»V'V

σ\ fc-σ \ fc-

tAtoe

W ti ® o a f J ° fW ti ® o a f J ° f

ra Vo Pra Vo P

y a ·ϋ Λ 3 ο W ο a o o r- o ΝΛ 1<2) 7y a · ϋ Λ 3 o W ο a o o r- o ΝΛ 1 <2) 7

O LAOh LA

O LAOh LA

I HI H

°fj ~ ka p.° fj ~ ka p.

^ 1 S^ 1 S

77 oj o77 oj o

+1 ώ X+1 ώ X

S o ω •P ^ 0 ώ * - Λ 3 g· I LA 03 ι-l w jxjS o ω • P ^ 0 ώ * - Λ 3 g · I LA 03 ι-l w jxj

OJ Q OOJ Q O

I—II-I

(1) Λ-- (d(1) Λ-- (d

EhEh

HH

OISLAND

OISLAND

OISLAND

Ύ) 'ojΎ) 'Oh

MM

o c\jo c \ j

KK

OISLAND

LALA

KK

OISLAND

118 151338118 151338

Eksempel 22Example 22

Med 1,5 g hydrochlorid af methoxymethylester af 7-[D(-)-a-amino-phenylacetamido3-3-methyl-A?-cephem-4-carboxylsyre og 0,65 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid gentoges fremgangsmåden ifølge eksempel 20 til dannelse af 1,6 g methoxymethylester af 7* [b(-) -a- (4-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenyl-acetamidoJ-3-methvl- /\^-cephem-4-carboxylsvre. smp. 146-148°C (dekomp.), udbytte 86%.With 1.5 g of hydrochloride of methoxymethyl ester of 7- [D (-) - α-amino-phenylacetamido3-3-methyl-A? -Cephem-4-carboxylic acid and 0.65 g of 4-methyl-2,3-dioxo- 1-Piperazinocarbonyl chloride was repeated in the procedure of Example 20 to give 1.6 g of methoxymethyl ester of 7 * [b (-) -a- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-methyl / \ ^ - cephem-4-carboxylic acid. mp. 146-148 ° C (decomp.), Yield 86%.

IR (KBr) cm"l: V^q_q· 1770 (lactam), 1710 (ester),IR (KBr) cm "l: ^ q__ · 1770 (lactam), 1710 (ester),

1680 - 1600 (-C0HO1680 - 1600 (-CO0HO

Eksempel 23Example 23

Til en suspension af 0,20 g 7-[p(-)-a-aminophenylacetamidoj-3-acetoxymethyl-A^-cephem-4-carboxylsyre i 15 ml vandfrit chloroform sattes 0,17 ml triethylamin under omrøring til dannelse af en opløsning, som derefter afkøledes til 0°C. Til denne opløsning sattes 0,11 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid, og den dannede blanding omsattes ved stuetemperatur i 2 timer. Ef-. ter reaktionen inddampedes den flydende reaktionsblanding under reduceret tryk, og remanensen blev opløst i 15 ml vand. Den dannede opløsning vaskedes med 10 ml ethylacetat. Det vandige lag forenedes igen med 20 ml ethylacetat, og derefter indstilledes på en pH-værdi på 1,5 ved tilsætning af 2N saltsyre under isafkøling. Derefter fraskiltes ethylacetatlaget, som vaskedes i rækkefølge med vand og en mættet vandig natriumchloridopløsning og derefter tørredes over magnesiumsulfat. Derpå fradestilieredes opløsningsmidlet under reduceret tryk til dannelse af 0,22 g hvide krystaller af 7-^D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)-phenyl-acetamido3-3-acetoxymethyl-A^-cephem-4-carboxylsyre, smp. 175°C (dekomp.), udbytte 76%.To a suspension of 0.20 g of 7- [p (-) - α-aminophenylacetamidoj-3-acetoxymethyl-Δ-cephem-4-carboxylic acid in 15 ml of anhydrous chloroform was added 0.17 ml of triethylamine with stirring to form a solution which was then cooled to 0 ° C. To this solution was added 0.11 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride and the resulting mixture was reacted at room temperature for 2 hours. Community. After the reaction, the liquid reaction mixture was evaporated under reduced pressure and the residue was dissolved in 15 ml of water. The resulting solution was washed with 10 ml of ethyl acetate. The aqueous layer was again combined with 20 ml of ethyl acetate and then adjusted to a pH of 1.5 by the addition of 2N hydrochloric acid under ice-cooling. Then, the ethyl acetate layer was separated which was washed successively with water and a saturated aqueous sodium chloride solution and then dried over magnesium sulfate. The solvent was then distilled off under reduced pressure to give 0.22 g of white crystals of 7- [D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -phenyl-acetamido-3-acetoxymethyl] ? -Cephem-4-carboxylic acid, m.p. 175 DEG C. (decomp.), Yield 76%.

115 151338 IR (XBr) cm-ΐϊ y^=0 177O (lactam), 1720 - 1650 (-00Ν<, -COOH) MR (dg-DMSO) T værdier: 0.25 (IH, d), 0.65 (IH, d), 2.66 (5H, s), 4.32 (IH, q), 4.43 (IH, d), 5.05 (IH, d), 5.21 (2H, q), 6.15 (2H, bs), 6.40 (2Ξ, bs), 6.57 (2H, bs), 7.0 (3H, s), 8.0 (3H, s)115 151338 IR (XBr) cm -ΐϊ yΐϊ = 0 177O (lactam), 1720 - 1650 (-00Ν <, -COOH) MR (dg-DMSO) T values: 0.25 (1H, d), 0.65 (1H, d ), 2.66 (5H, s), 4.32 (1H, q), 4.43 (1H, d), 5.05 (1H, d), 5.21 (2H, q), 6.15 (2H, bs), 6.40 (2Ξ, bs) , 6.57 (2H, bs), 7.0 (3H, s), 8.0 (3H, s)

Ovennævnte operation blev gentaget med den ændring, at 4-methyl- 2,3-dioxo-l-piperazinocarbonylchlorid blev erstattet med hver af de i tabel 22 viste reaktive derivater af forbindelser med formlen (III) til dannelse af de i tabel 22 viste slutprodukter. Strukturen af hver af de fremstillede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was replaced with each of the reactive derivatives of compounds of formula (III) shown in Table 22 to give the final products shown in Table 22 . The structure of each of the compounds prepared was confirmed by IR and NMR.

120 151338 to»120 151338 to »

MM

o Wo W

ο ίο ο Ο =§· W Ο Ο -ί ϋ so Ο -νΟ (Μ » Ο Ο Κ ΙΛ Ο m Ο Μ 00 OCO Μ 00 _(Ο CM Ο Μ .. / Λ ο Φ Μ Φ _I Ο Φ Φ Μ y-—U +3 Ο jxj -Ρ * Υι Ο -Ρ Μ VS Ρ I Ο -ρ C0 }-ϋ -ρ m 1 >> /Vv ° >> b 3 ^ g v_g s .4¾ •η ω ° 3 1 3 Γ^ο 3 f S "Λ Μ U ο ο g ο ο ο ω ο ο ο Ή Μ /7Λ ο g ο ο __ ο Ρ g<2> s 8 £ § Λ I ο-/θ) Η Η η 8 ~ Ι^-7 'Τ 8 ~ο ίο ο Ο = § · W Ο Ο -ί ϋ so Ο -νΟ (Μ »Ο Ο ΙΛ Ο m Ο Μ 00 OCO Μ 00 _ (Ο CM Ο Μ .. / Λ ο Φ Μ I _I Ο Φ Φ Μ y -— U +3 Ο jxj -Ρ * Υι Ο -Ρ Μ VS Ρ I Ο -ρ C0} -ϋ -ρ m 1 >> / Vv ° >> b 3 ^ g v_g s .4¾ • η ω ° 3 1 3 Γ ^ ο 3 f S "Μ g g g Λ Λ Λ Λ Λ Λ Λ Λ Λ Λ <<<<2 2 2 8 8 8 8 8 8 8 8 Η η 8 ~ Ι ^ -7 'Τ 8 ~

I °r*i ^ g & ο α II ° r * i ^ g & ο α I

φ o^-g^ Μ og, Μ X ) & U ι Φ Τ 1 φ Og φ &ι CM Η 1 J 'ΰ · 5* g w dnsr — Μα · I ο CM ft (Μ · CM · I hrt S’ I ώ ft I ^ Pi — o w— O B ^ & s tv] 1 KV I ί<Λ tø I K 02φ o ^ -g ^ Μ and, Μ X) & U ι Φ Τ 1 φ And φ & ι CM Η 1 J 'ΰ · 5 * gw dnsr - Μα · I ο CM ft (Μ · CM · I hrt S' I ώ ft I ^ Pi - ow— OB ^ & s tv] 1 KV I ί <Λ tø IK 02

cm ^ Μ ^ K "X Ocm ^ Μ ^ K „X O

Ρ O ρ o p —Ρ O ρ o p -

rH Φ PrH Φ P

cd----CD ----

BB

✓—·.✓- ·.

HH

HH

HH

PP

ΦΦ

PHPH

cdSCDS

P HP H

uo 3 huo 3 h

Φ<Η ο OΦ <Η ο O

-Ρ ο Η O-Ρ ο Η Oh

cdTj ι ο o >Φ og ο ι η a T j g °Υ^Ί ΦΦ θ4ι O^g, ,-,44 dia ι Ti o^g H om tdcdTj ι ο o> Φ and ο ι η a T j g ° Υ ^ Ί ΦΦ θ4ι O ^ g,, -, 44 dia ι Ti o ^ g H about td

ΦΦ W O g PΦΦ W O g P

ί>Η O I o HP ™ ™ J?ί> Η O I o HP ™ ™ J?

Sp § § ^ S 4 ^ g SS § g ~ 121 151338Sp § § ^ S 4 ^ g SS § g ~ 121 151338

Ovennævnte 7-[ρ(-)-α-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenylacetamido]-3-acetoxymethyl-Δ^-cephem-A—carboxylsyre, smp. 175°C (dekomp.) omkrystalliseredes af vandig acetone til dannelse af hvide krystaller som udviste et smeltepunkt på 198 - 200 °C (dekomp.).The above 7- [ρ (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-acetoxymethyl-Δ ^ -cephem-A-carboxylic acid 175 ° C (decomp.) Was recrystallized from aqueous acetone to give white crystals which exhibited a melting point of 198 - 200 ° C (decomp.).

Eksempel 24 (1)Example 24 (1)

Til en opløsning af 28,2 g natriumsalt af D(-)-phenylglyc in i 150 ml vand sattes 200 ml ethylacetat og 18,2 g triethylamin, og den dannede blanding afkøledes til 0°C. Til denne blanding sattes 34,3 g 4-methyl-2,3-dioxo-l-piperazinocarbonylchlorid i løbet af 15 minutter, og blandingen omsattes ved 5° til 10°C i 15 minutter. Derefter fraskiltes det vandige lag, som indstilledes på en pH-værid på 0,5 ved tilsætning af 2N saltsyre under isafkøling til udfældning af krystaller. De udfældede krystaller opsamledes ved filtrering og tørredes derefter til dannelse af 42 g hvide krystaller af D(-)-a-(4-methyl-2,3-dioxo-l-piperazino-carbonylamino)phenyleddikesyre, smp. 195°C (dekomp.).To a solution of 28.2 g of sodium salt of D (-) - phenylglyc in 150 ml of water was added 200 ml of ethyl acetate and 18.2 g of triethylamine and the resulting mixture was cooled to 0 ° C. To this mixture was added 34.3 g of 4-methyl-2,3-dioxo-1-piperazinocarbonyl chloride over 15 minutes and the mixture was reacted at 5 ° to 10 ° C for 15 minutes. Then, the aqueous layer was separated, which was adjusted to a pH of 0.5 by the addition of 2N hydrochloric acid under ice-cooling to precipitate crystals. The precipitated crystals were collected by filtration and then dried to give 42 g of white crystals of D (-) - α- (4-methyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetic acid, m.p. 195 ° C (dec.).

IR (KBr) cm-1; y)c=0 1700, 1660 NMR (dg-DMSO) T værdier: 0.1 (IH, d), 2.65 (5H, s), 4.60 (IH, d), 6.10 (2H, bs), 6.50 (2H, bs), 7.0 (3H, s) (2)IR (KBr) cm -1; y) c = 0 1700, 1660 NMR (d 6 -DMSO) T values: 0.1 (1H, d), 2.65 (5H, s), 4.60 (1H, d), 6.10 (2H, bs), 6.50 (2H, bs) ), 7.0 (3H, s) (2)

Til en suspension i 15 ml vandfrit methylenchlorid af 0,31 g D (-) -oc- (4-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenyleddike-syre dannet i ovennævnte trin (l) sattes 0,11 g N-methylmorpholin mider omrøring til dannelse af en opløsning, som derefter afkøledes til 20°C. Til denne opløsning sattes 3 ml af en vandfri methyl enchloridopløsning indeholdende 0,13 g ethylchlorcarbonat, og den dannede blanding omsattes ved fra -10 til 20°C i 60 minutter til dannelse af et blandet syreanhydrid. I det således dannede syreanhydrid dryppedes en opløsning, dannet ved tilsætning af 0,50 ml triethylamin til en suspension i 5 ml methanol af 0,41 g 122 151338 7-amino-3- [2- ( 5-methyl-l, 3,4-thiadiazolyl)-thiomethylj - A^-cephem- 4-carboxylsyre. Efter tildrypningen omsattes den dannede blanding ved -ί-500 til -r30°C i 30 minutter, ved ^30° til 4-20°C i 30 minutter, ved -r20° til 0°C i 60 minutter og derefter ved stuetemperatur i 30 minutter. Derefter inddampedes reaktionsvæsken under reduceret tryk, og koncentratet opløstes i 10 ml vand, vaskedes med 5 ml ethylacetat, forenedes atter med 15 ml ethylacetat og blandingen indstilledes på en pH-værdi på 1,5 ved tilsætning af 2N saltsyre under isafkøling. Derefter frafiltreredes uopløselige stoffer, og ethylacetatet fraskiltes, vaskedes i rækkefølge med vand og en mættet natriumchloridopløsning, tørredes over magnesiumsulfat og blev derefter befriet for opløsningsmidlet under reduceret tryk til dannelse af 0,58 g lysegule krystaller af 7-|p(-)-a-(4-methyl- 2.3- dioxo-l-piperazinocarbonylamino)phenylacetamido3 -3-[2-(5-me-thyl-1,3,4-thiadiazolyl) -thiomethyl] - A^-cePhem-4-carboxylsyre, smp. 160°C (dekomp.), udbytte 91%.To a suspension in 15 ml of anhydrous methylene chloride of 0.31 g of D (-) -oc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid formed in the above step (1) was added 0.11 g N-methylmorpholine mites stirring to form a solution which is then cooled to 20 ° C. To this solution was added 3 ml of anhydrous methylene chloride solution containing 0.13 g of ethyl chlorocarbonate and the resulting mixture was reacted at -10 to 20 ° C for 60 minutes to form a mixed acid anhydride. In the acid anhydride thus formed was added a solution formed by adding 0.50 ml of triethylamine to a suspension in 5 ml of methanol of 0.41 g of 122 7-amino-3- [2- (5-methyl-1,3, 4-thiadiazolyl) -thiomethylj-A 2 -cephem-4-carboxylic acid. After drip, the resulting mixture was reacted at -ί-500 to -r30 ° C for 30 minutes, at -30 ° to 4-20 ° C for 30 minutes, at -r20 ° to 0 ° C for 60 minutes, and then at room temperature for 30 minutes. 30 minutes. The reaction liquid was then evaporated under reduced pressure and the concentrate dissolved in 10 ml of water, washed with 5 ml of ethyl acetate, again combined with 15 ml of ethyl acetate and the mixture adjusted to a pH of 1.5 by adding 2N hydrochloric acid under ice-cooling. Then, insoluble matter was filtered off and the ethyl acetate separated, washed successively with water and a saturated sodium chloride solution, dried over magnesium sulfate and then freed of the solvent under reduced pressure to give 0.58 g of light yellow crystals of 7- µg (-) - a - (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido3 -3- [2- (5-methyl-1,3,4-thiadiazolyl) -thiomethyl] - Δ-cephem-4-carboxylic acid . 160 DEG C. (decomp.), Yield 91%.

IR (KBr) cm-1: i780 (lactam), 1650 - 1720 (-C0N< , -C00H) RMR (d6-DMS0) T værdier: 0.2 (IH, d), 0.6 (IH, d), 2.60 (5H, s), 4.35 (IH, q), 4.40 (IH, d), 5.0 (IH, d), 5.70 (2H, q), 6.10 (2H, bs), 6.25 - 6.55 (2H, 2H, bs), 7.0 (3H, s), 7.30 (3H, s)IR (KBr) cm -1: i780 (lactam), 1650-1720 (-CON <, -C00H) RMR (d6-DMSO) T values: 0.2 (1H, d), 0.6 (1H, d), 2.60 (5H , s), 4.35 (1H, q), 4.40 (1H, d), 5.0 (1H, d), 5.70 (2H, q), 6.10 (2H, bs), 6.25 - 6.55 (2H, 2H, bs), 7.0 (3H, s), 7.30 (3H, s)

Ovennævnte operation gentoges med den ændring, at D(-)-a-(4-methyl-The above operation was repeated with the change that D (-) - α- (4-methyl-

2.3- dioxo-l-piperazinocarbonylamino)phenyleddikesyren blev erstattet med de i tabel 23 viste forbindelser med formlen (V) til dannelse af de ligeledes i tabel 23 viste slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IRThe 2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid was replaced with the compounds of formula (V) shown in Table 23 to give the final products also shown in Table 23. The structure of each of the compounds formed was confirmed by IR

og NMR.and NMR.

123 151338 i i i l ^ o K* to=^ g I ra V *=< o ra ra *T to ra S to to ^ H^8 & 03 o to > KI Vo » CM _J o LT\ Vs m W H O 00 I 00 o to m to y-o —λ φ J Ο ί V-to ω Φ ω Γ\ ο ω i -P ., ° +> ,-i cq Vto +3 -Λ. -P g if123 151338 iiil ^ o K * to = ^ g I ra V * = <o ra ra * T to ra S to to ^ H ^ 8 & 03 o to> KI Vo »CM _J o LT \ Vs m WHO 00 I 00 o to m to yo —λ φ J Ο ί V-to ω Φ ω Γ \ ο ω i -P., ° +>, -i or Vto +3 -Λ. -P g if

1 4. j? g l 1 /->, I1 4. j? g l 1 / ->, I

s „ o s I I-® 9 ° § £ - I® o“ f of • m S 8 3 γ~] 3 3 g " °A ~ ° i " P I Qj J J CL CM ft I cx, to a o^to^ a to a a -y > o i o c o Φ T J CM ,¾ CM iis1 P CD to CD Φs "os I I-® 9 ° § £ - I® o" f of • m S 8 3 γ ~] 3 3 g "° A ~ ° i" PI Qj JJ CL CM ft I cx, to ao ^ to ^ a to aa -y> oioco Φ TJ CM, ¾ CM iis1 P CD to CD Φ

Qrd CM to C\J '—' CM '— to "— η I W I to I to .Qrd CM to C \ J '-' CM '- to "- η I W I to I to.

fM '-'O . ' O é — ft i r°i ft i fpc ft 1 jp afM '-'O. 'O é - ft i r ° i ft i fpc ft 1 jp a

, '-'to ff'-'to S4"W CQ, '-'to f' - 'to S4 "W CQ

H P O gpo gROH P O gpo gRO

PP

cdCD

Eh---- toEh ---- to

ϊ * II * I

I § -s-® § •g |^°) 8 °rB) S o o^to.In § -s-® § • g | ^ °) 8 ° rB) S o o ^ to.

® 8 I ) k, Ά vs °V g® 8 I) k, Ά vs ° V g

CD. J J CM CMCD. J J CM CM

P o^to w ^P o ^ to w ^

ri I O CMri I O CM

•H CM CM to P I to I to I to P — O O w ο i eft I eft I eft [x, ^ to — to '-'to P O P C P o 124 151338 m o V.• H CM CM to P I to I to I to P - O O w ο i eft I eft I eft [x, ^ to - to '-'to P O P C P o 124 151338 m o V.

*W s* W s

CQCQ

CM CDCM CD

W μ. "PW µ. "P

o W 43 _J 0 i>, ra~Vo !§ V-S 3 -l .o W 43 _J 0 i>, ra ~ Vo! § V-S 3 -l.

0 0 w 0 a c- 0 vo tQ 5¾ Pi -p o a δ å S °A 50 0 w 0 a c- 0 vo tQ 5¾ Pi -p o a δ å S ° A 5

CO Λ WCO Λ W

H ^ (¾ & a) *-> «5 fi EH _H ^ (¾ & a) * -> «5 fi EH _

WW

°A° A

1 o^a 5 §1 to 5 §

Eksempel 25 125 151338Example 25 125 151338

Med 0,3 g D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenyleddikesyre og 0,33 g 7-amino-3-[5-(l-methyl-l,2,3,4-tetra-zolyl)-thiomethy:Q-A^-cephem-4-carboxylsyre gentoges fremgangsmåden ifølge eksempel 24 til dannelse af 0,5 g 7- -(4-methyl- 2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido3-3- Jjp-(l“me-thyl-1,2,3,4-tetrazolyl)-thiomethyl] -^-cephem-4-carboxylsyre, smp. 161-163°C (dekomp.), udbytte 76%.With 0.3 g of D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid and 0.33 g of 7-amino-3- [5- (1-methyl-1,2 3,4-Tetrazolyl) -thiomethyl: QA 4 -cephem-4-carboxylic acid was repeated the procedure of Example 24 to give 0.5 g of 7- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido3-3- [alpha] - (1-methyl-1,2,3,4-tetrazolyl) -thiomethyl] -cephem-4-carboxylic acid, m.p. 161-163 ° C (decomp.), Yield 76%.

IR (nujol) cm-1: . y)c=Q 1775 (lactam), 1720 - 1660 (~CQN\ , -C00H) NMR (dg-DMSO) T værdier: 0.02 (IH, d), 0.34 (IH, d), 2.48 (5H, s), 4.17 (IH, q), 4.26 (IH, d), 4.92 (IH, d), 5.66 (2H, s), 6.01 (5H, s), 6.35 (4H, s), 7.0 (3H, s)IR (nujol) cm -1:. y) c = Q 1775 (lactam), 1720 - 1660 (~ CQN \, -C00H) NMR (dg-DMSO) T values: 0.02 (1H, d), 0.34 (1H, d), 2.48 (5H, s) , 4.17 (1H, q), 4.26 (1H, d), 4.92 (1H, d), 5.66 (2H, s), 6.01 (5H, s), 6.35 (4H, s), 7.0 (3H, s)

Ovennævnte operation blev gentaget med den ændring, at D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre blev erstattet med hver af de i tabel 24 viste forbindelser med formlen (V) til dannelse af de ligeledes i tabel 24 viste slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid was replaced with each of the compounds of formula (V) to form of the end products also shown in Table 24. The structure of each of the compounds formed was confirmed by IR and NMR.

126 151338 r\£ a=f S ^ pT ^ wf GQ » K-0>R S-Ov *126 151338 r \ £ a = f S ^ pT ^ wf GQ »K-0> R S-Ov *

iS1' 5 '»H $ =W SiS1 '5' »H $ = W S

OK CQ CQOK CQ CQ

f Ο Φ CM <D CM φf Ο Φ CM <D CM φ

-. / Vi O-P K .. *P * W -P-. / Vi O-P K .. * P * W -P

v CQ Vo +> OK-P OK-p ffl V« >, I O V _l o S>» Ή I n2 Ο η2 ΓΛ O £* φ _I ft cq Vo ft cq Λ)-ο ftv CQ Vo +> OK-P OK-p ffl V «>, I O V _l o S>» Ή I n2 Ο η2 ΓΛ O £ * φ _I ft cq Vo ft cq Λ) -ο ft

•ο “Λ Ώ yj* 3 - 3 I• ο “Λ Ώ yj * 3 - 3 I

c: o p I p i - gc: o p I p i - g

-η k —1 _L «J-η k —1 _L «J

Q ^ * vv ·* v ^ M O O O O _ 0 O g 0 oo K° Ko o lu K /—V Ο K t°v K to oYo) ^ o C- o ^Q ^ * vv · * v ^ M O O O O _ 0 O g 0 oo K ° Ko o lu K / —V Ο K t ° v K to oYo) ^ o C- o ^

V K \__/ H OH Ο HV K \ __ / H OH Ο H

5 JL ^ >®~ m~ « Η I K ft g& o jj o, j2L .o a o a . o a c p V^Y o o 9 o o s5 JL ^> ® ~ m ~ «Η I K ft g & o jj o, j2L .o a o a. o a c p V ^ Y o o 9 o o s

g °V I °AS 1 Vs 5 Ig ° V I ° AS 1 Vs 5 I

I Κ* W I · I O^isr 5I Κ * W I · I O ^ isr 5

— o i"~'l p, ^ I * U- o i "~ 'l p, ^ I * U

«φ i κλ ft i cq* g i /V η, n " ft § * § ft o ra ft (g) g ^ 3 $ Λ__;__^ <ΰ — ---tu«Φ i κλ ft i cq * g i / V η, n" ft § * § ft o ra ft (g) g ^ 3 $ Λ __; __ ^ <ΰ - --- tu

Eh 4JEh 4J

raraw

HH

> -H> -H

γ u · I 0-¾1γ u · I 0-¾1

Φ M d MΦ M d M

fj O u rHfj O u rH

So M W g g <2 K /—\ O O Q) ft ^ ο-/π) o o r-ι g π-i K\Y/ Ο o >i a) 1 1 , r<°> . m 11 iK s s aSo M W g g <2 K / - \ O O Q) ft ^ ο- / π) o o r-ι g π-i K \ Y / Ο o> i a) 1 1, r <°>. m 11 iK s s a

® o K_0 ο Ο H® o K_0 ο Ο H

cq yV ο ιλ o +j Η I J IK- i -H cn I ° r °rY° . Vs a s •H I K^ I CT'^t I Cr'&T β β ,ω-'-'Ο 'T'L ΎΛ. to tu δ ^ pT ^ w ^ fol > > ft ft O ft O ft 'V/ _ «cq yV ο ιλ o + j Η I J IK- i -H cn I ° r ° rY °. Vs a s • H I K ^ I CT '^ t I Cr' & T β β, ω -'- 'Ο' T'L ΎΛ. to tu δ ^ pT ^ w ^ fol>> ft ft O ft O ft 'V / _ «

Eksempel 26 127 f 51338Example 26 127 f 51338

Med 0,30 g D(-)-α-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenyleddikesyre og 0,34 g 7-amino->(5- (1»3,4-thiadiazolyl) -thiomethvlJ-/\^-cephem-4-carboxvlsvre gentoges fremgangsmåden i-følge eksempel 24 til dannelse af 0,47 g 7-* jjD(-)-oc-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)piienylacetamidoj-3-[~5-(1,3» 4-thiadiazolyl ) -thiomethyl Ι-Λ3 -cephem-4-carboxylsyre, smp. 158-159°C (dekomp.), udbytte 71,5%.With 0.30 g of D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid and 0.34 g of 7-amino -> (5- (1 »3,4-thiadiazolyl)) -thiomethylJ - [beta] -cephem-4-carboxylic acid was repeated the procedure of Example 24 to give 0.47 g of 7- * jD (-) - oc- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino ) pienylacetamidoj-3- [~ 5- (1,3 »4-thiadiazolyl) -thiomethyl Ι-β-cephem-4-carboxylic acid, mp 158-159 ° C (decomp.), yield 71.5%.

IR (nujol) cm"l: Vc=0 -^75 (lsctam), 1720 - 1660 (-C0N<, -C00H)IR (nujol) cm -1: Vc = 0-75 (lsctam), 1720-1660 (-CON <, -C00H)

Ovennævnte fremgangsmåde gentoges, idet D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre erstattedes af D(-)-et-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre til dannelse af 7-[p(“)-a-(4-ethyl-2,3-dioxo-l-piperazino-carbonylamino)phenylacetamidq]-3-j5-(1,3,4-thiadiazolyl)-thio-methvlj-A^-cephem-4-carboxylsyre« smp. 123°C (dekomp.), udbytte 64,5%.The above procedure was repeated, replacing D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid with D (-) - et- (4-ethyl-2,3-dioxo-1- piperazinocarbonylamino) phenylacetic acid to give 7- [p (") - α- (4-ethyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetamide] -3- [5- (1,3,4-thiadiazolyl) - thio-methyl-α-Cephem-4-carboxylic acid 123 ° C (decomp.), Yield 64.5%.

Eksempel 27Example 27

Med 0,31 g D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenyleddikesyre og 0,39 g 7-amino-3-{2-(l-methyl-l,3,4-triazolyl)-thiomethylj-AP-cephem-4-carboxylsyre gentoges fremgangsmåden i-følge eksempel 24, idet dog methanolet erstattedes med vandfrit methylenchlorid til dannelse af 0,43 g 7-jp(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidoJ-3{2-(l-methyl-1,3»4—triazolyl)—thiomethyll -A^-cephem-4-carboxylsyre, udbytte 70%.With 0.31 g of D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid and 0.39 g of 7-amino-3- {2- (1-methyl-1,3) 4-Triazolyl) -thiomethyl-3-AP-cephem-4-carboxylic acid was repeated according to Example 24, however, the methanol was replaced with anhydrous methylene chloride to give 0.43 g of 7-jp (-) - α- (4-methyl) -2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidoJ-3 {2- (1-methyl-1,3,4-triazolyl) -thiomethyl-A2-cephem-4-carboxylic acid, yield 70%.

IR (nujol) cm-1; 'J q=q ^80 (1ειο1:ειιη) > 1720 “ 1650 (-C0I<, -C00H) 128 151338IR (nujol) cm -1; 'J q = q ^ 80 (1ειο1: ειιη)> 1720 "1650 (-CO1 <, -C00H) 128 151338

Ovennævnte operation blev gentaget med den ændring, at D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino )phenyleddike syre blev erstattet med hver af de i tabel 25 viste forbindelser med formlen (V) til dannelse af de ligeledes i tabel 25 nævnte slut-' produkter. Strukturen af hver af de nævnte forbindelser blev bekræftet ved IR og NMR.The above operation was repeated with the change that D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid was replaced with each of the compounds of formula (V) to forming the end products also listed in Table 25. The structure of each of the compounds mentioned was confirmed by IR and NMR.

129 151338 T\ * I ψ—υ ly. ν to cR.129 151338 T \ * I ψ — υ ly. ν to cR.

1 * Τ=\ a ^1 * Τ = \ a ^

02 1Γ> I a-O02 1Γ> I a-O

W οο ISW οο IS

ο tu νο μ _I S CM φ / ν. Ο φ a -Ρ Λ1 02 Vo +5 Ο W +5 ® ya 5 ν R ^ “ ι >5 γλ ο ρ 'Η I ο1 02 Vo Ed <σ ο S. ι ^ ΰ a 3 _4 Η |Ζ! Χν 22 Ο Ο Ο Ο Μ Ο Ο Μ Ο ο a /—\ c- g oo «Η «-(Ο/ ^ Ο U} a \r7 Η ο Η +» a a /7Λ 3 8 7 |Λ°> 7 η ο 4 a ο +3 Υ 1 ο ο ο η 1 J Λ ι Λ I °τ å Vi s S ι a i o*ar ID ^ ° '· ^ l i - vi a" g1 ~ fol iο tu νο μ _I S CM φ / ν. Ο φ a -Ρ Λ1 02 Vo +5 Ο W +5 ® ya 5 ν R ^ “ι> 5 γλ ο ρ 'Η I ο1 02 Vo Ed <σ ο S. ι ^ ΰ a 3 _4 Η | Ζ! 22ν 22 Ο Ο Ο Ο Μ Ο Ο a a / - \ c- g oo «Η« - (Ο / ^ Ο U} a \ r7 Η ο Η + »aa / 7Λ 3 8 7 | Λ °> 7 η ο 4 a ο +3 Υ 1 ο ο ο η 1 J Λ ι Λ I ° τ å We s S ι aio * ar ID ^ ° '· ^ li - vi a "g1 ~ fol i

h n- o an Ay Sh n- o and Ay S

φ a> CO___ > V*/ h a Φ o ^ o a 5 IRo) § i § i^® w i a s °ra] § Φ ° 7 s i a™ i cAa' n 7 A 7 Av, o "p o n v/ P4 EKSEMPEL 28 . X30 151338φ a> CO___> V * / ha Φ o ^ oa 5 IRo) § i § i ^ ® wias ° ra] § Φ ° 7 sia ™ i cAa a 7 A 7 Av, o "ponv / P4 EXAMPLE 28. X30 151338

Proceduren ifølge eksempel 24 blev gentaget med den ændring, at D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddike-syren blev erstattet med hver af de i tabel 26 viste forbindelser med formlen (V) til dannelse af de ligeledes i tabel 26 angivne slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The procedure of Example 24 was repeated with the change that D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid was replaced with each of the compounds of the formula ( V) to form the end products also listed in Table 26. The structure of each of the compounds formed was confirmed by IR and NMR.

131 151338 ΚΛ κ\ a trj ο Ο fe / ^ I ο \r *w131 151338 ΚΛ κ \ a trj ο Ο fe / ^ I ο \ r * w

&2 CQ& 2 CQ

CQ CM iWCQ CM iW

CM W tCM W t

tri ο a CQtri ο a CQ

Ο Μ I ο CMΜ Μ I ο CM

_I Ο /O W_I Ο / O W

0) /-Λ. o CQ V-o o a0) / -Λ. o CQ V-o o a

tn gq y-u ya /-4 Stn gq y-u ya / -4 S

3 α Λ ”ør83 α Λ ”ear 8

c HH ° Ic HH ° I

H 'o W —k p a s V, o o o ___ a ^ a /—\ o-/o) o P g-fo) μΛ^/ o « gw g @45) d 8 ?H 'o W —k p a s V, o o o ___ a ^ a / - \ o- / o) o P g-fo) µΛ ^ / o «gw g @ 45) d 8?

P ' ο<ν^- RP 'ο <ν ^ - R

ω o. a 7 1 7 j V i T) ω fø i o i o i aω o. a 7 1 7 j V i T) ω fod i o i o i a

CM * i o --- CQ — ICM * i o --- CQ - I

I [Οι I IJCN I IPI [Οι I IJCN I IP

_i w η --- a — a ^ P o p o p o_i w η --- a - a ^ P o p o p o

PP

(0 EH______(0 EH______

NN

> .,Ν^ ' φ a na o •so o ?h o o a 0 o _ a /7\ o S I-® f® i® a o o a w o i a <D _ · °<νΐ2ίχ £? 1 χί °ή s i o io i ^a>., Ν ^ 'φ a na o • so o? H o o a 0 o _ a / 7 \ o S I-® f® i® a o o a w o i a <D _ · ° <νΐ2ίχ £? 1 χί ° ή s i o io i ^ a

H --— O -"- CQ IH --— O - "- CQ I

P I ro, I CP I IPP I ro, I CP I IP

-¾ —' a w a ^ a Ορο P o p o pt) 132 151338 Ν"\ Γ<Λ κ κ ο ο a4 κ i ra Ο ra οα o w CM . S=/ CM .-¾ - 'a w a ^ a Ορο P o p o pt) 132 151338 Ν "\ Γ <Λ κ κ ο ο a4 κ i ra Ο ra οα o w CM. S = / CM.

K I κK I κ

OK ra OKOK ok ok

_I o ™ i o /^λ ° ' W M ^\_o ra v>—o OK gq y-o_ I o ™ i o / ^ λ ° 'W M ^ \ _ o ra v> —o OK gq y-o

Vs /^4. £ V*3 4 °0hg 4 k __L k K ^ Κ s i-® L I®Vs / ^ 4. £ V * 3 4 ° 0hg 4 k __L k K ^ Κ s i-® L I®

ω a id /ΤΛ Kω a id / ΤΛ K

p o S-(0) op o S- (0) o

M O W \—I OM O W \ —I O

0 1 Κ I0 1 Κ I

- T) 7 f)- T) 7 f)

VD Sar 42^ o^SjTVD Sar 42 ^ o ^ SjT

01 CM , 1J CM01 CM, 1J CM

ι-t i k i o^a i k (1) ^ o ^ I ^-n oι-t i k i o ^ a i k (1) ^ o ^ I ^ -n o

8 I ΚΛ 1 I8 I ΚΛ 1 I

^ p ο « o p o^ p ο «o p o

K KK K

I® 1 I® i i® 1 1 § 1 o a o , V ΛI® 1 I® i i® 1 1 § 1 o a o, V Λ

CM , CMCM, CM

i k i o^a i k ο 'Τ' 1 "" o I ΚΛ I Jf\ I Κλi k i o ^ a i k ο 'Τ' 1 "" o I ΚΛ I Jf \ I Κλ

^ K ^ K ---- K^ K ^ K ---- K

P O · « o p o _J--1 133 151338 EKSEMPEL 29P O · «o p o _J - 1 133 EXAMPLE 29

Proceduren ifølge eksempel 25 "blev gentaget med den ændring, at D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddike-syren blev erstattet med hver af de i tabel 27 viste forbindelser med formlen (V) til dannelse af de ligeledes i tabel 27 angivne slutprodukter. Strukturen af hver af de dannede forbindelser blev bekræftet ved IR og NMR.The procedure of Example 25 "was repeated with the change that D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid was replaced with each of the compounds of formula 27 (V) to form the end products also listed in Table 27. The structure of each of the compounds formed was confirmed by IR and NMR.

134 151338'" 125=¾ to134 151338 '"125 = ¾ to

125=13 tp» I. \ M125 = 13 tp »I. \ M

I \ W £5-0 „p.I \ W £ 5-0 „p.

I B-o S=f S'In B-o S = f S '

!^i=f GO I jZI-O! ^ i = f GO I jZI-O

CO CM 13=! a O K mCO CM 13 =! and O K m

o W o CMo W o CM

/~i § afV-O o a « mvS"° V? 48 « ‘7 I 03 Vo i-l K0 y? β n ° g Λ ΐ § 8 _ w ° S- 8/3Λ SÆ\ 8 ·“ §Λ°> g^ g/-, φ o 8 §\9/ ho i a r-t i Oj2L o 3 vs t J ^ a V V vs/ ~ i § afV-O oa «mvS" ° V? 48 «'7 I 03 Vo il K0 y? β n ° g Λ ΐ § 8 _ w ° S- 8 / 3Λ SÆ \ 8 ·" §Λ °> g ^ g / -, φ o 8 § \ 9 / ho ia rt in Oj2L o 3 vs t J ^ a VV vs

u I o I I Wu I o I I W

1¾ — o —- go — i r- i κλ i tn I ΚΛ cm ' ^ a a yy a p o p o p o H Φ fi---—--1¾ - o —- go - i r- i κλ i tn I ΚΛ cm '^ a a yy a p o p o p o H Φ fi ---—--

HH

> N*>*> N *> *

! ^ L! ^ L

S g^ s @45) a ο o a \ry o i a * =<A T) ? s W t ‘Y's h i o i o i a S — o — ro — iS g ^ s @ 45) a ο o a \ ry o i a * = <A T)? s W t 'Y's h i o i o i a S - o - ro - i

7* I fr\ I ΚΛ I7 * I fr \ I ΚΛ I

δ ^ a - ~ a — a £ P o p o p o 135 151338 ψΗ & ' : ψ% a a-o I a-o w : B=^ ra I a-o j cqδ ^ a - ~ a - a £ P o p o p o 135 151338 ψΗ & ': ψ% a a-o I a-o w: B = ^ ra I a-o j cq

a · Wa · W

o a ra o a _i o cm ,_i oo a ra o a _i o cm, _i o

€^§ ? o \RS€ ^ §? o \ RS

i R i !-<§> 1 g® i ° S-{o) ° <ti o a \—/ o cq i a i p o a o IV Λ ° ti R i! - <§> 1 g® i ° S- {o) ° <ti o a \ - / o cq i a i p o a o IV Λ ° t

CM i J CMCM in J CM

- Λ g JL °V Λ g . w &Γ aT - a^ ^ p o P o p o 3 b_____ a a o o O ° o a o m i |^> § p g- Λ g JL ° V Λ g. w & Γ aT - a ^^ p o P o p o 3 b_____ a a o o O ° o a o m i | ^> § p g

vS s AvS s A

R jL cAa i a i oRJ i a1 ^ O i —- I ^ o I I ΡΛ I [<Λ a w a ^ a p o · p o p o EKSEMPEL 30 136 151338 På samme måde som angivet i eksempel 27 dannedes 7-[D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxyphenyl-acetamido]-3-[-5-(1-methyl-l,2,3,4-tetrazolyl)-thiomethyl]- Δ?-cephem-4-carboxylsyre ud fra 7-amino-3-[-5-(1-methyl-l,2,3,4-tetrazolyl)-thiomethyl ]-A^-cephem-4-carboxylsyre og D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino) -p-hydroxyphenyleddike-syre.R jL cAa iai oRJ i a1 ^ O i —- I ^ o II ΡΛ I [<Λ awa ^ apo · popo EXAMPLE 30 136 151338 In the same manner as given in Example 27, 7- [D (-) - a- ( 4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenyl-acetamido] -3 - [- 5- (1-methyl-1,2,3,4-tetrazolyl) -thiomethyl] -Δ cephem-4-carboxylic acid from 7-amino-3 - [- 5- (1-methyl-1,2,3,4-tetrazolyl) -thiomethyl] -Aβ-cephem-4-carboxylic acid and D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetic acid.

Smp.: (dekomp.), 147 - 9°C; udbytte 62,0$.Mp: (decomp.), 147 - 9 ° C; dividend $ 62.0.

IR (KBr) cm”1: 1765 (lactam), 1720 - 1660 (-CON—, -C00H) På samme måde som ovenfor fremstilledes 7-[D(-)-a-(4-ethyl-2,3-dioxø-l-piperazinocarbonylamino)-p-hydroxyphenylacetamido]-3-[5-(1-methyl-l,2,3,4-tetrazolyl)thiomethyl]-Z^-cephem-4-carbo-xylsyre, smp. 188-190°C (decomp.), udbytte 80,7%, ud fra 7-amino-3-[5-(1-methyl-l,2,3,4-tetrazolyl)thiomethyl]-/^-cephem-4-carboxylsyre og D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonyl-amino) -p-hydroxyphenyleddikesyre.IR (KBr) cm -1: 1765 (lactam), 1720-1660 (-CON-, -C00H) In the same manner as above, 7- [D (-) - α- (4-ethyl-2,3-dioxo) was prepared -1-piperazinocarbonylamino) -β-hydroxyphenylacetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] -Z ^-cephem-4-carboxylic acid, m.p. 188-190 ° C (decomp.), Yield 80.7%, from 7-amino-3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] - 4-carboxylic acid and D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetic acid.

EKSEMPEL 31 På samme måde som angivet i eksempel 24 dannedes 7~[D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-azidomethyl- -cephem-4-carboxylsyre ud fra D(-)-a-(4-methyl-2,3- dioxo-l-piperazinocarbonylamino)phenyleddikesyre og 7-amino-3- "*5 azidomethyl- Δ -cephem-4-carboxylsyre.EXAMPLE 31 In the same manner as in Example 24, 7 ~ [D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-azidomethyl-cephem-4-carboxylic acid was formed from D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid and 7-amino-3- "5 azidomethyl-Δ-cephem-4-carboxylic acid.

Smp.: (dekomp.), 185 - 8°C; udbytte 68,0% IR (KBr) cm"1: jc=Q 1775 (lactam), 1720 - 1660 (-C0N—, -C00H) 2090 EKSEMPEL 32 I 10 ml phosphorsyre-puffer med pH = 6,3 suspenderedes 0,57 g 7-[D(—)—a—(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacet- 137 151358 amido]-3-acetoxymethyl-Z^?-cephem-4-carboxylsyre, og 0,07 g na-triumhydrogenc arbonat opløstes heri. Til opløsningen sattes derpå 0,12 g l-methyl-5~mercapto-l,2,3,4-tetrazol til opløsning af sidstnævnte i den førstnævnte, og opløsningen underkastedes en reaktion i 24 timer, medens pH-værdien af opløsningen opretholdtes ved 6,5- 6,7 under anvendelse af fortyndet saltsyre og natriumhydrogencar-bonat. Efter reaktionen opsamledes reaktionsvæsken, som derefter indstilledes på en pH-værdi på 5,0 ved tilsætning af fortyndet saltsyre. Reaktionsblandingen vaskedes med tilstrækkeligt ethyl-acetat, hvorefter det vandige lag blev fraskilt og derpå indstillet på en pH-værdi på 1,5 ved tilsætning af fortyndet saltsyre.Mp: (decomp.), 185 - 8 ° C; yield 68.0% IR (KBr) cm -1: jc = Q 1775 (lactam), 1720-1660 (-CON-, -C00H) 2090 EXAMPLE 32 In 10 ml of phosphoric acid buffer with pH = 6.3 was suspended 0, 57 g of 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-acetoxymethyl-Z Z-cephem-4-carboxylic acid, and O 07 g of sodium hydrogen carbonate was dissolved herein. To this solution was then added 0.12 g of 1-methyl-5-mercapto-1,2,3,4-tetrazole to dissolve the latter in the former and the solution was subjected to a reaction for 24 h. The pH of the solution was maintained at 6.5- 6.7 using dilute hydrochloric acid and sodium hydrogen carbonate, and after the reaction, the reaction liquid was collected, which was then adjusted to a pH of 5.0 by the addition of dilute hydrochloric acid. The reaction mixture was washed with sufficient ethyl acetate, then the aqueous layer was separated and then adjusted to a pH of 1.5 by adding dilute hydrochloric acid.

De udfældede krystaller opsamledesved filtrering og tørredes, hvorefter de tørrede krystaller blev vasket med ethylacetat til dannelse af 0,40 g 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbo-nylamino)phenylacetamido]-3-[5-(l-niethyl-l,2,3,4-tetrazolyl) thiome-thyl-A^-cephem—4—carboxylsyre, smp.: 163-165°C (dekomp.), udbytte 74,5%.The precipitated crystals were collected by filtration and dried, then the dried crystals were washed with ethyl acetate to give 0.40 g of 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl-Δ-cephem-4-carboxylic acid, mp: 163-165 ° C (decomp.) 74.5%.

IR (KBr) cm"1: gc=Q 1775 (lactam), 1720 - 1660 (-CON^T, -C00H) NMR (dg-DMSO) værdier: 0,18 (IH, d), 0,55 (IH, d), 2,64 (5H, s), 4,3 (IH, q), 4,4 (IH, d), 5,0 (IH, d), 5,75 (2H, s), 6,05 (5H, s), 6,3 - 6,8 (6H), 8,92 (3H, t).IR (KBr) cm "1: gc = Q 1775 (lactam), 1720-1660 (-CON ^T, -C00H) NMR (d d-DMSO) values: 0.18 (1H, d), 0.55 (1H) , d), 2.64 (5H, s), 4.3 (1H, q), 4.4 (1H, d), 5.0 (1H, d), 5.75 (2H, s), 6 , 05 (5H, s), 6.3 - 6.8 (6H), 8.92 (3H, t).

På samme måde som ovenfor angivet fremstilledes de i tabel 28 viste forbindelser ud fra 7-[D(-)-o—(4-methyl-2,3-dioxo-l-piperazinocar-bonyl)phenylacetamido]-3-acetoxymethyl- Δ?-cephem-4-carboxylsyre eller 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenylacetamido]-3-acetoxymethyl-^5_Cephem-4-carboxylsyre og de i tabel 28 viste forbindelser med formel (VII). Alle de fremstillede forbindelser var D(-)-isomere, og strukturen af forbindelserne blev bekræftet ved IR og HMR.In the same manner as above, the compounds shown in Table 28 were prepared from 7- [D (-) - o- (4-methyl-2,3-dioxo-1-piperazinocarbonyl) phenylacetamido] -3-acetoxymethyl-Δ ? -cephem-4-carboxylic acid or 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -phenylacetamido] -3-acetoxymethyl-5-Cephem-4-carboxylic acid and those of Table 28 showed compounds of formula (VII). All the compounds prepared were D (-) - isomers and the structure of the compounds was confirmed by IR and HMR.

138 1 5 1 33 8138 1 5 1 33 8

tO VOtO VO

M RM R

vo o ;vo o;

£*=< CO£ * = <CO

CO | h ^ ψη tT ® ^~ϊ § f=\ ® I jj m I ψ £ Q) I ^—i' j>s fr* to >i ω GQ,Q ο Μ N ra ,0 S' «3 H8 . « „. 1CO | h ^ ψη tT ® ^ ~ ϊ § f = \ ® I jj m I ψ £ Q) I ^ —i 'j> s fr * to> i ω GQ, Q ο Μ N ra, 0 S' «3 H8. "". 1

'O O W CO \—O -P O K'O O W CO \ —O -P O K

c! _i 5 vs P’ ,_I o •ri o o 1^, r\ o o Λ ra Vo ο 1 p ra V-o o g VI ° Γο 1 V! sc! _i 5 vs P ', _I o • ri o o 1 ^, r \ o o Λ ra Vo ο 1 p ra V-o o g VI ° Γο 1 V! p

·* -\ H @ . -A H· * - \ H @. -A H

-P O I O O ., ° 1 <u o o W _ ih s oo W /T\ o a oo -< o vo 0-(0) ^ ° 10-P O I O O., ° 1 <u o o W _ ih s oo W / T \ o a oo - <o vo 0- (0) ^ ° 10

•Η , Ο H W V—/ Η o — H• Η, Ο H W V— / Η o - H

s· i i-® - i - m ~ - g ft I ft S & | * ? IT) Λ *? fl- S °rsV 5 °V 5 vs % oAr "' a w cAb·"1 “ I . O « I · : tov ft JO ft ft M a M S w a o m Ora o ra x) φ tu a w m n m CO ra Μ H ft=V ^ jj-3. I as-8 ra “s · i i-® - i - m ~ - g ft I ft S & | *? IT) Λ *? fl- S ° rsV 5 ° V 5 vs% oAr "'a w cAb ·" 1 “I. O «I ·: tov ft JO ft ft M a M S w a o m Ora o ra x) φ tu a w m n m CO ra Μ H ft = V ^ jj-3. I as-8 ra “

Ih *=*' =<„ ^ Ή © ίχΐ se g o o __I__L- 139 151538Ih * = * '= <„^ Ή © ίχΐ se g o o __I__L- 139 151538

JRJR

<1· ^ ^<1 · ^^

ΚΛ (Μ -VOΚΛ (Μ -VO

IS j £ K Ώ K=\ <D '^z^\ © ^ ;:=:ί,, © i fem s Ι3Μ s ®N f *1 s=f u u & m S ra jg o K 5 (ΛΙ K C\1 K , i o κ · K 3 W 3 / Vi o 3 0 K OK CQ VoIS j £ K Ώ K = \ <D '^ z ^ \ © ^;: =: ί ,, © i fem s Ι3Μ s ®N f * 1 s = fuu & m S ra jg o K 5 (ΛΙ KC \ 1 K, io κ · K 3 W 3 / Vi o 3 0 K OK CQ Vo

1 o , [θ'· V-K1 o, [θ '· V-K

ΓΛ o o 4 o O oΓΛ o o 4 o O o

GQ 7—O O 02 JT-O O -i OGQ 7 — O O 02 JT-O O -i O

§ Vt 2 jp s 5 4 H Λ H g cd o i o i o i cq K K S , , -p K LTv K ^ K fZ\§ Vt 2 jp s 5 4 H Λ H g cd o i o i o i or q K K S,, -p K LTv K ^ K fZ \

O 8 Η O Η KV?) HO 8 Η O Η KV?) H

ϋ m ~ m ~ § ~ oo S P< K ft I Pi S o a o a os. aϋ m ~ m ~ § ~ oo S P <K ft I Pi S o a o a os. a

% γ-) I °ή I ° ^ I% γ-) I ° ή I ° ^ I

IH i ·| · O * ft cfN ft p & k a k a k s o ra o © o vi g g g b4 p pIH i · | · O * ft cfN ft p & k a k a k s o ra o © o vi g g g b4 p p

KK j KK SKKK j KK SK

k=/ K=K s=^ 140 151338 ' £ cT ' £ cR o » .k = / K = K s = ^ 140 151338 '£ cT' £ cR o ».

O- U2 I_ 00, g ω g VO* O ^ s=V 5 SvAb ^ V 5 *=( I I £ & tf U I riB s ο Μ ο M ^ CO Vo _i O ~ _J O 3 \_^ .-Γ /-4. o 02 Π\ Ο I oO- U2 I_ 00, g ω g VO * O ^ s = V 5 SvAb ^ V 5 * = (II £ & tf UI riB s ο Μ ο M ^ CO Vo _i O ~ _J O 3 \ _ ^.-Γ / -4. O 02 Π \ Ο I o

02 VO O 02 Vo - _L O02 VO O 02 Vo - _L O

\\z <3\ V-js; O n> o V I CM I o o oo\\ z <3 \ V-js; O n> o V I CM I o o oo

I H _I GO M HI H _I GO M H

^ ^ X· <Ti s^^ X · <Ti s

-p O I o O I-p O I o O I

n . S oo S ' Μ /ΊΛ Ln +3 o cm o £ o4 O)n. S oo S 'Μ / ΊΛ Ln +3 o cm o £ o4 O)

fj ο H O 02 W X—/ Hfj ο H O 02 W X— / H

i m ~ m 2 s ^in m ~ m 2 s ^

» 8 i· g & cxA I»8 i · g & cxA I

5 ? 5 Ί a 1} a » Ϊ) s Ϊ J s k. s 3 °V °V g E*< KN * ΚΛ rt Q.5? 5 Ί a 1} a »Ϊ) s Ϊ J s k. S 3 ° V ° V g E * <KN * ΚΛ rt Q.

w g< m & m S'w g <m & m S '

° g ° § - ° I° g ° § - ° I

K2 WK2 W

M M W 02 02 02 O _ / V B=< Ο I I ° •B=Cv <n g g g 141 151338 1§ * *M M W 02 02 02 O _ / V B = <Ο I I ° • B = Cv <n g g g 141 151338 1§ * *

^ K\ IN^ K \ IN

η Λ tr* Ό /—\ Ο 00 g φ ^η Λ tr * Ό / - \ Ο 00 g φ ^

t=l £ éi £ ΓΛ It = l £ £ £ ΓΛ I

έκ jn >1 CM -P s CQ -Pέκ jn> 1 CM -P s CQ -P

V ,Q η >» V >-> 03 >CJ DWfl CQ ,ΟV, Q η> »V> -> 03> CJ DWfl CQ, Ο

cm h I ο τ3 cm tJcm h I ο τ3 cm tJ

ixj H r\ oh K 2ixj H r \ oh K 2

oK m Vo ^ oKoK m Vo ^ oK

_i o - V-K - I o r~\ o o i o /^¾. ο o ra Vo o I o ra Vo o V“ ϊ; Λ 8 Vi 8 4 H g H 4 •P o I Ο I O 1 m K CD K f7\ 0- K o_i o - V-K - I o r ~ \ o o i o / ^ ¾. ο o ra Vo o I o ra Vo o V “ϊ; Vi 8 Vi 8 4 H g H 4 • P o I Ο I O 1 m K CD K f7 \ 0- K o

So Ln a-(0) ° ® £ m ~ i ~ i<°> ^ ν' K ft I ft K Pi _ o a q^k a o a c° o O Yl o o o CM I M i J Λ I 3d , c> κ φ oVsf φ ovs Φ s XJ s !, s I 3 3So Ln a- (0) ° ® £ m ~ i ~ i <°> ^ ν 'K ft I ft K Pi _ oaq ^ kaoac ° o O Yl ooo CM IM i J Λ I 3d, c> κ φ oVsf φ ovs Φ s XJ s !, s I 3 3

P o^Sv K OKP o ^ Sv K OK

aj i » ο » I · eh 4 ft 4 pi ft k a k a k s o IQ o ra o raaj i »ο» I · eh 4 ft 4 pi ft k a k a k s o IQ o ra o ra

K K KK K K

ra CQ 03 K=^ / ( ra (Qa->° οra CQ 03 K = ^ / {ra (Qa-> ° ο

KK

o 142 151338o 142 151338

VP VQVP VQ

hi os [C\ Ho 00., /\ CM Κλ * Jpk ίφ a F\ ® ϊ I X j}hi os [C \ Ho 00., / \ CM Κλ * Jpk ίφ a F \ ® ϊ I X j}

ο-s .¾ -p cm if p -Pο-s .¾ -p cm if p -P

^ ixj >ΐ M >» 02 ,α ΟΜΛ ϋ K 5 cm tJ ,_ι o tJ _/0¾ W 3 /\. o 3, ' Λ O 3 0 K 02 v—o 02 'V-o 1 S - \j& ·> ya^ ixj> ΐ M> »02, α ΟΜΛ ϋ K 5 cm tJ, _ι o tJ _ / 0¾ W 3 / \. o 3, 'Λ O 3 0 K 02 v — o 02' V-o 1 S - \ j & ·> ya

/Ά Ο Ο I O IP/ Ά Ο Ο I O IP

02 7— O _L O _L O02 7— O _L O _L O

v a J- ^ ^ co I I oo o cn O [>·v a J- ^^ co I I oo o cn O [> ·

^ K H B H^ K H B H

« n ° ' 8 1 8 1 1¾ cm a rr\ cm k /r\ lπ £ g S i<2) 3 |λ2) 5 <M oYo') ^-O^O ^ ^ w V-V ο · o co Si1 i1 °VS i*«N ° '8 1 8 1 1¾ cm a rr \ cm k / r \ lπ £ g S i <2) 3 | λ2) 5 <M oYo') ^ -O ^ O ^^ w VV ο · o co Si1 i1 ° VS i *

" 8 5 Ϊ ) 3 Ϊ J I„8 5 Ϊ) 3 Ϊ J I

H O S » °V 5 ° *?H O S »° V 5 ° *?

-0 JO W ™ W-0 JO W ™ W

Π5 O s W WΠ5 O s W W

Eh I * O ‘ O * ft S1 sT ' & W S 0 pi s O KJ 03 O 03 « 02Eh I * O 'O * ft S1 sT' & W S 0 pi s O KJ 03 O 03 «02

Sfl ffl .Sfl ffl.

m m glsS . s-£s Jo) W "r ΝΛm m glsS. s- £ s Jo) W „r ΝΛ

WW

OISLAND

143 1 5 1 3 3 8 to io frj to « ^ o a to ? a r_ e 3 . S' . =! S . i · $ Ί <f V° oC B t to o=cq vjo 0=0 o=cq >>143 1 5 1 3 3 8 to io frj to «^ o a to? and r_ e 3. S '. =! S. i · $ Ί <f V ° oC B t to o = cq vjo 0 = 0 o = cq >>

a F? cq cq O iSof? cq cq O iS

oi >d oi <d ,^03oi> d oi <d, ^ 03

Mo M aj a +j M PMo M aj a + j M P

0 M 3 ο M £ ο M £ ο M0 M 3 ο M £ ο M £ ο M

1 O ~ | O TL , I O X. _I o ·> r~i ο o r\ ο £ Γ\ o jy /—\ ο o OQ Vo 0 CQ Vo a CQ Vo M CQ Vo o ya co y_a a V-!? g v-a ^ 2 H s -Λ : Λ . Λ s cd loi o o o o ^ o i1 O ~ | O TL, I O X. _I o ·> r ~ i ο o r \ ο £ Γ \ o you / - \ ο o OQ Vo 0 CQ Vo a CQ Vo M CQ Vo o ya co y_a a V- !? g v-a ^ 2 H s -Λ: Λ. Λ s cd loi o o o o ^ o i

cq ώ ώ o Μ o Mcq ώ ώ o Μ o M

+3gLOgCriatO|2jH+ 3gLOgCriatO | 2JH

ShOOOOOOOOOOOOShOOOOOOOOOOOO

OOHOHOHOHOOHOHOHOH

* m o m ~ iv> o m - co a a a a § a a ft* m o m ~ iv> o m - co a a a a § a a ft

So a o a o a o a w - o o o o O o o o jjj V, I °rV I V I °<A 1 o^a^ o^a^ o^a"1 o^-a^ tn i I " I * I · CO rt CO i, CO si CO ft Μ&Μ&Μ&Μδ o § o § o g u co ._;___,i- cd a cq cd i cd aSo aoaoaoaw - oooo O ooo jjj V, I ° rV IVI ° <A 1 o ^ a ^ o ^ a ^ o ^ a "1 o ^ -a ^ tn i I" I * I · CO rt CO i, CO si CO ft Μ & Μ & Μ & Μδ o § o § ogu co ._; ___, i-cd a and cd cd i cd a

o = CQ a CQo = CQ and CQ

I CQ IIn CQ I

0 1 o = CQ0 1 o = CQ

0=0 o0 = 0 o

I OJI OJ

^ a co i r ° o^ a co i r ° o

a CO to I COand CO to I CO

cd MM J=& ffl a o o ocd MM J = & ffl a o o o

____I____IN

144 151338 EKSEMPEL 33 I 10 ml vand suspenderedes 1,15 g 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-acetoxymethyl-A^-cephem-4-carboxylsyre og 0,17 g natriumhydrogencarbonat blev derefter opløst heri, hvorefter 0,48 g pyridin og 4,1 g kaliumthio-cyanat blev tilsat. Den dannede blanding omsattes ved 60°C i 5 ' timer, medens pH-værdien af blandingen holdtes på 6,0 til 6,3 ved tilsætning af fortyndet saltsyre eller natriumhydrogencarbonat. Efter reaktionen tilsattes 20 ml vand til fortynding af reaktionsblandingen, som derefter blev vasket med chloroform. Det vandige lag fraskiltes derefter og indstilledes på en pH-værdi på 1,5 ved tilsætning af fortyndet saltsyre. De udfældede krystaller blev opsamlet ved filtrering, tørret og derpå vasket med acetone til dannelse af 1,04 g (udbytte 79,6%) thiocyansyresalt af 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3- •z pyridinpmethyl-.A-cephem-4-carboxylsyre-betain med et smeltepunkt (dekomp.) på 155-160°C, hvilket produkt har formlen: OG.EXAMPLE 33 In 10 ml of water, 1.15 g of 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-acetoxymethyl-A 4-carboxylic acid and 0.17 g of sodium bicarbonate were then dissolved herein, after which 0.48 g of pyridine and 4.1 g of potassium thiocyanate were added. The resulting mixture was reacted at 60 ° C for 5 'hours while maintaining the pH of the mixture at 6.0 to 6.3 by the addition of dilute hydrochloric acid or sodium bicarbonate. After the reaction, 20 ml of water was added to dilute the reaction mixture, which was then washed with chloroform. The aqueous layer was then separated and adjusted to a pH of 1.5 by adding dilute hydrochloric acid. The precipitated crystals were collected by filtration, dried and then washed with acetone to give 1.04 g (yield 79.6%) of thiocyanic acid salt of 7- [D (-) - α- (4-ethyl-2,3-dioxo) -l-piperazinocarbonylamino) phenylacetamido] -3- [z pyridine ppmethyl] -A-cephem-4-carboxylic acid betaine having a melting point (decomp) of 155-160 ° C, the product having the formula: AND.

\V - ^\ V - ^

ΟΗτΟΗη-Ν ST-CONHCHCONH—i—Τ'"SΟΗτΟΗη-Ν ST-CONHCHCONH — i — Τ '"S.

^ é) 0^Vch2-O^ é) 0 ^ Vch2-O

u cooh scar® IR (KBr) cm-1: JC_Q 1780 (lactam), 1720 - 1660 (-C0i<J ^SCN 2040 På samme måde som angivet ovenfor dannedes et thiocyansyresalt af 7-[D(-)-a-(4-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido ]-3-pyridinomethyl- A^-cephem-4-carboxylsyre-betain af 7- [D (- ) - a- (4-methyl-2,3-dioxo-l-piperazinocarbonylamino )phenyl-acetamido]-3-acetoxymethyl- A^-cephem-4-carboxylsyre og pyridin, hvilket produkt har formlen: 151338 145u cooh scar® IR (KBr) cm -1: JC_Q 1780 (lactam), 1720-1660 (-CO1 <J ^ SCN 2040) In the same manner as indicated above, a thiocyanic acid salt of 7- [D (-) - α- ( 4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-pyridinomethyl-Δ-cephem-4-carboxylic acid betaine of 7- [D (-) - α- (4-methyl-2,3) -dioxo-1-piperazinocarbonylamino) phenyl-acetamido] -3-acetoxymethyl-Δ-cephem-4-carboxylic acid and pyridine, which product has the formula:

O OISLAND ISLAND

)>—‘ζ σ CH^-N N-COKHCHCONH—ι—f ] ©ΓΛ w A 1-νΑοη2-νΑ 0 COOH SCAT®)> - 'ζ σ CH 2 -N N-COKHCHCONH-ι-f] © ΓΛ w A 1-νΑοη2-νΑ 0 COOH SCAT®

Smp.: (dekomp.) 180 - 185°C; udbytte 82,0%.Mp: (decomp.) 180 - 185 ° C; yield 82.0%.

På konventionel måde behandledes ovennævnte to produkter med en ionbytterharpiks til dannelse af det ønskede 7-[D(-)-a-(4-ethyl- 2.3- dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-pyridino-methyl-ZsAcephem-4-carboxylsyrebetain og 7-[D(-)-a-(4-methyl- 2.3- dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-pyridino-me thyl-Δ^- c ephem-4-carb oxyl syr eb e tain.Conventionally, the above two products were treated with an ion exchange resin to give the desired 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-pyridino-methyl-ZsAcephem-4 -carboxylic acid betaine and 7- [D (-) - α- (4-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-pyridino-methyl-Δ ^ - c ephem-4-carboxylic acid eb e tain .

EKSEMPEL 34 I 85 ml vandfrit methanol opløstes 1,5 g natriumsalt af 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]- 3-[2-pyridyl-l-oxid)thiomethyl|-2V’-cephem-4-carboxylsyre. Til den dannede opløsning sattes 0,65 g vandfrit kuprichlorid, og den dannede blanding omrørtes ved stuetemperatur i 15 minutter og omsattes ved 50°C i 14 timer. Efter reaktionen førtes gasformigt hydrogensulfid gennem reaktionsopløsningen under isafkøling i 20 minutter. Det dannede uopløselige stof frafiltreredes, og filtratet inddampedes under reduceret tryk. Til remanensen sattes 20 ml af en 5% vandig natriumhydrogencarbonatopløsning, og det uopløselige stof frafiltreredes, hvorefter fortyndet saltsyre sattes til filtratet til indstilling af pH-værdien på 6,5. Filtratet blev derefter vasket med 10 ml portioner ethylacetat tre gange, hvorefter det vandige lag blev fraskilt og derefter indstillet på en pH-værdi på 1,8 ved tilsætning af fortyndet saltsyre. De således udfældede krystaller opsamledes ved filtrering og tørredes derefter under reduceret tryk og vaskedes med 20 ml af en ethylacetatchloroform-blanding (1:1 efter rumfang) til dannelse af 0,40 g 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-methoxymethyl-£^-c ephem-4-carboxylsyre, smp.: 16 2-6 ° C (dekomp.), udbytte 30,5%.Example 34 In 85 ml of anhydrous methanol was dissolved 1.5 g of sodium salt of 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3- [2-pyridyl-1 oxide) thiomethyl | -2V'-cephem-4-carboxylic acid. To the resulting solution was added 0.65 g of anhydrous cuprichloride, and the resulting mixture was stirred at room temperature for 15 minutes and reacted at 50 ° C for 14 hours. After the reaction, gaseous hydrogen sulfide was passed through the reaction solution under ice-cooling for 20 minutes. The insoluble substance formed was filtered off and the filtrate was evaporated under reduced pressure. To the residue was added 20 ml of a 5% aqueous sodium bicarbonate solution and the insoluble filter was filtered off, then dilute hydrochloric acid was added to the filtrate to adjust the pH to 6.5. The filtrate was then washed with 10 ml portions of ethyl acetate three times, then the aqueous layer was separated and then adjusted to a pH of 1.8 by adding dilute hydrochloric acid. The crystals thus precipitated were collected by filtration and then dried under reduced pressure and washed with 20 ml of an ethyl acetate chloroform mixture (1: 1 by volume) to give 0.40 g of 7- [D (-) - α- (4- ethyl 2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-methoxymethyl-β-c ephem-4-carboxylic acid, mp: 16-26 ° C (decomp.), yield 30.5%.

146 151338 IR (KBr) cm"1: \jQ=Q 1770 (lactam), 1700 (-C00H), 1666 (-COiO MR (dg-DMSO) H værdier: 0.13 (IH, d), 0.53 (IH, d), 2.61 (5H, s), 4.31 (IH, q), 4.41 (IH, d), 4.96 (IH, d), 5.82 (2H, s), 6.10 (2H, bs), 6.33 (2H, 2H, 2H. bs), 6.79 (3H, s), 8.89 (3H, t).146 151338 IR (KBr) cm "1: jQ = Q 1770 (lactam), 1700 (-C00H), 1666 (-COiO MR (dg-DMSO) H values: 0.13 (1H, d), 0.53 (1H, d ), 2.61 (5H, s), 4.31 (1H, q), 4.41 (1H, d), 4.96 (1H, d), 5.82 (2H, s), 6.10 (2H, bs), 6.33 (2H, 2H, 2H, bs), 6.79 (3H, s), 8.89 (3H, t).

EKSEMPEL 35EXAMPLE 35

Til en opløsning af 3,2 g D(-)-a-(4-ethyl-2,3-dioxo-l-piperazino-carbonylamino)phenyleddikesyre i 20 ml vandfrit methylenchlorid og 5 ml dimethylformamid sattes 1,33 g Ν,Ν-dimethylanilin. Den resulterende blanding blev afkølet til mellem -15 og -10°C, og en opløsning af 1,14 g ethylchlorcarbonat i 5 ml vandfrit methylenchlorid blev tildryppet denne blanding i løbet af 5 minutter. Blandingen fik lov at reagere ved denne temperatur i 60 minutter.To a solution of 3.2 g of D (-) - α- (4-ethyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetic acid in 20 ml of anhydrous methylene chloride and 5 ml of dimethylformamide was added 1.33 g Ν, Ν dimethylaniline. The resulting mixture was cooled to between -15 and -10 ° C and a solution of 1.14 g of ethyl chlorocarbonate in 5 ml of anhydrous methylene chloride was added dropwise over 5 minutes. The mixture was allowed to react at this temperature for 60 minutes.

Til en suspension af 3,28 g 7-amino-3-[5-(l-methyl-l,2,3,4-tetra-zolyl) thiomethyl ] -^-cephem-4-carboxylsyre i 65 ml vandfrit aceto-nitril sattes på den anden side 3,04 g N,O-bis(trimethylsilyl)-acetamid til opnåelse af en opløsning. Opløsningen blev afkølet til -20°C og hældt ud i den førnævnte reaktionsblanding. Derefter fik blandingen lov at reagere ved mellem -10 og -5°C i 60 minutter og ved 5-10°C i 60 minutter. Efter fuldførelse af reaktionen sattes 5 ml methanol til reaktionsblandingen, og blandingen blev befriet for uopløseligt materiale ved filtrering. Derefter blev opløsningsmidlet fjernet ved destillation under formindsket tryk. Remanensen opløstes i et blandet opløsningsmiddel bestående af 100 ml vand og 50 ml ethylacetat, og den resulterende opløsning blev indstillet til en pH-værdi på 7,5-8,0 ved tilsætning af na-triumhydrogencarbonat, hvorefter der tilsattes 80 ml ethylacetat og 20 ml acetone, og den resulterende opløsning blev indstillet til en pH-værdi på 1,5 ved tilsætning af fortyndet saltsyre.To a suspension of 3.28 g of 7-amino-3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] -1-cephem-4-carboxylic acid in 65 ml of anhydrous acetone nitrile, on the other hand, added 3.04 g of N, O-bis (trimethylsilyl) acetamide to give a solution. The solution was cooled to -20 ° C and poured into the aforementioned reaction mixture. Then the mixture was allowed to react at between -10 and -5 ° C for 60 minutes and at 5-10 ° C for 60 minutes. After completion of the reaction, 5 ml of methanol was added to the reaction mixture and the mixture was freed from insoluble material by filtration. Then, the solvent was removed by distillation under reduced pressure. The residue was dissolved in a mixed solvent consisting of 100 ml of water and 50 ml of ethyl acetate, and the resulting solution was adjusted to a pH of 7.5-8.0 by the addition of sodium bicarbonate, after which 80 ml of ethyl acetate and 20 ml of ethyl acetate were added. ml of acetone, and the resulting solution was adjusted to a pH of 1.5 by the addition of dilute hydrochloric acid.

Derpå blev det organiske lag skilt fra, vasket tilstrækkeligt med vand, og opløsningsmidlet blev fjernet fra ethylacetatlaget 1« 151338 ved destillation under formindsket tryk. Remanensen opløstes i 15 ml acetone, og til denne opløsning sattes 60 ml 2-propanol under omrøring til udfældning af hvide krystaller. De udfældede krystaller blev opsamlet ved filtrering, vasket tilstrækkeligt med 2-propanol og tørret, hvorved der blev opnået 5,26 g 7-[D-(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacet-amido]-3-[5-(1-methyl-l,2,3,4-tetrazolyl)thiomethyl]-4^-cephem- 4-carboxylsyre, smp. 163-165°C (decomp.), udbytte 83,6%. Strukturen af denne forbindelse blev bekræftet ved IR og MR.Then, the organic layer was separated, washed sufficiently with water, and the solvent was removed from the ethyl acetate layer 1, by distillation under reduced pressure. The residue was dissolved in 15 ml of acetone and to this solution was added 60 ml of 2-propanol with stirring to precipitate white crystals. The precipitated crystals were collected by filtration, washed sufficiently with 2-propanol and dried to give 5.26 g of 7- [D - (-) - oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) ) phenylacetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] -4β-cephem-4-carboxylic acid, m.p. 163-165 ° C (decomp.), Yield 83.6%. The structure of this compound was confirmed by IR and MRI.

Den ovennævnte procedure blev gentaget, undtagen at D(-)-0(.-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenyleddikesyre blev erstattet med hver af de i tabel 29 anførte forbindelser med formlen (V) til opnåelse af de respektive ønskede forbindelser som vist i tabel 29. Strukturen af hver fremstillet forbindelse blev bekræftet ved ir og NMR.The above procedure was repeated except that D (-) - O (.- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid was replaced with each of the compounds of formula (V) to obtain the respective desired compounds as shown in Table 29. The structure of each compound prepared was confirmed by ir and NMR.

·> 1 !-^-115 !-!—IS1.31Å ry hk T*\ bP f=a\ bP $ Ύ P~5 w~ * κχ ί .·> 1! - ^ - 115! -! - IS1.31Å ry hk T * \ bP f = a \ bP $ Ύ P ~ 5 w ~ * κχ ί.

c\iin cj in \ / okIc \ iin cj in \ / okI

s : s : Vs p f>i ss: s: Vs p f> i s

-4 I! yÅJg I ir\ s ^ I-4 I! yÅJg I ir \ s ^ I

vr°i V- 1 1 i K t i - æ ^ i 3 « Y k —Y O S o g /-Λ o i i ^ ;? r ? o i i s-®?. HH D Y ivr ° i V- 1 1 i K t i - æ ^ i 3 «Y k —Y O S o g / -Λ o i i ^ ;? r? o i i s-® ?. HH D Y i

3 VN i VY '1 »" |JY I3 VN i VY '1 »" | YOU I

3 J e L J 9 % §o I §3 J e L J 9% §o I §

8 T° (Γ i 7° i £ Λ 8 . K8 T ° (Γ i 7 ° i £ Λ 8. K

fa « * S sP “ - *" I , g Ifa «* S sP“ - * "I, g I

o po w Λ 3 m i mo po w Λ 3 m i m

σ\ '—'Hσ \ '--'H

cm P Ocm P O

AI 1 w m ri: i--------- E-<AI 1 w m ri: i --------- E- <

M MM M

O § ! h§> |jg> (D ht-1 Pi O r~\ «-i δ o o o g S O o Λ O i ‘: |Ao> ih®-» H) n .1 \A ys $ ..i xyy yy # l y $ A° g AS AgO §! h§> | jg> (D ht-1 Pi O r ~ \ «-i δ ooog SO o Λ O i ': | Ao> ih®-» H) n .1 \ A ys $ ..i xyy yy # suffer $ A ° g AS Ag

£ Q A sP A bP SbP£ Q A sP A bP SbP

p o p o p o 149 151338 EKSEMPEL 36p o p o p o 149 EXAMPLE 36

Proceduren fra eksempel 35 blev gentaget under anvendelse af 3,1 g D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenyl eddike syre og 3,0 g 7-amino-3-[5-(l,2,3-triazolyl)thio-methyl]-å^-cephem-4-carboxylsyre, hvorved der blev opnået 4,5 g 7_[D(_)_a-(4_ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenyl-acetamido]-3-[5-(1,2,3-triazolyl)thiomethyl]-Z^-cephem-4-carbo-xylsyre, smp. 177-180°C (decomp.)» udbytte 76,7%· IR (KBr) cm-1: 1>C=0 1770 (lactam), 1703 (-C00H), 1680,The procedure of Example 35 was repeated using 3.1 g of D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenyl acetic acid and 3.0 g of 7-amino-3- [5- (1,2,3-triazolyl) thio-methyl] -α-cephem-4-carboxylic acid to give 4.5 g of 7 [D (_) _ α- (4-ethyl-2,3-dioxo) -1-piperazinocarbonylamino) -phenyl-acetamido] -3- [5- (1,2,3-triazolyl) thiomethyl] -Z ^ -cephem-4-carboxylic acid, m.p. 177-180 ° C (decomp.) »Yield 76.7% · IR (KBr) cm -1: 1> C = 0 1770 (lactam), 1703 (-C00H), 1680,

1667 (-CONO1667 (-CONO

EKSEMPEL 37EXAMPLE 37

Proceduren fra eksempel 35 blev gentaget under anvendelse af 1,9 g D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenyleddikesyre og 2,2 g 7-amino-3-[5-(1,3,4-thiadiazolyl)thiomethyl ]-^-cephem-4-carboxylsyre, hvorved der blev opnået 3,1 g 7-[D(-)-oc-( 4- ethyl- 2,3- di oxo -1 -p ip e r a zino carbony lamino) phenyl-acetamido 3-3-[5-(1,3,4-thiadiazolyl) -thiomethyl ] -/^-cephem-4-carboxylsyre, smp. 165-170°C (decomp.), udbytte 82%.The procedure of Example 35 was repeated using 1.9 g of D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid and 2.2 g of 7-amino-3- [5 - (1,3,4-Thiadiazolyl) thiomethyl] - ^ - cephem-4-carboxylic acid to give 3.1 g of 7- [D (-) - oc- (4-ethyl-2,3-di oxo) -1-p ip era zino carbonylamino) phenyl-acetamido 3-3- [5- (1,3,4-thiadiazolyl) -thiomethyl] -β-cephem-4-carboxylic acid, m.p. 165-170 ° C (decomp.), Yield 82%.

IR (KBr) cm-1: j7c=0 1775 (lactam), I705 (-C00H), 1685,IR (KBr) cm -1: j7c = 0.1775 (lactam), I705 (-C00H), 1685,

1675 (-CON O1675 (-CON O.

EKSEMPEL 38EXAMPLE 38

Proceduren fra eksempel 35 blev gentaget under anvendelse af 1,5 g D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxyphenyleddikesyre og 1,5 g 7-amino-3-[5-(2-methyl-l,3,4-thiadiazolyl)-thiomethyl]-^-cephem-4-carboxylsyre, hvorved der blev opnået 2,3 g 7-[D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazino-carbonylamino)-p-hydroxyphenylacetamido]-3-[5-(2-methyl-l,3,4-thiadiazolyl)thiomethyl]-^-cephem-4-carboxylsyre, smp. 172-177°C (decomp.), udbytte 77,7%.The procedure of Example 35 was repeated using 1.5 g of D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetic acid and 1.5 g of 7-amino-3- [5- (2-methyl-1,3,4-thiadiazolyl) -thiomethyl] -cephem-4-carboxylic acid to give 2.3 g of 7- [D (-) - oc- (4-ethyl) -2,3-dioxo-1-piperazino-carbonylamino) -p-hydroxyphenylacetamido] -3- [5- (2-methyl-1,3,4-thiadiazolyl) thiomethyl] - cephem-4-carboxylic acid, m.p. 172-177 ° C (decomp.), Yield 77.7%.

150 151338 IR (KBr) cm”1: \) C=0 1780 (lactam)» 1710 (-COOH) 1685, 1672 (-CONC) På samme måde som ovenfor fremstilledes de i tabel 30 anførte forbindelser ud fra D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonyl-amino)phenyleddikesyre eller D(-)-a-(4-ethyl-2,3-dioxo-l-pipera-zinocarbonylamino)-p-hydroxyphenyleddikesyre og de i tabel 30 viste forbindelser med formlen (IV). Strukturen af hver fremstillet forbindelse blev bekræftet ved IR og NMR.IR (KBr) cm ”1: C = 0 1780 (lactam) 17 1710 (-COOH) 1685, 1672 (-CONC) In the same manner as above, the compounds listed in Table 30 were prepared from D (-) -oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid or D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetic acid and the compounds of formula (IV) shown in Table 30. The structure of each compound prepared was confirmed by IR and NMR.

151 151338151 151338

KNCN

ιτΐ Οιτΐ Ο

OJOJ

;;

! OJ! OJ

i ro Eat rest E

i Ein E

Krrs °ft ^Krrs ° ft ^

I \ . os I . \ ►—i <£SI \. us I. \ ► — i <£ S

s~o ¥* s-o ^ I . e\ * y ** b' " 7 Oii £^4 * i-i ^—i in- i is.s ~ o ¥ * s-o ^ I. e \ * y ** b '"7 Oii £ ^ 4 * i-i ^ —i in- i is.

2» I "w I2 »I" w I

o +f o if ω /“A 8' *§ /r“i 8 § « &o y-8 3 w y-o s H Vs3 '’· V"s • s I <P I ° > '$ Jrte £ é § t tøjtes Π E rH ^ ^ d O £ -p o ύ S c. s ft c s ft I T Ί § T ) §o + fo if ω / “A 8 '* § / r“ i 8 § «& o y-8 3 w yo s H Vs3' '· V" s • s I <PI °>' $ Jrte £ é § t clothes Π E rH ^^ d O £ -po ύ S c. S ft cs ft IT Ί § T) §

£ tes Φ cte O£ tes Φ cte O

> 5 > 3 ο ✓Λ o o : 00 i - ‘ JT· a J E CL ^ — g H E Ο & E ^ m m cq C _ '____.> 5> 3 ο ✓Λ o o: 00 i - 'JT · a J E CL ^ - g H E Ο & E ^ m m cq C _' ____.

Eh -——---- ?r\Eh -——----? R \

EE

_ o > w H ^_ o> w H ^

rc\ Erc \ E

CJ E OCJ E O

H 5“2 8\J EetSH 5 “2 8 \ J EetS

g I V-g Wg ο I / J._/ «Η ZC=/ E-( I 1 - Ό CO K , (D CM ft a e ^ O °g I V-g Wg ο I / J ._ / «Η ZC = / E- (I 1 - Ό CO K, (D CM ft a e ^ O °

φ I E I hCφ I E I hC

3 «ryl «fys •h « te3 «ryl« phys • h «te

^ i —L^ i —L

O j E Ϊ3 o &4 ' CV ftO j E Ϊ3 o & 4 'CV ft

X EX E

* i* i

Isa 151338 Κλ w ο ft ro νλ η! S 3 s —= "ru ' s-s ro - -=r\ ^ .Isa 151338 Κλ w ο ft ro νλ η! S 3 s - = "ru 's-s ro - - = r \ ^.

Ϊ )=-§ f | p~° ^ i M PΪ) = - § f | p ~ ° ^ i M P

«=Y· ^ S 85 =Y * , “tv, WCV) Φ ' 5 ft -P g Ή o >» _I k i>, ;_I ft +i .—f c · ^ o a . § g /y8 · 3 C2 y— o ^ CQ y-O . 3 07 y-o Ϊ2; ' \—s * \—2 » i o° \ <p i ,.A> s Jr\> d +Λ . s 2ΰ H i i ^ ^ i-Ø-s -s 1-0§ s l^g s r—I J3 ϊ I a 1 i c c c o ^ O o ^ I · i · I ·«= Y · ^ S 85 = Y *,“ tv, WCV) Φ '5 ft -P g Ή o> »_I k i>,; _I ft + i. — F c · ^ o a. § g / y8 · 3 C2 y— o ^ CQ y-O. 3 07 y-o Ϊ2; '\ —S * \ —2 »i o ° \ <p i, .A> s Jr \> d + Λ. s 2ΰ H i i ^ ^ i-Ø-s -s 1-0§ s l ^ g s r — I J3 ϊ I a 1 i c c c o ^ O o ^ I · i · I ·

Cft X ft O. ft ft C . ft ftCft X ft O. ft ft C. ft ft

~ p: I i 3 I X) I~ p: I i 3 I X) I

Id eft a ¢5 cr ft ω cr ft ω W I Ό I "ft I Ό +5 CO ^ (\! ' ft! ^ Έ j e i ft i a 0-^0 ^ o . ^ o <j_j I rC\ · I ΓΌ, Ql I *ft · w ^ o, w e g ^ s ft ft o. s ft O CQ ft c S .Id eft a ¢ 5 cr ft ω cr ft ω WI Ό I "ft I Ό +5 CO ^ (\! 'Ft! ^ Έ jei ft ia 0- ^ 0 ^ o. ^ O <j_j I rC \ · I ΓΌ , Ql I * ft · w ^ o, away ^ s ft ft o. S ft O CQ ft c S.

o , 03 03 m I ___J_ i-1 rfto, 03 03 m I ___J_ i-1 rft

H KH K

' ffl o 5; ro B Qo'ffl o 5; ro B Qo

ΝΛ HΝΛ H

E OE O

O ^ a—ft co ft-x a co ft-=\O ^ a — ft co ft-x a co ft - = \

i \ e i \ W Ii \ e i \ W I

I »-o I +-° l ,MI »-o I + - ° l, M

ft.—/ E=/ i i i 03 02 W , cj ro ft' ft ft ^ ^ ft ' *f ft I ft /“i c o f~i oft .— / E = / i i i 03 02 W, cj ro ft 'ft ft ^^ ft' * f ft I ft / “i c o f ~ i o

10 y—O rQ y—O 02 y—O10 y — O rQ y — O 02 y — O

U tt UoU tt Uo

Cj ro ftCj ro ft

X EX E

___;--——*—.—-* 153 151338 » 1 i ΝΡ KN g· tM Λ ho. o tn 8 §___; --—— * —.—- * 153 151338 »1 i ΝΡ KN g · tM Λ ho. o tn § 8

jk o -Pjk o -P

_J o ffl f-i O g /Vs $ Ar8 3_J o ffl f-i O g / Vs $ Ar8 3

Y-f % WY-f% W

A i U °* £ c g ° 5 i© i I©* ϊ d '-I £?A i U ° * £ c g ° 5 i © i I © * ϊ d '-I £?

O OISLAND ISLAND

ϋ Oϋ Oh

§ X ) S CXJ§ X) S CXJ

-p cr s P c "t ii JL. I Ό * w O cm — ,-^ ~ <h i re * tt w o '-v * JK', · i S1 o ^ s a 5 ,1 -n o S .-i O oj-p cr s P c "t ii JL. I Ό * w O cm -, - ^ ~ <hi re * tt wo '-v * JK', · i S1 o ^ sa 5, 1 -no S.-i Oh my

CQCQ

H ____ pq -- : cH ____ pq -: c

EHEH

1Ό.1Ό.

ffiffi

*\ O* \ O

K oK o

I II I

As A§ \—s \— ^If A§ \ —s \ - ^

[A U[A U

zr. C » o CM ^ ________:--i 154 1 5 1 3 3 8 EKSEMPEL 39 I et blandet opløsningsmiddel bestående af 80 ml vand og 40 ml ethylacetat suspenderedes 4,0 g 7-[D-(-)-a-aminophenylacetami-do]-3-acetoxymethyl-^-cephem-4-carboxylsyre, og derpå opløstes 1,65 g vandfrit kaliumcarbonat deri under isafkøling.zr. EXAMPLE 39 In a mixed solvent consisting of 80 ml of water and 40 ml of ethyl acetate, 4.0 g of 7- [D - (-) - α-aminophenylacetamide was suspended. do] -3-acetoxymethyl-β-cephem-4-carboxylic acid, and then 1.65 g of anhydrous potassium carbonate was dissolved therein under ice-cooling.

Til denne opløsning sattes 7,3 g 4-(a-hydroxyethyl)-2,3-dioxo- 1-piperazinocarbonylchlorid ved 0-5°C i løbet af 15 minutter, og den resulterende blanding fik lov at reagere ved 10-15°C i 30 minutter. Efter fuldførelse af reaktionen blev det vandige lag skilt fra, det tilsattes 100 ml acetonitril, og den resulterende opløsning blev indstillet til en pH-værdi på 1,5 ved tilsætning af fortyndet saltsyre, og blev mættet med natriumchlorid. Derefter blev acetonitrillaget skilt fra, vasket to gange med 30 ml af en mættet opløsning af natriumchlorid og derpå tørret ved formindsket tryk. Remanensen opløstes i et blandet opløsningsmiddel bestående af 50 ml acetone og 10 ml ethanol, og uopløseligt materiale blev skilt fra. Derpå sattes 100 ml isopropyl-alkohol til den resulterende opløsning, og denne blev koncentreret til 2/3 volumen ved formindsket tryk. De udfældede krystaller blev opsamlet ved filtrering, vasket med isopropylalkohol og tørret, hvorved der blev opnået 4,5 g 7-[D{-)-a-(4—fp-hydro-xyethyl^ -2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-acetoxymethyl-A^-cephem-4-carboxylsyre, smp. 142-144°C (decomp.) udbytte 76,3%· η ·. 1770 (lactam), 1708 (-C0GH) IR (KBr) cm“J' : S) C=0 1680, 1665 (-C0N<)To this solution was added 7.3 g of 4- (α-hydroxyethyl) -2,3-dioxo-1-piperazinocarbonyl chloride at 0-5 ° C over 15 minutes, and the resulting mixture was allowed to react at 10-15 ° C for 30 minutes. After completion of the reaction, the aqueous layer was separated, 100 ml of acetonitrile was added and the resulting solution was adjusted to a pH of 1.5 by adding dilute hydrochloric acid and saturated with sodium chloride. The acetonitrile layer was then separated, washed twice with 30 ml of a saturated solution of sodium chloride and then dried at reduced pressure. The residue was dissolved in a mixed solvent consisting of 50 ml of acetone and 10 ml of ethanol and the insoluble material was separated. Then 100 ml of isopropyl alcohol was added to the resulting solution, which was concentrated to 2/3 volume at reduced pressure. The precipitated crystals were collected by filtration, washed with isopropyl alcohol and dried to give 4.5 g of 7- [D {-) - α- (4-fp-hydroxyethyl) -2,3-dioxo-1- piperazinocarbonylamino) phenylacetamido] -3-acetoxymethyl-Δ-cephem-4-carboxylic acid, m.p. 142-144 ° C (decomp.) Yield 76.3% · η ·. 1770 (lactam), 1708 (-COGH) IR (KBr) cm -1 J: S) C = 0 1680, 1665 (-CON <)

Den ovenstående procedure blev gentaget, undtagen at 7-[D{-)-a-aminophenylacetamido]-3-acetoxymethyl-fc?-cephem-4-carboxy1syren blev erstattet med hver af de i tabel 31 angivne forbindelser med formlen (II) til fremstilling af de respektive ønskede forbindelser som anført i tabel 31. Strukturen af hver fremstillet forbindelse blev bekræftet ved IR og NMR.The above procedure was repeated except that 7- [D {-) - α-aminophenylacetamido] -3-acetoxymethyl-β-cephem-4-carboxylic acid was replaced with each of the compounds of formula (II) to preparation of the respective desired compounds as listed in Table 31. The structure of each compound prepared was confirmed by IR and NMR.

155 151338 fe i S = K to,155 151338 fe in S = K two,

N"N I \ WN "N I \ W

K K-OK K-O

o o ^ —1 · O I · O c\] CO <] · *o o ^ —1 · O I · O c \] CO <] · *

<u . $ JVI S<u. $ JVI S

κ w O φ o ω !«.+> £ -pκ w O φ o ω! «. +> £ -p

r-Å c +» /—d g -Pr-Å c + »/ —d g -P

ω / V\ o f»> / o >, m CQ \V- o _£? ra y-o s ti V« ? W § ti ίΛ o° cHb pω / V \ o f »> / o>, m CQ \ V- o _ £? ra y-o s ti V «? W § ti ίΛ o ° cHb p

,¾ S IN S lA, ¾ S IN S lA

0 C LI'» C ΊΓ ,«Η O ,_, ^ o -. r-i % 1 ιΌ Η ϋ '— hog: t—1 H O cf\ O •et* •H · O Ή O _ r-t -p r i ra os ^ ov s ^ 1 l) s J i ft o s O o s o I O I o CM Φ CM G) K Ό S X) o ^ o w0 C LI '»C ΊΓ,« Η O, _, ^ o -. ri% 1 ιΌ Η ϋ '- hog: t — 1 HO cf \ O • et * • H · O Ή O _ rt -prri ra os ^ ov s ^ 1 l) s J i ft os O oso IOI o CM Φ CM G) K Ό SX) o ^ ow

I CM I CMI CM I CM

^ S * s I O ft I O * ^ - o S w o ft^ S * s I O ft I O * ^ - o S w o ft

Ψ) SK CO s S · SΨ) SK CO s S · S

s ft pq <! „______—......—-- Έή : s—S ros ft pq <! „______ — ......—-- Έή: s — S ro

ΓΓ to, I \ KΓΓ two, I \ K

£j K s-o ~ O S=/ ι-H O « 'S o co£ j K s-o ~ O S = / ι-H O «'S o co

^ CM CM^ CM CM

d κ s p o o £ Λ^Λ, B ^“4-° 1 V"° Y" § 1—1 1—l H K O g ° 1 I©d κ s p o o £ Λ ^ Λ, B ^ “4- ° 1 V" ° Y "§ 1—1 1 — l H K O g ° 1 I ©

s (MN-' CMs (MN- 'CM

£ ® w 151338£ ® w 151338

*» I* »I

... 156... 156

ϋ ~ = ΚΝ i \ Kϋ ~ = ΚΝ i \ K

i=/ Ai = / A

rl COrl CO

*· * i r\ cv u' 9-—\ er φ* · * I r \ cv u '9 -— \ is φ

U 4JU 4J

I » 5 / NX 8 § V-s/ • 1I »5 / NX 8 § V-s / • 1

JrS> £2 PC\ k»8 ;JrS> £ 2 PC \ k »8;

O INO IN

O Ή 1 ϊ 1 irO Ή 1 ϊ 1 ir

.p O 53 O.p O 53 O

t, I Ot, I O

O CV 0) <H · K Ό O ^ I cv rH ^ K · rO l O ft ^ o a ηϊ « = w • S .O CV 0) <H · K Ό O ^ I cv rH ^ K · rO l O ft ^ o a ηϊ «= w • S.

• 9 ·• 9 ·

EHEH

is zSis zS

• ^ a j £2-0 co _jv- a• ^ a j £ 2-0 co _jv- a

AiAi

AA

a o V^“° 157 151338 EKSEMPEL 40 . (l) Til en opløsning af 0,63 g D(-)-a-(4-ethyl-2,3“åioxo-l-piperazinocarbonylamino)phenyleddikesyre i 10 ml vandfrit methylenchlorid sattes 0,5 g oxalylchlorid og en dråbe N,N-dimethylformamid, og den resulterende blanding fik lov at rea- 1 gere ved stuetemperatur i 30 minutter. Efter fuldførelse af reaktionen blev opløsningsmidlet fjernet ved destillation under formindsket tryk. Remanensen blev vasket med vandfrit benzen, hvorved der blev opnået 0,6 g D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetylchlorid, smp. 112-116°C (decomp.) udbytte 88,8$.EXAMPLE 40 EXAMPLE 40. (1) To a solution of 0.63 g of D (-) - α- (4-ethyl-2,3'-oxo-1-piperazinocarbonylamino) phenylacetic acid in 10 ml of anhydrous methylene chloride was added 0.5 g of oxalyl chloride and a drop of N, N-dimethylformamide, and the resulting mixture was allowed to react at room temperature for 30 minutes. After completion of the reaction, the solvent was removed by distillation under reduced pressure. The residue was washed with anhydrous benzene to give 0.6 g of D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetyl chloride, m.p. 112-116 ° C (decomp.) Yield $ 88.8.

IR (KBr) cm"1: >)NH 3280 ~)ο=0 179°- 1695 (2) Til en suspension af 0,27 g 7-aminocephalosporansyre i 6 ml vandfrit methanol sattes 0,24 g triethylamin. Den resulterende opløsning blev afkølet til -40°C, og til opløsningen sattes en opløsning af 5 ml vandfrit methylenchlorid indeholdende 0,34 g D(—)-oc- (4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylace-tylchlorid, og derpå blev reaktionsvæskens temperatur gradvist hævet til stuetemperatur i løbet af 1 time. Efter fuldførelse af reaktionen blev opløsningsmidlet fjernet ved destillation under formindsket tryk. Remanensen blev fyldt i 20 ml vand, og den resulterende opløsning blev vasket to gange med 5 ml ethyl-acetat. Til det vandige lag sattes 20 ml ethylacetat, og opløsningen blev indstillet til en pH-værdi på 1,5 ved tilsætning af 2N saltsyre under omrøring. Derefter blev det organiske lag skilt fra, vasket med en mættet vandig natriumchloridopløsning, tørret over vandfrit magnesiumsulfat, og opløsningsmidlet fjernet ved destillation under formindsket tryk, hvorved der blev opnået 453 mg 7-[D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenylacetamido]-3-acetoxymethyl-^-cephem-4-carboxylsyre, smp.IR (KBr) cm "1: NH 3280 ~ ο = 0 179 ° - 1695 (2) To a suspension of 0.27 g of 7-aminocephalosporanoic acid in 6 ml of anhydrous methanol was added 0.24 g of triethylamine. The resulting solution was cooled to -40 ° C and to the solution was added a solution of 5 ml of anhydrous methylene chloride containing 0.34 g of D (-) - oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetyl chloride, and then the reaction liquid temperature was gradually raised to room temperature over 1 hour. After completion of the reaction, the solvent was removed by distillation under reduced pressure. The residue was filled with 20 ml of water and the resulting solution was washed twice with 5 ml of ethyl acetate. To the aqueous layer was added 20 ml of ethyl acetate and the solution was adjusted to a pH of 1.5 with the addition of 2N hydrochloric acid with stirring, then the organic layer was separated, washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate. , and the solvent removed by distillate ion under reduced pressure to give 453 mg of 7- [D (-) - oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -phenylacetamido] -3-acetoxymethyl-3-cephem-4 carboxylic acid, m.p.

165-166°C (decomp.), udbytte 79,0$.165-166 ° C (decomp.), Yield 79.0 $.

På samme måde som ovenfor fremstilledes 7-[D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxyphenylacetamido]-3-acetoxy-A^-cephem-4-carboxylsyre, smp. 168-174°C (decomp.), udbytte 72,3$, ud fra D(-)-a-(4-ethyl-2,3-dioxo-l-piperazino- 158 1 5 1 3 3 8 carbonylamino)-p-hydroxyphenylacetylchlorid og 7-aminocephalo-sporansyre.In the same manner as above, 7- [D (-) - oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] -3-acetoxy-λ-cephem-4-carboxylic acid, mp. 168-174 ° C (decomp.), Yield 72.3 $, from D (-) - α- (4-ethyl-2,3-dioxo-1-piperazino-carbonylamino) carbonylamino) - p-hydroxyphenylacetyl chloride and 7-aminocephalo-sporanoic acid.

EKSEMPEL 41EXAMPLE 41

Til en suspension af 2,16 g 6-aminopenicillansyre i 20 ml methylen-chlorid sattes 2,02 g triethylamin. Til den resulterende opløsning sattes 3,4 g D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-phenylacetylchlorid ved 10-15°C, og den resulterende blanding fik lov at reagere ved 10-15°C i 2 timer. Efter fuldførelse af reaktionen blev opløsningsmidlet fjernet ved destillation under formindsket tryk. Remanensen blev fyldt i 20 ml vand, og til den resulterende opløsning sattes 30 ml ethylacetat. Opløsningen blev indstillet til en pH-værdi på 2,5 ved tilsætning af 2N saltsyre og blev omrørt i 4 timer til udfældning af krystaller.To a suspension of 2.16 g of 6-aminopenicillanic acid in 20 ml of methylene chloride was added 2.02 g of triethylamine. To the resulting solution was added 3.4 g of D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetyl chloride at 10-15 ° C and the resulting mixture was allowed to react at 10 ° C. -15 ° C for 2 hours. After completion of the reaction, the solvent was removed by distillation under reduced pressure. The residue was filled with 20 ml of water and 30 ml of ethyl acetate were added to the resulting solution. The solution was adjusted to a pH of 2.5 by the addition of 2N hydrochloric acid and stirred for 4 hours to precipitate crystals.

De udfældede krystaller blev omsamlet ved filtrering, hvorved der blev opnået 4,4 g 6-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazino-carbonylamino)phenylacetamido]penicillansyre, smp. 154-156°C (decomp.), udbytte 82,2%.The precipitated crystals were collected by filtration to give 4.4 g of 6- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetamido] penicillanic acid, m.p. 154-156 ° C (decomp.), Yield 82.2%.

På samme måde som ovenfor fremstilledes 6-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxyphenylacetamido]-penicillansyre, smp. 160-161°C (decomp.), udbytte 70,5%, ud fra 6-amino-penicillansyre og D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxyphenylacetylchlorid.In the same manner as above, 6- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] penicillanic acid, m.p. 160-161 ° C (decomp.), Yield 70.5%, from 6-amino-penicillanic acid and D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetyl chloride .

EKSEMPEL 42EXAMPLE 42

Proceduren fra eksempel 35. blev gentaget under anvendelse af D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenyl-eddikesyre og 7-amino-3-carbamoyloxymethyl-A.^-cephem-4-carboxyl-syre, hvorved der blev opnået 7-[D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-carbamoyloxymethyl-/^-cephem-4-carboxylsyre, smp. 175-180°C (decomp.), udbytte 68,0%.The procedure of Example 35. was repeated using D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid and 7-amino-3-carbamoyloxymethyl-A. 4-carboxylic acid to give 7- [D (-) - oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-carbamoyloxymethyl - + - cephem-4-carboxylic acid , m.p. 175-180 ° C (decomp.), Yield 68.0%.

IR (KBr) cm"1: 0 NH? 3430’ 3350 0 coSh 3300 ^ c=0 1778, 1710, 1670 159 151338 På samme måde som ovenfor fremstilledes 7-(D(-)-a-(4-ethyl-2,3-di oxo-1-piperazinocarbonylamino)-p-hydroxyphenylacetamido-3-carbamoyloxymethyl-Æ?-cephem-4-carboxylsyre, smp. 178-182° C (decomp.), udbytte 65,090, ud fra D(-)-a-(4-ethyl—2,3-dioxo-l-piperazinocarbonylamino)-p-hydroxyphenyleddikesyre og 7-amino - 3 - c arbamoy 1 oxyme thy 1 -ip-c ephem-4- c arb oxy 1 syre.IR (KBr) cm -1: 0 NH? 3430 ° 3350 ° Cd 3300 ° c = 0 1778, 1710, 1670 159 151338 In the same manner as above, 7- (D (-) - α- (4-ethyl-2) was prepared 3-di oxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido-3-carbamoyloxymethyl-α? -Cephem-4-carboxylic acid, mp 178-182 ° C (decomp.), Yield 65.090, from D (-) - α- (4-Ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetic acid and 7-amino-3-carbamoyl oxyme thi-ip-c ephem-4- c arb oxy 1 acid.

EKSEMPEL 43 (1) Til en opløsning af 0,32 g D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre i 15 ml methylen-chlorid sattes 0,1 g N-methylmorpholin. Den resulterende opløsning blev afkølet til -20°C og til opløsningen sattes en opløsning af 0,11 g ethylchlorcarbonat i 2 ml methylenchlorid, hvorefter den resulterende opløsning fik lov at reagere ved mellem -10 og -20°C i 1 time. Derpå blev reaktionsvæsken tildryppet en opløsning af 0,44 g af en benzhydrylester af 7-amino-3-carbamoyloxymethyl-/^-cephem-4-carboxylsyre i 5 ml methylenchlorid ved -20°C. Efter tildrypningen fik den resulterende opløsning lov at reagere ved mellem -lb og -20°C i 1,5 timer, hvorefter temperaturen blev hævet til stuetemperatur. Derefter blev opløsningsmidlet fjernet ved destillation under formindsket tryk, og remanensen opløstes i 15 ml ethylacetat. Derefter blev den resulterende opløsning successivt vasket med 10 ml vand, 5 vægt-% natriumhydrogencarbonatopløsning og mættet vandig na-triumchloridopløsning og derpå tørret over vandfrit magnesiumsulfat. Opløsningsmidlet blev fjernet ved destillation under formindsket tryk. Derpå blev remanensen renset ved søjlechro-matografi (silicagel/chloroform), hvorved der blev opnået 0,53 g benzhydrylester af 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocar-bonylamino)phenylacetamido]-3-carbamoyloxymethyl-Δ^-cephem-4-carboxylsyre, smp. 120-125°C (decomp.), udbytte 71,6%.Example 43 (1) To a solution of 0.32 g of D (-) - o - (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid in 15 ml of methylene chloride was added 0.1 g of N-methylmorpholine. . The resulting solution was cooled to -20 ° C and to the solution was added a solution of 0.11 g of ethyl chlorocarbonate in 2 ml of methylene chloride, after which the resulting solution was allowed to react at between -10 and -20 ° C for 1 hour. Then, the reaction liquid was added dropwise to a solution of 0.44 g of a benzhydryl ester of 7-amino-3-carbamoyloxymethyl-β-cephem-4-carboxylic acid in 5 ml of methylene chloride at -20 ° C. After drip, the resulting solution was allowed to react at between -1b and -20 ° C for 1.5 hours, after which the temperature was raised to room temperature. Then, the solvent was removed by distillation under reduced pressure and the residue was dissolved in 15 ml of ethyl acetate. Then, the resulting solution was successively washed with 10 ml of water, 5% by weight sodium bicarbonate solution and saturated aqueous sodium chloride solution and then dried over anhydrous magnesium sulfate. The solvent was removed by distillation under reduced pressure. The residue was then purified by column chromatography (silica gel / chloroform) to give 0.53 g of benzhydryl ester of 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-carbamoyloxymethyl-Δ ^ -cephem-4-carboxylic acid, m.p. 120-125 ° C (decomp.), Yield 71.6%.

160 1 5 1 3 3 8 IR (KSr) cm"1 : ^ ^ 34-80, $$S0,160 1 5 1 3 3 8 IR (KSr) cm "1: 34-80

Dconh 5500» £)C=0 1780» 1-718, 1680 KKR (CDCl^) <~ζ ‘.Værdier -0,1 (IH, d), 2;05 ClH, d), 2,64 (15H, bs), 3;19 (IH, s), 4;20 (2H, m), 4,86 (IH, d), 5,20 (2H, s), 5,25 (2H, bs), 6,1 (2H, o), 6,3 - 6,9 (6H, m), 8,9 (3H, t) (2) Til en opløsning af 0,2 g af benzhydrylesteren af 7-[D(-)-oc-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]- 3-carbamoyloxymethyl-A^-eephem-4-carboxylsyre i 5 ml anisol sattes 5 ml trifluoreddikesyre,Under isafkøling, og den resulterende blandede opløsning fik lov at reagere i 30 minutter under isafkøling. Efter fuldførelse af reaktionen blev opløsningsmidlet fjernet ved destillation under formindsket tryk. Derefter opløstes remanensen i 15 ml ethylacetat, og til den resulterende opløsning sattes 10 ml vand, hvorefter opløsningens pH-værdi blev indstillet til 7,5 ved tilsætning af natriumhydrogencarbonat under omrøring. Derefter blev det vandige lag skilt fra, sat til 20 ml ethylacetat og derpå indstillet til en pH-værdi på 2,0 ved tilsætning af 2N saltsyre. Det organiske lag blev skilt fra, vasket successivt med vand og mættet vandig natriumchlorid-opløsning og derpå tørret over vandfrit magnesiumsulfat. Opløsningsmidlet blev fjernet ved destillation under formindsket tryk til udfældning af krystaller. De udfældede krystaller blev opsamlet ved filtrering, hvorved der blev opnået 0,13 g 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino )phenylacetamido ] -3-carbamoyloxymethyl-2^-cephem-4-carboxylsyre, smp. 175-180°C (decomp.), udbytte 83,8%.Dconh 5500 ° C C = 0 1780 »1-718, 1680 KKR (CDCl3) <~ ζ '. Values -0.1 (1H, d), 2; 05 ClH, d), 2.64 (15H, bs), 3; 19 (1H, s), 4; 20 (2H, m), 4.86 (1H, d), 5.20 (2H, s), 5.25 (2H, bs), 6, 1 (2H, o), 6.3 - 6.9 (6H, m), 8.9 (3H, t) (2) To a solution of 0.2 g of the benzhydryl ester of 7- [D (-) - o- (4-Ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-carbamoyloxymethyl-Δ-eephem-4-carboxylic acid in 5 ml of anisole was added 5 ml of trifluoroacetic acid, under ice cooling allowed to react for 30 minutes under ice-cooling. After completion of the reaction, the solvent was removed by distillation under reduced pressure. Then, the residue was dissolved in 15 ml of ethyl acetate and to the resulting solution was added 10 ml of water, after which the pH of the solution was adjusted to 7.5 by adding sodium bicarbonate with stirring. Then, the aqueous layer was separated, added to 20 ml of ethyl acetate and then adjusted to a pH of 2.0 by the addition of 2N hydrochloric acid. The organic layer was separated, washed successively with water and saturated aqueous sodium chloride solution and then dried over anhydrous magnesium sulfate. The solvent was removed by distillation under reduced pressure to precipitate crystals. The precipitated crystals were collected by filtration to give 0.13 g of 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-carbamoyloxymethyl-2 -cephem-4-carboxylic acid, m.p. 175-180 ° C (decomp.), Yield 83.8%.

IR (KBr) cm"1 : pIiH 3450, 3350, ])C0NH2 3500, pCm0 177S, 1710, 1670 161 151338 KKH (d^-DMSO) •ητ Værdier 0,15 (IH, d), 0,55 (IH, c), 2,60 (5H, b), 5-,47 (2H, s), 4,28 (2H, c), 4;95 (Hi, d), 5,25 (2H, q), 6,10 (2H, n>, 6;25 - 6,90 (6H, m), 8,9 (3H, t) EKSEMPEL 44 (1) Til en opløsning af 0,32 g D(-)-a-(4-ethyl-2,3-<iioxo-l-piperazinocarbonylamino)phenyleddikesyre i 15 ml vandfrit methylenchlorid sattes Q,1 g N-methylmorpholin. Den resulterende opløsning blev afkølet til -20°C, og til opløsningen sattes en opløsning af 0,11 g ethylchlorcarbonat i 1 ml ethylenchlorid, hvorpå den resulterende blandede opløsning fik lov at reagere ved mellem -10 og -20°C i 1 time. Derefter blev reaktionsopløsningen tildryppet en opløsning af 0,46 g β,β,β-trichlorethylester af 7-amino-3-cephem-3-carboxylsyre i 5 ml methylenchlorid ved -20°C. Efter til-drypningen fik den resulterende blandede opløsning lov at reagere ved mellem -10 og -20°C i 1 time og ved stuetemperatur i 30 minutter. Efter fuldførelse af reaktionen blev opløsningsmidlet fjernet ved destillation under formindsket tryk, remanensen blev successivt vasket med 5 vægt-% vandig natriumhydrogencarbonatopløsning og mættet vandig natrium-chloridopløsning og tørret over vandfrit magnesiumsulfat.IR (KBr) cm -1: pIHH 3450, 3350,]) COHH2 3500, pCm0 177S, 1710, 1670 161 151338 KKH (d d -DMSO) ητ Values 0.15 (1H, d), 0.55 (1H) , c), 2.60 (5H, b), 5-, 47 (2H, s), 4.28 (2H, c), 4; 95 (Hi, d), 5.25 (2H, q), 6.10 (2H, n>, 6; 25 - 6.90 (6H, m), 8.9 (3H, t) EXAMPLE 44 (1) To a solution of 0.32 g of D (-) - (4-Ethyl-2,3- (10-oxo-1-piperazinocarbonylamino) phenylacetic acid in 15 ml of anhydrous methylene chloride was added Q, 1 g of N-methylmorpholine. The resulting solution was cooled to -20 ° C and to the solution a solution of 0 , 11 g of ethyl chlorocarbonate in 1 ml of ethylene chloride, and the resulting mixed solution was allowed to react at -10 to -20 ° C for 1 hour, then a solution of 0.46 g of β, β, β-trichloroethyl ester of the reaction mixture was added dropwise. 7-Amino-3-cephem-3-carboxylic acid in 5 ml of methylene chloride at -20 C. After drip, the resulting mixed solution was allowed to react at between -10 and -20 ° C for 1 hour and at room temperature for 30 hours. After completing the re The reaction was removed by distillation under reduced pressure, the residue was washed successively with 5% by weight aqueous sodium hydrogen carbonate solution and saturated aqueous sodium chloride solution and dried over anhydrous magnesium sulfate.

Derefter blev opløsningsmidlet fjernet ved destillation under formindsket tryk, remanensen blev renset ved søjlechromatografi (silicagel/benzen-ethylacetat), hvorved der blev opnået 0,53 g β,β,β-trichlorethylester af 7-[D(-)-a-(4-ethyl-2,3-dloxo-l-piperazinocarbonylamino)-phenylacetamido]-3-[5-(1-methyl-1,2,3>4-tetrazolyl)thiomethyl]-A^-cephem-4-carboxylsyre, smp. 125-135°C (decomp.), udbytte 69,6%.Then, the solvent was removed by distillation under reduced pressure, the residue was purified by column chromatography (silica gel / benzene-ethyl acetate) to give 0.53 g of β, β, β-trichloroethyl ester of 7- [D (-) - α- ( 4-ethyl-2,3-dioxo-l-piperazinocarbonylamino) -phenylacetamido] -3- [5- (1-methyl-1,2,3> 4-tetrazolyl) thiomethyl] -A ^ -cephem-4-carboxylic acid, mp. 125-135 ° C (decomp.), Yield 69.6%.

IR (KBr) cm"1: } C=0 1780’ 1715 ’ 1680 162 151338 (2) Til én opløsning-af 0,5 g β,β,β-trichlorethylester af 7-[D-(-) - oc- (4-ethyl-2,3-dioxo-l-piperazinocarbonylamino )phenylacetamido ] - 3- [ 5- (1-methyl-l ,2,3,4-tetrazolyl) thiomethyl-A^-cephem-4-carboxyl-syre sattes 0,5 g zinkstøv og 0,5 ml eddikesyre, og den resulterende opløsning fik lov at reagere i 1,5 timer. Efter fuldførelse af reaktionen blev reaktionsvæsken filtreret, og filtratet blev befriet for opløsningsmidlet ved destillation under formindsket tryk. Derefter opløstes remanensen i 15 ml vand, og den resulterende opløsning blev indstillet til en pH-værdi på 1,5 ved tilsætning af 2N saltsyre til udfældning af krystaller. De udfældede krystaller blev opsamlet ved filtrering, tørret og derpå vasket med ethylacetat, hvorved der blev opnået 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-3-[5-(1-methyl-l,2,3,4-tetrazolyl)thiomethyl]-^-cephem-4-carboxylsyre , smp. I63-I650C (decomp.), udbytte 82,1%.IR (KBr) cm -1: C = 0 1780 '1715' 1680 162 151338 (2) To one solution-of 0.5 g of β, β, β-trichloroethyl ester of 7- [D - (-) - and (4-Ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl-Δ-cephem-4-carboxylic acid 0.5 g of zinc dust and 0.5 ml of acetic acid were added and the resulting solution was allowed to react for 1.5 hours. After completion of the reaction, the reaction liquid was filtered and the filtrate was liberated from the solvent by distillation under reduced pressure. in 15 ml of water and the resulting solution was adjusted to a pH of 1.5 by the addition of 2N hydrochloric acid to precipitate crystals The precipitated crystals were collected by filtration, dried and then washed with ethyl acetate to give 7 - [D (-) - a- (4-ethyl-2,3-dioxo-l-piperazinocarbonylamino) phenylacetamido] -3- [5- (1-methyl-l, 2,3,4-tetrazolyl) thiomethyl] - β-cephem-4-carboxylic acid, mp I63-I650C (decomp.), yield 82.1%.

TCK.qRMPKT . 45 10,0 g D (- )-oc- (4-ethyl-2,3-dioxo-l-piperazinocarbonylamino ) -p-hydro-xyphenyleddikesyre blev suspenderet i 60 ml vandfrit methylenchlo-rid, og der sattes 6,31 g af trimethylsilylchlorid til denne suspension. Blandingen blev afkølet til 5° C efterfulgt af dråbevis tilsætning ag 6,04 g triethylamin ved samme temperatur i løbet af 15 minutter og omrøring ved 10 - 15° C i 90 minutter, indtil reaktionen var fuldført. Derpå blev reaktionsblandingen afkølet til -20° C, der tilsattes 2,18 g dimethylformamid, og derpå tilsattes dråbevis 3,25 g trichlormethylchlorformiat i løbet af 15 minutter. Den resulterende blanding fik lov at reagere ved samme temperatur i 120 minutter.TCK.qRMPKT. 10.0 g of D (-) -oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetic acid was suspended in 60 ml of anhydrous methylene chloride and 6.31 g was added. of trimethylsilyl chloride for this suspension. The mixture was cooled to 5 ° C followed by dropwise addition of 6.04 g of triethylamine at the same temperature over 15 minutes and stirring at 10 - 15 ° C for 90 minutes until the reaction was complete. Then, the reaction mixture was cooled to -20 ° C, 2.18 g of dimethylformamide was added and then 3.25 g of trichloromethyl chloroformate was added dropwise over 15 minutes. The resulting mixture was allowed to react at the same temperature for 120 minutes.

På den anden side blev 10,0 g af 7-amino-3-[5-(1-methyl-l,2,3,4-tetrazolyl)thiomethyl]-Z\ ^-cephem-4-carboxylsyre suspenderet i 90 ml vandfrit methylenchlorid, og der sattes trimethylsilylchlorid til denne suspension under isafkøling. Til blandingen sattes dråbevis 7,40 gtriethylamin i løbet af 20 minutter, hvorpå den fik lov at reagere ved samme temperatur i 60 minutter. Derefter sattes denne blanding dråbevis til den ovenstående reaktionsblanding ved mellem -15 og 10° C i løbet af 30 minutter, og blandingen fik lov at reagere ved samme temperatur i omkring 90 minutter. Efter at reaktionstemperaturen var hævet til 0° C, tilsattes 6,69 g metha- 163 151338 nol. Blandingen fik lov at reagere yderligere ved 0° C i 30 minutter og hældtes derpå ud i 280 ml vandig opløsning af 10,0 g natriumhydrogencarbonat. Den resulterende opløsning blev adskilt i et vandigt lag og et organisk lag. Det organiske lag blev extra-heret med 20 ml 3% vandig natriumhydrogencarbonatopløsning, og ekstrakten sattes til det ovennævnte vandige lag. Til den kombinerede vandige opløsning sattes 130 ml acetonnitril. Efter at blandingen var indstillet til pH 5,0 ved tilsætning af 6N saltsyre, tilsattes 4 g aktiv kul, og blandingen blev filtreret. Filtratet blev opvarmet til 40° C, indstillet til pH 2,0 ved tilsætning af 6N saltsyre, omrørt ved 35° C i 120 minutter og ved 25° C i 60 minutter og derpå afkølet med is til udfældning af krystaller. De udfældede krystaller blev opsamlet ved filtrering, vasket med 20 ml 20% vandig aceonitrilopløsning og tørret, hvorved der blev opnået 15,9 g krystaller af 7-[D(-)-oc-(4-ethyl-2,3-dioxo-l-pi-perazinocarbonylamino)-p-hydroxyphenyl-acetamido]-3-[5-(1-me-thyl-1,2,3,4-tetrazolyl)thiomethyl] -Δ ^-cephem-4-carboxylsyre, smp.(dokomp.) 170 - 171° C, udbytte 78,3%.On the other hand, 10.0 g of 7-amino-3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] -Z 2 -cephem-4-carboxylic acid was suspended in 90 ml. anhydrous methylene chloride and trimethylsilyl chloride was added to this suspension under ice cooling. To the mixture was added dropwise 7.40 g of triethylamine over 20 minutes and then allowed to react at the same temperature for 60 minutes. Then, this mixture was added dropwise to the above reaction mixture at between -15 and 10 ° C over 30 minutes, and the mixture was allowed to react at the same temperature for about 90 minutes. After the reaction temperature was raised to 0 ° C, 6.69 g of methanol was added. The mixture was allowed to react further at 0 ° C for 30 minutes and then poured into 280 ml of aqueous solution of 10.0 g of sodium bicarbonate. The resulting solution was separated into an aqueous layer and an organic layer. The organic layer was extracted with 20 ml of 3% aqueous sodium hydrogen carbonate solution and the extract was added to the above aqueous layer. To the combined aqueous solution was added 130 ml of acetonitrile. After the mixture was adjusted to pH 5.0 by the addition of 6N hydrochloric acid, 4 g of activated carbon was added and the mixture was filtered. The filtrate was heated to 40 ° C, adjusted to pH 2.0 by the addition of 6N hydrochloric acid, stirred at 35 ° C for 120 minutes and at 25 ° C for 60 minutes, and then cooled with ice to precipitate crystals. The precipitated crystals were collected by filtration, washed with 20 ml of 20% aqueous aononitrile solution and dried to give 15.9 g of crystals of 7- [D (-) - oc- (4-ethyl-2,3-dioxo- 1-piperazinocarbonylamino) -p-hydroxyphenyl-acetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] -α-cephem-4-carboxylic acid, m.p. 170 DEG-171 DEG C., yield 78.3%.

NMR (dg-acetone τ D20) værdier 8,9 (3H, t), 6,8 - 6,3 (4H, m), 6,2 - 5,9 (7H, m), 5,78 (2H, ABq), 5,04 (IH, d), 4,58 (IH, s), 4,31 (IH, d), 3,08 (4H, A2B2q) EKSEMPEL 46 i 70 ml methylenchlorid suspenderedes 3,5 g 6-[D(-)-a-aminophenyl-acetamido]penicillansyre, og derpå tilsattes 2,2 g triethylamin for at omdanne suspensionen til opløsning. Til den resulterende opløsning tilsattes dråbevis en opløsning af 2,28 g 4-ethyl-2-oxo-1-piperazinocarbonylchlorid i 10 ml methylenchlorid ved 5 -10° C. Efter at blandingen havde fået lov at reagere i yderligere en time, blev opløsningsmidlet afdestilleret, og remanensen opløst i 30 ml vandig natriumchlorid opløsning. Til den resulterende opløsning tilsattes 50 ml acetonitril, og pH-værdien indstilledes til 3,0 med 2N saltsyre. Acetonitrillaget blev vasket med en vandig na-triumchloridopløsning, hvorefter opløsningsmidlet blev afdestilleret 164 151338 til opnåelse af 2,61 g (udbytte 50%) rå krystaller. Krystallerne blev opløst i tetrahydroforan og derpå renset ved hjælp af "Sepha-dex (S)LH-20" (fremstillet af Fine Chemical Company, udviklingsopløsningsmiddel; tetrahydroforan), hvorved der blev opnået 6-[D (-)-a-(4-ethyl-2-oxo-l-piperazinocarbonylamino)phenylacetamido]-penicillansyre, smp. 169 - 170° C (dekomp.).NMR (dg-acetone τ D 2 O) values 8.9 (3H, t), 6.8 - 6.3 (4H, m), 6.2 - 5.9 (7H, m), 5.78 (2H, ABq), 5.04 (1H, d), 4.58 (1H, s), 4.31 (1H, d), 3.08 (4H, A2B2q) EXAMPLE 46 in 70 ml of methylene chloride was suspended 3.5 g of - [D (-) - α-aminophenyl-acetamido] penicillanic acid, then 2.2 g of triethylamine was added to convert the suspension into solution. To the resulting solution was added dropwise a solution of 2.28 g of 4-ethyl-2-oxo-1-piperazinocarbonyl chloride in 10 ml of methylene chloride at 5-10 ° C. After the mixture was allowed to react for an additional hour, the solvent was distilled off and the residue dissolved in 30 ml of aqueous sodium chloride solution. To the resulting solution was added 50 ml of acetonitrile and the pH was adjusted to 3.0 with 2N hydrochloric acid. The acetonitrile layer was washed with an aqueous sodium chloride solution and the solvent was distilled off to obtain 2.61 g (yield 50%) of crude crystals. The crystals were dissolved in tetrahydroforan and then purified by "Sepha-dex (S) LH-20" (manufactured by Fine Chemical Company, developing solvent; tetrahydroforan) to give 6- [D (-) - α- (4) -ethyl-2-oxo-1-piperazinocarbonylamino) phenylacetamido] -penicillanic acid, m.p. 169 DEG-170 DEG C. (decomp.).

IR (KBr) cm"1;'^=0 1765, 1700 - 1665 NMR (dg-DMSO) ppm værdier : 1.01 ( 3H, t, CH3CH2), 1,40 (3H, s, C2-CH3), 1,55 ( 3H, s, C2-CH3), 2,50 (2H, m, CH3CH2), 2,70 ( 2H, m, piperazinring C3-CH2), 3,28 (2H, s, piperazinring C3-CH2J, 3,60 (2H, m, piperazinring ^ Cg-CH2), 4,18 (IH, s, C3-H), 5,30 - 5,76 (3H, m, C5>6_Ca a-H) 7,35 (5H, s, C6H5), 9,20 (IH, d, NH), 10.1 (IH, d, NH),IR (KBr) cm "1; δ = 0 1765, 1700 - 1665 NMR (d 6 -DMSO) ppm values: 1.01 (3H, t, CH 3 CH 2), 1.40 (3H, s, C 2 -CH 3), 1, 55 (3H, s, C2-CH3), 2.50 (2H, m, CH3CH2), 2.70 (2H, m, piperazine ring C3-CH2), 3.28 (2H, s, piperazine ring C3-CH2J, 3 , 60 (2H, m, piperazine ring + Cg-CH2), 4.18 (1H, s, C3-H), 5.30 - 5.76 (3H, m, C5> 6_Ca aH) 7.35 (5H, s, C6H5), 9.20 (1H, d, NH), 10.1 (1H, d, NH),

De følgende forbindelser blev fremstillet på samme måde som ovenfor ved passende udvælgelse af udgangsforbindelser med formlen (II) og reaktive derivater af forbindelser med formlen (III): 6-[D(-)-a-(4-methyl-2-0X0-l-piperazinocarbonylamino)-phenylacetamido ]penicillansyre,The following compounds were prepared in the same manner as above by appropriate selection of starting compounds of formula (II) and reactive derivatives of compounds of formula (III): 6- [D (-) - α- (4-methyl-2-OXO- 1-piperazinocarbonylamino) -phenylacetamido] penicillanic acid,

Smp.: 160 - 164° C (dekomp.) IR (KBr) cm"1: γ C=0 1765, 1700 -1665; 6-[D(-)-cl-(4-n-propyl-2-oxo-l-piperazinocarbonylamino)-phenylacetamido ]penicillansyre,Mp: 160 - 164 ° C (decomp.) IR (KBr) cm -1: γ C = 0 1765, 1700 -1665; 6- [D (-) - c1- (4-n-propyl-2-oxo) (1-piperazinocarbonylamino) -phenylacetamido] penicillanic acid,

Smp.: 164 - 165° C (dekomp.) IR (KBr) cm"1: γ C=Q 1765, 1700 -1665; 6-[D(-)-a-(4-ethyl-2-oxo-l-piperazinocarbonylamino)-p-hydroxyphenylacetamido jpenicillansyre,Mp: 164 - 165 ° C (decomp.) IR (KBr) cm -1: γ C = Q 1765, 1700 -1665; 6- [D (-) - α- (4-ethyl-2-oxo-1) -piperazinocarbonylamino) -p-hydroxyphenylacetamidojpenicillanic acid,

Smp.: 167 - 169°C (dekomp.) IR (KBr) cm : γ c=0 17?0> 1?00 _ l665 6- [d( -) -cl- (4-ethyl-2-oxo-l-piperazinocarbonylamino) - 2-thienylacetamido)penicillansyre, K5 151338Mp: 167 - 169 ° C (decomp.) IR (KBr) cm: γ c = 0.176.0> 0000665 6- [d (-) -cl- (4-ethyl-2-oxo- 1-piperazinocarbonylamino) -2-thienylacetamido) penicillanic acid, K5 151338

Smp.: 164 - 167° C (dekomp.) IR (KBr) cm 1: ^ c=0 1770, 1700 - 1665 EKSEMPEL 47 I 15 ml 80% vandigt tetrahydrofuran suspenderedes 1,0 g 6-[D (-) -oc-aminophenylacetamido Jpenicillansyre-trihydrat, og der tilsattes dråbevis triethylamin under omrøring til indstilling af pH-værdien til 8,0 - 8,5. Den resulterende opløsning blev afkølet til 10° C, og der tilsattes 530 mg 4-ethyl-3-oxo-l- piperazinocarbonyl chlorid under tildrypning af triethylamin for at holde pH-værdien ved 7,5 - 8,0. Ved den samme temperatur fik reaktionen lov at forløbe i en time, hvorefter tetra-hydrofuranet blev afdestilleret, og der tilsattes 10 ml vand og 15 ml ethyl acetat til remanensen, hvorved denne opløstes i vandet. Den resulterende opløsning tilsattes fortyndet saltsyre for at indstille pH-værdien til 2,0. Derefter blev ethyl acetatlaget skilt fra, vasket grundigt med vand og koncentreret til 2/3 af begyndelsesvolumenet, hvorefter de udfældede krystaller blev opsamlet ved filtrering, hvorved der blev opnået 1,0 g (udbytte 80%) 6-[D(-)-oc-(4-ethyl-3-oxo-l-piperazi-nocarbonylamino)-phenylacetamido]penicillansyre smp. 190 -191° C.Mp: 164 - 167 ° C (decomp.) IR (KBr) cm 1:: c = 0 1770, 1700-1665 EXAMPLE 47 In 15 ml of 80% aqueous tetrahydrofuran, 1.0 g of 6- [D (-) - oc-aminophenylacetamido Jpenicillanic acid trihydrate, and triethylamine was added dropwise with stirring to adjust the pH to 8.0 - 8.5. The resulting solution was cooled to 10 ° C and 530 mg of 4-ethyl-3-oxo-1-piperazinocarbonyl chloride was added under the drop of triethylamine to keep the pH at 7.5 - 8.0. At the same temperature, the reaction was allowed to proceed for one hour, after which the tetrahydrofuran was distilled off and 10 ml of water and 15 ml of ethyl acetate were added to the residue and dissolved in the water. The resulting solution was added with dilute hydrochloric acid to adjust the pH to 2.0. Then, the ethyl acetate layer was separated, washed thoroughly with water and concentrated to 2/3 of the initial volume, then the precipitated crystals were collected by filtration to give 1.0 g (yield 80%) of 6- [D (-) - o- (4-ethyl-3-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid m.p. 190 -191 ° C.

IR (KBr) cm"1: / C=0 1770 (^tam), 1735 (-C00H), 1680 - 1620 (-C0NH-).IR (KBr) cm -1: C = 0 1770 (µm), 1735 (-C00H), 1680 - 1620 (-CONH-).

På samme måde som beskrevet ovenfor fremstilledes de følgende forbindelser ved passende udvælgelse af udgangsforbindelser med formlen (II) og reaktive derivater- af forbindelser med formlen (III): 6-[D(-)-a-(3-oxo-l-piperazinocarbonylamino)-phenyl-acetamido ]penicillansyr e,In the same manner as described above, the following compounds were prepared by appropriate selection of starting compounds of formula (II) and reactive derivatives of compounds of formula (III): 6- [D (-) - α- (3-oxo-1-piperazinocarbonylamino ) -phenyl-acetamido] penicillanic acid e,

Smp.: 172 - 173° C (dekomp.); 6- [Di -)—ex— (4-methyl-3-oxo-l-piperazinocarbonylami-no) -phenylacetamido ]penicillansyre,Mp: 172 - 173 ° C (decomp); 6- [Di -) - ex- (4-methyl-3-oxo-1-piperazinocarbonylamino) -phenylacetamido] penicillanic acid,

Smp.: 196 - 197° C (dekomp.); 6-[D(-)-a-(4-n-propyl-3-oxo-l-piperazinocarbonyl-amino )phenylacetamido ]penicillansyre, 166 151338Mp: 196 - 197 ° C (decomp); 6- [D (-) - α- (4-n-propyl-3-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid, 166 151338

Smp.: I65 - 166° C (dekomp.); 6-[D(-)-a-(4-benzyl-3-oxo-l-piperazinocarbonylami-no )phenylacetamido )penicillansyr e,Mp: I65 - 166 ° C (decomp); 6- [D (-) - α- (4-Benzyl-3-oxo-1-piperazinocarbonylamino) phenylacetamido) penicillanic acid e,

Smp.: 148 - 149° C (dekomp.); 6-[D(-)-a-(4-n-butyl-3-oxo-l-piperazinocarbonylami-no )phenylacetamido ]penicillansyre,Mp: 148 - 149 ° C (decomp); 6- [D (-) - α- (4-n-butyl-3-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid,

Smp.: 144 - 146° C (dekomp.); 6-[D(- )-a- (4-ethyl-3-oxo-l-piperazinocarbonylamino)-p-hydroxyphenylacetamido ]penicillansyre,Mp: 144 - 146 ° C (decomp); 6- [D (-) -a- (4-ethyl-3-oxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] penicillanic acid,

Smp.: 189 - 191° C (dekomp.) IR (KBr) cm"1: / C=Q 1775 (lactam), 1735 (-COGH), 1680 - 1620 (-C0NH-); 6- [D (-) - a- (4-ethyl-3-oxo-l-piperazinocarbonylamino)- 2-thienylaeetamido]penicillansyre,Mp: 189 - 191 ° C (decomp.) IR (KBr) cm -1: C = Q 1775 (lactam), 1735 (-COGH), 1680 - 1620 (-CONH-); 6- [D (- ) - α- (4-Ethyl-3-oxo-1-piperazinocarbonylamino) -2-thienylate etamido] penicillanic acid,

Smp.: 183 - 187° C (dekomp.) IR (KBr) cm"1: γ C=01775 (laatam)> 1735 (-C0QH), 1680 - 1620 (-CCMH).Mp: 183 - 187 ° C (decomp.) IR (KBr) cm -1: γ C = 01775 (latam)> 1735 (-COQH), 1680-1620 (-CCMH).

EKSEMPEL 48 I en blanding af 25 ml vandfrit methylenchlorid og 6 ml dimethyl-formamid opløses 3>44 g natriumsalt af D(-)-α-(4-ethyl-2-oxo-l-piperazinocarbonylamino ) -p-hydroxyphenyleddikesyre, og der til-sattes en dråbe N-methylmorpholin. Den resulterende opløsning blev afkølet til mellem -15 og - 10° C. Til opløsningen sattes dråbevis 1,14 g ethylchlorcarbonat i løbet af 5 minutter, og reaktionen fik lov at foregå i en time ved samme temperatur. Derefter tilsattes 1,22 ml N,O-bis(trimethylsilyl)acetamid, og den resulterende blanding blev afkølet til -20°C.EXAMPLE 48 In a mixture of 25 ml of anhydrous methylene chloride and 6 ml of dimethylformamide dissolve 3> 44 g of sodium salt of D (-) - α- (4-ethyl-2-oxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetic acid and a drop of N-methylmorpholine was added. The resulting solution was cooled to between -15 and -10 ° C. To the solution was added dropwise 1.14 g of ethyl chlorocarbonate over 5 minutes and the reaction allowed to proceed for one hour at the same temperature. Then 1.22 ml of N, O-bis (trimethylsilyl) acetamide was added and the resulting mixture was cooled to -20 ° C.

På den anden side blev 3,28 g 7- amino-3-[5-(l-methyl-l,2,3, 4-tetrazolyl)thiomethyl]--cephem-4-carboxylsyre suspenderet i 50 ml methylenchlorid, og der tilsattes 3»66 ml N,O-bis(tri-methylsilyl)acetamid til opnåelse af en opløsning, som derefter blev afkølet til -20° C. Denne opløsning sattes til den ovennævnte blanding afkølet til -20°C, og den resulterende blanding fik lov at reagere ved mellel 15 og -10° C i to timer og derpå ved mellem -5 og 0° C i to timer timer.On the other hand, 3.28 g of 7- amino-3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] cephem-4-carboxylic acid was suspended in 50 ml of methylene chloride, and 3, 66 ml of N, O-bis (trimethylsilyl) acetamide were added to give a solution which was then cooled to -20 ° C. This solution was added to the above mixture cooled to -20 ° C and the resulting mixture was allowed to react at between 15 and -10 ° C for two hours and then at between -5 and 0 ° C for two hours.

167 1 5 1 3 38167 1 5 1 3 38

Derefter blev opløsningsmidlet afdestilleret, og remanensen tilsattes 30 ml mættet vandig natriumchloridopløsning og 50 ml acetonitril, og den resulterende blanding blev omrørt i en time, hvorefter der tilsattes natriumhydrogencarbonat for at indstille pH-værdien til 3,0. Acetonitrillaget blev vasket med en mættet vandig natriumchloridopløsning, opløsningsmidlet blev af destilleret. Der sattes ether til remanensen, og blandingen blev filtreret, hvorved der blev opnået 3,3 g (udbytte 52,1%) 7- [D(- )-a- (4-ethyl-2-oxo-l-piperazinocarbonylamino) -p-hydroxy-phenylacetamido]-3-[5-(1-methyl-l,2,3,4-tetrazolyl)thiomethyl]-^^-cephem-4-carboxylsyre, smp. 120° - 123° C (dekomp.).Then, the solvent was distilled off and the residue was added to 30 ml of saturated aqueous sodium chloride solution and 50 ml of acetonitrile, and the resulting mixture was stirred for one hour, then sodium bicarbonate was added to adjust the pH to 3.0. The acetonitrile layer was washed with a saturated aqueous sodium chloride solution, the solvent was distilled off. Ether was added to the residue and the mixture was filtered to give 3.3 g (yield 52.1%) of 7- [D (-) -a- (4-ethyl-2-oxo-1-piperazinocarbonylamino) - p-hydroxy-phenylacetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] - cephem-4-carboxylic acid, m.p. 120 ° - 123 ° C (decomp.).

IR (KBr) cm-1: y'' C=0 1770, 1715 - 1660.IR (KBr) cm -1: δ C = 0 1770, 1715 - 1660.

EKSEMPEL· 49 (1) I 20 ml vandfrit methylenchlorid suspenderedes 1,72 g 2,3-di-oxo-l-piperazinoeddikesyre, og der tilsattes dråbesvis 2,38 g trimethylsilylchlorid og 2,22 g triethylamin i. denne rækkefølge ved stuetemperatur, hvorefter den resulterende blanding fik lov at reagere i 1,5 timer ved samme temperatur. Derefter blev reaktionsopløsningen afkølet til -50° C, og der tilsattes dråbevis 1,0 g trichlormethylchloroformiat, hvorefter opløsningen fik lov at reagere ved samme temperatur i 30 minutter og ved -30° C i en time. Derefter blev opløsningens temperatur hævet til stuetemperatur i løbet af en time for at fuldføre reaktionen. Opløsningsmidlet blev derefter afdestilleret under formindsket tryk til opnåelse af krystaller.EXAMPLE 49 (1) In 20 ml of anhydrous methylene chloride, 1.72 g of 2,3-dioxo-1-piperazinoacetic acid were suspended and 2.38 g of trimethylsilyl chloride and 2.22 g of triethylamine were added dropwise in this order at room temperature. after which the resulting mixture was allowed to react for 1.5 hours at the same temperature. The reaction solution was then cooled to -50 ° C and 1.0 g of trichloromethyl chloroformate was added dropwise, after which the solution was allowed to react at the same temperature for 30 minutes and at -30 ° C for one hour. Then, the solution temperature was raised to room temperature over an hour to complete the reaction. The solvent was then distilled off under reduced pressure to obtain crystals.

På den anden side blev 1,5 g D8-)-a-aminophenyleddikesyre suspenderet i 30 ml vandfrit methylenchlorid, og der blev tildryppet 2,4 g trimethylsilylchlorid og 2,1 g triethylamin i denne rækkefølge ved stuetemperatur. Den resulterende blanding fik lov at reagere ved denne temperatur i en time til fuldførelse af sily-leringen. Derefter blev reaktionsopløsningen afkølet til -40° C, og der tilsattes dråbevis en opløsning af de ovenfor opnåede krystaller i 40 ml vandfrit methylenchlorid. Den resulterende blanding fik lov at reagere ved denne temperatur i 30 minutter og ved 0° C i en time, hvorefter blandingens temperatur blev hævet til stuetemperatur i løbet af 30 minutter for at fuldføre reaktionen.On the other hand, 1.5 g of D8 -) - α-aminophenylacetic acid was suspended in 30 ml of anhydrous methylene chloride and 2.4 g of trimethylsilyl chloride and 2.1 g of triethylamine were added dropwise at room temperature. The resulting mixture was allowed to react at this temperature for one hour to complete the silylation. Then, the reaction solution was cooled to -40 ° C and a solution of the crystals obtained above in 40 ml of anhydrous methylene chloride was added dropwise. The resulting mixture was allowed to react at this temperature for 30 minutes and at 0 ° C for one hour, after which the temperature of the mixture was raised to room temperature over 30 minutes to complete the reaction.

168 1 5 1 3 38168 1 5 1 3 38

Derefter indførtes reaktionsopløsningen i 30 ml vand, og den resulterende blandings pH-værdi blev indstillet til 1,0 med 2N-saltsyre. Det organiske lag blev skilt fra og tilsat 30 ml vand, hvorefter blandingens pH-værdi blev indstillet til 8,0 med en mættet vandig natriumhydrogencarbonatopløsning. Den resulterende blanding fik lov at stå, og det vandige lag blev skilt fra og tilsat 30 ml ethylacetat, og derpå tilsattes 2Nsaltsyre til indstilling pH-værdien til 1,0. Det organiske lag blev skilt fra, vasket med 20 ml mættet natriumchloridopløsning og tørret over vandfrit magnesiumsulfat. Opløsningsmidlet blev af destilleret under formindsket tryk, og remanensen blev behandlet med diethylether, hvorved der blev opnået 3,0 g (udbytte 85%) hvide krystaller D(-)-a-(4-carboxymethyl-2,3-dioxo-l-piperazinocarbonylamino )phenyleddikesy-re, smp. 70 - 75° C.Then, the reaction solution was introduced into 30 ml of water and the pH of the resulting mixture was adjusted to 1.0 with 2N hydrochloric acid. The organic layer was separated and 30 ml of water was added, after which the pH of the mixture was adjusted to 8.0 with a saturated aqueous sodium bicarbonate solution. The resulting mixture was allowed to stand and the aqueous layer was separated and added with 30 ml of ethyl acetate, then 2N hydrochloric acid was added to adjust the pH to 1.0. The organic layer was separated, washed with 20 ml of saturated sodium chloride solution and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was treated with diethyl ether to give 3.0 g (yield 85%) of white crystals D (-) - α- (4-carboxymethyl-2,3-dioxo-1 piperazinocarbonylamino) phenylacetic acid, m.p. 70 - 75 ° C.

IR (KBr) cm"1: / ^3300 Y c=01270 (“C00H)> 1710 -1685 (-CON C) NMR (dg-DMSO) ppm værdier: 3,45 - 4,30 (4H, m >CEZ x 2) 4,17 (2H, s, 3CH2), 5,38 (IH, d, ^CH), 7,40 (5H, s, aromatisk proton), 9,80 (IH, d,^NH).IR (KBr) cm "1: 3300 Y c = 01270 (" C00H)> 1710 -1685 (-CON C) NMR (dg-DMSO) ppm values: 3.45 - 4.30 (4H, m> CEZ x 2) 4.17 (2H, s, 3CH2), 5.38 (1H, d, 1CH), 7.40 (5H, s, aromatic proton), 9.80 (1H, d, 1H).

169 151338169 151338

Den resulterende blandings pH-værdi blev indstillet til 8,0 med natriumhydrogencarbonat. Det vandige lag blev skilt fra, der tilsattes 30 ml methylenchlorid, og blandingens pH-værdi blev indstillet til 1,0 med 2Nsaltsyre. Det organiske lag blev skilt fra, vasket med 20 ml mættet vandige natriumchloridopløsning, og tørret over vandfrit magnesiumsulfat og inddampet under formindsket tryk. Remanensen blev renset ved søjlechromatografi (elueret med benzen/ethylacetat), hvorved der blev opnået 2,1 g (udbytte 34,8%) hvide krystaller af 7-[D(-)-oc-(4-carboxymethyl-2,3-dioxo-l-pipe-razinocarbonylamino)-phenylacetamido]-3-acetoxymethyl-A ^-cephem- 4-carboxylsyre, smp. 185 - 190° C (dekomp.) IR (KBr) cm"1: \f NH 3300 V c=o 1775, 1720 - 1665The pH of the resulting mixture was adjusted to 8.0 with sodium bicarbonate. The aqueous layer was separated, 30 ml of methylene chloride was added and the pH of the mixture was adjusted to 1.0 with 2N hydrochloric acid. The organic layer was separated, washed with 20 ml of saturated aqueous sodium chloride solution, and dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by column chromatography (eluted with benzene / ethyl acetate) to give 2.1 g (yield 34.8%) of white crystals of 7- [D (-) - oc- (4-carboxymethyl-2,3- dioxo-1-piperazinocarbonylamino) -phenylacetamido] -3-acetoxymethyl-Δ-cephem-4-carboxylic acid, m.p. 185 DEG-190 DEG C. (decomp.) IR (KBr) cm "1: δ NH 3300 V c = 0 1775, 1720 - 1665

Forbindelser med formlen (IV) og reaktive derivater af forbindelser med formlen (V) blev udvalgt og omsat på samme måde som beskrevet ovenfor til opnåelse af de følgende forbindelser: 7- [D(- )-oc- [4-(2-carboxyethyl)-2,3-dioxo-l-piperazi-nocarbonylamino]phenylacetamido]-3-acetoxymethyl- Δ cephem-4-earboxylsyre.Compounds of formula (IV) and reactive derivatives of compounds of formula (V) were selected and reacted in the same manner as described above to give the following compounds: 7- [D (-) -oc- [4- (2-carboxyethyl) ) -2,3-dioxo-1-piperazinocarbonylamino] phenylacetamido] -3-acetoxymethyl-Δcephem-4-earboxylic acid.

Smp.: 150 - 155° C (dekomp.) IR (KBr) cm-1: ^/^^1773 (lactam), ’ 1720 - 1685 (-CONO; 7-[D(-)-a-(4-carboxymethyl-2,3-dioxo-l-piperazino-carbonylamino )phenylacetamido ]-3- [5- (l-methyl-1,2,3, 4-tetrazolyl)thiomethyl]- A^-cephem-4-carboxylsyre,Mp: 150 - 155 ° C (decomp.) IR (KBr) cm -1: 177 (lactam), 1720-1685 (-CONO; 7- [D (-) - α- carboxymethyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] -α-cephem-4-carboxylic acid,

Smp.: 170 - 175° C (dekomp.) IR (KBr) cm-1: \/ ¢=01^0 (lac'tam)> ^ 1720 - 1680 (-CON -); 7-{D(-)-a-[4-(2-carboxyethyl)-2,3-dioxo-l-piperazi-nocarbonylamino]phenylacetamido}3-[5-(l-methyl-1, 2,3,4-tetrazolyl)thiomethyl]-Δ -cephem-4-carboxyl-syre,Mp: 170 - 175 ° C (decomp.) IR (KBr) cm -1: λ = δ = 0 (lac'tam)> 1720 - 1680 (-CON -); 7- {D (-) - α- [4- (2-carboxyethyl) -2,3-dioxo-1-piperazinocarbonylamino] phenylacetamido} 3- [5- (1-methyl-1,2,3,4 -tetrazolyl) thiomethyl] -Δ-cephem-4-carboxylic acid,

Smp.: 162 - 165° C (dekomp.) IR (KBr) cm-1: n n1770 (lactam) 1 υ=υ1710 - 1680 (-C0N<); 170 151338 7-(d(-)-a-[4-(3-carboxypropyl)-2,3-dioxo-l-pipera-zinocarbonylamino ]phenylacetamido}-3- [5-(l-methyl- 1,2,3,4-tetrazolyl)thiomethyl]-^ -cephem-4-carb°xyl-syre,Mp: 162 - 165 ° C (decomp.) IR (KBr) cm -1: n n1770 (lactam) 1 υ = υ1710 - 1680 (-CON <); 7- (d (-) - α- [4- (3-carboxypropyl) -2,3-dioxo-1-piperazinocarbonylamino] phenylacetamido} -3- [5- (1-methyl-1,2, 3,4-tetrazolyl) thiomethyl] -cephem-4-carboxylic acid,

Smp.: 145° C (dekomp.) IR (KBr) cm-1: v / c=01775 (lactam)> A ~ 1720 - 1680 (-C0NC).Mp: 145 ° C (decomp.) IR (KBr) cm -1: v / c = 01775 (lactam)> A ~ 1720 - 1680 (-CONC).

EKSEMPEL 50 (1) I 70 ml vandfrit methylenchlorid suspenderedes 3,4 g D-(-)-phenylglycin, og der tilsattes 6 ml trimethylsilylchlorid, hvorefter der blev tildryppet 6,26 ml triethylamin. Den resulterende blanding fik lov at reagere ved stuetemperatur i en time. Derefter tilsattes 4-éthyl-6S-methyl-2,3-dioxo-l-piperazinocarbonyl-chlorid under isafkøling, og den resulterende fik lov at reagere ved stuetemperatur i 1,5 timer. Til reaktionsproduktet sattes 50 ml vand, og blandingen blev omrørt i en time. De udfældede krystaller blev opsamlet ved filtrering, vasket med vand og tørret, hvorefter de blev underkastet azeotrop dehydratisering med 150 ml toluen, hvorved der blev opnået 6,2 g (udbytte 90,78%) D(-)-a- (4-ethyl-6S-methyl-2,3-dioxo-l-piperazinocarbonylamino )phenyl-eddikesyre, IR (KBr) cm”1: >/μϊι3300 ^J®01710. 1660 (2) i 10 ml methylenchlorid suspenderedes 0,6 g D(-)-a-(4-ethyl-6S-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre og der tilsattes 0,189 ml N-methyl-morpholin til dannelse af en opløsning. En blanding af 0,18 ml ethylchlorcarbonat og 1 ml methylenchlorid blev dryppet til blandingen ved -15° C. Opløsningen fik lov at reagere ved samme temperatur i 90 minutter og derpå afkølet til -30° C. Til opløsningen sattes dråbevis en opløsning af 0,7 g af triethylaminsaltet af 6-aminopenicillansyre i 10 ml methylenchlorid ved mellem -25 og -30° C i løbet af 10 minutter, Den resulterende opløsning fik lov at reagere ved mellem -25 og -15° C i 60 minutter og derpå ved mellem -15 og 0° C i 30 minutter, hvorefter opløsningsmidlet blev afdestilleret under formindsket tryk, og remanensen blev opløst i 20 ml 1% vandig na- 151338 171 triumhydrogencarbonat opløsning og vasket med ethylacetat. Der tilsattes yderligere 30 ml ethylacetat og den resulterende blandings pH-værdi blev indstillet til 2,0 med 2Nsaltsyre under isafkøling. Det organiske lag blev skilt fra, vasket grundigt med vand, tørret over vandfrit magnesiumsulfat, og opløsningsmidlet derefter afdestilleret under formindsket tryk, hvorved der blev opnået 0,7 g (udbytte 72,4%) 6-[D(-)-a-(4-ethyl-6S-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamido]-penicillansyre.EXAMPLE 50 (1) In 70 ml of anhydrous methylene chloride, 3.4 g of D - (-) - phenylglycine was suspended and 6 ml of trimethylsilyl chloride were added and then 6.26 ml of triethylamine was added. The resulting mixture was allowed to react at room temperature for one hour. Then, 4-ethyl-6S-methyl-2,3-dioxo-1-piperazinocarbonyl chloride was added under ice-cooling, and the resulting was allowed to react at room temperature for 1.5 hours. To the reaction product was added 50 ml of water and the mixture was stirred for one hour. The precipitated crystals were collected by filtration, washed with water and dried, then subjected to azeotropic dehydration with 150 ml of toluene to give 6.2 g (yield 90.78%) of D (-) - α- (4- ethyl 6S-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid, IR (KBr) cm -1:> / μϊι3300 1660 (2) in 10 ml of methylene chloride was suspended 0.6 g of D (-) - α- (4-ethyl-6S-methyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetic acid and 0.189 ml of N-methyl-morpholine was added. to form a solution. A mixture of 0.18 ml of ethyl chlorocarbonate and 1 ml of methylene chloride was added dropwise to the mixture at -15 ° C. The solution was allowed to react at the same temperature for 90 minutes and then cooled to -30 ° C. To the solution was added dropwise a solution of 0 7 g of the triethylamine salt of 6-aminopenicillanic acid in 10 ml of methylene chloride at between -25 and -30 ° C over 10 minutes. The resulting solution was allowed to react at between -25 and -15 ° C for 60 minutes and then at between -15 and 0 ° C for 30 minutes, after which the solvent was distilled off under reduced pressure and the residue was dissolved in 20 ml of 1% aqueous sodium hydrogen carbonate solution and washed with ethyl acetate. An additional 30 ml of ethyl acetate was added and the pH of the resulting mixture was adjusted to 2.0 with 2N hydrochloric acid under ice-cooling. The organic layer was separated, washed thoroughly with water, dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure to give 0.7 g (yield 72.4%) of 6- [D (-) - (4-ethyl-6 S-methyl-2,3-dioxo-l-piperazinocarbonylamino) phenylacetamido] -penicillanic acid.

IR (KBr) cm-1: VC=0 1770 ’ 1710’ 1680 NMR (dg-DMSO) værdier: 8,88 (3H, t, CH3), 8,75 (3H, d, CH3), 8,58 (3H, s, CH3), 8,44 (3H, s, CH3), 5,85 - 6,85 (4H, m, CH2 x 2), 5,84 (IH, s, CH), 4,60 (IH, m, CH), 4,48 - 5,85 (2H, m, CH x 2), 4,32 (IH, d, CH), 2,67 (5H, s, C6H5), 0,79 (IH, d, NH), 0,15 (IH, d, NH)IR (KBr) cm -1: VC = 0 1770 '1710' 1680 NMR (d 6 -DMSO) values: 8.88 (3H, t, CH 3), 8.75 (3H, d, CH 3), 8.58 ( 3H, s, CH 3), 8.44 (3H, s, CH 3), 5.85 - 6.85 (4H, m, CH 2 x 2), 5.84 (1H, s, CH), 4.60 ( 1H, m, CH), 4.48 - 5.85 (2H, m, CH x 2), 4.32 (1H, d, CH), 2.67 (5H, s, C6H5), 0.79 ( 1H, d, NH), 0.15 (1H, d, NH)

Den samme procedure som beskrevet ovenfor blev gentaget, undtagen at der anvendtes andre reaktive derivater af forbindelser med formlen (V) i stedet for D(-)-a-(4-ethyl-6S-methyl-2,3-dioxo-l-piperazinocarbonylamino)phenyleddikesyre til opnåelse af de følgende forbindelser: 6-[D(-)-a-(4-ethyl-6S-ethyl-2,3-dioxo-l-piperazino-carbonylamino )phenylacetamido ]-penicillansyre,The same procedure as described above was repeated except that other reactive derivatives of compounds of formula (V) were used instead of D (-) - α- (4-ethyl-6S-methyl-2,3-dioxo-1- piperazinocarbonylamino) phenylacetic acid to give the following compounds: 6- [D (-) - α- (4-ethyl-6S-ethyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 156° C (dekomp.) IR (KBr) vnf1: Yc=0 1780, 1710» l67°’* 6-[D(-)-a-(4-ethyl-6S-n-propyl-2,3-dioxo-l-pipera-zinocarbonylamino)phenylacetamido]-penicillansyre,Mp: 156 ° C (decomp.) IR (KBr) vnf1: Yc = 0.1780, 1710 ° l67 ° + 6- [D (-) - α- (4-ethyl-6S-n-propyl-2, 3-dioxo-l-piperazine zinocarbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 150° C (dekomp.) IR (KBr) cm"1: γQ=Q 1775, 1705, 1670; 6- [d(- )-oc- (4-ethyl-6S-n-butyl-2,3-dioxo-l-piperazi-nocarbonylamino)phenylacetamido]-penicillansyre,Mp: 150 ° C (decomp.) IR (KBr) cm -1: γQ = Q 1775, 1705, 1670; 6- [d (-) -oc- (4-ethyl-6S-n-butyl-2, 3-dioxo-l-piperazino-nocarbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 125° C (dekomp.) IR (KBr) cm"1: ^0=01775, 1710» 1680; 6-[D(-)-a-(4-ethyl-6S-n-hexyl-2,3-dioxo-l-piperazi-Mp: 125 ° C (decomp.) IR (KBr) cm "1: 0 O = 01775, 1710» 1680; 6- [D (-) - α- (4-ethyl-6S-n-hexyl-2, 3-dioxo-l-piperazi-

. I. IN

172 151338 nocarbonylamino )phenylacetamido ]-penicillansyre,172 (nocarbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 125° C (dekomp.) IR (KBr) cm"1: γο=0 1780, 1720 - 1680; 6- [D(-)-cc- (4-eth.yl-5S-meth.yl-2,3-dioxo-l-piperazino-carbonylamido)phenylacetamido]-penicillansyre,Mp: 125 ° C (decomp.) IR (KBr) cm -1: γο = 0 1780, 1720 - 1680; 6- [D (-) - cc- (4-ethyl-5S-methyl) 2,3-dioxo-l-piperazino-carbonylamido) phenylacetamido] -penicillanic acid,

Smp.: 156 - 157° C (dekomp.) IR (KBr) cm"1: \f c=0 1770 ’ 1705’ 16705 6- [D(-)-oc- (4-ethyl-6R-methyl-2,3-dioxo-l-piperazi-nocarbonylamino )phenylacetamido ]-penicillansyr e,Mp: 156 - 157 ° C (decomp.) IR (KBr) cm "1: δ fc = 0 1770 '1705' 16705 6- [D (-) - oc- (4-ethyl-6R-methyl-2, 3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 155° C (dekomp.) IR (KBr) cm"1: ^c=0 1780, 17°5, l680; 6- [D (-)-a- (4-ethyl-6R-ethyl-2,3-dioxo-l-piperazino-carbonylamino )phenylacetamido ]-penicillansyr e,Mp: 155 ° C (decomp.) IR (KBr) cm "1: δ c = 0 1780, 17 ° 5, 1680; 6- [D (-) - α- (4-ethyl-6R-ethyl-2 3-dioxo-1-piperazino-carbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 154° C (dekomp.) IR (KBr) cm"1: yc=Q 1775, 1705, 1675; 6- [D(- )-a- (4-ethyl-6R-n-propyl-2,3-dioxo-l-piperazi-nocarbonylamino )phenylacetamido ]-penicillansyre,Mp: 154 ° C (decomp.) IR (KBr) cm -1: yc = Q 1775, 1705, 1675; 6- [D (-) -a- (4-ethyl-6R-n-propyl-2, 3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 155° C (dekomp.) IR (KBr) cm"1: YC=Q 1780, 1705, 1670; 6-[D(-)-a-(4-ethyl-6R-n-butyl-2,3-dioxo-l-piperazi-nocarbonylamino )phenylacetamido ]-penicillansyre,Mp: 155 ° C (decomp.) IR (KBr) cm -1: YC = Q 1780, 1705, 1670; 6- [D (-) - α- (4-ethyl-6R-n-butyl-2, 3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 125° C (dekomp.) IR (KBr) cm"1: YC=Q 1780, 1705, 1680, 1675; 6-[D(- )-oc- (4-ethyl-6R-n-hexyl-2,3-dioxo-l-piperazi-nocarbonylamino)phenylacetamido]-penicillansyre,Mp: 125 ° C (decomp.) IR (KBr) cm -1: YC = Q 1780, 1705, 1680, 1675; 6- [D (-) -oc- (4-ethyl-6R-n-hexyl) 2,3-dioxo-l-piperazino-nocarbonylamino) phenylacetamido] -penicillanic acid,

Smp.: 121° C (dekomp.) IR (KBr) cm"1: y"c=0 1785» 1710’ 1685; 6-[D(-)-a-(4-ethyl-5R-methyl-2,3-dioxo-l-piperazino-carbonylamino )phenylacetamido ]-penicillansyr e,Mp: 121 ° C (decomp.) IR (KBr) cm -1: y "c = 0 1785» 1710 '1685; 6- [D (-) - α- (4-ethyl-5R-methyl-2,3-dioxo-1-piperazino-carbonylamino) -phenylacetamido] -penicillanic acid e,

Smp.: 150 - 152° C (dekomp.) IR (KBr) cm"1: γ C=Q 1780, 1710, 1670.Mp: 150 - 152 ° C (decomp.) IR (KBr) cm -1: γ C = Q 1780, 1710, 1670.

EKSEMPEL 51EXAMPLE 51

Forbindelser med formlen (II) eller (IV) og reaktive derivater af forbindelser med formlen (III) eller (V) blev udvalgt og omsat på samme måde som beskrevet under (1) eller (2) i de ovenstående eksempler til opnåelse af de følgende forbindelser: 173 151338 6-[D(-)-a-(4-benzyl-2-oxo-l-piperazinocarbonylamino)-phenylacetamido jpenicillansyre,Compounds of formula (II) or (IV) and reactive derivatives of compounds of formula (III) or (V) were selected and reacted in the same manner as described under (1) or (2) in the above examples to obtain the following Compounds: 173 6- [D (-) - α- (4-Benzyl-2-oxo-1-piperazinocarbonylamino) -phenylacetamido-ypenicillanic acid,

Smp.: 146 - 147° C (dekomp.); pivaloyloxymethyl-6-[D(-)-a-(4-acetyl-2-oxo-l-pipe-razinocarbonylamino )phenylacetamido ]-peniclllanat,Mp: 146 - 147 ° C (decomp); pivaloyloxymethyl 6- [D (-) - α- (4-acetyl-2-oxo-1-piperazinocarbonylamino) phenylacetamido] penicillanate,

Smp.: 159 - 162° C (dekomp.) IR (KBr) cm"1: '(CaQ 1775 - 1740, 1710 - 1650; 6-[D(-)-a-(4-cyclohexyl-2,3-dioxo-l-piperazinocarbo-nylamino)phenylacetamido]penicillansyre,Mp: 159 - 162 ° C (decomp.) IR (KBr) cm -1: (CaQ 1775 - 1740, 1710 - 1650; 6- [D (-) - α- (4-cyclohexyl-2,3- dioxo-l-piperazinocarbo-nylamino) phenylacetamido] penicillanic acid,

Smp.: 166 - 167° C (dekomp.) IR (KBr) cm”1: ^C=0 1780’ 1730’ 1710 ’ 16705 6-[D(-)-a-(4-benzyl-2,3-dioxo-l-piperazinocarbonyl-amino)phenylacetamido]penicillansyre,Mp: 166 - 167 ° C (decomp.) IR (KBr) cm ”1: C = 0 1780 '1730' 1710 '16705 6- [D (-) - α- (4-benzyl-2,3- dioxo-l-piperazinocarbonyl-amino) phenylacetamido] penicillanic acid,

Smp.: 154 - 155° C (dekomp.) IR (KBr) cm"1: \/Q=0 1775, 1705, 1685, 1670; 6- [D(-)-a- (2,3-dioxo-l-piperazinocarbonylamino)-phenylacetamido jpenicillansyre,Mp: 154 - 155 ° C (decomp.) IR (KBr) cm "1: / / Q = 0 1775, 1705, 1685, 1670; 6- [D (-) - α- (2,3-dioxo) 1-piperazinocarbonylamino) -phenylacetamido -penicillanic acid,

Smp.: 154 - 156° C (dekomp.) IR (KBr) cm"1: ^c==0 1770, 1710, 1670; 6-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonyl-amino)-2-thienylacetamido jpenicillansyre,Mp: 154 - 156 ° C (decomp.) IR (KBr) cm -1: C = 0.1770, 1710, 1670; 6- [D (-) - α- (4-ethyl-2,3- dioxo-1-piperazinocarbonylamino-2-thienylacetamido -penicillanic acid,

Smp.: 152 - 153° C (dekomp.) IR (KBr) cm"1: '(Q=Q 1775, 1720 - 1660 NMR (dgDMSO)Tvserdier: 8,91 (3H, t, CH3), 8,56 (3H, s, CHj), 8,42 (3H, s, CH3), 6,35 - 6,80 (4H, m, (¾ x 2), 5,95 - 6,20 (2H, m, CH2), 5,80 (IH, s, CH), 4,45 - 4,55 (2H, m, CH x 2), 4,05 (1H, d, CH), 2,89 - 3,13 (2H, m, CH x 2), 2,57 - 2,58 (1H, m, CH), 0,75 (IH, d, NH), 0,25 (IH, d, NH); 1” 151338 IR (KBr) om-1: y c=01765, 1710 - 1630; 6- [d(- )-a- (4-n-dodecyl-2,3-dioxo-l-piperazinocarbo-nylamino )phenylacetamido Jpenicillansyre,Mp: 152 - 153 ° C (decomp.) IR (KBr) cm -1: (Q = Q 1775, 1720 - 1660 NMR (dgDMSO) TVs: 8.91 (3H, t, CH 3), 8.56 (3H, s, CH 2), 8.42 (3H, s, CH 3), 6.35 - 6.80 (4H, m, (¾ x 2), 5.95 - 6.20 (2H, m, CH 2)) ), 5.80 (1H, s, CH), 4.45 - 4.55 (2H, m, CH x 2), 4.05 (1H, d, CH), 2.89 - 3.13 (2H , m, CH x 2), 2.57 - 2.58 (1H, m, CH), 0.75 (1H, d, NH), 0.25 (1H, d, NH); KBr) om-1: yc = 01765, 1710-1630; 6- [d (-) -a- (4-n-dodecyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido

Smp.: 114 - 116° C (dekomp.); indanyl-6-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazino-carbonylamino)phenylacetamido]penicillanat,Mp: 114 - 116 ° C (decomp); indanyl-6- [D (-) - a- (4-ethyl-2,3-dioxo-l-piperazino-carbonylamino) phenylacetamido] penicillanate,

Smp.: 95 - 100° C (dekomp.) IR (KBr) cm"1: 3300 ^c=0 1780, 1710, 1690 - 1670; 6-[D(- )-oc-(4-benz oyloxyethyl-2,3-dioxo-1-pip eraz ino-carbonylamino )phenylacetamido ]penicillansyre,Mp: 95-100 ° C (decomp.) IR (KBr) cm -1: 3300 ° C = 0.1780, 1710, 1690-1670; 6- [D (-) -oc- (4-benz oyloxyethyl-2) , 3-dioxo-1-pip erazo-carbonylamino) phenylacetamido] penicillanic acid,

Smp.: 175 - 180° C (dekomp.) IR (KBr) om’1; yc=0 ^73,.1730, 1720 -1660; 6—[D(—)-a-(4-p-hydroxyethyl-2,3-dioxo-l-piperazino-carbonylamino )phenylacetamido jpenicillansyre,Mp: 175-180 ° C (decomp.) IR (KBr) about 1; yc = 0 ^ 73, .1730, 1720 -1660; 6 - [D (-) - α- (4-p-hydroxyethyl-2,3-dioxo-1-piperazino-carbonylamino) phenylacetamido-ypenicillanic acid,

Smp.: 183 - 184° C (dekomp.); 6- [D( -) -a- (4-isovaleryloxyethyl-2,3-dioxo-l-pipera-zinocarbonylamino )phenylacetamido ]penicillansyre,Mp: 183 - 184 ° C (decomp); 6- [D (-) -a- (4-isovaleryloxyethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid,

Smp.: 105 - 110° C (dekomp.) IR (KBr) cm"*1: γσ=0 1775, 1730, 1720 - 1640.Mp: 105-110 ° C (decomp.) IR (KBr) cm -1: γσ = 0.1775, 1730, 1720-1640.

EKSEMPEL 52EXAMPLE 52

Forbindelser med formlen (V), (IV) eller (VI) og reaktive derivater af forbindelser med formlen (III) eller (V) eller forbindelser med formlen (VII) blev udvalgt og omsat på samme måde som beskrevet under (1), (2) eller (3) i de ovenstående eksempler til opnåelse af de følgende forbindelser: 7- [D(-)-a-(4-n-butylaminocarbonyl-2,3-dioxo-l-pipe-razinocarbonylamino )phenylacetamido ]-3- [5- (l-methyl- 1,2,3,4-tetrazolyl)thiomethyl]-A3-cephem-4-carboxylsyre,Compounds of formula (V), (IV) or (VI) and reactive derivatives of compounds of formula (III) or (V) or compounds of formula (VII) were selected and reacted in the same manner as described under (1), ( 2) or (3) in the above examples to give the following compounds: 7- [D (-) - α- (4-n-butylaminocarbonyl-2,3-dioxo-1-pipe-razinocarbonylamino) phenylacetamido] -3 - [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl] -A3-cephem-4-carboxylic acid,

Smp.: 144° C (dekomp.); 7_[d(-)(4-ethyl-2,3-dioxo-l-piperazinocarbonyla-mino )phenylacetamido ]-3-n-propylthiomethyl- Δ^-cephem- 4-carboxylsyre,Mp: 144 ° C (dec.); 7_ [d (-) (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-n-propylthiomethyl-Δ ^ -cephem-4-carboxylic acid,

Smp.: 155 - 157° C (dekomp.); 151338 175 7-[D(-)-α-(4-ethyl-2,3-dioxo-l-piperazinocarbonyl-amino)phenylacetamido]-3-carboxymethylthiomethyl-Δ3 -cephem-4-carboxylsyre,Mp: 155 - 157 ° C (dec.); 7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] -3-carboxymethylthiomethyl-Δ3-cephem-4-carboxylic acid,

Smp.: 135 - 137° C (dekomp.); phthalidyl-7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazi-nocarbonylamino)-p-hydroxyphenylacetamido]-3-[5-(1-methyl-1,2,3,4-tetrazolyl)-thiomethyl]-A^-cephem- 4-carboxylat,Mp: 135-137 ° C (decomp.); phthalidyl 7- [D (-) - a- (4-ethyl-2,3-dioxo-l-piperazino-nocarbonylamino) -p-hydroxyphenylacetamido] -3- [5- (1-methyl-1,2,3 4-tetrazolyl) -thiomethyl] -Aβ-cephem-4-carboxylate,

Smp.: 152 - 155° C (dekomp.) IR (KBr) cm-1: 3300 yc=0 1780, 1715, 1670; 7-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylami-no)-2-thionylacetamido]-3-[5-(1-methyl-l,2,3,4-tetrazolyl )thiomethyl]-å ^-cephem-4-carboxylsyre,Mp: 152 - 155 ° C (decomp.) IR (KBr) cm -1: 3300 µc = 0 1780, 1715, 1670; 7- [D (-) - a- (4-ethyl-2,3-dioxo-l-piperazinocarbonylami-amino) -2-thionylacetamido] -3- [5- (1-methyl-l, 2,3,4 -tetrazolyl) thiomethyl] -α-cephem-4-carboxylic acid,

Smp.: I60 - 162° C (dekomp.) IR (KBr) cm-1: 1770, 1710 - 1660; 7-[D(-)-a-(4-p-chlorethyl-2,3-dioxo-l-piperazinocar-bonylami.no) -p-hydroxyphenylacetamido ]-3- [5- (1-methyl- 1,2,3,4-tetrazolyl)thiomethyl]- Δ^-cephem-4-carboxyl-syre,Mp: I60-162 ° C (decomp.) IR (KBr) cm -1: 1770, 1710-1660; 7- [D (-) - α- (4-p-chloroethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] -3- [5- (1-methyl-1,2 3,4-tetrazolyl) thiomethyl] - [beta] -cephem-4-carboxylic acid,

Smp.: 193 - 195° C (dekomp.); 7-[D-)-a-(4-allyl-2,3-dioxo-l-piperazinocarbonylami-no)-p-hydroxyphenylacetamido]-3-[5-(1-methyl-l,2,3, 4-tetrazolyl)thiomethyl]- zs3 -cephem-4-carboxylsyre,Mp: 193 - 195 ° C (decomp); 7- [D -) - α- (4-Allyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] -3- [5- (1-methyl-1,2,3,4-dioxide) tetrazolyl) thiomethyl] - zs3-cephem-4-carboxylic acid,

Smp.: 183 - 185° C (dekomp.); 7-[D(-)-a-(2,3-dioxo-l-piperazinocarbonylamino) -phe-nylacetamido]-3-[5-(1-methyl-l,2,3,4-tetrazolyl)-thiomethyl]- A ^-cephem-4-carboxylsyre,Mp: 183 - 185 ° C (decomp); 7- [D (-) - α- (2,3-Dioxo-1-piperazinocarbonylamino) phenylacetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) -thiomethyl] -? -Cephem-4-carboxylic acid,

Smp.: I53 - 157° C (dekomp.); valeryloxymethyl-7- [D(-)-oc- (4-ethyl-2,3-dioxo-l-pi-perazinocarbonylamino) -p-hydroxyphenylacetamido ] - 3-[5-(1-methyl-l,2,3»4-tetrazolyl)thiomethyl]-A ^-cephem-4-carboxylat,Mp: I53 - 157 ° C (decomp.); valeryloxymethyl-7- [D (-) - oc- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] -3- [5- (1-methyl-1,2,3 4-tetrazolyl) thiomethyl] -Aβ-cephem-4-carboxylate,

Smp.: 105 - 110° C (dekomp.); pivaloyloxymethyl-7- [D(- )-a- (4-ethyl-2,3-dioxo-i-pi-perazinocarbonylamino) -p-hydroxyphenylacetamido ]- 3- [5- (1-methyl-l ,2,3» 4-tetrazolyl)thiomethyl]-/\ ^-cephem-4-carboxylat,Mp: 105 - 110 ° C (decomp.); pivaloyloxymethyl-7- [D (-) -a- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] -3- [5- (1-methyl-1,2,3 (4-tetrazolyl) thiomethyl] -β-cephem-4-carboxylate,

Smp.: 110 - 115° C (dekomp.); 151338 176 isopropoxymethyl-7-[D(-)-α-(4-ethyl-2,3-dioxo-l-pi-perazinocarbonylamino)-p-hydr oxyphenylacetamido]- 3- [5- (1-methyl-1,2,3,4-tetrazolyl)thiomethyl]-cephem-4-carboxylat,Mp: 110 - 115 ° C (decomp); Isopropoxymethyl-7- [D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenylacetamido] -3- [5- (1-methyl-1, 2,3,4-tetrazolyl) thiomethyl] -cephem-4-carboxylate,

Smp.: 115 - 120° C (dekomp.) EKSEMPEL 53 I 20 ml vandfrit methylenchlorid suspenderedes 1,72 g 2,3-dioxo-1-piperazinoeddikesyre, og der tilsattes 3,25 g trimethylsilyl-chlorid og derpå 2,93 g triethylamin ved 5° C, hvorefter blandingen fik lov at reagere ved stuetemperatur i en time. Reaktionsopløsningen blev derefter afkølet til -50° C, der tilsattes 1,1 g trichlormethylchlorformiat, og temperaturen af den resulterende blanding blev hævet til stuetemperatur i løbet af en time, hvorefter blandingen fik lov at reagere ved denne temperatur i en time. Opløsningsmidlet blev derefter fjernet ved destillation under formindsket tryk til opnåelse af hvide krystaller.Mp: 115-120 ° C (decomp.) Example 53 In 20 ml of anhydrous methylene chloride 1.72 g of 2,3-dioxo-1-piperazinoacetic acid was suspended and 3.25 g of trimethylsilyl chloride was added and then 2.93 g triethylamine at 5 ° C, after which the mixture was allowed to react at room temperature for one hour. The reaction solution was then cooled to -50 ° C, 1.1 g of trichloromethyl chloroformate was added and the temperature of the resulting mixture was raised to room temperature over one hour, after which the mixture was allowed to react at that temperature for one hour. The solvent was then removed by distillation under reduced pressure to give white crystals.

På den anden side blev 3,49 g 6-[D(-)-a-aminophenylacetamido]-penicillansyre suspenderedes i 40 ml 50% vandfrit tetrahydro-furan, og der tilsattes 1,85 g natriumhydrogencarbonat til dannelse af en opløsning, som derpå blev afkølet til -5° C. Til denne opløsning sattes, langsomt en opløsning af de ovenfor opnåede krystaller i 15 ml tetrahydrofuran, og reaktionen fik lov at foregå i en time ved 5 - 7° C. Derefter blev det organiske opløsningsmiddel fjernet ved destillation under formindsket tryk, og der sattes 15 ml ethylacetat til remanensen. Efter henstand blev det vandige lag skilt fra, tilsat 50 ml ethylacetat, og blandingens pH-værdi blev indstillet til 2 ved 2Nsaltsyre, hvorefter det organiske lag blev skilt fra. Dette blev vasket med 10 ml mættet natriumchloridopløsning, og tørret over vandfrit magnesiumsulfat og opløsningsmidlet derpå fjernet ved destillation under formindsket tryk. Remanensen blev behandlet med diethyl-ether, hvorved der blev opnået 2,74 (udbytte 50,1%) 6-[D(-)-a-(4-carboxymethyl-2,3-dioxo-l-piperazinocarbonylamino )phenylacet-amido jpenicillansyre, IR (KBr) cm"1: 1780, 1720, 1690 - 1670 177 151538 MR (dg-DMSO) ppm værdier: 1,4 (3H, s, CH3), 1,55 (3H, s, CH,,), 3,4- 4,0 (4H, m, CH2 x 2), 4,15 (IH, s, CH), 4,18 (2H, s, CH2), 5,3- 5,75 (3H, m, CH x 3), 7,32 (5H, bs, aromatisk proton), 9,22 (IH, d, NH), 9,75 (IH, d, NH).On the other hand, 3.49 g of 6- [D (-) - α-aminophenylacetamido] penicillanic acid were suspended in 40 ml of 50% anhydrous tetrahydrofuran and 1.85 g of sodium hydrogen carbonate was added to form a solution which was cooled to -5 ° C. To this solution was slowly added a solution of the crystals obtained above in 15 ml of tetrahydrofuran and the reaction was allowed to proceed for one hour at 5-7 ° C. Then the organic solvent was removed by distillation. under reduced pressure and 15 ml of ethyl acetate were added to the residue. After standing, the aqueous layer was separated, 50 ml of ethyl acetate added, and the pH of the mixture was adjusted to 2 by 2N hydrochloric acid, after which the organic layer was separated. This was washed with 10 ml of saturated sodium chloride solution and dried over anhydrous magnesium sulfate and the solvent then removed by distillation under reduced pressure. The residue was treated with diethyl ether to give 2.74 (yield 50.1%) of 6- [D (-) - α- (4-carboxymethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido Ipenicillanic acid, IR (KBr) cm -1: 1780, 1720, 1690-1670 177 151538 MR (dg-DMSO) ppm values: 1.4 (3H, s, CH 3), 1.55 (3H, s, CH ), 3.4-4.0 (4H, m, CH 2 x 2), 4.15 (1H, s, CH), 4.18 (2H, s, CH 2), 5.3-5.75 (3H , m, CH x 3), 7.32 (5H, bs, aromatic proton), 9.22 (1H, d, NH), 9.75 (1H, d, NH).

På samme måde som beskrevet ovenfor fremstilledes følgende forbindelser : 6-[D(-)-a-(4-carboxymethyl-2,3-dioxo-l-piperazino-carbonylamino)-p-hydroxyphenylacetamido]penicillan-syre,In the same manner as described above, the following compounds were prepared: 6- [D (-) - α- (4-carboxymethyl-2,3-dioxo-1-piperazino-carbonylamino) -p-hydroxyphenylacetamido] penicillanic acid,

Smp.: 191 - 195° C (dekomp.) IR (KBr) cm"1: ^c=0 1770, 1715, 1700 - 1670; 6-[D(-)-a-(4-V- carboxy-n-propyl-2,3-dioxo-l-pipe-razinocarbonylamino )phenylac et amido ]penicillansyre,Mp: 191 - 195 ° C (decomp.) IR (KBr) cm "1: δ c = 0 1770, 1715, 1700 - 1670; 6- [D (-) - α- (4-V-carboxy-n -propyl-2,3-dioxo-1-pipe-razinocarbonylamino) phenylac et amido] penicillanic acid,

Smp.: 170° C (dekomp.) IR (KBr) cm"1: ^C=Q 1775, 1715, 1710 - 1670.Mp: 170 ° C (decomp.) IR (KBr) cm -1: C = Q 1775, 1715, 1710 - 1670.

KKftttMPEL 54KKftttMPEL 54

Forbindelserne med formlen (II) eller (IV) og reaktive derivater af forbindelser med formlen (III) eller (V) blev udvalgt og omsat på samme måde som beskrevet under (1) eller (2) i de ovenstående eksempler til opnåelse af 6-[D(-)-a-(4-ethyl-2,3-dioxo-l-piperazinocarbonyl-amino)phenylacetamido]penicillansyre med de følgende substituenter som R1 i formlen (I) 151338 178 2 SmeltepunktThe compounds of formula (II) or (IV) and reactive derivatives of compounds of formula (III) or (V) were selected and reacted in the same manner as described under (1) or (2) in the above examples to give 6- [D (-) - α- (4-Ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamido] penicillanic acid having the following substituents as R 1 of formula (I)

R (Dekomp.) 0 CR (decomp.) 0 C

-CH20C2H5 125 - 136 -ch2oc-^o> m. uo o -CH20(CH2)2CH3 135 - 137 -CH20(CH2)5CH5 90 - 95 -CH2OCH2CH<™3 95 - 97-CH2O2H5 125 - 136 -ch2oc-> o .muo o -CH2O (CH2) 2CH3 135 - 137 -CH2O (CH2) 5CH5 90 - 95 -CH2OCH2CH <™ 3 95 - 97

Ull-7Ull-7

DD

7°¾ -CH20CH2C^ CH3 108 - 1127 ° ¾ -CH20CH2C ^ CH3 108 - 112

\cEL\ Cel

5 126 . 130 nch3 -CH20CH<^3ch 80 - 83 I-U- 179 151338 -CE^CR^2^ 81 - 84 _<¥*5__ /¾ ~CH2OC <-CH3 129 - 133 \ch3 -CH 0(CH2)3CH3 65 - 67 ch3 /CH3 -ch-o-ch2ch< 3 104,5 CH3 CH3 /CH, -CH-0-CH2CH 70 - 75 c2h5 3 -CH-0CH2CH3 gg5 126. 130 nch3 -CH20CH <^ 3ch 80 - 83 IU- 179 151338 -CE ^ CR ^ 2 ^ 81 - 84 _ <¥ * 5__ / ¾ ~ CH2OC <-CH3 129 - 133 \ ch3 -CH 0 (CH2) 3CH3 65 - 67 ch3 / CH3 -ch-o-ch2ch <3 104.5 CH3 CH3 / CH, -CH-O-CH2CH 70 - 75 c2h5 3 -CH-OCH2CH3 gg

CHCH

ch3ch3 -CH-0(CH2)3CH3 CH 175 - 180 rv.ch3ch3 -CH-0 (CH2) 3CH3 CH 175 - 180 rv.

ch3ch3 /CH3 -CH-0CH—CH^ 175 _ 1?7ch3ch3 / CH3 -CH-OCH-CH ^ 175 _ 1? 7

CHCH

/\ CH,CH, 5 3 /CH, -CH9OCCH< 5 185 - 189 2 0 -ch2oc(ch2)3ch3 176 _ 1?9 0 -CHOC(CH«),CB, I j 233 105 - 110 ΓΗ/ \ CH, CH, 5 3 / CH, -CH9OCCH <5 185 - 189 2 0 -ch2oc (ch2) 3ch3 176 _ 1? 9 0 -CHOC (CH «), CB, I j 233 105 - 110 ΓΗ

Claims (5)

1. Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner eller cephalosporiner med den almene formel: (0)n z™ir™\ A-N N-C-NH-CH-CONH—j—f /-m u· JXj . rZ r3 R 0 COOR1 hvori R1 betyder hydrogen, en kation, som danner et ikke-toxisk salt, eller en phthalidyl-, indanyl, (C1_4)alkoxy-(C1_4)alkyl-, (C2_4) acyloXy- (ci_4)alkyl·-, piperidino-(C]L_4)alkyl- eller morpho- lino-(C1-4)alkylgruppe, n er 1 eller 2, idet oxygruppen eller -grupperne kan være vilkårligt tilknyttet 2- og 3-positionerne i 2 3 piperazinnngen, R og R kan være ens eller forskellige og hver for sig betyder hydrogen eller en (C1_g)alkylgruppe, A betyder hydrogen, en (C2_4)alkenyl-, (C5_7)cycloalkyl-, phenyl-, benzyl-, (C1_4)alkylaminocarbonyl-, (C-L_7)acyloxy-(C1_4)alkyl- eller (Ci_4)alkylsulfonylgruppe, en (C^_^g)acylgruppe, som kan være substitueret med chlor, eller en (C^^) alkyl gruppe, som kan være substitueret med chlor, hydroxy eller carboxyl,betyder ch3 V eller | ch3 5=c-ch2r^ hvor R4 betyder hydrogen, en azidogruppe, en pyridinium-gruppe, en (C-L_Zf)alkoxy-, (C-L_Zf)acyloxy- eller carbamoyloxy-gruppe, en (C-L_^) alkoxythiocarbonylthiogruppe, en (C-L_^)al-kylthiogruppe, som kan være substitueret med carboxyl, eller 151338 1S1 en oxazolylthio-, thiazolylthio-, thiazolinylthio-, imidazolyl-thio-, pyridazinylthio-, pyrimidinylthio-, oxadiazolylthid-, thiadiazolylthio-, triazolylthio-, tetrazolylthio-, piperazi-nylthiocarbonylthio-, isoxazolylcarbonylthio-, (pyridyl-1-oxid)thio- eller (5-oxo-2,5-dihydro-l,2,4-triazinyl)thiogrup-pe, som kan være substitueret med (C^_^>alkyl, og R° betyder en (C5_(g)cycloalkadienyl-, thienyl-, phenyl- eller hydroxy-phenylgruppe, kendetegnet ved, (a) at en racemisk eller optisk aktiv forbindelse med den alalmene formel: R7-NH-CH-CONE-r-f S ^ (χχ) i 5 R5 0 i C00Rla 5 la hvori R og Z har den ovenstående betydning, R betyder hydrogen , en saltdannende kation eller en beskyttende gruppe, som er kendt inden for penicillin- eller cephalosporin-området, og R betyder hydrogen eller en konventionel beskyttende silylgruppe eller phosphorholdig gruppe, som let kan fjernes ved behandling med vand eller en alkohol, omsættes med et reaktivt derivat i carboxylgruppen af en forbindelse med den almene formel: <$>n A-H H-C-OH (ΠΙ) w II R^R3° 2 3 hvori A, R , R og n har den ovenstående betydning, eller (b) at en forbindelse med den almene formel: (it) . C00Rla 182 151338 la 7 v, hvori R , R og ✓ Z har den ovenstående betydning, omsættes med en racemisk eller optisk aktiv forbindelse med formlens „„ . 0„ (V) A-H S-C-SH-CH-ξ-ΟΗ Jrfs0 *5° R .R p x 5 hvori A, R , r, r og n har den ovenstående betydning·, eller med et reaktivt derivat deraf i carboxyl-gruppen, eller (c) at en racemisk eller optisk aktiv forbindelse med den almene formel: v£\n δ A-NIJ-C-HHtCH-CONH-γ—( Λ · (VI) w* *5 ° “ K · COOR13 hvori A, Rla, R2, R3, R5 og n har den ovenstående betydning, og B betyder en substituent, som let kan erstattes med et nucleo-filt reagens, omsættes med en forbindelse med den almene formel: R8M (VII) hvori M betyder et hydrogenatom eller et alkalimetal- eller Q jordalkalimetalatom, og R betyder en azidogruppe, en (C^_^)al-koxygruppe, en (C1_^)alkoxythiocarbonylthiogruppe, en al kyl thiogruppe , som kan være substitueret med carboxyl, eller en oxazolylthio-, thiazolylthio-, thiazolinylthio-, imidazolylthio-, pyridazinylthio-, pyrimidinylthio, oxadiazolylthio-, thiadiazo-lylthio-, triazolylthib-, tetrazolylthio-, piperazinylthiocarbo-nylthio-, isoxazolylcarbonylthio-, (pyridyl-l-oxid)thio- eller (5-oxo-2,5-dihydro-l,2,4-triazinyl)thiogruppe, som eventuelt kan være substitueret med (C^^)alkyl, eller omsættes med pyridin, 183 1 5 1 3 3 8 hvorpå om nødvendigt den beskyttende gruppe fjernes fra en under (a), (b) eller (c) dannet forbindelse, hvori R·1"3 er en beskyttende gruppe.1. Analogous process for the preparation of racemic or optically active penicillins or cephalosporins of the general formula: (0) n z ™ ir ™ \ A-N N-C-NH-CH-CONH-j-f / -m u · JXj. wherein R 1 is hydrogen, a cation which forms a non-toxic salt, or a phthalidyl, indanyl, (C1-4) alkoxy (C1-4) alkyl, (C2_4) acyloXy- (c1-4) alkyl · - , piperidino (C1-4) alkyl or morpholino (C1-4) alkyl group, n is 1 or 2, the oxy group or groups may be arbitrarily attached to the 2- and 3-positions of the 2-piperazine group, R and R may be the same or different and each represents hydrogen or a (C1-6) alkyl group, A represents hydrogen, a (C2-4) alkenyl, (C5-7) cycloalkyl, phenyl, benzyl, (C1-4) alkylaminocarbonyl, (C -L_7) acyloxy- (C1-4) alkyl or (C1-4) alkylsulfonyl group, a (C1-6) acyl group which may be substituted by chlorine, or a (C1-4) alkyl group which may be substituted by chlorine, hydroxy or carboxyl, means ch3 V or | ch3 5 = c-ch2r ^ where R4 represents hydrogen, an azido group, a pyridinium group, a (C-L_Zf) alkoxy, (C-L_Zf) acyloxy or carbamoyloxy group, a (C-L_ ^) alkoxythiocarbonylthio group, a (C 1 -C 6) alkylthio group which may be substituted by carboxyl, or an oxazolylthio, thiazolylthio, thiazolinylthio, imidazolylthio, pyridazinylthio, pyrimidinylthio, oxadiazolylthioid, oxadiazolylthioid , tetrazolylthio, piperazinylthiocarbonylthio, isoxazolylcarbonylthio, (pyridyl-1-oxide) thio or (5-oxo-2,5-dihydro-1,2,4-triazinyl) thio group which may be substituted by (C ^ _ ^ alkyl) and R ° means a (C5_ (g) cycloalkadienyl, thienyl, phenyl or hydroxyphenyl group, characterized by, (a) a racemically or optically active compound of the general formula: R7 -NH-CH-CONE-rf S ^ (χχ) in R5 O in C00R1a 5a wherein R and Z are as defined above, R is hydrogen, a salt-forming cation or a protecting group known in the art the penicillin or cephalosporin region, and R is hydrogen or a conventional protecting silyl group or phosphorus containing group which can be easily removed by treatment with water or an alcohol, reacted with a reactive derivative in the carboxyl group of a compound of the general formula: <$> n AH HC-OH (ΠΙ) w II R 2 R 3 ° 2 3 wherein A, R, R and n are as defined above, or (b) a compound of the general formula: (it). C00Rla 182 151338 la 7 v, wherein R, R and ✓ Z have the above meaning, are reacted with a racemic or optically active compound of formula "". 0 '(V) AH SC-SH-CH-ξ-ΟΗ Jrfs0 * 5 ° R .R px 5 wherein A, R, r, r and n have the above meaning · or with a reactive derivative thereof in the carboxyl group or (c) a racemic or optically active compound of the general formula: v £ \ n δ A-NIJ-C-HHtCH-CONH-γ— (Λ · (VI) w * * 5 ° “K · COOR13 wherein A, Rla, R2, R3, R5 and n have the above meaning, and B represents a substituent which can be easily replaced by a nucleophilic reagent, reacted with a compound of the general formula: R8M (VII) wherein M is a hydrogen atom or an alkali metal or Q alkaline earth metal atom, and R is an azido group, a (C 1-4) alkoxy group, a (C thiazolylthio, thiazolinylthio, imidazolylthio, pyridazinylthio, pyrimidinylthio, oxadiazolylthio, thiadiazoylthio, triazolylthib, tetrazolylthio, piperazinylthiocarbonylthioc, isoxazylthioc (oxide) thio- or (5-oxo-2,5-dihydro-1,2,4-triazinyl) thio group, which may be optionally substituted with (C 1-4) alkyl, or reacted with pyridine, 183 1 5 1 3 388, where necessary removing the protecting group from a compound formed under (a), (b) or (c) wherein R · 1 "3 is a protecting group. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at piperazinoringen har oxygenatomer i positionerne 2 og 3·Process according to claim 1, characterized in that the piperazine ring has oxygen atoms at positions 2 and 3 · 3. Fremgangsmåde ifølge krav 2, kendetegnet ved, at A er hydrogen, en (C2_^)alkenyl-, phenyl- eller benzylgruppe eller en (C-, Ί 5)alkylgruppe, som eventuelt er substitueret med -L-Xd 2 * chlor, hydroxy eller carboxyl, og R og hver for sig er hydrogen eller (C^g)alkyl.Process according to claim 2, characterized in that A is hydrogen, a (C 2 -C) alkenyl, phenyl or benzyl group or a (C-, 5) alkyl group optionally substituted with -L-Xd 2 * chlorine , hydroxy or carboxyl, and R and each are hydrogen or (C1-6) alkyl. 4. Fremgangsmåde ifølge krav 3, kendetegnet ved, at den fremstillede forbindelse med formlen (i) er 6— ØD(—)— a-(4-ethyl-2,3-dioxo-l-piperazinocarbonylamino)phenylacetamidoj penicillansyre eller et farmaceutisk acceptabelt salt deraf.Process according to claim 3, characterized in that the compound of formula (i) prepared is 6- (N - (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) phenylacetamidoj penicillanic acid or a pharmaceutically acceptable salt thereof. 5. Fremgangsmåde ifølge krav 3, kendetegnet ved, at den fremstillede forbindelse med formlen (I) er 7-{D(-)-a- (4-ethyl-2,3-dioxo-l-piperazinocarbonylamino) -p-hydroxyphenyl-acetamido] -3- [5- (l-methyl-1,2,3,4-tetrazolyl)thiomethyl3 cephem-4-carboxylsyre eller et farmaceutisk acceptabelt salt deraf.Process according to claim 3, characterized in that the compound of formula (I) prepared is 7- {D (-) - α- (4-ethyl-2,3-dioxo-1-piperazinocarbonylamino) -p-hydroxyphenyl acetamido] -3- [5- (1-methyl-1,2,3,4-tetrazolyl) thiomethyl-3-cephem-4-carboxylic acid or a pharmaceutically acceptable salt thereof.
DK201975A 1974-05-09 1975-05-07 METHOD OF ANALOGUE FOR THE PREPARATION OF RACEMIC OR OPTICALLY ACTIVE PENICILLIN OR CEPHALOSPORINES DK151338C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK104979A DK149950C (en) 1974-05-09 1979-03-14 2,3-DIOXOPIPERAZINOCARBOXYLIC ACID DERIVATIVES FOR USE AS INTERMEDIATES
DK95880A DK151958C (en) 1974-05-09 1980-03-06 2,3-DIOXOPIPERAZINE DERIVATIVES FOR USE AS INTERMEDIATES

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
JP5066374 1974-05-09
JP5066374A JPS539238B2 (en) 1974-05-09 1974-05-09
JP5225474 1974-05-13
JP5225474A JPS539239B2 (en) 1974-05-13 1974-05-13
JP6078774A JPS539240B2 (en) 1974-05-31 1974-05-31
JP6078774 1974-05-31
JP9199674 1974-08-13
JP9199674A JPS5123284A (en) 1974-08-13 1974-08-13 Shinkina penishirinruino seizoho
JP10995474A JPS5139687A (en) 1974-09-26 1974-09-26 SHINKINAPENISHIRINRUINOSEIZOHO
JP10995474 1974-09-26
JP14249974A JPS5170788A (en) 1974-12-13 1974-12-13 Shinkina sefuarosuhorinruino seizoho
JP14249974 1974-12-13
JP50037207A JPS51113890A (en) 1975-03-27 1975-03-27 Method for preparing novel cephalosporins
JP3720775 1975-03-27

Publications (3)

Publication Number Publication Date
DK201975A DK201975A (en) 1975-11-10
DK151338B true DK151338B (en) 1987-11-23
DK151338C DK151338C (en) 1988-07-18

Family

ID=27564446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK201975A DK151338C (en) 1974-05-09 1975-05-07 METHOD OF ANALOGUE FOR THE PREPARATION OF RACEMIC OR OPTICALLY ACTIVE PENICILLIN OR CEPHALOSPORINES

Country Status (18)

Country Link
AR (1) AR209607A1 (en)
AT (1) AT344906B (en)
BE (1) BE828692A (en)
CH (1) CH605995A5 (en)
CY (1) CY1026A (en)
DD (1) DD117882A5 (en)
DE (2) DE2560239C2 (en)
DK (1) DK151338C (en)
FI (1) FI63760C (en)
FR (2) FR2269937B1 (en)
GB (2) GB1508064A (en)
HK (1) HK26279A (en)
HU (1) HU169633B (en)
IL (2) IL47168A (en)
KE (1) KE2923A (en)
NL (1) NL162386C (en)
PH (5) PH21545A (en)
SE (2) SE431457B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528079A1 (en) * 1975-06-24 1977-01-20 Bayer Ag PENICILLIN, THE METHOD FOR MANUFACTURING IT AND THEIR USE AS A MEDICINAL PRODUCT
CH624958A5 (en) * 1975-06-24 1981-08-31 Bayer Ag Process for the preparation of beta-lactam compounds
FR2338046A2 (en) * 1976-01-19 1977-08-12 Toyama Chemical Co Ltd Broad-spectrum cephalosporin antibiotics resistant to beta-lactamase - 7-(alpha-(4pethyl-2,3-dioxo-piperazinocarbonylamino)-para-hydroxy- phenylacetamido)-ceph-3-em-4-carboxylic acids
JPS6026800B2 (en) * 1976-01-22 1985-06-25 富山化学工業株式会社 Novel 7α-methoxycephalosporins and their production method
JPS52106883A (en) * 1976-02-13 1977-09-07 Toyama Chem Co Ltd Novel penicillins and cephalosporins
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
DE2857696C2 (en) * 1977-07-23 1984-08-30 Toyama Chemical Co. Ltd., Tokio / Tokyo Cephalosporins
DE2810083A1 (en) * 1978-03-08 1979-09-20 Bayer Ag BETA-LACTAM COMPOUNDS
DE2813771A1 (en) * 1978-03-30 1979-10-11 Bayer Ag BETA-LACTAM COMPOUNDS
DE2817228A1 (en) * 1978-04-20 1979-10-31 Bayer Ag PROCESS FOR MANUFACTURING SEMI-SYNTHETIC BETA-LACTAMANTIBIOTICS
EP0015240A1 (en) * 1979-02-16 1980-09-03 Ciba-Geigy Ag Azacyclyl (thio) ureidoacetyl compounds and their preparation
CA1209477A (en) * 1981-03-26 1986-08-12 Bruce E. Haeger Composition of matter comprising a lyophilized preparation of a penicillin derivative
CA1200239A (en) * 1981-03-30 1986-02-04 Donald C. Boop Process for preparing 6-¬d-(-)-alpha-(4-c1-c4 alkyl- 2,3-dioxo-1-piperazinocarbonyl-amino)- phenylacetamido|penicillanic acid
JPS57118587A (en) * 1981-11-26 1982-07-23 Toyama Chem Co Ltd Novel penicillin
BG46664A1 (en) * 1985-08-16 1990-02-15 Druzhestven N Izsledovatelski Method for preparing of 6- /d (-)- alpha- (4- ethyl- 2, 3- dioxo- 1- piperazine carbonylamino)- phenylacetamido/- penicillanic acid
DE3619562A1 (en) * 1986-06-11 1987-12-17 Basf Ag METHOD FOR PRODUCING 2,3-DIOXO-4-OXICARBONYLPIPERAZINE DERIVATIVES, NEW 2,3-DIOXO-4-OXICARBONYLPIPERAZINE DERIVATIVES AND THE USE THEREOF
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB0025354D0 (en) 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
ES2335092T3 (en) 2001-08-24 2010-03-22 Yale University PIPERAZINONA COMPOUNDS AS ANTITUMOR AND ANTICANCER AGENTS.
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
JP2005522436A (en) 2002-02-08 2005-07-28 グラクソ グループ リミテッド Piperidylcarboxamide derivatives or their use in the treatment of tachykinin-mediated diseases
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
CN101611040A (en) * 2007-01-31 2009-12-23 富山化学工业株式会社 The novel crystal of piperacillin sodium
RS55365B1 (en) 2008-10-31 2017-03-31 Shionogi & Co Cephalosporin having catechol group
WO2011125966A1 (en) 2010-04-05 2011-10-13 塩野義製薬株式会社 Cephem compound having pseudo-catechol group
KR20130018845A (en) 2010-04-05 2013-02-25 시오노기세야쿠 가부시키가이샤 Cephem compound having catechol group
US9085589B2 (en) 2010-04-28 2015-07-21 Shionogi & Co., Ltd. Cephem derivative
CA2833121A1 (en) 2011-04-28 2012-11-01 Shionogi & Co., Ltd. Novel cephem compound having catechol or pseudo-catechol structure
US9242999B2 (en) 2011-06-27 2016-01-26 Shionogi & Co., Ltd. Cephem compound having pyridinium group
CN110746445B (en) * 2019-10-16 2021-03-16 深圳海关食品检验检疫技术中心 Preparation method of cefoperazone deuterated internal standard substance

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139754B (en) * 1972-05-08 1979-04-09 Yamanouchi Pharma Co Ltd Analogous process for the preparation of heterocyclic acyl-substituted ampicillin derivatives.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (en) * 1968-06-12 1971-11-11 Bayer Ag New penicillins
DE2104580C3 (en) * 1971-02-01 1981-04-02 Bayer Ag, 5090 Leverkusen Acylureidopenicillins
DE2025415C3 (en) * 1970-05-25 1981-01-22 Bayer Ag, 5090 Leverkusen Process for the preparation of cyclic acylureido penicillins
US3741962A (en) 1971-05-21 1973-06-26 Squibb & Sons Inc Alpha-thioureidocephalosporanic acid compounds
BE790440A (en) * 1971-10-23 1973-04-24 Bayer Ag
BE794886A (en) * 1972-02-22 1973-08-02 Pfizer 6- (ALPHA- (OMEGA-GUANIDINOALCANOYLAMINO) ACYLAMINO) -PENICILLANIC ACIDS
CH570407A5 (en) * 1972-03-29 1975-12-15 Ciba Geigy Ag
AR208171A1 (en) 1972-09-29 1976-12-09 Ciba Geigy Ag PROCEDURE FOR OBTAINING NEW DERIVATIVES OF CEF-3-EM-4-CARBOXYL ACID

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139754B (en) * 1972-05-08 1979-04-09 Yamanouchi Pharma Co Ltd Analogous process for the preparation of heterocyclic acyl-substituted ampicillin derivatives.

Also Published As

Publication number Publication date
AU8043175A (en) 1976-10-28
PH21987A (en) 1988-05-02
DE2519400C3 (en) 1982-02-11
FI751340A (en) 1975-11-10
GB1508064A (en) 1978-04-19
DD117882A5 (en) 1976-02-05
HU169633B (en) 1976-12-28
IL53485A0 (en) 1978-01-31
SE7505392L (en) 1975-12-23
IL47168A0 (en) 1975-06-25
NL162386B (en) 1979-12-17
PH21545A (en) 1987-12-11
FR2269937A1 (en) 1975-12-05
CY1026A (en) 1980-08-01
FR2320295A1 (en) 1977-03-04
DK201975A (en) 1975-11-10
KE2923A (en) 1979-04-06
PH20534A (en) 1987-02-09
NL162386C (en) 1980-05-16
DE2519400A1 (en) 1976-03-04
FR2269937B1 (en) 1979-06-15
FI63760B (en) 1983-04-29
FR2320295B1 (en) 1980-11-07
DK151338C (en) 1988-07-18
SE431457B (en) 1984-02-06
BE828692A (en) 1975-11-03
CH605995A5 (en) 1978-10-13
SE7808204L (en) 1978-07-27
AR209607A1 (en) 1977-05-13
SE435062B (en) 1984-09-03
AT344906B (en) 1978-08-25
GB1508062A (en) 1978-04-19
HK26279A (en) 1979-05-04
FI63760C (en) 1983-08-10
DE2560239C2 (en) 1984-10-11
PH22346A (en) 1988-08-12
DE2519400B2 (en) 1981-05-21
ATA828976A (en) 1977-12-15
IL47168A (en) 1979-07-25
NL7505375A (en) 1975-11-11
PH22336A (en) 1988-08-12

Similar Documents

Publication Publication Date Title
DK151338B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF RACEMIC OR OPTICALLY ACTIVE PENICILLIN OR CEPHALOSPORINES
US4297488A (en) 7-α-Methoxy cephalosporins
LU83650A1 (en) NOVEL CEPHALOSPORINS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
CZ6493A3 (en) Process for preparing cephalosporin derivatives and pharmaceutical preparations in which they are comprised
EP0009008A2 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
IE76147B1 (en) Beta-Lactames
CH617703A5 (en) Process for the preparation of the syn-isomer or of a mixture of syn- and anti-isomers of novel antibiotically active 7 beta -acylamino-ceph-3-em-4-carboxylic acids
NO780074L (en) METHOD OF PREPARING 7-ACYLAMIDO-3-CEFEM-4-CARBOXYLIC DERIVATIVES
DK145262B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF CEPHALOSPORANIC ACID DERIVATIVES AND ESTERS AND SALTS THEREOF
NO903112L (en) PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED VINYL CEPHALOSPORINE DERIVATIVES.
DK160313B (en) 7-AMINOCEPHALOSPORINE DERIVATIVES FOR USE AS INTERMEDIATE FOR THE PRODUCTION OF CEPHALOSPORINE DERIVATIVES
DE2945248A1 (en) CEPHEM COMPOUNDS, METHOD FOR THEIR PRODUCTION AND ANTIBACTERIAL PHARMACEUTICAL AGENTS CONTAINING THE SAME
US4061748A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4374134A (en) Cephalosporin compounds with terminal aminocarboxylic acid groupings and anti-bacterial use thereof
US4247548A (en) 7α-Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity
KR870002181B1 (en) Process for preparing cephalosporins
GB2300856A (en) Beta-lactam preparation
DK164169B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 7-ALFA METHOXYCEPHALOSPORINES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF AND AN INTERMEDIATE USE FOR USE THEREOF
NL193660C (en) Novel penam derivatives and salts thereof and antibacterial agent containing such a compound.
NO162470B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ESTERS OF 7BETA- (2- (2-AMINO-TIAZOL-4-YL) ACETAMIDO) -3 - ((1- (2-DIMETYLAMINO-ETHYL) -1H-TETRAZOL-5-YL) ) thio) methyl) ceph-3-em-4-carboxylic acid.
EP0043205B1 (en) Penicillin derivatives
US4338437A (en) Cephalosporin antibiotics
US4160829A (en) Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins
GB2105329A (en) Penem-3-carboxylic acid derivatives their preparation and their use as antimicrobial agents
HUT55789A (en) Process for producing new penicillin derivatives and pharmaceutical compositions containing them as active components

Legal Events

Date Code Title Description
PUP Patent expired